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“Physically speaking, we humans are rather 
unimpressive specimens, as organisms go….We have come to 
dominate the earth only by grace of one rather important 
specialization – the brain” 
- Isaac Asimov 
 
 
 “Recent studies like those of Pearson in England, Mach 
in Germany, and Henri Poincaré in France, agree rather with 
Hume than with Kant: all science, even the most rigorous 
mathematics, is relative in its truth. Science itself is not worried 
about the matter; a high degree of probability contents it.” 
- Will Durant 
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copyright holders and where information has been derived from other sources, it has 
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Abstract 
BACKGROUND: Alzheimer's disease (AD) is characterised by initial episodic 
amnesia followed by deficits in divided attention. Amnestic mild cognitive 
impairment (AMCI), considered prodromal for AD, is characterised by isolated 
amnesia but attentional deficits have also been observed. Amnesia in AD is 
ascribed to medial temporal lobe pathology; however, attention deficits are likely 
due to lesions in other areas that demonstrate early AD neuropathology e.g. 
prefrontal cortex and basal forebrain cholinergic system. These lesions could 
contribute to episodic amnesia and causes attention deficits in prodromal AD. 
Acetylcholinesterase inhibitor drugs are used as treatment in AD and their effects 
on memory and attention remain to be determined in AMCI.  
METHODS: Functional magnetic resonance imaging (fMRI) was used to study 
divided and selective attention, and verbal episodic memory in AMCI (n=20) by 
comparison to controls (n=10). AMCI were followed to identify those that 
progressed to AD. A controlled treatment trial was conducted to study the effects 
of the acetylcholinesterase inhibitor rivastigmine.  
RESULTS: The AMCI sample had a high rate of progression to AD (n=12). 
AMCI demonstrated slower reaction times and altered cortical activation during 
divided attention. Reaction times correlated inversely with default mode network 
activation. Cortical activation was altered during selective attention. Verbal 
amnesia was associated with semantic deficits that correlated with altered cortical 
activation. Rivastigmine improved reaction times on divided attention but did not 
affect memory. 
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CONCLUSIONS: Divided attention is impaired and selective attention processing 
altered in prodromal AD. Verbal amnesia appears partly related to executive failure. 
Furthermore, correlations between memory and attention deficits suggest that 
executive failure contributes to deficits across cognitive domains in prodromal AD. 
Activation changes in prodromal AD during memory and attention processing suggest 
impaired regulation and failure of cortical resources. Rivastigmine improves divided 
attention via enhanced cortical processing but it does not benefit verbal episodic 
memory. 
 
 
Key words: Alzheimer’s disease, amnestic mild cognitive impairment, episodic 
memory, divided attention, prefrontal cortex, executive functioning, rivastigmine, 
fMRI. 
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1. Introduction 
The aims of the work reported in this thesis were to study the neural correlates of 
verbal episodic memory, selective and divided attention, and drug treatment response 
in prodromal Alzheimer’s dementia (AD). We therefore employed functional 
magnetic resonance imaging (fMRI) to study these cognitive processes and 
acetylcholinesterase inhibitor (ACEI) treatment responses in patients with amnestic 
mild cognitive impairment (AMCI), a prodromal stage of AD. 
• Section 1.1 introduces AD and considers the merits and methods of identifying 
preclinical and prodromal AD. 
• Section 1.2 introduces AMCI and concludes with a discussion on the validity 
of considering AMCI as prodromal for AD. 
• Section 1.3 examines controversies in distinguishing AD and AMCI from 
normal ageing and theories accounting for cognitive decline in ageing are 
discussed.  
• In Section 1.4, episodic memory, the brain networks that underpin it and 
relevant neuropsychological concepts are introduced. This is followed by a 
discussion of episodic amnesia in AMCI and of findings from functional 
neuroimaging studies of verbal and picture encoding tasks. 
• Section 1.5 introduces attention by looking at relevant neuropsychological 
aspects and research findings in AMCI. This is followed by a discussion on 
the functional anatomy of attention in AMCI. 
• In Section 1.6, cognitive regulation is introduced by looking at the functional 
relationships between the central executive, basal forebrain cholinergic 
system, prefrontal cortex, brainstem locus coeruleus, memory and attention. 
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• Section 1.7 discusses the role of acetylcholine in attention and memory, 
acetylcholinesterase inhibitor treatment, and the status of acetylcholinesterase 
inhibitor treatment in AD and AMCI. 
 
1.1 Alzheimer’s dementia  
Alzheimer’s dementia is currently the leading cause of dementia, engendering huge 
personal and financial costs to individuals and society. This section summarises the 
epidemiology, clinical characterisation, aetiology and neuropathology of AD, with the 
aim of providing the necessary background on which the concept of AMCI as a high-
risk and often prodromal state for developing AD will be considered. 
 
1.1.1 Epidemiology and Clinical Characterisation. 
Dementia is characterised by acquired cognitive deficits sufficient to impair activities 
of daily living. Globally, more than 25 million people are affected by dementia and 
this is set to rise to 40 million by 2020, doubling in prevalence every 20 years (Ferri et 
al., 2005). The prevalence of dementia is 1% in individuals aged 60-64 years but it 
increases almost exponentially with age leading to a prevalence of more than 20% in 
people aged over 85 (Blennow et al., 2006).  AD remains the leading cause of 
dementia accounting for 50-60% of cases while other common causes of dementia 
include vascular pathology and diffuse Lewy body disease. AD is therefore common 
and the associated human and financial costs make it a major health problem.  Figure 
1.1 illustrates the predominance of AD as underlying dementia aetiology and also the 
relative prevalence of the high-risk states for developing AD. 
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The first symptom of AD is forgetfulness (amnesia) and this is followed by minor 
difficulties in everyday functioning (dyspraxia), speech (dysphasia), and object 
recognition (agnosia). AD is clinically characterised by an initial amnestic syndrome 
followed by the gradual emergence of deficits in other cognitive domains. Amnesia is 
usually followed by deficits in attention, then abstract reasoning, language and 
visuospatial ability (Grady et al., 1988; Hodges and Patterson, 1995). Progressive 
cognitive impairment causes functional and behavioural decline leading to severe 
disability and eventually death (McKhann et al., 1984). 
  
Figure 1. Dementia epidemiology and the high-risk states that contribute to AD. 
AD remains the leading cause of dementia followed by vascular and other causes; 
however, isolated neuropathology of any specific type occurs rarely and AD is most 
often accompanied by vascular neuropathology. AMCI represents the most prevalent 
identifiable high-risk group where prodromal AD can be studied and is associated 
with a 10 – 15 % annual conversion rate (Blennow et al., 2006; Petersen et al., 1999). 
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1.1.2 Aetiology and Neuropathology 
Although there is a wealth of information on AD, the aetiology of the sporadic form 
accounting for 99% of cases remains unclear. Risk factors for AD include ageing, 
decreased brain reserve, and factors associated with vascular disease including 
hypercholesterolemia, ischaemic heart disease, hypertension, obesity, smoking, 
atherosclerosis, and diabetes (Mayeux, 2003). It is unclear at this stage which of the 
risk factors contribute directly to the onset and progression of AD and which renders 
the brain more vulnerable to the effects of AD neuropathology thereby precipitating 
the clinical syndrome. The early onset familial form of AD is autosomal dominant and 
is caused by mutations in the genes for the amyloid precursor protein, presenilin 1 and 
2. Presenilin 1 mutations account for 60-70% of cases (Blennow et al., 2006).  
Genetic factors have been identified that play a role in the sporadic form of 
AD. An increased risk and earlier age of onset is found in carriers of the 
apolipoprotein Є4 (APOE4) allele (Farrer et al., 1997). The risk appears dose-
dependent with the lowest risk associated with no APOE4 allele whilst the risk is 3 
times higher in heterozygotes and 15 times higher in homozygotes for APOE4. The 
risk is also increased in first-degree relatives of those with sporadic late onset-AD 
(relative risk 3.2) (Fratiglioni et al., 1993). The frequency of APOE4 is double (47%) 
in familial late-onset cases of AD compared to the sporadic form thereby accounting 
for some but not all of these cases (Lannfelt et al., 1994). It therefore appears that 
there are still some undiscovered heritability factors accounting for the remainder of 
familial cases. 
 
The aetiology of the sporadic form of AD remains unclear and the three leading 
hypothesis are related to the typical neuropathological lesions namely amyloid or 
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senile plaques, neurofibrillary tangles and vascular lesions. We will look at each of 
them in turn. 
 
Amyloid 
The amyloid hypothesis of AD neuropathology proposes that extracellular 
accumulation of beta-amyloid peptide (Aβ), as both the soluble Aβ fibrils and 
insoluble Aβ plaques, contributes to neurotoxicity and disrupts neuronal functioning 
resulting in the clinical syndrome of AD (Hardy and Selkoe, 2002). This is supported 
by genetic studies, which indicate that familial types of AD relate to mutations of the 
amyloid precursor protein (precursor to Aβ) and the generating enzyme (presenilin). 
Further support comes from findings of early Aβ plaque formation in the trisomy of 
Down’s syndrome where an extra copy of the amyloid precursor protein gene is 
present, which may lead to increased protein production thereby increasing the 
substrate for Aβ (for a review see (Blennow et al., 2006)). 
 
Tauopathy 
On the other hand, recent neuropathological studies indicate tauopathy as the initial 
lesion in AD. Tauopathy is the hyperphosphorylation of microtubule-associated tau 
protein that results in intracellular accumulation of toxic tau and disassembly of 
microtubules leading to neurofibrillary tangle (NFT) formation. NFTs impair axonal 
transport and function. The earliest NFTs appear in the basal forebrain cholinergic 
system (BFCS), which is comprised of the nucleus basalis of Meynert, diagonal band 
of Broca and medial septal nucleus (Mesulam et al., 2004). The BFCS provides 
almost all cholinergic (acetylcholine) input to the cerebral cortex, entorhinal cortex, 
amygdala and hippocampus, the later being crucial for the formation of episodic 
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memory which is characteristically impaired in AD (Squire and Zola, 1996). NFT 
density and spread in entorhinal and hippocampal regions show inverse correlation 
with hippocampal volume and cognitive performance (MMSE scores) in AD (Jack et 
al., 2002). NFT density in the ventromedial temporal lobe (entorhinal cortex, 
hippocampus area CA1, amygdala and subiculum) and inferior parietal lobe 
distinguishes between normal, AMCI and AD subjects, and episodic memory 
(delayed word recall) shows significant negative correlation with the NFT counts in 
entorhinal cortex (r=-0.44) and hippocampus (r=-0.50) (Markesbery et al., 2006; 
Mitchell et al., 2002). NFT density and pre-tangle tau accumulation in nucleus basalis 
of Meynert neurones similarly distinguish these groups and correlates negatively with 
delayed word recall (Mesulam et al., 2004). There are therefore very significant 
associations between tauopathy in BFCS and medial temporal lobe (MTL) structures, 
episodic memory impairment and global cognitive functioning spanning the transition 
from normal ageing to AMCI and AD. These findings add weight to the claim the 
tauopathy is the leading neuropathological lesion in AD. Impaired cholinergic 
neurotransmission due to BFCS pathology and the strong associations between 
memory and cholinergic function provide the rationale for treating AD with 
compounds that prolong the effects of acetylcholine in synapses. Furthermore, the 
apparent gradual accumulation and presence of NFTs in the BFCS and the 
correlations with memory function provides the rationale for similar treatment in 
AMCI. 
Figure 1.2 shows extracellular neuritic plaques and intraneuronal tangles 
visible in the same slice demonstrating that these two pathological features co-occur 
in established AD. Neuritic plaques, also know as senile plaques, consist of a central 
extracellular core of amyloid surrounded by swollen abnormal neuroglia and 
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neurones. NFTs consist of intracellular paired helical filaments of tau protein that 
eventually occupies almost the entire cell volume. 
 
 
Figure 2. Neuritic plaques and neurofibrillary tangles in AD. 
The light microscopy preparation depicted above has been stained to reveal plaques 
and tangles in AD in the cerebral cortex. Aβ forms extracellular plaques surrounded 
by neuroglia. Tangles, formed of hyperphosphorelated tau, are visible intracellular in 
neurones (Blennow et al., 2006). Reproduced from The Lancet, with permission from 
Elsevier. 
 
Neurovascular pathology 
Strong associations exist between AD and neurovascular risk factors such as 
hypercholesterolemia, ischaemic heart disease, hypertension, obesity, smoking, 
atherosclerosis, and diabetes (Mayeux, 2003). Furthermore, ischaemic stress due to 
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cerebrovascular disease and hypotension results in increased amyloid precursor 
protein expression and Aβ deposition in the cerebral artery boundary zones that are 
most vulnerable to hypoxia. These findings have lead to the neurovascular hypothesis 
of AD (Jendroska et al., 1995). A recent study reported increased hippocampal Aβ 
deposition and apolipoprotein expression following MTL ischaemia related to nearby 
focal cerebral infarct in adults not meeting histopathological criteria for AD (Qi et al., 
2007). Ischaemia also increases the expression of pre-tangle tau epitomes in neurones 
and neuroglia in animal models and human brains after occlusive stroke events; 
however, NFTs have not been observed and this may be related to the degree and 
duration of hypoxia or activation of different chemical cascades (Uchihara et al., 
1995; Uchihara et al., 2000). These and similar studies have lead some authors to 
argue that cerebral hypoxia may play a pivotal role in AD (Castellani, 2007). 
 
 The respective contributions to the initiation and progression of AD from these three 
leading neuropathological processes have not been clearly established and all three 
appear together in cortical areas in established AD. Other possible neuropathological 
mechanisms include inflammatory and infectious agents. Neither NFT nor Aβ is 
specific to AD as the former also occurs in other neurodegenerative disorders and the 
latter in normal ageing. Recent studies of brain amyloid deposition indicate that not 
everyone with increased amyloid load progress to AD but that most individuals with 
AD have increased amyloid (Jack et al., 2009; Kemppainen et al., 2007). However, 
tauopathy with NFT formation causes dementia in the absence of amyloid in non-AD 
neurodegenerative disorders including fronto-temporal dementia, cortico-basal 
degeneration, Pick’s disease and progressive supranuclear palsy (Iqbal et al., 2005; 
Iqbal and Grundke-Iqbal, 2008). Furthermore, NFT density in the MTL lobes shows 
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inverse correlation with episodic memory performance in normal ageing, AMCI and 
AD, therefore apparently accounting for memory changes in all these states (Guillozet 
et al., 2003). The relevance of these findings to the work reported in this thesis, is that 
tauopathy appears to accumulate gradually in the BFCS and MTL and correlates with 
cognitive functioning thereby providing a neuropathological background for 
distinguishing different stages in the progression of AD and for acetylcholinesterase 
inhibitor treatment trials in predementia stages. In the following section, we discuss 
the necessity of early diagnosis and intervention in AD and the validity of AMCI as a 
prodromal stage of AD. 
 
1.1.3 Identifying Preclinical and Prodromal AD 
1.1.3.1 The case for reliable biomarkers in AD 
Identifying sensitive and specific biomarkers is essential in the fight against AD. The 
low efficacy of currently available treatments for AD drives the search for reliable 
preclinical biomarkers to aid the development of interventions that arrest disease 
progression early in the course of AD. Efforts to develop such disease arresting 
treatments are complicated by the lack of specific biomarkers and at present a 
neuropathological diagnosis of AD at autopsy remains the gold standard (McKhann et 
al., 1984). Even the gold standard has limitations as specificity is reduced by the 
presence of significant cerebrovascular disease in around 50% of clinically diagnosed, 
autopsy positive cases, and as few as 30% of AD cases have isolated AD 
neuropathology. Cerebrovascular disease is an important comorbid condition because 
it contributes to cognitive decline and dementia and its typical symptoms overlap with 
AD (Kalaria, 2002; Roman, 2003).  Ischaemic interruption of subcortical-prefrontal 
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circuits in cerebrovascular disease impairs executive control of working memory, 
attention, language, affect, motivation, and complex organisational and construction 
skills resulting in forgetfulness, changes in speech, affect and mood, similar to what 
can occur in AD (for a review see (Roman et al., 2002).  
The sensitivity of the neuropathological diagnosis for AD is also poor as 20-
40% of cognitively normal elderly cases are autopsy positive for AD. This highlights 
the current lack of understanding of the contributions made to the clinical presentation 
of AD by the two leading neuropathological lesions. These findings have lead to calls 
for the diagnostic criteria of AD to be revised and to include biomarkers (Blennow et 
al., 2006). Suggested biomarkers include structural neuroimaging (MTL volume), 
functional and molecular neuroimaging (positron emission tomography (PET) of 
cortical glucose metabolism and beta-amyloid) and cerebrospinal spinal fluid markers. 
Although these biomarkers may improve the sensitivity and specificity of diagnostic 
criteria for AD, the problem of identifying and quantifying the contributions from 
comorbid disorders remains. This in turn complicates the design of treatment studies, 
such as the work reported here, and limits the conclusions that can be drawn.  
 
1.1.3.2 Neuropathological disease progression in AD  
Preclinical and prodromal AD stages may exist because AD neuropathology appears 
to accumulate gradually thereby providing opportunities for early investigations and 
interventions. The functional brain changes and the progression of symptoms in AD 
could be ascribed to the presence and accumulation of AD neuropathology. This is 
supported by the strong inverse correlations between cognitive performance and 
neuropathology load (Arnold et al., 1991; Samuel et al., 1994; Terry and Katzman, 
2001). For example, the strong inverse correlation between dementia severity and 
 35 
synapse density in frontal cortex in autopsy confirmed AD suggests, by extrapolating 
backwards, that there is lesser but still significant reductions in synapse density in the 
prodromal and possibly preclinical stages. Further support for this comes from studies 
examining the basal forebrain cholinergic system (BFCS) where AD neuropathology 
seems to appear first. Autopsy studies have reported negative correlations between 
NFT density and pre-tangle tau accumulation in nucleus basalis of Meynert neurones 
and episodic memory (Mesulam et al., 2004). Similar negative correlation has been 
found between the low affinity p75 neurotrophin receptor (a marker of cholinergic 
neurones in the nucleus basalis) and measures of global cognition, working memory 
and attention in mild cognitive impairment and mild AD (Mufson et al., 2002). 
Furthermore, brain derived neurotrophic factor (important for nucleus basalis neurone 
survival) and its precursor (proBDNF) are reduced in the cortex of patients with MCI 
and AD, leading to their conclusion that “from a neurotrophic pathobiologic 
perspective, MCI is already early AD” (Mufson et al., 2007).  
Taken together these results appear to indicate that AD is preceded by a 
preclinical phase where cognitive functioning appears normal but functional brain 
activation is altered due to accumulating AD neuropathology. 
 
1.1.3.3 The role of functional neuroimaging in studying prodromal AD 
Functional neuroimaging may aid in identifying and studying prodromal AD. 
Neuropathology accumulates gradually over many years in AD and functional 
neuroimaging has been used to determine if brain metabolism is altered in the 
preclinical phase of AD (Braak and Braak, 1997; Ohm et al., 1995). The potential for 
functional neuroimaging to reveal brain changes that precede the onset of symptoms 
is based on findings of altered activation in the face of maintained behavioural 
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performance in disease states and normal ageing (Becker et al., 1996; Jaeggi et al., 
2007; Reuter-Lorenz et al., 2001). Less efficient cortical processing is associated with 
increased and/or decreased activation in task related cortical areas and with altered 
activation in functionally connected areas.  Decreased activation in task related areas 
is thought to indicate less efficient processing whilst increased activation reflects 
reallocation of neural resources, functional reorganisation (where new areas take on 
the role of diseased areas), or deployment of alternative cognitive strategies (Han et 
al., 2009). Greater activation in task related areas, correlating with better performance, 
have been reported in several studies of normal adults. In healthy older adults, there is 
a shift from lateralised towards bilateral activation and this is often associated with 
better performance. These findings form the basis of the “Hemispheric asymmetry 
reduction in older adults” or HAROLD model (Cabeza, 2002). A study specifically 
designed to examine the causes of additional activation in contralateral areas was 
conducted using older adults who were matched on memory task performance by 
varying the number of words in a list that had to be encoded in order to achieve 75% 
accuracy. The task was parameterised and increased activation, in line with 
predictions based on the HAROLD model, was found during the more difficult 
condition, leading the authors to concluded that increased activation in additional 
areas was related to extra attentional and monitoring demands required for superior 
performance (Anderson et al., 2002). 
 
Taken together, these findings indicate that functional neuroimaging can be used to 
demonstrate compensatory functional brain changes associated with maintained 
behavioural performance and activation changes associated with behavioural deficits. 
These methods therefore appear potentially useful in studying populations at high-risk 
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for diseases and disorders that have a long preclinical and/or prodromal stage, such as 
AD, where brain function is compromised but performance maintained preclinically 
due to automatic compensatory functions. We next look at the results from functional 
neuroimaging studies in high-risk, asymptomatic AD groups. 
 
1.1.3.4 Functional neuroimaging studies of high-risk states for AD 
Functional neuroimaging studies have been conducted on cognitively healthy middle-
age adults at increased genetic risk of AD in order to look for evidence of 
compensatory brain activation that may indicate the presence of early pathology. 
Subjects at risk by virtue of a positive family history of AD (at least one first-degree 
relative with clinical AD) and APOE4 status (at least one APOE4 allele) 
demonstrated reduced activation in mid- and posterior inferior temporal areas during 
the recall of items from both working and long-term memory whilst still matching the 
performance of controls (Smith et al., 1999). The authors suggested that attenuated 
activation in task related areas was the consequence of local or distant neuropathology 
that reduced neural inputs to these areas. In contrast, greater extent and magnitude of 
activation in left hippocampal, parietal and prefrontal areas were reported in a similar 
high-risk group (APOE4 carriers) during the encoding of word pairs (Bookheimer et 
al., 2000). The authors concluded that the additional activation most likely reflects 
compensatory recruitment of extra neurones or increased firing rates of neurones 
required to match the performance of controls. This conclusion accords with the 
neural efficiency hypothesis, which posits that cortical activation correlates inversely 
with experience and cortical specialisation on a given task, and the findings therefore 
imply failing resources and/or loss of specialisation in the high-risk group (Haier et 
al., 1988; Neubauer and Fink, 2009). A recent large cross sectional study examined 
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the contributions of first-degree family history of AD and APOE4 carrier status on 
brain activation during encoding in middle aged adults (Johnson et al., 2006b). 
Activation was reduced in the MTL in APOE4 carriers without a family history and 
further reduced in carriers with a positive family history. The authors suggest that a 
yet unidentified inheritance factor contributes to the effects of APOE4 on brain 
activation during encoding. The findings from these studies in middle-aged 
cognitively healthy but high-risk groups reveal altered cortical activation when 
matching the performance of controls. This suggests that cortical resources may 
already be affected by early neuropathology in the preclinical stages of AD resulting 
in compensatory efforts in the face of failing resources. The findings of increased and 
decreased activation also highlights the fact that changes in regional brain activity 
should preferably be correlated with behavioural measures because our current 
understanding allows only limited interpretation of activation changes in isolation. 
Studies in older adults have also been conducted with similar findings. A large 
cross sectional study of asymptomatic offspring of autopsy confirmed, late-onset 
familial AD cases (n=95, age range 50-75 years) demonstrated greater activation in 
frontal and temporal cortex during a memory encoding task compared to age matched 
controls (n=90) (Bassett et al., 2006). These findings occurred independently of 
APOE4 status. The effects of APOE4 carrier status on brain activation in older adults 
were demonstrated by a study comparing groups with (n=10) and without (n=10) 
APOE4. Similar findings of increased brain activation during memory encoding were 
reported, suggesting that the influence of APOE4 on activation appeared independent 
of age-related memory deficits or atrophy (Bondi et al., 2005). 
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The findings from these studies in cognitively healthy middle-aged and older 
adults appear to indicate that functional brain changes precede the symptomatic 
expression of AD.  
 
1.1.3.5 Prodromal syndromes in the study of disease progression 
Clinical syndromes, consisting of hallmark or characteristic initial symptoms of the 
disorder or disease of interest, are frequently used to diagnose and study prodromal 
disease stages. Interest in the transition between normal ageing and dementia has 
increased and so has the number of suggested prodromal syndromes spanning this 
gap. In the presence of underlying disease, normal cognitive functioning may initially 
be followed by subjective cognitive impairment where early neuropathology is 
overcome by compensatory mechanisms resulting in maintained cognitive function 
but increased cognitive effort (Rodda et al., 2009). This may in turn be followed by 
the onset of the first objective symptoms such as episodic amnesia, thereby meeting 
the criteria for a diagnosis of amnestic mild cognitive impairment (AMCI) which is 
discuss in detail in the following section (§1.2). Subjective cognitive impairment is 
likely to be more heterogeneous than AMCI but both are predictors of late-onset AD 
(Heun et al., 2006b; van Oijen et al., 2007). 
Prodromal stages have also been used to study other neuropsychiatric 
disorders including schizophrenia where a prodromal stage signified by psychosis has 
been identified. The use of structured interviews to identify high-risk individuals 
results in high inter-rater reliability and accuracy for distinguishing schizophrenia 
from relevant differential diagnoses and from controls. High-risk subjects identified 
with these methods have conversion rates of around 50% at one-year follow-up 
(Miller et al., 2002; Woods et al., 2009; Woods et al., 2001). Functional neuroimaging 
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studies of such high-risk groups have demonstrated deficits in frontotemporal 
connectivity similar to that found in schizophrenia (Broome et al., 2009; Crossley et 
al., 2009). Functional neuroimaging has also been used to study the effects of atypical 
antipsychotic medication in a high-risk group. Treatment effects were found in task 
related cortical areas, thereby demonstrating the potential of these methods to study 
the cortical effects of pharmacological interventions (Fusar-Poli et al., 2007). It is 
therefore apparent that both prodromal stages and treatment responses can be 
examined using functional neuroimaging. In this thesis, similar methodology was 
employed to identify and study AMCI as prodromal for AD. 
 
Summary 
AD neuropathology accumulates gradually and appears to affect cortical processing in 
preclinical and prodromal stages. High-risk asymptomatic stages are associated with 
altered brain activation changes as demonstrated by functional neuroimaging. Altered 
brain activation in these high-risk stages is likely related to failing resources, damaged 
by AD neuropathology, and to compensatory efforts that maintain cognitive 
performance. Studying brain activation in high-risk populations can improve our 
understanding of disease progression in AD and may reveal the effects of treatment 
on brain function. These approaches are necessary, as our current understanding of 
AD has not enabled the development of satisfactory preventative, curative or 
symptomatic treatments. In the next section, we consider the validity of AMCI as a 
high-risk and prodromal stage of AD. 
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1.2 Amnestic Mild Cognitive Impairment 
The mild symptomatic phase of AD that precedes the fully developed dementia 
syndrome, with implicit loss of personal autonomy, does not have any official clinical 
standing (Dubois and Albert, 2004). Amnestic mild cognitive impairment (AMCI) has 
emerged as one of the syndromes that span the gap between normal ageing and AD. 
AMCI diagnosed with sufficient clinical rigor can be highly predictive of AD. It is a 
refinement of mild cognitive impairment (MCI) which was initially conceived to span 
the gap between normal ageing and dementia in general (Flicker et al., 1991). In this 
section, we consider the construct validity of AMCI as prodromal AD by examining 
its epidemiology, clinical characterisation and neuropathology. 
 
1.2.1 Clinical Characterisation and Epidemiology 
AMCI denotes a prodromal stage of AD and it has been used to study disease 
progression in AD as it represents a high-risk state for conversion to AD. It stands to 
reason that the clinical utility of identifying a prodromal disease stage is in allowing 
early intervention, and the accuracy with which a prodromal stage is identified and 
distinguished from other confounding disorders depends on the sensitivity and 
specificity of the disease markers employed. AMCI thought to be prodromal for AD 
has recently been further refined to AMCI-single domain, which is characterised by 
isolated episodic memory impairment in the absence of other obvious cognitive or 
behavioural deficits and not related to pre-existing physical or emotional disorders. 
The current most widely used diagnostic criteria for AMCI include: 
1. Memory complaint corroborated by an informant. 
2. Objective memory impairment for age. 
3. Essentially preserved general cognitive function. 
 42 
4. Largely intact functional activities. 
5. Not meeting criteria for dementia (Petersen, 2004).  
Several further clarifications in conjunction with these criteria have been suggested to 
improve the construct validity of MCI as prodromal for dementia (Werner and 
Korczyn, 2008). These additional clarifications appear equally important in 
improving the construct validity of AMCI as prodromal AD. First, other causes of 
cognitive impairment such as vitamin B12 deficiency should be excluded along with 
dementia per se, as mentioned in the criteria. Second, the cognitive impairment 
should be of recent onset in order to exclude impairments associated with brain 
trauma and mental retardation. Third, it should be made clear to those diagnosed with 
AMCI that, although they are at high-risk of progressing to dementia, it is not a 
certainty. The first two additional clarifications were already incorporated into 
suggested criteria for identifying MCI that progress to AD (Dubois and Albert, 
2004). 
The other subtypes of AMCI include AMCI-multiple domains, non-AMCI-
single domain and non-AMCI-multiple domains; each subtype respectively considered 
a prodromal stage for AD or vascular dementia; dementia with Lewy bodies or 
frontotemporal dementia; dementia with Lewy bodies or vascular dementia (Petersen, 
2004). These were previously included under MCI and explains the aetiological 
heterogeneity of MCI. 
AMCI appears to represent a high-risk and prodromal state for AD with a 10-
15% annual conversion rate compared to 1-2% in healthy elderly. The most 
compelling argument for AMCI as a high-risk prodromal state comes from 
longitudinal studies which report a 80% dementia conversion rate after 6 years of 
follow-up (Fischer et al., 2007; Ganguli et al., 2004; Petersen, 2004; Petersen et al., 
 43 
2001; Petersen et al., 1999). Despite this high conversion rate, not all AMCI patients 
convert but it appears to be a reliable and prevalent risk indicator (Fischer et al., 
2007). 
The prevalence for AMCI varies between 3% and 19% in individuals aged 
over 65. Not surprisingly, higher prevalence rates have often been reported in cross-
sectional studies, where AMCI had been diagnosed after interview and examination, 
compared to cohort studies where criteria had been applied retrospectively to data 
collected from general questionnaires and cognitive tests (Ganguli et al., 2004; 
Gauthier et al., 2006; Gavrila et al., 2009; Low et al., 2004). Taken together, available 
findings on AMCI indicate a high prevalence rate, particularly in clinical populations, 
and a high dementia conversion rate, suggesting that sensitive and specific diagnostic 
methods could identify a group that may in future benefit from disease specific 
interventions. 
 
1.2.2 AD Neuropathology in AMCI 
Available evidence strongly suggests that AD neuropathology accumulates gradually 
for many years prior to the onset of the clinical syndrome and this provides an 
opportunity to identify, study and treat preclinical and prodromal stages. AD is 
neuropathologically characterised by numerous amyloid (neuritic) plaques and NFTs 
in the cerebral cortex, hippocampus, amygdala, nucleus basalis, locus coeruleus and 
hypothalamus (Markesbery et al., 2006). These changes are accompanied by 
substantial neuronal loss and subsequent cortical atrophy. NFTs and plaques also 
occur in normal ageing; however, findings from combined neuropathological and 
structural neuroimaging studies in health and AD indicate that neuropathological 
measures (NFT density and spread in entorhinal and hippocampal regions) correlate 
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inversely with hippocampal volume (r=-0.6) and cognitive performance (MMSE; -
0.7) in AD but not in normal ageing (Jack et al., 2002). These neuropathological 
markers therefore suggest that AD is qualitatively different from normal ageing and 
not associated with hippocampal atrophy. Furthermore, the correlations indicate a 
gradual accumulation of AD neuropathology and this suggests that a prodromal AD 
stage will exist where the pathological load is lower and the clinical syndrome less 
pronounced. 
Complaints of forgetfulness and the presence of episodic amnesia make AMCI 
clinically suggestive of prodromal AD. The notion that AMCI is in fact prodromal 
AD is supported by reports of inverse correlations between cognitive performance and 
NFT densities in medial temporal lobe (MTL) areas where AD neuropathology first 
appears (nucleus basalis of Meynert, entorhinal area). Inverse correlations between 
MTL NFT densities and episodic memory performance has been demonstrated in 
normal ageing, AMCI and AD (Guillozet et al., 2003). Furthermore, NFT densities in 
the ventromedial temporal lobe (entorhinal cortex, hippocampus area CA1, amygdala 
and subiculum) and inferior parietal lobe distinguished between normal ageing, 
AMCI and AD, and episodic memory (delayed word recall) correlated inversely with 
NFT density in entorhinal cortex (r=-0.44) and hippocampus (r=-0.50) (Markesbery et 
al., 2006; Mitchell et al., 2002). In nucleus basalis of Meynert neurones, NFT 
densities and pre-tangle tau accumulation similarly distinguished between normal 
ageing, AMCI and AD, and also correlated negatively with delayed word recall 
(Mesulam et al., 2004). There are therefore consistent reports of inverse correlations 
between NFT densities in the MTL and cognition that distinguish normal ageing from 
AMCI and AD, indicating that AMCI differs from AD quantitatively but not 
qualitatively in this area. 
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Neuropathological changes have also been demonstrated in cortical areas 
outside the hippocampal and basal forebrain areas in AMCI. Increased amyloid 
plaques are evident in the frontal, temporal, inferior parietal lobe, posterior cingulate 
gyrus, and amygdala, and increased NFTs are evident in temporal lobes (temporal 
pole, inferior temporal gyrus, fusiform gyrus), dorsolateral prefrontal cortex 
(DLPFC), orbitofrontal cortex, parietal cortex, amygdala and entorhinal cortex 
(Guillozet et al., 2003; Markesbery et al., 2006). Areas containing AD neuropathology 
in AMCI largely overlap with areas of cortical atrophy as demonstrated by volumetric 
studies. These areas include the, hippocampus, amygdala, parahippocampal gyrus 
(entorhinal area), fusiform gyrus, medial frontal areas, lateral temporal areas, 
posterior cingulate and precuneus (for a review see (Ries et al., 2008). A prospective 
cohort study of AMCI patients (n=34) who progressed to clinically diagnosed AD 
demonstrated neuropathological AD in 71% of cases (Jicha et al., 2006). Secondary 
pathologies thought to contribute to the diagnosis were also present (vascular lesion in 
33%; Lewy bodies in 25%). Further evidence supporting the gradual emergence of 
AD neuropathology and the notion that AMCI is prodromal AD comes from 
neuroimaging studies. 
A positron emission tomography (PET) study using a ligand that binds to 
amyloid and NFTs in vitro found that average binding in temporal, parietal, frontal 
and posterior cingulated areas distinguished between healthy ageing, AMCI and AD 
(Small et al., 2006). Furthermore, PET binding showed a similar amyloid and NFT 
distribution pattern in AMCI as seen in AD. Regional NFT involvement correlates 
well with behavioural impairment across the spectrum of healthy controls to AMCI to 
AD, whilst the amyloid load in AMCI is more similar to controls than AD (Petersen et 
al., 2006). This suggests that the ligand binding distribution pattern found in AMCI by 
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Small et al. is due to binding with NFTs rather than amyloid. Nevertheless, these 
findings reveal a consistent pattern of graded neuropathology proceeding from normal 
ageing to AMCI and AD, supporting the notion that AD neuropathology emerges 
gradually and that a prodromal and even preclinical stage may be identified.  
In summary, the neuropathology in AMCI is qualitatively similar to that seen 
in AD and quantitatively somewhere between normal ageing and AD. Furthermore, 
the neuropathology affects areas crucial for memory processing, thereby explaining 
the high predictive value of episodic memory tests in dementia progression. In the 
next section, memory and other measures that predict progression to dementia are 
discussed.  
 
1.2.3 AMCI Represents Prodromal AD 
Prodrome is defined as “an early sign of a developing condition” or as “the earliest 
phase of a developing condition or disease” (Mosby, 2009). AMCI appears 
prodromal for AD because of its clinical and neuropathological characteristics, and 
due to the predictive value of neurocognitive, CSF and structural brain imaging 
biomarkers in AMCI. 
The clinical phenotype of AMCI mirrors that of mild AD which presents with 
prominent episodic amnesia, measurable deficits in other domains and everyday 
activities, and progressive cognitive and functional decline (Morris, 2006). 
Furthermore, in well defined clinical samples, where AMCI is diagnosed using 
operationalised criteria and norm-based cognitive testing, more than 90% have AD 
confirmed at autopsy, with or without comorbid pathology (Storandt et al., 2006). It 
appears that ensuring high construct validity for AMCI as prodromal AD depends on 
specialist clinical settings that employ objective neurocognitive measures and 
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operationalised diagnostic criteria. However, even pre-clinical AD could potentially 
be identified based solely on a history of progressive episodic amnesia. A longitudinal 
study of individuals with informant corroborated complaints of progressively 
deteriorating memory, who were unimpaired on norm-based cognitive testing, found 
high conversion rates (91%) to neuropathologically confirmed AD and the mean 
duration of progression to AD was twice as long as in AMCI (Storandt et al., 2006). 
These findings indicate that sensitive neuropsychological measures and detailed 
symptomatic history can identify prodromal AD. 
AD conversion rates in AMCI samples vary between clinic (10%-15% per 
year) and community (3.8% to 4.6% per year) based cohorts and the variation appears 
related to more advanced disease in clinical cohorts as evident from more pronounced 
everyday activity deficits (Farias et al., 2009). Impairment in everyday activities may 
be a motivating factor for seeking help resulting in referral. Although these 
impairments are subtle and not severe enough to indicate dementia, they nevertheless 
indicate a high risk of progression to dementia. 
AMCI is characterised by episodic memory impairment which, if measured by 
delayed recall of spoken words or narrative, appears to be one of the most sensitive 
neuropsychological predictors of progression from normal ageing and AMCI to AD 
(Artero et al., 2003; Backman et al., 2001; Sarazin et al., 2007; Tierney et al., 1996; 
Tierney et al., 2005). Results from studies examining the predictive potential of 
delayed verbal recall measures compared to structural neuroimaging and 
cerebrospinal fluid (CSF) biomarkers for AD are summarised in Table 1 (Decarli et 
al., 2007; Hansson et al., 2006; Korf et al., 2004). It is apparent that both 
neuropsychological measures and other special investigations can have satisfactory 
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sensitivity and specificity and that combination of these measures further improves 
diagnostic validity. 
Study Measures  Se  Sp Follow-up 
duration 
n Conversio
n rate 
Sampling 
characteristic 
Artero  
et al. 
2003 
-Delayed 
verbal recall 
-Construction 
-Category 
fluency 
73 99 2 year 127 30% Symptomatic 
memory 
complaint 
Tierney 
et al. 
2005 
-Delayed 
verbal recall 
-Animal 
fluency 
-Information 
74 83 5 years 551 14% Modified 
MMSE score 
Sarazin 
et al. 
2007 
-Delayed 
verbal recall 
80 90 3 years 251 24% MCI 
 
Hansson 
et al. 
2006 
-CSF total tau  
-CSF beta 
amyloid-42 
95 83 4 to 6 years 137 42% MCI 
Korf et 
al. 2004 
-Quantitative 
MTL atrophy 
70* 68* 3 years 75 49% MCI 
DeCarli 
et al. 
2007 
-Qualitative 
MTL atrophy 
51 69 3 years 187 34% MCI 
Table 1. Sensitivity and specificity of delayed verbal recall, structural imaging 
and CSF biomarkers for AD. 
Se=sensitivity; Sp=specificity; n=number of AMCI enrolled at baseline. *=Sensitivity 
and specificity calculated for all types of dementia which included 8% vascular 
dementia cases. 
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Combining CSF markers with regional cerebral blood flow measures can also deliver 
highly predictive models (hazard ratio = 24), but this combines two highly specialist 
procedures which currently limits its clinical use (Hansson et al., 2009). Nevertheless, 
such specialist measures may become useful in future when disease specific 
treatments become available that arrest AD progression. 
 
Some authors have argued that AMCI diagnosed in specialist memory clinics settings 
using sensitive episodic memory tests, is sensitive and specific enough to consider it 
prodromal AD (Dubois and Albert, 2004; Morris, 2006). This is supported by the 
neuropathological findings discussed above which indicate that the lesions are 
qualitatively similar and quantitatively somewhere between normal ageing and AD. 
Inclusion of the best progression predictors in diagnostic criteria for AMCI has further 
advanced the concept of AMCI as prodromal AD. These criteria are: 
1. Memory complaints made by the patient or the family. 
2. Progressive onset. 
3. Normal or mildly impaired complex activities of daily living. 
4. Amnestic syndrome of the “hippocampal type” defined by: 
a. Very poor free recall despite adequate (controlled) encoding; 
b. Decreased total recall because of insufficient effect of cueing or 
recognition; 
c. Numerous intrusions. 
5. Persistence of memory changes at subsequent assessment. 
6. Absence of fully developed dementia syndrome. 
7. Exclusion of other disorders that may cause AMCI, with adequate tests, 
including neuroimaging and biomarkers (Dubois and Albert, 2004). 
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The combination of criteria 2 and 5 can overcome the concern raised by some 
critics of AMCI that memory impairment identified as deviations from norms (1.5 
SD) is insufficient for it is not person specific (Werner and Korczyn, 2008). However, 
demonstrating the persistence of amnesia requires repeated measures and the ideal 
follow-up interval remains to be determined. Furthermore, this approach could attract 
criticism from the point of view that valuable treatment opportunities may be missed 
due to the delay. The efficacy and adverse effects of future treatments will determine 
the relevance of either viewpoint. 
The criteria listed above are similar to what we adopted in our memory clinic 
and for this study to diagnose AMCI (§3.4). We required the increased diagnostic 
accuracy achieved by these criteria due to the relatively small sample size - more 
vulnerable to the adverse affects of heterogeneous aetiology –as required for fMRI 
studies as reported on in his thesis. The benefits of studying smaller samples with 
fMRI are offset by the potential confounds of heterogeneity introduced by unreliable 
diagnostic tools and poor sampling procedures. Accurate diagnosis of AMCI that is 
highly predictive of AD is therefore essential and we seem to have accomplished this 
as illustrated by the high AD conversion rate in our sample (§4.1). 
Apart from the episodic memory tests mentioned, two other measures are also 
good predictors of conversion to AD from AMCI; (1) CSF concentrations of tau and 
Aβ, and (2) quantitative and qualitative estimates of MTL atrophy (Table 1). 
Nevertheless, utilising neuropsychological measures to predict AD has several 
advantages over CSF and structural neuroimaging; they are affordable, portable and 
require relatively low levels of expertise to administer. 
It should be noted, the measures of delayed verbal recall used for the work 
reported on in this thesis, and those included above (Table 1), are more sensitive than 
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standard measures such as the MMSE used in general psychiatric and neurological 
practice. The increased sensitivity of these measures is due to specific design 
elements. For example, the Free and Cued Selective Reminding Test used in the study 
by Sarazin et al. 2007 controls attentional and semantic processing during learning 
and is therefore robust against confounding effects of age-related changes in cognitive 
processing (Grober et al., 2009). The stimuli for encoding on this test are pictures of 
common objects presented in sets of four on a card. Subjects are asked to point and 
name an object following a cue during the learning phase. For example, the subject 
will point to and name “grapes” following the cue “fruit”. This procedure ensures that 
all participants achieve a basic level of semantic elaboration and attentional focus that 
minimises possible confounding effects of impairments in these domains. The New 
Learning subscale from the Cambridge Cognitive Examination (CAMCOG), that we 
used to verify episodic memory impairment in our sample of AMCI, similarly 
controls for attention but not for semantic processing. It does however include both 
free recall and recognition and population norms are available (Huppert et al., 1995). 
The inclusion of recognition recall is relevant in our sample for it appears more 
sensitive at distinguishing AMCI from normal ageing (Anderson et al., 2008; Bennett 
et al., 2006; Westerberg et al., 2006). Combining two verbal learning tasks (Wechsler 
Memory Scale-III Logical Memory Test, California Verbal Learning Test-II) 
increases sensitivity (92%) and specificity (95%) and can accurately predict 
progression from AMCI to AD in 88% of cases (Rabin et al., 2009). Verbal learning 
tasks are therefore sensitive, specific and practical measures for identifying 
progressive AMCI. 
Taken together, the findings from the studies discussed above indicate that 
accurate prediction of progression from AMCI to AD is possible and that tests of 
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delayed verbal recall are probably the most practical. Furthermore, the high degree of 
similarity between the neurocognitive measures and diagnostic criteria discussed 
above and our methods, suggest that our AMCI patients are prodromal for AD and 
this is supported by their high AD conversion rate. 
  
Summary 
The evidence presented in this section demonstrates that AMCI is neuropathologically 
qualitatively similar but less severe than AD. Furthermore, AMCI can be 
distinguished from normal ageing and AD in clinical populations with high inter-rater 
reliability when combinations of standardised and sensitive methods are used. Taken 
together these findings indicate that AMCI can be considered prodromal AD when 
specific methods are used. The prevalence of AMCI remains high when such methods 
are used rendering AMCI practical for studying prodromal AD. The similarities 
between the diagnostic methods with high predictive value described above and those 
we used to identify our sample suggest that we can confidently consider our sample of 
AMCI as prodromal for AD.  Nevertheless, it does not necessarily indicate isolated 
AD neuropathology and anyone diagnosed with AMCI is likely to have comorbid 
cerebrovascular disease as is the case for clinically diagnosed AD and other 
neurodegenerative disorders. Some authors have argued that AD and AMCI are 
extreme presentations of normal cognitive ageing, undermining the construct validity 
of AD. Several flaws are apparent in this argument; nevertheless, a discussion of the 
relevant findings will inform the interpretation of our results and follows in the next 
section. 
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1.3 AMCI, AD and Ageing 
There is considerable overlap between ageing, AMCI and mild AD. Normal ageing is 
associated with modest cognitive decline evident on everyday tasks and on 
neuropsychological testing. In addition, AD neuropathology (neuritic plaques and 
NFTs) is evident to a minor degree in the brains of older adults considered cognitively 
normal. These two findings have raised doubts over the status of AD as a disease and 
it has been proposed that AD is accelerated ageing (Anderton, 1997; Anderton, 
2002). Conversely, it can be argued that cognitively normal older adults with AD 
neuropathology are in fact suffering from preclinical AD by virtue of the presence of 
diagnostic markers, and this introduces the notion that ageing is disease related. This 
is a key point because society treats ageing as a disease as illustrated by the 
substantial research efforts that have gone into treating ageing (Butler et al., 2008). 
Ageing is associated with progressive loss of neocortical synapses and it has 
been suggested that even in the absence of concomitant AD neuropathology a critical 
limit of 60% synapses loss will be reached by the age of 130 years, thereby making 
dementia the inevitable outcome of ageing even in the absence of any distinct 
neuropathology (Terry and Katzman, 2001). However, this dementia is likely to be 
clinically distinct from AD that has a predilection for affecting certain areas that 
translates into specific symptoms (§1.1.3.2; 1.2.2) 
These findings and views constitute the main controversies of the accelerated 
ageing debate. This section examines the relevant evidence on the accelerated ageing 
hypothesis by defining the terminology, comparing the causes of ageing and AD and 
by looking at the structural and neuropsychological similarities and differences. Age 
related cognitive changes that have bearing on our findings are also discussed. 
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1.3.1 Defining Normal, Ageing and Disease 
Normal is defined as “occurring naturally and not because of disease, inoculation, or 
any experimental treatment” (Merriam, 2002). Ageing is the accumulation of changes 
to an individual over time due to environmental and genetic factors. Disease is 
defined as “an impairment of the normal state of the living animal or plant body or 
one of its parts that interrupts or modifies the performance of the vital functions, is 
typically manifested by distinguishing signs and symptoms, and is a response to 
environmental factors (as malnutrition, industrial hazards, or climate), to specific 
infective agents (as worms, bacteria, or viruses), to inherent defects of the organism 
(as genetic anomalies), or to combinations of these factors” (Merriam, 2002). This 
definition includes the term normal, which is defined in terms of naturally occurring 
events, and this introduces a contradiction because disease appears to affect all known 
living organisms and is therefore thoroughly natural. Both AD and healthy ageing can 
therefore be considered as normal because both appear naturally. Conversely, the 
current and historic attempts to find a cure for ageing demonstrate that society has 
long regarded ageing as a disease, similar to AD, and continues to do so. Neither 
society nor prevailing definitions therefore clearly distinguish ageing and AD. Debate 
about the difference between aging and disease has a long history and continues in the 
literature (for reviews see (Butler et al., 2008; Carnes and Olshansky, 2007). We next 
look at the aetiology of ageing and AD to see if they can be differentiated on this 
basis. 
 
1.3.2 The Aetiology of Ageing and AD 
Cellular ageing occurs when cellular division fails, which in humans appears 
predominantly related to the shortening of telomeres (Blackburn, 2001; Blasco, 2005; 
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Collins and Mitchell, 2002). Telomeres occur at the ends of chromosomal DNA 
chains and consist of repetitive DNA sequences that protect the chromosome from 
accidental enzymatic destruction and recombination. When cells without the enzyme 
that maintains the length of telomeres (telomerase) replicate, they gradually lose 
telomeric length and eventually stop dividing. Furthermore, the length of telomeres is 
maintained in cells that appear immortal. Ageing of an organism occurs when 
damaged tissue can no longer be replaced because cell division has failed. Ageing 
effects are not uniform in individuals of a species and are not inevitable for all living 
organisms as numerous species show negligible ageing effects. These and other 
findings suggesting contributions from other mechanisms of aging raise the possibility 
that ageing is a disease, apparently partly genetic. 
 Cellular ageing could affect brain function. There is comparatively little 
neuronal proliferation evident in the adult brain although it does occur, in particular in 
the hippocampus. Nevertheless, there is proliferation of neuroglia that support 
neurones directly and neurotransmission indirectly; neurones are dependent on 
neuroglia (astrocytes) for the energy essential for neurotransmission. Impaired 
neuroglial proliferation can affect their support of neurones and neurotransmission 
and can therefore influence cognition. There is also microglial (central nervous 
system immune cells) proliferation in the normal brain. Microglia defend the brain 
against infection and play a role clearing away amyloid and in supporting or 
destroying injured neurones (Lucin and Wyss-Coray, 2009). Ageing is associated with 
microglial degeneration and this may cause some of the age related structural changes 
seen in normal ageing and also in neurodegenerative disorders (Streit, 2006). 
Furthermore, recent evidence suggests that microglia lose the ability to replicate in 
old age indicating that the apparent telomeric mechanism of ageing discussed above 
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may be at work (Streit et al., 2008). Brain ageing may therefore also not be inevitable 
if neuronal and glial health could be maintained by continuous proliferation, and if 
brain tissue could be protected against exogenous and endogenous traumatic and toxic 
effects, including that caused by endogenous immune dysregulation.  
A further difficulty encountered in distinguishing between AD and ageing is 
that the exact disease mechanism of AD is not clear. As mentioned in the 
introduction, several causative hypotheses exist for AD including genetic, 
environmental and infectious causes (§1.1.2). However, at present AD appears less 
like the result of a single mechanism and more like that of a complex interplay 
between genetic and environmental factors. AD could conceivably involve some of 
the mechanisms of ageing but appear different clinically due to genetic and 
environmental influences. 
In the next section, we look at age-related cognitive decline in domains 
relevant to the work reported here, in order to inform the discussion of our findings. 
 
1.3.3 Age-related Cognitive Decline 
Age-related decline affects brain structure as well as several cognitive functions and, 
although there is overlap between ageing and AD, there are some distinct features 
apparent only in AD (for reviews see (Anderton, 1997; Anderton, 2002)). 
 
1.3.3.1 Structural brain changes in AD and ageing 
Table 2 summarises the known structural differences between normal ageing, AMCI 
and AD. Impairment on the majority of these measures progresses gradually from 
normal ageing towards AD supporting the accelerated ageing hypothesis. However, 
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age-related changes are absent on other measures where abnormalities are clearly 
present in AD therefore arguing against the accelerated ageing hypothesis. Findings 
that appear specific to AD include parietal lobe atrophy, neuronal loss in the nucleus 
basalis of Meynert, synapse loss in layers III and V in frontal cortex, and NFTs in the 
entorhinal, hippocampal C1 and thalamic areas (Anderton, 2002; Giannakopoulos et 
al., 2007; Giannakopoulos et al., 1997; Paskavitz et al., 1995). These areas are 
persistently implicated in AD indicating a qualitative difference from ageing. AD 
therefore appears to have regional specificity that distinguishes it from ageing. 
Supporting evidence comes from diffusion tensor imaging that reveals micro 
structural changes in normal ageing in frontal white matter, anterior cingulate and 
genu of the corpus callosum, and in AD and MCI in the posterior cingulate, 
parahippocampus, temporal white matter and splenium of corpus callosum (Chua et 
al., 2008). 
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 Ageing AMCI AD 
Macro anatomical changes    
 Brain volume decrease + ++ +++ 
 Increased ventricular volume + ++ +++ 
 Hippocampal atrophy + ++ +++ 
 Frontal atrophy + + ++ 
 Parietal atrophy - + ++ 
 White matter atrophy + ++ ++ 
Micro anatomical changes    
 Hippocampal neurone loss + ++ +++ 
 Cortical neurone loss + ++ +++ 
 Nucleus basalis neurone loss - ++ +++ 
 Synapse loss + ++ +++ 
 Synapse loss in layers III and V 
of frontal cortex 
- No data ++ 
 Amyloid plaques + ++ +++ 
 Hirano bodies + No data  +++ 
 Granulovacuolar degeneration + No data  +++ 
 NFT in hippocampal C1 region - ++ +++ 
 NFT in transentorhinal area + + ++ 
 NFT in entorhinal area - + ++ 
 NFT in thalamus - No data +++ 
 Small infarcts + + + 
 Cerebral amyloid angiopathy + No data +++ 
Table 2. Micro and macro anatomical similarities and differences between 
normal ageing, AMCI and AD. 
Neuropathological findings in ageing, AMCI and AD reveal a gradual accumulation 
of abnormalities on many aspects; however, neuropathology affects distinct areas in 
AD and AMCI that are spared in normal ageing (shaded rows). These findings 
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suggest that neuropathology in AD and AMCI is qualitatively different from normal 
ageing and argues against the accelerated ageing hypothesis. 
 
1.3.3.2 Neuropsychological findings in ageing 
Advancing age is associated with a systematic decline in performance on a variety of 
cognitive tasks.  Decline is not evident in all situations or on all cognitive domains 
and performance on some tasks may even improve with advancing age.  There are 
currently two competing hypothesis explaining age-related cognitive decline. The first 
ascribes the widespread cognitive impairments to deficits in one or a few general 
factors (global interpretations), implying that the various impairments are related. The 
second hypothesis posits that impairments are task or process specific (analytical 
interpretations) caused by discreet structural or processing deficits (Van der Linden, 
2002 ). We will look at each of these hypotheses in turn. 
 
Global interpretations 
Several general factors have been identified that may explain the decline of cognition 
associated with normal ageing. These include decreased processing speed, reduced 
working memory capability, impaired inhibitory efficiency, and sensory processing 
deficits (Park, 2000). 
 Processing speed refers to the speed with which elementary processing 
operations can be executed. Compelling evidence suggests that nearly all age-related 
variants in cognition can be explained by the variance in the speed at which 
individuals make rapid comparisons during perceptual speed tasks (Salthouse, 1996a; 
Salthouse, 1996b; Salthouse, 1996c). A decline in processing speed results in a 
decrease in the speed with which cognitive operations are executed. This leads to 
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behavioural deficits when the processing is to slow to allow completion of tasks 
(limited time mechanism) and when necessary working memory traces cannot be 
maintained long enough for later use (simultaneity mechanism).  The decline in 
processing speed is linear and very gradual as indicated by a small intercept on scatter 
plots of age and processing speed (for a review of meta-analyses see (Verhaeghen and 
Cerella, 2002). The reaction times of older adults can therefore be expressed as a 
fixed ratio of younger adult’s reaction times and this speed of processing deficit is 
called general slowing. 
According to the working memory hypothesis, cognitive decline results from a 
reduction in the amount of cognitive resources available to temporarily store new 
information while simultaneously processing incoming or recently accessed 
information (Baddeley, 1986). Working memory refers to a cognitive system that 
stores and manipulates information during complex cognitive tasks such as learning, 
reasoning and language comprehension (§1.6.2). It is classically measured on dual-
tasks where subjects are asked to both store and process information simultaneously. 
Much evidence suggests that age-related cognitive decline on several tasks is 
mediated by working memory deficits and there is some indication that the effects of 
processing speed and inhibitory attention mechanisms are mediated via working 
memory (Bopp and Verhaeghen, 2005; Salthouse et al., 1991; Van der Linden et al., 
1994; Van der Linden et al., 1999). Dual-tasks differ from the divided attention task 
we employed by requiring storage of novel information during the task; this is 
discussed in detail in the methods section (§3.9.1.1). 
According to the inhibitory hypothesis, irrelevant distracting information gains 
access to working memory in older adults due to deficits in inhibitory attentional 
mechanisms.  The irrelevant information may come from external sources or from 
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automatic activation of semantic representations.  It follows from this that task 
completion can be interrupted or delayed as processing resources are diverted to 
irrelevant information. 
Sensory processing shows as strong age-based relationship with cognitive 
performance (Lindenberger and Baltes, 1994; Lindenberger and Baltes, 1997). A life-
span study revealed compelling evidence that cognitive decline is in part mediated by 
decline in sensory function (Baltes et al., 1999). It has subsequently been shown that 
the decline is likely related to the integrity of brain structure and function and not due 
to the effects of impaired visual or auditory sensory acuity during testing 
(Lindenberger et al., 2001). Greater impairment in both near and far vision have been 
reported in AD compared to controls, and the degree of vision impairment correlates 
with the degree of cognitive impairment (Uhlmann et al., 1991). Similar findings have 
been reported in relation to hearing impairment and AD (Uhlmann et al., 1989). It is 
not certain at present if sensory impairments unmask and exacerbate the symptoms of 
dementia. It is also not clear if these sensory impairments are related to pathology in 
the sensory apparatus or visual processing. 
It is most likely that these suggested general factors are interdependent as 
suggested by findings indicating that the contributions of slowed processing speed 
and inhibitory failure are indirect and mediated by working memory which itself 
appears to play a crucial role in age-related cognitive decline (Van der Linden et al., 
1999). These findings have been contradicted by other studies and it has been 
suggested that the contributions to cognitive deficits in ageing is likely to be task 
dependent. The situation is further complicated by the composite nature of working 
memory. Baddeley’s model of working memory is composed of a phonological loop, 
visuospatial sketchpad, central executive and episodic buffer (Baddeley, 1986; 
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Baddeley, 2000; Baddeley and Della, 1996). In turn the central executive appears to 
have distinguishable functions including the selection and manipulation of 
information in long-term memory, selecting and inhibiting information, attentional 
control, coordination of two or more concurrent activities, and updating working 
memory. It is therefore clear that working memory cannot be considered as a single 
factor influencing cognition and that an analytic approach may be more suitable to 
investigate cognitive decline in ageing.  
I report on our comparison of divided attention performance in this thesis and 
divided attention is underpinned by processing speed, working memory and executive 
processing and therefore vulnerable to the effects of age-related decline in these 
processes. Divided attention performance does indeed decrease with age and these 
deficits are more pronounced during more complex dual-task conditions associated 
with complex task rules such as those require memory encoding or manipulation of 
information held in working memory (for a review see (Sarter and Turchi, 2002). 
Divided attention impairment has been demonstrated in healthy older adults on a 
driving simulation task using visual stimuli (Brouwer et al., 1991). A visual and 
auditory dual-task, requiring visual letter-stimulus matching and simple choice 
reaction to an infrequent auditory stimulus, revealed impairment in older adults 
compared to young adults for conditions where the probes followed a warning signal 
more than 75 ms. Nevertheless, on shorter trials (50 ms) the groups were comparable 
(Greenwood and Parasuraman, 1991). The authors further divided the older 
participants into two groups (60-69 years; 70-79 years) and found no differences in 
accuracy or speed between these two groups on simple choice reaction. These results 
indicate that age-related differences in divided attention are dependent on the type of 
task and the timing of stimuli. Furthermore, there appears to be no differences in the 
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age range 60 to 79 on the simple choice reaction aspect of the task suggesting that 
age-related differences are unlikely to be a source of significant variability in this age 
group on the choice reaction aspect of similar divided attention tasks. This finding is 
relevant to the interpretation of our results, on a similar divided attention task, in 
groups not closely matched on age. 
 
Analytic interpretations 
The analytical approach to cognitive ageing assumes that the cognitive processing 
involved in completing a specific task can be divided into the elements that constitute 
it. Age-related cognitive impairment may therefore be localised to specific brain areas 
and the frontal and medial temporal areas appear more vulnerable to ageing. Based on 
the approach, process specific deficits can be examined by reference to the attention 
related neural networks, each responsible for a different attentional function (Fan et 
al., 2005; Posner, 2004; Posner et al., 2000; Van der Linden, 2002; Wang and Fan, 
2007). These functions include alerting, orienting and executive control. 
Alerting achieves and maintains a heightened state of arousal in preparation 
for a task. It supports vigilance (maintained response readiness over long periods of 
time for infrequent targets), phasic alertness (periodic increased response readiness 
following a warning stimulus), and sustained attention (maintained response readiness 
over shorter periods of time to detect frequent targets) and is underpinned by a 
network which includes thalamic nuclei, frontal and parietal cortices. Alerting appears 
largely unaffected by ageing and older adults still benefit from warning stimuli. The 
only deficits reported are of earlier fatigue during demanding long (30 min) sustained 
attention tasks (Mouloua and Parasuraman, 1995). 
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Orienting focuses attention on one stimulus amongst many (selective 
attention) and relies on shifting attention from one stimulus to the next. It relies on a 
network that includes the parietal lobes, frontal eye fields, superior colliculi, and 
thalamus (pulvinar). Selective attention shows age-related impairment and this 
appears more pronounced when target stimuli are presented with highly similar 
distractor stimuli, and less pronounced when target stimuli are preceded by a cue, 
diminishing the need to process irrelevant stimuli (Hartley, 1993; Rogers, 2000).   
Executive control is an amalgam of processes that monitor and resolve 
conflicts in planning, decision-making, it contributes to error detection, and it inhibits 
automatic execution of habitual actions. Contradictory findings have been reported in 
relation to the effects of ageing on executive control and this has been ascribed to 
methodological differences in assessing potential confounders such as slowed 
processing speed (Van der Linden, 2002). Nevertheless, deficits have been 
demonstrated which remain after controlling for the general effects of slowed 
processing speed. 
 
1.3.3.3 Neuropsychological findings specific to AD and AMCI 
In spite of the considerable overlap between ageing and AD, neuropsychological 
studies have demonstrated evidence of specific disease related cognitive impairments 
that cannot be accounted for by generalised effects of ageing. 
 Specific episodic memory impairment, demonstrated as impaired delayed 
recall of spoken words or narrative, appears to be one of the most sensitive 
neuropsychological predictors of progression from normal ageing and AMCI to AD 
and this has already been discussed (§1.2.3) (Artero et al., 2003; Backman et al., 
2001; Sarazin et al., 2007; Tierney et al., 1996; Tierney et al., 2005).  
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Several reports found that recognition is less impaired that free recall in ageing 
compared to AMCI and AD (Anderson et al., 2008; Bennett et al., 2006; Westerberg 
et al., 2006). Furthermore, impairments in item, associative and semantic memory are 
evident in AMCI and AD compared to normal older adults and we will look at this in 
more detail in a later section (§1.4.4). 
Normal ageing, AMCI and AD can be distinguished from one another on 
selective visual attention task performance (RT) after controlling for the potential 
confounding effects of general slowing in normal ageing by logarithmic 
transformation of behavioural measures, therefore indicating that the visual attention 
impairment in AMCI and AD is very likely disease related (Tales et al., 2005a).  
Patients with AD and AMCI also demonstrate significant deficits in the ability to 
disengage attention from an incorrectly cued location and the ability to use a visual 
cue to produce an alerting effect compared to controls and after controlling for the 
effects of general cognitive slowing (Tales et al., 2005b). 
 
Summary 
Taken together the findings from structural and neuropsychological studies indicate 
that in spite of the considerable quantitative overlap between ageing, AMCI and AD, 
qualitative and quantitative differences exist which distinguish normal ageing from 
AD. AD and AMCI therefore does not appear to be accelerated ageing. However, the 
effects of ageing on cognition continue to apply to AMCI and AD and this should be 
kept in mind when interpreting the result from studies.  
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1.4 Episodic Memory 
Memory refers to the capacity to form mental representations of experiences (memory 
encoding) and to the ability to reactivate or reconstruct such representations (memory 
retrieval). Memory underpins important survival and social processes and amnesia is 
associated with declines in everyday activities. Memory appears particularly 
vulnerable to AD neuropathology and gradually progressive amnesia is typically the 
first symptom reported in AD and characteristic of both AMCI and AD. Amnesia 
usually presents in AD as complaints of forgetfulness, that appear related to 
neuropathology affecting the network of brain areas supporting episodic memory. 
Damage to this network makes it increasingly difficult to store new information whilst 
existing memory representations remain relatively intact. Episodic memory 
performance shows negative correlations with AD neuropathology in key areas in 
normal ageing, AMCI and AD (§1.2.2). The temporal gradient of memory loss 
accounts for the finding that amnesia is more pronounced for recently acquired 
memories than for distant memories. This finding is clinically useful because the 
ability to lay down new memories (new learning) can be measured and reflects the 
current integrity of episodic memory and is unconfounded by memory representations 
encoded prior to the onset of amnesia. Based on this disproportionate impairment in 
new learning in AD, tests of general intelligence such as the National Adult Reading 
Test (NART) can be used to assess premorbid intellectual functioning (O'Carroll et 
al., 1987). Good performance on the NART relies on recognition of written words and 
their correct pronunciation, both accessing memory acquired over the lifetime of the 
individual and therefore not dependent on recent or current encoding ability. 
Memory deficits indicate high-risk, is essential for a diagnosis of AMCI and 
AD, predicts premorbid cognitive function and indicates pathological load. These 
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findings illustrate the utility of understanding the neuropsychology of episodic 
memory in prodromal AD. In this section, episodic memory is introduced in more 
detail and its associations with MTL and frontal lobe structures are discussed. 
Neuropsychological and functional neuroimaging findings in health and AMCI 
relevant to the interpretation of the results from our studies of verbal episodic 
encoding in AMCI are also presented and discussed. 
 
1.4.1 Theoretical Background 
Episodic memory is a type of long-term declarative memory where both factual 
knowledge of the world and the context (time, space, affect) in which it was acquired 
are amenable to conscious recollection (Baddeley, 2001). It involves the three 
processes of encoding, consolidation and retrieval. Encoding refers to the generation 
of new memory representations and retrieval to the recollection of these 
representations.  The other type of long-term declarative memory is semantic memory 
where only factual knowledge is amenable to conscious recollection. Episodic 
memory was recently described by Endel Tulving, who first distinguished it from 
semantic memory in 1972, as “a recently evolved, late-developing, and early-
deteriorating past-oriented memory system, more vulnerable than other memory 
systems to neuronal dysfunction, and probably unique to humans. It makes possible 
mental time travel through subjective time, from the present to the past, thus allowing 
one to re-experience, through autonoetic awareness, one’s own previous experiences. 
Its operations require, but go beyond, the semantic memory system. Retrieving 
information from episodic memory (remembering or conscious recollection) is 
contingent on the establishment of a special mental set, dubbed episodic “retrieval 
mode.” Episodic memory is subserved by a widely distributed network of cortical and 
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subcortical brain regions. This network overlaps with but also extends beyond the 
networks subserving other memory systems. The essence of episodic memory lies in 
the conjunction of three concepts—self, autonoetic awareness, and subjectively 
sensed time.” (Tulving, 2002). Autonoetic consciousness refers to remembering 
episodic events and it is defined as the subjective feeling of re-experiencing or 
reliving the past and mentally travelling back in subjective time, and to therefore 
remember the time, place and affect associated with the encoding episode (Tulving, 
1985). 
 The exact mechanisms that underpin episodic memory is not clear yet 
however it does appear to rely heavily on key structures that are vulnerable to AD and 
this probably explains the salience of amnesia in prodromal and mild AD. In the 
following section, I discuss the neural network that underpins episodic memory 
function. 
 
1.4.2 Episodic Memory Network  
Episodic memory depends on a widely distributed network of cortical and subcortical 
brain regions that overlap with and extend beyond the networks subserving other 
memory functions. Permanent representation of learned episodes seems to rely on 
distributing information into multiple neocortical areas and on the MTLs binding this 
information together (Squire and Zola, 1996). Normal MTL function during encoding, 
and for a period afterwards, appears essential for permanent declarative episodic 
memory formation. We will consider the contributions from the temporal and frontal 
lobes to episodic memory in more detail as they appear particularly important and 
altered activation in these areas have been demonstrated during episodic memory 
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processing in AD and high-risk states. The roles of the frontal and temporal lobes 
have been revealed by lesion and functional neuroimaging studies. 
 
1.4.2.1 Lesion studies - the medial temporal lobes  
The MTL is comprised of the hippocampal region (dentate gyrus, hippocampal cell 
fields C1-C3, subicular complex) and parahippocampal region (entorhinal cortex, 
Brodmann area (BA) 28,34; and perirhinal cortex BA 35) (Witter et al., 1989). During 
memory processing, information from sensory cortices pass to unimodal and 
polymodal association areas in frontal, temporal and parietal lobes and then through 
the parahippocampal region to the hippocampal region. The hippocampal region in 
turn projects back to the cortex via the parahippocampal region. The entorhinal cortex 
in the hippocampal region receives the majority of these projections from the 
parahippocampal region, via the dentate gyrus. This circuitry explains why episodic 
memory crucially depends on MTL structures as indicated by lesion studies. Medial 
temporal lesions results in dense amnesia for personal experiences whilst leaving 
semantic memory largely intact (Wheeler and McMillan, 2001). Selective lesions of 
MTL areas cause differential impairment on memory tasks and more extensive 
damage causes more substantial anterograde (formation of novel memory 
representations) and retrograde (recollection of pre-lesion memory representations) 
amnesia (Squire and Zola, 1996). MTL structures therefore appear crucial in episodic 
memory function and this has lead to the large number of studies that have focused 
exclusively on this area, to the exclusion of other areas. 
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1.4.2.2 Lesion studies - the frontal lobes 
Lesion studies in humans also demonstrated impaired episodic memory following 
frontal cortex damage. Such impairments are evident on tasks that are more complex 
and that involve high levels of interference and disruption of the temporal order of 
memory (Incisa della Rocchetta and Milner, 1993; Janowsky et al., 1989). The 
influence of such interference and disruption is not routinely tested although similar 
distracting circumstances occur frequently in everyday life in crowded and noisy 
surroundings. Frontal lesions are thought to cause failure in the control processes of 
memory rather than of automatic storage processes and we will look at this in detail in 
a later sections on attention and executive control (§1.6.1-3). 
Lesion studies in animals have revealed contributions from other structures 
including the fornix, mammillo-thalamic tract and anterior thalamic nuclei to normal 
episodic memory function (reviewed by (Aggleton and Pearce, 2001)). 
 
1.4.2.3 The functional neuroanatomy of episodic memory 
Functional neuroimaging has been widely used to investigate memory processes in 
cognitively normal individuals and in those with memory impairment. Verbal 
episodic encoding consistently activates left hemispheric prefrontal cortex (PFC) and 
temporal lobe structures, confirming the findings from lesion studies [for a review see 
(Cabeza and Nyberg, 2000)].  
Left PFC activity during encoding relates to deep meaning-based semantic 
processing that optimises memory and involves the executive processes of generating, 
maintaining, selecting and organising semantically related information (Fletcher and 
Henson, 2001; Wagner et al., 1998). Indeed, disruption of left PFC function by 
transcranial magnetic stimulation results in impaired verbal encoding (Floel et al., 
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2004), and disruption of semantic elaboration results in decreased left PFC activation 
and reduced memory performance (Fletcher et al., 1995; Grady et al., 1995). The 
extent of activation of the left frontal cortex and hippocampus during verbal encoding 
correlates positively with subsequent successful recognition (Morcom et al., 2003; 
Wagner et al., 1998). 
The PFC can be divided by the inferior frontal sulcus into dorsolateral 
(DLPFC) and ventrolateral PFC (VLPFC) with the former loosely corresponding to 
Brodmann areas (BA) 9 and 46, and the latter to BA 44,45 and 47 (Fletcher and 
Henson, 2001). Activation in the left DLPFC reflects the working memory processes 
of reorganising information and subvocal rehearsal of working memory content 
whereas activation in VLPFC relates to semantic processing during verbal encoding 
(for reviews see (Desgranges et al., 1998; Fletcher and Henson, 2001).  
Activation in the MTL appears predominantly on the left during word 
encoding and left sided lateralisation of activation for non-verbal stimuli appears 
related to the verbalisability of the stimuli (Desgranges et al., 1998; Golby et al., 
2001).  Not all verbal encoding tasks activate the MTL and it appears that novelty and 
associative encoding (encoding pairs of items) are more likely to recruit MTL areas. 
The effect of novelty and MTL activation is further illustrated by the finding that 
repeated exposure to initially novel face-name pairs results in deactivation in the 
hippocampus (Rand-Giovannetti et al., 2006; Sperling et al., 2003a; Sperling et al., 
2003b).  
Activation in MTL and PFC predicts subsequent recall performance and 
demonstrate the interaction between these two key areas in episodic encoding 
(Kirchhoff et al., 2000; Sperling et al., 2003a; Staresina and Davachi, 2008; Wagner 
et al., 1998).  
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Recent studies have also revealed correlations between memory performance 
and parietal and cerebellar activation (Brassen et al., 2006; Fliessbach et al., 2007; 
Staresina and Davachi, 2006). 
 
In summary, the PFC and MTL are key nodes in the network that underpins verbal 
episodic memory. This network also receives contributions from other cortical areas. 
Next, we look at the neuropsychology of normal memory that depends on this 
functional network. 
 
1.4.3 The Neuropsychology of Episodic Memory 
The design and choice of the memory paradigm that we used to study verbal episodic 
memory in AMCI is based on available findings from studies in health, AMCI and 
AD. What follows is an introduction to the neuropsychology of episodic memory that 
will inform the discussion that follows on the available findings in AMCI and on the 
design aspects of the tasks described in the methods section (§3.9.3). 
Episodic memory can be examined on tasks that measure retrieval success 
following intentional or incidental encoding (learning phase) of sensory stimuli in any 
modality. Free recall is retrieval that is unsupported by external cues and the most 
demanding retrieval mode. A typical task would require a subject to name as many 
items as remembered from the set of items presented during the learning phase. The 
recall phase is termed free because no external cues related to the studied items are 
provided. Conversely, cues are presented during recognition tasks and retrieval is 
therefore supported and less demanding. For recognition tasks cues are presented and 
subjects have to decide whether or not they had been encountered during the learning 
phase. Typical cues are non-target semantic associates, such as a particular category 
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to which an item belongs, or previously learned items (targets). Recognition can be 
measured on forced-choice or yes/know tasks. During a forced-choice recognition 
task, a target and one or more non-target (distractor) items are presented 
simultaneously, and subjects are forced to choose one item as a target. For a yes/not 
task, a single probe is presented and the subject has to decide if it is a target or not. 
Figure 3 illustrates the two types of recognition task and the difference between 
forced-choice and yes/no tasks. 
Recognition may be more sensitive than free recall in distinguishing normal 
ageing from AD because it is more robust against age-related changes (Craik and 
McDowd, 1987; Parker et al., 2004). Recognition may therefore the preferred 
measure of episodic memory in smaller samples not closely matched on age. 
Recognition can be further divided into familiarity, which refers to a feeling of prior 
exposure to an item without recall of associated contextual information, and 
recollection referring to the retrieval of the item bound to contextual features such as 
the time, place or source of experience (for a recent review see (Yonelinas, 2002). 
Forced choice is a more sensitive measure of familiarity and, yes/know of 
recollection.  
 
Figure 3. Measures of episodic memory retrieval. 
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The figure illustrates forced choice and yes/no recognition tests used to examine 
familiarity and recollection based recognition respectively. Recollection tests appear 
more sensitive at distinguishing normal ageing from AMCI. 
 
Specific episodic memory tasks can distinguish between item recognition 
(recognition of an item as presented during learning on a given set of stimuli) and 
cross modal associative memory (encoding and recall of relations between items, such 
as for an object and its spatial location, or the pairing of two items). The verbal 
episodic memory task we employed consisted of an implicit associative learning task 
with a yes/know recognition phase. The associations were implicit because all the 
words in a list were semantically related but participants were not informed of this 
(§3.9.3-4). The ability to examine dissociable memory processes allows more 
sophisticated methodology to study specific brain areas and how they are affected by 
pathology. For instance, implicit associative learning allows examination of distinct 
memory processes such as automatic semantic elaboration that is strongly associated 
with the PFC, an area of interest in studies of AD. Also, the ability to examine 
dissociable memory processes may enable tracking of AD progression because 
distinct memory processes such as familiarity and recollection appear to depend on 
different cortical areas; recollection appears to rely on the hippocampus and prefrontal 
cortex and familiarity on the regions surrounding the hippocampus (Yonelinas, 2002). 
AD neuropathology proceeds from entorhinal cortex to hippocampus and then on to 
neocortical association cortices. Impairment on specific memory tasks may therefore 
indicate pathology in certain areas. 
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These findings illustrate the potential of specific memory studies to shed light 
on the component processes that constitute everyday memory processing. We next 
look at the findings from such studies in AMCI. 
 
1.4.4 Neuropsychological Findings in AMCI 
Episodic memory is characteristically impaired in AMCI and progress has been made 
to improve the sensitivity and specificity of tests that can distinguish normal ageing 
from AMCI and AD. Several reports indicate that recognition tests may be more 
sensitive than free recall at distinguishing AMCI from normal ageing and of the 
recognition tests, recollection rather than familiarity appears more sensitive 
(Anderson et al., 2008; Bennett et al., 2006; Westerberg et al., 2006). However, one 
recent study reported greater impairment in familiarity in AMCI when controlling for 
task difficulty (Wolk et al., 2008). These findings indicate that yes/know recognition 
tasks are sensitive in distinguishing between ageing, AMCI and AD. 
Both item- and associative- memory appears affected in AMCI. An 
experiment examining famous person naming (person specific semantic memory), 
subsequent recognition (item recognition), and recall of the position where faces 
initially appeared (spatial associative episodic memory) revealed impairment in all 
three measures in AMCI (Dudas et al., 2005). A study of incidental and intentional 
item and associative encoding in AMCI demonstrated greater impairment on 
associative memory on two tasks (symbol-symbol pairs and object-location pairs) 
(Troyer et al., 2008). Taken together these findings indicate impairment in semantic 
memory, associative learning, free recall and recognition recall in AMCI and suggest 
that an associative learning task with a yes/no recognition phase may be a particularly 
sensitive measure to discriminate AMCI from normal ageing. 
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Although AMCI implies isolated episodic memory impairment, deficits in 
other areas including semantic memory have also been reported (De Jager et al., 2003; 
Dudas et al., 2005; Joubert et al., 2008). These results indicate that semantic memory 
for conceptual entities, which have distinctive and unique properties such as famous 
events and people, deteriorate before semantic memory for objects in AMCI. 
Nevertheless, the older reports on semantic memory precede the more recent 
amnestic-single domain distinction and may therefore refer to the more heterogeneous 
MCI group. 
In summary, the findings discussed above illustrate the potential of specific 
memory paradigms to examine distinct memory processes that appear differentially 
affected in ageing, AMCI and AD. Combining such tasks with functional 
neuroimaging has the potential to reveal the functional neuroanatomy of memory 
processing in health, AMCI and AD and may be useful in diagnosis and treatment 
monitoring. In the next sections, I summarise functional neuroimaging findings of 
memory processing in health and AMCI. 
 
1.4.6 Functional Anatomy of Episodic Memory Encoding in AMCI 
We have seen that lesion and functional neuroimaging studies indicate that episodic 
memory relies on a network of brain areas. In this section, we look at the available 
findings from functional neuroimaging studies of episodic encoding in AMCI. 
Almost all functional neuroimaging studies of episodic memory in AMCI have used 
picture stimuli or picture-word pairs and only a few studies have employed visually 
presented words similar to our methods. This is at odds with the majority of clinical 
measures of delayed episodic memory, which use verbal stimuli (New York 
University Paragraph Recall Test, Logical Memory Test). Moreover, even when 
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picture stimuli are used, it usually involves naming the pictures as part of encoding 
(Boston Naming Test) (Fleisher et al., 2007). There appears to be a mismatch between 
clinical and research instruments and employing an experimental task involving 
auditory presented words or narrative would therefore more closely mirror clinical 
measures. It is at present not possible to adequately monitor compliance during verbal 
encoding tasks where stimuli are read to subjects because under such circumstances 
they could engage in cognitive activity unrelated to the task without the knowledge of 
the researcher. Monitoring compliance is especially important when studying clinical 
groups with cognitive impairment that can affect the ability to comply with task 
requirements. Researchers therefore often use tasks involving picture naming or overt 
reading of word lists during encoding which allows some compliance monitoring but 
does not exactly match clinical measures. Generalising results from picture encoding 
to verbal encoding is problematic due to the modality (visual or verbal) and memory 
phase (encoding or recognition) dependent lateralisation of activation in PFC and 
MTL (Johnson et al., 2003; Kelley et al., 1998; Otten and Rugg, 2001). What follows 
is therefore a discussion of available verbal encoding studies and selected picture-
word and picture encoding studies that are of interest. 
 
1.4.6.1 Verbal encoding studies  
An encoding study using visually presented words demonstrated greater activation in 
AMCI subjects compared to controls in the left hippocampus, medial frontal gyrus 
(BA 6), anterior cingulate (BA 24) and post central gyrus (BA 3) specifically during 
encoding of words that were subsequently retrieved (Kircher et al., 2007). The authors 
suggest that greater activity in AMCI relates to compensatory mechanisms required in 
the face of failing resources because increased cognitive effort and more demanding 
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tasks lead to greater magnitude or extent of functional activation (Grady et al., 1994; 
Raichle et al., 1994). Results from this study indicate that matched encoding 
performance requires larger activation in relevant areas in AMCI. 
 
1.4.6.2 Picture encoding studies 
Using a picture encoding task, where novel scenes were contrasted with repeated 
scenes, greater extent of activation in the MTL regions correlated with better 
recognition performance but also paradoxically with greater functional impairment 
and faster cognitive decline in the subsequent 2.5 years in AMCI subjects (Dickerson 
et al., 2004). The authors recently conducted a further analysis which showed that 
greater magnitude of hippocampal activation at encoding correlated with greater 
degree and rate of subsequent cognitive decline (Miller et al., 2008). A further study 
by this group, using the same task, an expanded original participant group and a 
model-free independent component analysis of activation across the whole brain, 
revealed increased MTL activation in less impaired AMCI subjects and decreased 
activation in the more impaired AMCI subjects (Celone et al., 2006). Their findings 
could indicate that greater activation during a compensated state affords better recall 
but also heralds the onset of a period of fast decline, whereas decreased activation 
indicates more advanced impairment and relatively slower decline. Findings from 
these studies are unfortunately difficult to generalise to the AMCI population because 
the authors did not require objective evidence of episodic memory impairment for a 
diagnosis, instead they relied on subjective reports. Their patient group therefore 
included subjects that we would describe as suffering from subjective cognitive 
impairment and likely represents an even more heterogeneous group than MCI. 
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Finding a correlation between MTL activation and subsequent decline is of 
interest as a recent study that combined functional neuroimaging of encoding (picture-
word pairs) and voxel-based morphometery reported a positive correlation between 
increased posterior MTL (hippocampus, parahippocampus, fusiform areas) activation 
and anterior MTL atrophy in AMCI subjects (Hamalainen et al., 2007). This 
correlation was absent in controls and AD patients and the authors suggest that 
increased posterior MTL activation is compensatory for anterior MTL atrophy in 
AMCI. The magnitude of compensatory activation could therefore correlate with 
disease progression and differentiate between AMCI, ageing and AD. These findings 
could also explain the result discussed above that indicate a correlation between MTL 
hyperactivation and subsequent rapid decline. 
An incidental, deep picture encoding task (requiring participants to decide if a 
stimulus was man-made or natural) demonstrated impaired memory performance 
associated with decreased activation in AMCI in left hemispheric PFC (BA 47), 
entorhinal cortex (BA 34), superior temporal cortex, extrastriate visual cortex and 
anterior cingulate, in right hemispheric middle temporal gyrus, lentiform nucleus 
(putamen) and caudate, and in bilateral medial parietal (precuneus) cortex (Mandzia et 
al., 2007). In this study, recognition accuracy correlated with the extent of activation 
in bilateral parahippocampal gyri in controls but not in AMCI subjects. The result 
from this study reveals altered activation across a range of areas associated with 
sensory processing and higher processing of stimuli. The loss of correlation between 
activation and performance may indicate that parahippocampal areas were already 
maximally activated, and/or deployment of a compensatory encoding strategy that is 
less dependent on parahippocampal activation. 
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 Altered metabolism in parahippocampal and bilateral medial parietal areas 
has also been reported in AMCI using the recently developed perfusion fMRI method. 
During picture encoding, AMCI demonstrated attenuated medial parietal (precuneus, 
cuneus and posterior cingulate) and absent right parahippocampal regional cerebral 
blood flow (CBF) increases compared to controls (Xu et al., 2007). The mean CBF in 
the medial parietal cluster correlated with MMSE score and more so with delayed 
verbal recall performance. Furthermore, when the groups were compared at rest, 
similar decreased medial parietal (precuneus and cuneus) perfusion persisted and 
again correlated with MMSE and delayed verbal recall performance. This appears to 
indicate a close association between activity in medial parietal areas, episodic 
memory and global cognition. The medial parietal area is comprised of the precuneus, 
posterior cingulate and retrosplenial cortex. This area appears vulnerable to AD 
neuropathology as evidenced by findings of volume loss, hypoperfusion and 
hypometabolism. Volumetric differences in this area are evident between normal and 
AMCI subjects and decreased volume in this area predicts dementia conversion. The 
area also suffers accelerated atrophy in progressive AMCI. Hypoperfusion and 
hypometabolism have been demonstrated in this area and these findings predict 
progression to AD from AMCI and also correlate with episodic memory performance 
(for a review see(Ries et al., 2008))(Xu et al., 2007). The medial parietal area receives 
cholinergic input from the BFCS via the medial cholinergic pathway and are the most 
distant area supplied via this pathway (Selden et al., 1998). Functional and structural 
changes could therefore be related to AD neuropathology in the BFCS affecting 
cholinergic innervation and therefore cholinergic regulation, first affecting the most 
distant areas innervated by the medial cholinergic pathway. 
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 Impaired memory and decreased bilateral PFC and left cerebellar activation 
were demonstrated in AMCI on a face-name paired associates encoding task (Petrella 
et al., 2006). A more recent intentional picture naming encoding task revealed 
decreased left PFC activation and increased right MTL activation in AMCI compared 
to controls specifically for successfully encoded items (Trivedi et al., 2008). This 
indicates that matching the performance of controls requires different contributions 
from PFC and MTL structures, which may be compensatory.  
The available experimental data does not allow a coherent description of 
functional activation changes associated with encoding processes in AMCI. This is 
due to the small number of studies, the varying encoding tasks and the lack of 
consistent application of operationalised diagnostic criteria for AMCI. Generalisable 
results from these few studies indicate that matching the encoding performance of 
controls is accompanied by greater MTL activation whilst altered PFC and medial 
parietal activation is often present but not clearly related to encoding success. Future 
studies need to clarify the roles of incidental/intentional and successful/failed 
encoding of verbally/visually presented material as the networks that underpin them 
may overlap but are not identical. At present there appears to be a lack of appropriate 
studies designed to reveal the neural correlates of impaired performance on standard 
clinical verbal episodic memory tests. The verbal episodic memory paradigm that we 
employed bares much closer resemblance to clinical measures and our data will 
therefore be informative of the neural correlations of clinically observed amnesia 
(§3.9.3). The following section deals with attention and the interaction between 
episodic memory and attention.  
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1.5 Attention 
Attention is crucial for everyday functioning and the ability to direct attention to 
information sources relevant to survival helps to compensate for the limited capacity 
of human cognition. Attention underpins almost all other cognitive processing; 
consequently, attentional deficits can have widespread effects on behaviour. 
Attentional is impaired early in the course of AD but appears intact in AMCI. 
However, clinical observation in AD and the cholinergic hypothesis (§1.1.2) suggest 
that attentional deficits may be present in AMCI. We studied the neural correlates of 
selective and divided attention in AMCI, and in this section, attention is introduced 
and the available findings from behavioural and functional neuroimaging studies are 
discussed to inform the interpretation of the results. 
 
1.5.1 Theoretical Background 
Attention refers to the capacity to direct consciousness towards specific internal or 
external stimuli. It can be sustained (maintained over a period of time), selective 
(ignoring non-task relevant stimuli) and divided. Divided attention refers to the 
capacity to simultaneously attend to multiple stimuli that may come from one (within-
modal) or more (across-modal) sensory inputs. Attention is typically studied using 
tasks during which subjects are required to monitor a series of stimuli and to react to 
the presentation of predetermined target stimuli. Pressing a button usually registers a 
participant’s reaction and the time recorded is known as the reaction time (RT). 
Target stimuli can be presented at regular or varying frequency and in isolation or 
together with other distractor stimuli. Sustained attention is typically studied on tasks 
where target stimuli are presented with regular frequency and in isolation. Selective 
attention is studied on tasks where target stimuli are presented together with distractor 
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stimuli. A measure of accuracy is usually calculated and this can vary from the basic 
percentage of correct responses to more sophisticated measures that take into account 
incorrect responses on non-targets (false recognition). We will look into the details of 
measuring accuracy in the methods section (§3.9.1.3). 
The increased cognitive effort required during divided attention results in a 
dual-task decrement, evident as slower RT and/or decreased accuracy (Posner, 1978). 
An example of such a divided attention task involves serial visual search of a series 
of images and responses to predetermined target images, and simultaneous serial 
auditory search of words or tones with responses to target stimuli. 
Recent functional neuroimaging studies have identified three attention related 
neural networks, each responsible for a different attentional function (Fan et al., 2005; 
Posner, 2004; Posner et al., 2000; Wang and Fan, 2007).  These functions include 
alerting, orienting and executive control. Understanding each of these functions and 
the network that underpins them will inform the discussion of our functional 
neuroimaging results and we will look at them in turn. 
Alerting achieves and maintains a heightened state of arousal in preparation 
for a tasks, it is underpinned by a network which includes thalamic nuclei, frontal and 
parietal cortices. Orienting selectively focuses attention on single or multiple items 
among distracters, it relies on a network that includes the parietal lobes, frontal eye 
fields, superior colliculi, and thalamus (pulvinar). Executive control monitors and 
resolves conflicts in planning and decision-making, it contributes to error detection, 
and it inhibits automatic execution of habitual actions; it relies on a network that 
includes the PFC, anterior cingulate, supplementary motor area and basal ganglia. 
Varying contributions from these functions seem to underpin the attentional capacities 
referred to earlier (selective, divided, sustained) so whereas divided attention may 
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make heavy demands on all three capacities, selective attention will require less 
orienting and executive control.  We next look at the findings from studies of 
attention in AMCI. 
1.5.2 Neuropsychological findings of attention in AMCI 
 Although AD is characterised by episodic memory impairment, findings of impaired 
everyday activities in AD in excess of that expected for the degree of amnesia, as well 
as attentional impairment predicted by the cholinergic hypothesis of AD lead to a 
closer examination of attentional function in AD.  Subsequent studies found 
attentional deficits in the early AD that typically followed the onset of episodic 
amnesia (Chun and Turk-Browne, 2007; Perry and Hodges, 1999). Divided attention 
appeared to be the first non-memory cognitive domain affected in AD. Furthermore, 
greater impairment on divided attention tasks could distinguished AD from ageing 
and the specificity of such tasks could be enhanced by increasing the similarity 
between target and distractor stimuli (Baddeley et al., 2001).  
 As attention appeared effected in very mild AD, studies were conducted to 
examine if attention was also impaired in MCI.  In fact, attentional deficits were 
found in this more heterogeneous group and these deficits, together with other non-
amnestic impairments, increased the risk of conversion to dementia (Levinoff et al., 
2005; Nestor et al., 2004). 
Only a few studies have examined attention in AMCI and these have found a 
range of deficits. A retrospective study found impaired forward digit span (a measure 
of sustained attention and phonological working memory) in 29% of AMCI patients 
who had converted to dementia (Bozoki et al., 2001). A study of visual selective 
attention found that increased interference from distractor stimuli resulted in longer 
RTs in AMCI compared to controls (Perry and Hodges, 2003). The task used in this 
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study required subjects to ignore a non-target stimulus that briefly appeared before a 
target. The results indicate a failure of attentional selection or top-down (task driven) 
control of attention.  Top-down mechanisms are proposed to regulate attention 
according to the demands of predetermined goals (Sarter et al., 2005). Top-down 
attentional modulation is associated with activation in prefrontal and parietal nodes of 
the attentional networks and appears mediated by cholinergic neurotransmission.  The 
modulation of attention is discussed in more detail in a later section (§1.6.3). A study 
of attention in normal ageing, AMCI and AD using a visual search task requiring 
selective visual attention and attentional shifting, revealed impaired visual attention 
(slower RT) in AMCI and AD which distinguished these conditions from normal 
ageing and from each other (Tales et al., 2005a). Furthermore, in this study the 
potential confounding effects of age related general cognitive slowing was controlled 
for by logarithmic transformation of behavioural measures and results indicate that 
the attention impairment is disease related. Impaired selective attention (on a task 
where subjects search for symbols on a map) and impaired attentional switching (on a 
task where subjects alternate between counting up or down) in AMCI have also been 
reported by another group which indicates the consistency of this finding (Silveri et 
al., 2007).  
In summary, findings from the few behavioural studies conducted in AMCI 
reveal deficits on selecting, switching, dividing and sustaining attention. Furthermore, 
attentional deficits increasingly appear a consistent finding in AMCI when more 
sensitive neuropsychological measures are used. In the following section, the 
functional anatomy of divided attention is discussed before we look at findings from 
functional neuroimaging studies of attention in AMCI. 
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1.5.3 Functional anatomy of divided attention 
A systematic review of functional neuroimaging findings of attention and other 
functions domains in control groups revealed that selective attention tasks typically 
activate frontal (BA 9) and parietal (BA 7, 40) cortex together with relevant sensory 
cortices whilst activation is suppressed in non-relevant sensory cortices (Cabeza and 
Nyberg, 2000). Divided attention tasks typically activate unilateral prefrontal cortex 
for both within-modal stimuli (visual) (Corbetta et al., 1991; D'Esposito et al., 1995) 
and for mixed modality stimuli (visual and somatosensory) (Johannsen et al., 1999; 
Johannsen et al., 1997). More complex dual-tasks (divided attention tasks that require 
additional working memory and semantic processing) typically activate bilateral 
prefrontal cortices (Iidaka et al., 2000a; Koechlin et al., 1999). A study employing a 
well-designed divided attention task requiring concurrent processing of auditory tones 
and visual patterns showed activation of the left prefrontal cortex when contrasted 
with activation during visual selective attention or auditory selective attention alone 
(Loose et al., 2003). Figure 4 demonstrates the areas of activation during this task, 
which appears typical for divided attention conditions compared to selective attention 
conditions. The design of this task and the stimuli used are similar to the divided 
attention paradigm designed for our study. 
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Figure 4. Functional activation during divided attention. 
Activation during divided attention to auditory and visual stimuli is evident in 
bilateral anterior cingulate, prefrontal and occipital cortex, left superior temporal 
gyrus and precuneus and, right superior and inferior parietal cortex. (Loose et al., 
2003). Reprinted with permission of Wiley-Liss, Inc. a subsidiary of John Wiley & 
Sons, Inc. 
 
A more recent study comparing bimodal visual and auditory sustained 
attention, selective attention and divided attention also found left PFC activation only 
during divided attention (Johnson and Zatorre, 2006). Activation during divided 
attention appears not to be a simple summation of activation during selective 
attention; activation consistently decreases in relevant sensory cortices during divided 
attention relevant to selective attention and this has been ascribed to inter-sensory 
cortex inhibition or to limitations on processing control. The study by Johnson et al. 
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2006 revealed no differences in sensory cortex activation between divided attention 
and passive bimodal attention (attending to stimuli with no further reaction or 
processing required) indicating that sensory activation was not modulated by 
additional attentional task requirements. Selective attention to a sensory modality 
leads to increased activation in the relevant sensory cortex and decreased activation in 
the ignored modality’s cortex, as would be expected. Combined sensory activation 
during divided attention was significantly less than the sum of activation during 
selective attention, supporting the idea of neural resource limitations. Furthermore, 
activation in DLPFC (BA 9) showed a negative correlation with task performance and 
sensory cortex activation. The authors suggested that poor performers were unable to 
sufficiently recruit sensory cortices during divided attention and that increased 
activation in DLPFC represents compensatory efforts and illustrates functional 
interactions between PFC and sensory cortices. A more recent study compared within-
modal and across-modal divided attention in an effort to clarify if either is more 
resource demanding (Vohn et al., 2007). Auditory stimuli for the task consisted of 
serially presented single or paired musical notes and within-modal divided attention 
targets were note pairs increasing in tone. Visual stimuli were serially presented 
circles and squares, which increased (circles) or decreased (squares) in size during 
presentation; within-modal targets were consecutive shapes increasing in size. Across-
modal targets were consecutive note pairs increasing in tones and consecutive visual 
squares decreasing in size. All divided attention conditions activated right PFC, 
inferior and superior parietal lobe and claustrum. Contrasting within-modal against 
across-modal conditions revealed increased activation during across-modal divided 
attention in bilateral DLPFC (BA 46), left DLPFC (BA 9), medial PFC (BA 8), and 
inferior parietal lobe (BA 40) and, in right anterior cingulate (BA 32). The authors 
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concluded that this reflected increased demand for coordination of cross-modal 
attentional resources, requiring more top-down control of attentional processing. 
Their were no significant behavioural differences during the different conditions and 
increased functional activation indicating greater effort during across-modal 
processing is therefore not supported by performance decrements; however, the task 
appears not to have been difficult enough to study this conclusively. From the few 
available studies, it appears that across-modal divided attention may be the more 
processing intensive attentional function and specifically associated with left DLPFC 
activation. Our divided attention task required across-modal divided attention 
therefore requiring greater cognitive effort making it more suitable as a probe for 
early attentional impairment. We look at findings from studies of attention in AMCI 
in the next section. 
 
1.5.4 The functional anatomy of divided attention in AMCI. 
Only a handful of functional studies of attention - none of divided attention - have 
been conducted in AMCI and we will therefore first look at the findings from studies 
of divided attention in AD. Even in AD, only a few studies have been conducted and 
this may be related to the difficulties in conducting functional imaging studies with 
participants who are cognitively impaired.  
 
Functional neuroimaging studies of divided attention in AD 
A PET study which correlated resting state cortical metabolism with RT during 
auditory and visual a selective attention tasks, as well as during a dual-task paradigm, 
found negative correlations between brain metabolism in the right PFC and parietal 
areas and RT only during the dual-task condition (Nestor et al., 1991). The task 
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required responses to the presentation of an auditory tone or when two serially 
presented visual stimuli were identical. Responses to the visual stimuli therefore 
required working memory, which renders this a dual-task rather than a divided 
attention task, and it would therefore be more reliant on PFC activation.  The results 
from this study indicate an association between resting metabolism and attentional 
performance in AD. 
A PET study using a divided attention task that required subjects to attend to 
and detect a change in frequency in a visual stimulus (a red and black reversing 
chequerboard) or tactile stimulus (vibration applied to the fingers of the right hand), 
demonstrated reduced activation in right cuneus and putamen, and left thalamus in 
AD (Johannsen et al., 1999). A further comparison of patients against controls across 
all attention tasks (divided attention, sustained attention) revealed reduced activation 
in AD in right PFC (BA 47), anterior pole (BA 10, 11) and occipital areas (BA 17). 
Increasing cognitive demand in the face of a limited resource leads to attenuated 
activation within that region and can therefore explain the attenuated activation during 
attention in AD (Goldberg et al., 1998; Nestor et al., 1991). That PFC is a key 
component of the attentional network and attention related PFC activation is related to 
modality independent executive control of attention whereas activation in occipital 
areas in the study above is likely specific to the visual modality. AD neuropathology 
have been demonstrated in the PFC in AD and AMCI (Guillozet et al., 2003; 
Kordower et al., 2001; Markesbery et al., 2006; Riley et al., 2002). The attenuated 
PFC activation may therefore be related to local neuropathology. Alternatively, 
distant pathology may influence PFC due to damaged association fibres or because of 
diminished cholinergic inputs into the PFC caused by neuropathology in the basal 
forebrain area. 
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Functional neuroimaging studies of attention in AMCI 
The study of attention in high-risk AD states has received even less interest to date. 
Apart from our studies, only two other functional neuroimaging studies of attention in 
AMCI have been reported and none on divided attention. The first, an fMRI study 
limited to specific regions of interest (bilateral anterior cingulate, DLPFC and 
posterior parietal cortex), demonstrated greater PFC and posterior parietal cortex 
activation in AMCI patients when they matched the performance of control subjects 
on a task requiring visual sustained attention and working memory (Rosano et al., 
2005). The task required participants to press a corresponding or opposing directional 
button following a probe presented by an arrow, each directional probe was preceded 
by a cue that indicated if responses should be congruent or incongruent with the 
directional. Increased activation whilst maintaining performance indicates that the 
AMCI group found the task more difficult. Interestingly, a parameterised increase in 
task difficulty was associated with greater activation of the posterior parietal cortex in 
AMCI patients, with decrements in speed and accuracy, whereas controls 
demonstrated greater PFC and anterior cingulate activity with a decrement only in 
speed. It is not clear if the failure to increase PFC activity in AMCI was due to a 
limitation in the reserve capacity for PFC activation or to deployment of an alternative 
but unsuccessful cognitive strategy. The second study examined the effects of reward 
on visuospatial attention. In AMCI, negative reinforcement (the prospect of losing 
money) enhanced attentional shifts and this correlated with posterior cingulated cortex 
activation, whereas positive reinforcement (the prospect of winning money) enhanced 
attentional shifts in controls and correlated with activation in orbitofrontal cortex 
(Bagurdes et al., 2008). The authors concluded that their results suggest a 
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reorganisation of the relationships between the limbic system and the spatial attention 
network in AMCI. 
These limited findings indicate impaired sustained attentional processing in 
AMCI associated with PFC dysfunction and altered relationships between the nodes 
in the neural networks that underpin attention; however, due to the task characteristics 
these findings reflect altered processing in attention and executive processing as they 
were not separated. No functional studies of isolated sustained, selective or divided 
attention in AMCI had been published prior to our work and the functional status of 
these attentional conditions were therefore unknown in AMCI. 
The PFC is a key constituent of the working memory network that controls 
attention and memory resources (Baddeley, 1986; Fletcher and Henson, 2001). 
Altered attentional and memory processing in AMCI may be related to impaired 
cholinergic modulation of cortical neuronal responsiveness and I discuss this in the 
next section where we also look at the role of the PFC in more detail.  
 
Summary 
In summary, behavioural findings in AD indicate divided attention as the first non-
memory domain to show impairment following episodic memory deficits, most likely 
because it appears to be the most resource demanding attentional function. Divided 
attention could therefore serve as a potentially useful indicator of early regional 
cortical functional deficits in AMCI patients. Very limited functional neuroimaging 
findings are available for appraisal in AMCI but from these indicate that attentional 
impairment is associated with altered cortical activation. Based on the behavioural 
and functional neuroimaging findings of attention in AD and AMCI we hypothesised 
that AMCI will be associated with divided attention deficits and altered cortical 
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activation because increasing cognitive demand in the face of failing capacity leads to 
attenuated activation of participating brain areas. In the next section we discuss the 
relationships between attention, memory, the PFC and the BFCS as these 
relationships appear relevant to the results of the individual tasks as well as overall 
results of the work I report on here. 
 
1.6 The Regulation of Memory and Attention: The Central 
Executive, Prefrontal Cortex, Basal Forebrain Cholinergic System 
and Brainstem Locus Coeruleus.  
Memory and attention are controlled and optimised by the central executive that is 
closely related to PFC function. Close relationships, as well as significant overlap 
exists between the central executive, PFC, memory and attention. In addition, 
memory, attention and PFC activity are regulated via the BFCS and brainstem locus 
coeruleus. In this section, the PFC, BFCS and locus coeruleus are introduced and their 
relationships with memory and attention discussed. 
 
1.6.1 Memory - Attention Interaction 
The close interaction between memory and attention is complex and the distinction 
between these two cognitive modalities is increasingly less clear (Chun and Turk-
Browne, 2007). Attention is optimised by previous experience on a task because task 
specific learning takes place - a memory effect. For example, practice on a dual-task 
or it subcomponents has considerable beneficial effects on behavioural performance 
during the dual-task.  In turn, memory has a limited capacity and attention plays an 
important role in selecting specific stimuli for encoding.  Consequently, focusing 
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attention on an item during encoding increases retrieval success. It follows that 
memory can be influenced by the demands made on attentional resources (ability to 
attend) and selection (consciously directing resources towards particular stimuli). 
When demands on attentional resources or selection reach critical levels, it can have a 
detrimental effect on memory performance. Disease processes affecting attentional 
resources can therefore impair memory by inhibiting the ability to attend or the 
mechanism of selection. 
Impairment in divided attention or episodic memory is often reciprocated in 
the other. Divided attention deficits impair encoding of contextual information related 
to the episodic memory (source monitoring), which improves recall.  In turn, memory 
deficits result impaired divided attention because the beneficial effects of practice, 
which reduces attentional load via automating parallel processing, are attenuated 
(Johnson, 1997; Sarter and Turchi, 2002; Schneider and Shiffrin, 1977).  Encoding 
processes generally consume more cognitive resources than retrieval processes and 
memory processes overall make large demands on cognitive resources which makes it 
particularly vulnerable to the effects of attention deficits (Craik et al., 1996; Nyberg et 
al., 1997). The bidirectional relationship between divided attention and memory 
appears to explain the rapid decline from early deficits towards generalised cognitive 
impairment and dementia (Sarter and Turchi, 2002). 
These findings indicate the close reciprocal relationship between attention and 
memory and that a deficit in one affects the other; furthermore, they illustrate why a 
thorough investigation of either would require close examination of both.  Memory 
and attention are controlled and optimised by the central executive and we look at this 
next. 
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1.6.2 Central Executive Function 
Working memory refers to a brain system that provides short-term storage of 
information and manipulation of this information that is required to complete complex 
cognitive tasks such as learning, reasoning and language comprehension (Baddeley, 
1986). Working memory is proposed to consist of the central executive, the 
phonological loop, the visuospatial sketchpad and the episodic buffer (Baddeley and 
Della, 1996). In turn the central executive appears to have distinguishable functions 
including the selection and manipulation of information in long-term memory, 
selecting and inhibiting information, attentional control, coordination of two or more 
concurrent activities, and updating working memory. The role of the central executive 
is to optimise memory and control attentional processing. The phonological loop and 
visuospatial sketchpad are materials specific information stores, with limited capacity, 
concerned with the maintenance of verbal and visual spatial information respectively.  
Memory optimisation relies on the executive functions of maintaining, listing, 
comparing and associating information in working memory. Executive control of 
attentional relates to switching, focusing or dividing attention. Memory optimisation 
and attentional control are required because the demands on memory and attention 
vary depending on the task. A dual-task requiring encoding of alternating visual and 
auditory stimuli can be demanding on attentional selection by requiring frequent fast 
switching between sensory modalities whilst having little or no effect on encoding 
selection or resources per se, as long as the stimuli are easily recognisable and 
memorable. Conversely, a dual-task requiring encoding of visual and auditory stimuli 
that are difficult to recognize, as for example faces with a large degree of similarity or 
distorted sound, could tax encoding resources whilst placing relatively little demand 
on attentional selection resources.   
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Central executive function is therefore essential for optimal memory and 
attention performance and executive deficits affect performance to varying degrees 
depending on the characteristics of the task.  Central executive function is strongly 
associated with PFC activation and we look at the PFC in the next section. 
  
1.6.3 The Prefrontal Cortex 
Anatomy 
The PFC corresponds to the lateral aspect of the frontal cortex and is subdivided into 
the dorsolateral prefrontal cortex (DLPFC) and ventrolateral prefrontal cortex 
(VLPFC)(Fletcher and Henson, 2001). The DLPFC loosely consists of the area 
superior to the inferior frontal gyrus and contains BA’s 9 and 46 while the VLPFC 
consists of the lateral aspect of the inferior frontal gyrus and contains BA’s 44, 45 and 
47. The cortical area anterior to the PFC, known as the anterior frontal cortex, 
contains BA’s 8 and 9.  
 
Function  
The DLPFC, VLPFC and anterior frontal cortex areas are involved in working 
memory functions; however, there appears to be a degree of functional specialisation. 
The DLPFC activates more often during tasks requiring manipulation, the VLPFC 
during tasks requiring maintenance of information, and the anterior frontal cortex 
during more complex processes requiring maintenance of goals and products of one 
task while performing another. Furthermore, there is some evidence of lateralisation 
depending on the type of material with left dominance for verbal material and right 
dominance for visuospatial material. (Fletcher and Henson, 2001). 
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The PFC in AD and AMCI 
Episodic amnesia in AD and AMCI can readily be explained by AD pathology in 
MTL areas; however, attention deficits are more likely related to pathology affecting 
areas typically active during attention tasks including the PFC, cingulate and parietal 
cortices. The PFC typically activates during both verbal memory and attention tasks 
and PFC dysfunction could therefore contribute to impairments in both. PFC 
activation during memory and attention tasks appears related to the activity of the 
central executive as discussed above. Neocortical areas including the PFC and parietal 
cortex are already affected by neuropathology in very mild AD and neocortical 
synapse densities in these cortices are highly correlated with dementia severity in AD 
(Morris et al., 1991; Samuel et al., 1994). The attentional and memory deficits evident 
in AD and AMCI could therefore in part be due to interrupted connectivity between 
the PFC and other nodes in the networks supporting these cognitive functions. 
Alternatively, pathology affecting the BFCS and therefore cholinergic modulation 
could account for much of the cognitive impairments seen in the AD spectrum via 
direct effects on cortical areas and/or indirect effects mediated by PFC failure and 
concomitant executive failure. The BFCS provides the main cholinergic innervation 
to all neocortical areas and the hippocampi. It is affected in the very early stages by 
AD neuropathology and already shows evidence of tauopathy in AMCI (Mesulam et 
al., 2004; Mesulam and Geula, 1988). In this section, we have seen the important role 
of executive functioning in memory and attention processing and how this relates to 
the PFC. It is also apparent how the PFC and other cortical areas that constitute the 
networks that support executive functioning, memory and attention can be affected by 
local AD neuropathology or distant pathology affecting the BFCS and thereby 
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cholinergic modulation of cortical processing. These relationships are illustrated in 
Figure 5. We next look at the BFCS in more detail. 
 
Figure 5. Executive control of memory and attention. 
The figure illustrates the role of the central executive part of working memory in 
optimising memory and controlling attention. Memory tasks requiring manipulation in 
working memory (listing, maintaining, comparing or associating items to be encoded) 
activate the prefrontal cortex. Similarly, attention tasks requiring switching, focusing 
and dividing attention activate the prefrontal cortex. The prefrontal cortex appears to 
be a key node in the network that underpins executive functions. Other areas in the 
executive network include the anterior cingulate, premotor areas, limbic system, MTL 
and association cortices. 
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1.6.4 The Role of the BFCS in attention and memory 
Anatomy  
The basal forebrain cholinergic system (BFCS) is the major source of acetylcholine in 
the brain and provides its primary cholinergic input to the hippocampus and 
entorhinal cortex, but it also projects to all cortical areas and to the amygdala (for a 
review see (Auld et al., 2002). Figure 6 illustrates the cholinergic pathways that 
originate from the Ch4 region of the nucleus basalis of Meynert in the human brain. 
The medial bundle supplies areas close to the midline including olfactory, cingulate, 
retrosplenial and medial occipital cortex. The lateral pathway supplies the rest of the 
cortex via two branches. The two pathways merge anterior in the orbitofrontal area 
and posterior in the occipital area. Figure 7 illustrates the major cholinergic afferents 
from the BFCS to the neocortex, entorhinal cortex, amygdala and hippocampus.  
 
 
Figure 6. Cholinergic pathways in the brain. 
This figure illustrates the medial (green) and lateral cholinergic pathways that 
originate from the Ch4 region of the nucleus basalis of Meynert in the human brain. 
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The medial bundle supplies areas close to the midline including olfactory, cingulate, 
restrosplenial and medial occipital cortex. The lateral pathway supplies the rest of the 
cortex via two branches (red and orange). The two pathways merge anterior in the 
orbitofrontal area and posterior in the occipital area. Sections proceed from rostral (A) 
to ventral (C). (Selden et al., 1998). Reproduced by permission of Oxford University 
Press. 
 
Function 
The function of Ach and therefore cholinergic neurotransmission in memory and 
attention processing is discussed in detail in §1.7.1. 
 
The BFCS in AD and AMCI 
From the comprehensive cholinergic innervation of the cerebrum discussed above, it 
follows that AD neuropathology affecting the basal forebrain nuclei could diminish 
cholinergic neurotransmission to all these areas in AMCI and AD. Research findings 
support this notion as cholinergic neurotransmission is prominently affected in AD 
where degeneration of cholinergic neurones of the basal forebrain nuclei leads to 
diminished cortical and hippocampal input (Francis et al., 1999; Perry et al., 1999; 
Sarter et al., 2003). The status of cholinergic neurotransmission in AMCI is less clear. 
Post mortem reports suggest reduced numbers of basal forebrain cholinergic neurones 
(Mufson et al., 2002), but upregulated cholinergic neurotransmission as indicated by 
elevated levels of cholinesterase acetyltransferase (responsible for acetylcholine 
synthesis) (DeKosky et al., 2002). Recent animal studies suggest that upregulated 
cholinergic neurotransmission may be caused by noradrenergic deficits whilst AMCI 
is associated with AD neuropathology in the locus coeruleus that is the source of 
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cerebral noradrenaline. We look at this in detail in the following section (§1.6.5). 
Findings from functional neuroimaging studies are more consistent. PET studies of in 
vivo activity of acetylcholinesterase (AChE), the enzyme that rapidly metabolises 
acetylcholine, have found a similar pattern of deficiency in AMCI as seen in AD 
(Rinne et al., 2003). Furthermore, decreased cortical AChE activity in AMCI 
predicted conversion to AD (Herholz et al., 2005).  A recent PET study using a ligand 
that binds to the most prevalent cortical acetylcholine receptor (nicotinic α4β2 
subtype) reported significantly decreased hippocampal, caudate, frontal cortex, 
temporal cortex, parietal cortex, anterior and posterior cingulated binding in AMCI 
and AD patients compared to controls (Sabri et al., 2008). Acetylcholine receptor 
binding in MTL positively correlated with MMSE scores, indicating that better global 
cognition associates with the availability of more cholinergic receptors. Interestingly, 
it appears that nicotinic acetylcholine receptor binding correlates more with attention 
than with episodic memory as significant correlations have been demonstrated 
between receptor binding (whole brain, frontal association cortex, parietal cortex) and 
measures of attention, with no correlations evident between receptor binding and 
episodic memory in any cortical area in mild AD (Kadir et al., 2006). In summary, 
these findings indicate that AMCI and AD are associated with reduced cholinergic 
innervation and reduced neuronal cholinergic receptors on the background of very 
early pathology in the BFCS, the source of Ach. 
Animal models indicate that BFCS lesions can cause memory deficits in the 
absence of hippocampal damage, apparently mediated via impaired attentional 
modulation rather than specific memory impairment (Auld et al., 2002; Chiba et al., 
1999). The cholinergic hypothesis of cognitive impairment in AD may therefore 
explain impairments in memory and non-memory functions such as attention 
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(Lawrence and Sahakian, 1995; Parasuraman et al., 1995; Parasuraman et al., 1992), 
which are regulated by the BFCS (for a review see (Sarter et al., 2005)).  
Several lines of evidence indicate regulation of attentional processing via 
cholinergic input to sensory cortices where it improves the signal-to-noise ratio 
(signal-driven or bottom-up modulation), and to frontal and parietal cortex where it 
regulates processing in selective cortical areas (task driven or top-down modulation) 
(Sarter et al., 2005). BFCS pathology appears to be the earliest lesions in AD and it 
could affect the MTL via reduced cortical cholinergic innervation disrupting cognitive 
modulation, explaining the amnesia and impairment on other cognitive functions. 
Figure 7 illustrates the cholinergic innervation of various brain areas. The entorhinal 
cortex and hippocampus receive inputs from the medial septal nucleus and diagonal 
band of Broca whilst the nucleus basalis of Meynert projects to the amygdala and 
neocortical association areas. This illustrates how neuropathology affecting any of the 
nuclei that comprise the BFCS can affect memory and attention either directly or 
indirectly.  
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Figure 7. Cerebral cholinergic afferents. 
The figure illustrates the major cholinergic afferents (dashed light blue lines) from the 
BFCS to the neocortex, entorhinal cortex, amygdala and hippocampus.  
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1.6.5 The Role of the Brainstem Locus Coeruleus in Attention and Memory 
The locus coeruleus contributes substantially to the control of attention and memory. 
Its role in cognitive control, small size and vulnerability to AD neuropathology 
highlight it as one of the areas that may be key in the development of AD, similar to 
the BCFS discussed above (§1.6.4). 
 
Anatomy and function 
The locus coeruleus is located in the tegmentum in the brainstem and the sole source 
of noradrenaline to the neocortex, cerebellum, hippocampus and most of the thalamus. 
Noradrenaline from the locus coeruleus regulates attentional selection, arousal, and 
stress reactions related to environmental challenges (Aston-Jones, 2005; Foote et al., 
1983).  
Animal studies indicate that unpredictable but relevant stimuli activate the locus 
coeruleus more than irrelevant stimuli and this holds for multiple sensory modalities. 
The locus coeruleus also shows increased activation under other stressful situations 
including loud noise, punishment, pain, emotionally aversive images of snakes and 
angry faces (Raizada and Poldrack, 2008). 
Lesions of the locus coeruleus, therefore noradrenergic lesions, affect learning 
in animal models and exacerbate the amnestic effects of cholinergic deficits induced 
by either muscarinic receptor blockade or BFCS lesions, on new learning and recall of 
pre-lesion episodic memory (Abe et al., 1997; Murchison et al., 2004; Ohno et al., 
1993; Ohno et al., 1997). Furthermore, experimentally induced lesions of the locus 
coeruleus promote amyloid plaque deposition and neuronal loss in projection areas 
whilst sparing non-projection areas (Heneka et al., 2002; Heneka et al., 2006). These 
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lesions also reduce cerebral glucose metabolism and aggravates memory deficits in a 
transgenic animal model of AD. These findings indicate that noradrenergic lesions 
result in cognitive and metabolic changes characteristic of AD.  
Activation in the locus coeruleus, and in the right PFC, appears to correlate 
with sudden unpredictable increases in task difficulty that constitutes a challenge to 
attentional resources. This was demonstrated by an fMRI study of attentional resource 
allocation during challenging attentional conditions (Raizada and Poldrack, 2008). 
The task for this study employed high intensity visual (flashed white disc) and 
auditory stimuli (bursts of noise) with unpredictable onset. A period of stimulation 
would start with either visual or auditory, or visual and auditory stimulation with the 
latter condition being the most challenging. Increased activation in the locus coeruleus 
and right PFC occurred during the most challenging attentional condition. These 
findings revealed a close correlation between activation in these two areas, indicating 
a high level of functional connectivity that is supported by structural and functional 
connectivity studies in animals. Furthermore, they demonstrated close correlation 
between activation in these areas and task difficulty; however, PFC activation 
increased gradually whilst the brainstem only activated during the most challenging 
conditions. Activation in the locus coeruleus was also correlated with activation in the 
visual, auditory and parietal cortices. The locus coeruleus is the main source of 
noradrenaline to the cortex and this pattern of correlation mirrors that of the known 
widespread projections from the locus coeruleus. The authors suggested their findings 
indicate that meeting attentional demands on challenging tasks are mediated by a 
frontal-brainstem network wherein the brainstem signals the onset of a challenging 
attentional condition and the right PFC allocates cognitive resources. 
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The locus coeruleus in AD and AMCI 
AD neuropathology in the locus coeruleus has long been implicated in the 
pathogenesis of AD and several studies have revealed prominent neuronal loss 
(reaching 70% in the rostral nucleus) and significant reduction of cortical and limbic 
NA levels in AD (Grudzien et al., 2007; Heneka, 2009). The reduction of 
noradrenaline concentration is highly correlated with disease progression, memory 
deficits and cognitive impairment. Findings indicate that more extensive neuronal loss 
in the locus coeruleus correlates better with disease progression compared to 
cholinergic cell loss in the in the nucleus basalis of Meynert (Forstl et al., 1994; 
Zarowet al., 2003). Meta-analysis of locus coeruleus neuronal loss (311 brains from 
24 autopsy studies) indicates that AD patients invariably had substantially reduced 
cell counts (effect sizes = 2.28; 95% confidence interval = 2.06–2.51) (Lyness et 
al.2003). Altered activation in the locus coeruleus in AMCI may be caused by NFTs 
that occur therein in AMCI and AD; the number of NFTs correlate inversely with 
cognitive performance as measured by the MMSE (Grudzien et al., 2007). 
The locus coeruleus contain a small number of neurones, approximately 20 
000 in total, therefore minor pathological lesions can have widespread effects on 
cognition. Serotonin release in the hippocampus, and Ach release in the hippocampus 
and nucleus basalis of Meynert is regulated (inhibited) by locus coeruleus derived NA 
(Siniscalchi et al., 1994), and serotonin and Ach are upregulated in MCI compared to 
both age-matched controls and AD patients (DeKosky et al., 2002; Truchot et al., 
2008). Animal studies reveal that chemical ablation of the locus coeruleus can 
upregulate Ach and serotonin metabolism similar to that reported in MCI (Jackisch et 
al., 2008). These findings suggest that AD neuropathology in the locus coeruleus 
impairs noradrenergic outflow to the cortex and hippocampus in AMCI, resulting in 
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unopposed serotonin and Ach release. Furthermore, findings that indicate synaptically 
linked noradrenergic input from the locus coeruleus to the nucleus basalis of Meynert 
suggest direct modulation of Ach release from the latter by the former (Jones and 
Yang, 1985; Smiley et al., 1999). This has lead to the suggestion that degeneration of 
the locus coeruleus would have to precede degeneration of the nucleus basalis of 
Meynert (and raphe nucleus) in order to give rise to the observed upregulation of Ach 
metabolism in AMCI, followed by the reduction that marks advanced AD (Heneka, 
2009). 
 
The locus coeruleus in ageing 
Locus coeruleus noradrenaline signalling may also play a role in ageing. Performance 
on certain attentional tasks can be restored in aged rats to levels seen in young 
animals by electrical stimulation of the locus coeruleus. Furthermore, memory is 
enhanced by pharmacological manipulation to increase locus coeruleus activity, 
intraventricular transplantation of locus coeruleus neurones, and by direct 
intraventricular infusion of noradrenaline ((Heneka, 2009) and references therein). 
The beneficial effects of increased noradrenergic neurotransmission by these 
manipulations suggest that early AD neuropathology in the locus coeruleus in AMCI 
can exacerbate the cognitive deficits caused by BFCS pathology. However, it remains 
to be established if similar locus coeruleus stimulation will be beneficial in AMCI and 
AD where neuropathology affects connectivity.  
 
Taken together, these findings indicate that AD neuropathology is likely to be present 
in the locus coeruleus in AMCI and that it can have widespread cortical effects that 
can contribute to attention and memory deficits.  
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Summary 
This section has highlighted the interactions between memory, attention, the central 
executive, PFC, BFCS and locus coeruleus. Attention is regulated in sensory cortices 
by the central executive via the PFC and BFCS, and both these areas are regulated by 
the locus coeruleus. Memory is regulated in the MTL by the central executive via the 
PFC, BFCS and locus coeruleus. In addition, memory and attention closely interact. It 
is also apparent how neuropathology affecting the BFCS and locus coeruleus very 
early in the course of AD may account for the widespread cognitive deficits 
associated with AD. In the following section would take a closer look at acetylcholine 
and acetylcholinesterase inhibitor treatment. 
  
1.7 Acetylcholine and Acetylcholinesterase Inhibitor Treatment 
Acetylcholine (Ach) is a neurotransmitter in both the central and peripheral nervous 
systems where it functions as a neuromodulator. The cortical effects of the 
cholinergic system, comprised of the cholinergic neurons and Ach, are predominantly 
excitatory. Cholinergic function plays a role in arousal and reward mechanisms and in 
the regulation of sensory attention and sustained attention. AD neuropathology affects 
cholinergic neurotransmission by damaging cholinergic neurons in the BFCS and 
cholinergic axons. In this section, we look at the role of acetylcholine in memory and 
attention before we look at acetylcholine esterase and acetylcholinesterase inhibitors. 
I will discuss the treatment effects of acetylcholinesterase inhibitors on attention in 
health and on cognitive and behavioural impairments in AD and AMCI 
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1.7.1 The Role of Acetylcholine in Memory and Attention 
Memory 
Acetylcholine (Ach) appears critical for the modulation of memory consolidation. 
Animal studies in the 1950’s and 1960’s showed the beneficial effects of increased 
Ach following acetylcholinesterase inhibitor (ACEI) exposure and the detrimental 
effects of the cholinergic receptor antagonists atropine and scopolamine (which could 
be reversed by ACEI administration) on maze learning in rats (for a reviews see 
(Blokland, 1995; Power et al., 2003).  Increased Ach could potentially influence 
memory directly or via effects on attention. Studies where cholinergic enhancement 
followed the learning phase were able to dissociate its effects on attentional 
processing at the time of learning from its effects on memory consolidation and the 
effects on memory consolidation appear independent of any attentional enhancement. 
Infusion of a cholinergic drug directly into isolated brain areas revealed its strategic 
role in memory consolidation in the amygdala, hippocampus and anterior cingulate. 
Long term disruption of Ach production by local infusion of the high affinity choline 
uptake inhibitor AF64A in frontoparietal cortex resulted in impaired episodic memory 
((Power et al., 2003) and references therein). It appears from these findings that 
cholinergic inputs into the amygdala, hippocampus, anterior cingulate and 
frontoparietal cortex all contribute to normal episodic memory function. Findings 
from functional neuroimaging reveal considerable overlap with these areas in spite of 
being dependent on task design and choice of stimuli. Left prefrontal and MTL 
activation consistently appear during memory processing with less reliable activation 
evident in cingulate, parietal, occipital and other areas (for a review see (Cabeza and 
Nyberg, 2000). Together, these studies demonstrate the key areas where cholinergic 
modulation of episodic memory takes place and again highlight the role of the BFCS, 
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which is the main source of cholinergic innervation to all these areas, in memory 
function. 
 
Attention 
Ach regulates attention by promoting attentional selection and stimulus 
discrimination. It is released diffusely throughout the neocortex during periods of 
increased attentional demand. It regulates processing in higher cortical areas 
(prefrontal) through bottom-up or stimulus-driven effects from sensory cortices and, 
in early sensory cortices (e.g. primary visual cortex) through top-down or task-driven 
effects from higher cortical areas which amplify signal and reduces noise in sensory 
cortices (for a review see (Knudsen, 2007) (McGaughy and Sarter, 1998; Murphy and 
Sillito, 1991; Sato et al., 1987). Information about the world enters the nervous 
system and is processed in sensory cortices where salience filters allow infrequent or 
important stimuli to pass through to higher cognitive processing, this is know as 
bottom-up or signal driven modulation of processing. Signals related to sensory 
information, memories, affective state and movement compete for entry into working 
memory. Goal orientated representations active in working memory can direct top-
down biased signals to regulate the sensitivity of representations that are being 
processed in working memory, i.e. task driven modulation. 
 
Ach therefore appears crucial in memory consolidation and in top-down and bottom-
up regulation of attention. The role of cholinergic neurotransmission in attention and 
memory therefore indicates potentially beneficial effects of increased synaptic Ach 
following ACEI treatment in disease states associated with cholinergic deficits.  In the 
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next section, we look at the enzyme acetylcholinesterase (AChE), which inactivates 
Ach. 
 
1.7.2 Acetylcholinesterase  
Ach released from the axon terminal in response to neuronal depolarisation is rapidly 
hydrolysed to choline and acetate by cholinesterase enzymes. AChE is the major 
cholinesterase enzyme and is found throughout the brain in neurones and axons and 
its action is specific to Ach. Butyrylcholinesterase also metabolises Ach and other 
neuropeptides, it is mainly found in glial and endothelium cells and occurs in high 
concentrations in the hippocampus, thalamus and amygdala (Lane et al., 2006). Ach is 
mainly regulated by AChE with additional regulation from butyrylcholinesterase. It is 
for this reason that AChE became a target of drug development with the potential of 
increasing Ach through inhibition of AChE.  We next look at acetylcholinesterase 
inhibitors (ACEI) and in particular at rivastigmine.  
 
1.7.3 Acetylcholinesterase Inhibitors and Rivastigmine 
There are three main ACEI drugs in general clinical use (rivastigmine, donepezil, 
galantamine) and their introduction followed initial trials with tacrine which was 
discontinued due to more pronounced side effects. Rivastigmine (Exelon – Novartis 
Pharmaceuticals) is a non-competitive inhibitor of AChE (Spencer and Noble, 1998). 
It readily crosses the blood-brain barrier and inhibits AChE and butyrylcholinesterase 
for about 10 hours following a single dose. It is available as oral preparations taken 
twice daily and the daily dose range is between 3mg and 12 mg. The recommended 
dosing regime starts with 1.5mg twice daily and increases in steps of 1.5mg twice 
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daily at intervals of at least 2 weeks. Common side effects include asthenia, anorexia, 
dizziness, drowsiness, nausea and vomiting. Side effects are dose related and 
commonly occur at the start of therapy or when the dose in increased. 
 
1.7.4 ACEI Treatment Effects on Verbal Episodic Memory in Health, AMCI and 
AD. 
Delayed verbal episodic memory as measured by delayed recall of word lists does not 
appear to benefit from ACEI treatment in healthy subjects. A double blind placebo 
controlled treatment trial of donepezil for 30 days, in 30 young healthy adult males, 
revealed improvement on verbal working memory (immediate recall) but not on 
delayed recall after 30 minutes (Gron et al., 2005). A double blind placebo controlled 
trial of 14 days donepezil treatment in healthy elderly subjects (n=26), which used a 
sensitive computerised cognitive test battery, failed to demonstrated treatment effects 
on verbal episodic memory and found impaired working memory and executive 
functioning (Beglinger et al., 2005). The same group also reported absent treatment 
effects on episodic memory and similar impairments on executive functioning and 
working memory in healthy young adults following seven days of donepezil treatment 
(Beglinger et al., 2004).  
Findings from ACEI treatment trials in AMCI have also failed to demonstrate 
clear improvements in verbal episodic memory. A double blind placebo controlled 
study of ACEI treatment effects (donepezil, 28 days) in AMCI patients (n=270) failed 
to demonstrate improvements on delayed verbal episodic memory on the intention-to-
treat, last observation carried forward analysis (Salloway et al., 2004). A large double 
blind placebo controlled trial (n=769) of donepezil and vitamin E treatment for AMCI 
failed to demonstrate improved episodic memory at study endpoint (36 months) as 
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measured by a compound score which included immediate (working memory) and 
delayed verbal recall; however, slight improvements were evident at 18 months 
(Petersen et al., 2005). It is not clear from this report if the improved memory score at 
18 months was due to effects on tests assessing immediate recall, a measure of 
working memory, or on delayed recall, a measure of episodic memory. A meta-
analysis of three unpublished and two published (Petersen et al., 2005; Salloway et 
al., 2004) randomised controlled ACEI treatment trials conducted in AMCI-multiple 
domain, between 1999 and 2004, demonstrated no significant effects on verbal 
episodic memory (Raschetti et al., 2007). A Cochrane review of two published and 
one unpublished double blind placebo controlled trials of donepezil found no 
significant effect on verbal episodic memory (Birks and Flicker, 2006).  
Meta-analysis of rivastigmine and of rivastigmine, donepezil and galantamine 
combined, have not demonstrated any significant treatment effects on verbal episodic 
memory although modest effects were evident on global cognitive performance 
(Birks, 2006; Birks et al., 2000; Birks et al., 2009).  
Taken together these findings in health, AMCI and AD fail to indicate significant 
ACEI treatment effects on verbal episodic memory.  Treatment of cholinergic neurone 
loss by increasing the availability of synaptic Ach has been modelled on the 
replacement of dopamine in Parkinson’s disease and assumes that cortical cholinergic 
inputs have predominantly tonic activity (Sarter and Turchi, 2002). However, it is 
unlikely that the complex neuronal systems mediating episodic memory function 
operate on the basis of tonic activity. Increased synaptic Ach is therefore unlikely to 
replace the functions of presynaptic neurones and may in fact impair the ability of the 
cholinergic system to regulate cortical information processing because of dissociation 
between presynaptic activity and postsynaptic receptors (Bowers et al., 1964; Sarter, 
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1994).  In fact, increased Ach in the synaptic cleft may impair the ability of 
presynaptic neurones to encode information because of excessive autoreceptor 
stimulation by Ach (Becker and Giacobini, 1988a; Becker and Giacobini, 1988b; 
Sarter and Turchi, 2002). The findings in AD can also in part be related to the lack of 
sensitivity of the commonly used outcome measure, the Alzheimer’s Disease 
Assessment Scale (Benge et al., 2009; Rosen et al., 1984). It is as yet not clear why 
visual episodic memory appears to respond to ACEI treatment but not verbal episodic 
memory and it may be related to differential processing of verbal and visual stimuli as 
far as hippocampal involvement in long term storage is concerned (Gron et al., 2005). 
  
1.7.5 ACEI Treatment Effects on Attention in Health, AMCI and AD. 
The effects of ACEI on attentional processing are mediated via task-driven effects in 
prefrontal and parietal cortices and via signal-driven effects in sensory cortices, as 
described above. Only a few behavioural studies have examined the effects of 
prolonged ACEI treatment on attention in healthy subjects in a manner resembling 
clinical treatment. Healthy airline pilots treated with donepezil for 30 days 
demonstrated superior sustained (visual) attention during flight simulator exercises 
compared to treatment with placebo (Mumenthaler et al., 2003; Yesavage et al., 
2002). A similar study in healthy young subjects found improvements in verbal 
working memory and visual episodic memory, but not in attention (Gron et al., 2005).  
The results from these studies do not appear consistent but the reports related to the 
flight simulator exercises lacks sufficient detail to be appraised alongside the later 
study by Gron et al. 2005.  Nevertheless, the findings from single dose and prolonged 
ACEI treatment in healthy controls demonstrate beneficial effects on aspects of 
cognitive processing. 
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Functional neuroimaging studies of attention and working memory have demonstrated 
ACEI effects on behaviour and activation. Given the small number of relevant studies, 
we will look at the findings from behavioural and functional studies in AMCI and AD 
together in this section.  
Improved visual working memory (faster reaction times) together with 
decreased activation in associated frontal cortical regions and increased activation in 
extrastriate visual cortex were reported following single dose physostigmine 
administration in healthy adults (Furey et al., 2000; Furey et al., 1997). The authors 
suggested their findings indicate that improved perceptual processing in primary 
sensory cortices leads to simplified working memory demands which in turn required 
less PFC participation. This conclusion is supported by findings from recent animal 
studies demonstrating that visual cortex stimulation causes increased local 
acetylcholine release via a pathway that proceeds from visual cortex to PFC to the 
basal forebrain and back to visual cortex. Increased sensory cortex responsiveness due 
to physostigmine could consequently require less effort from the PFC to enhance 
sensory cortex excitability (Rasmusson et al., 2007). Physostigmine administration 
also resulted in improved reaction time associated with decreased primary visual 
cortex and increased extrastriate cortex activation during visuospatial working 
memory and selective visual attention tasks with additionally improved accuracy on 
the later (Bentley et al., 2004). These results suggest that the improvements in sensory 
processing during working memory following ACEI treatment is the results of 
improved signal-noise ratios in primary sensory cortices that increases activation in 
secondary sensory areas and reduces the requirements of top-down regulation from 
the PFC. 
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The effects of ACEI treatment on attentional processing have not being 
studied in AMCI; however, the effects on working memory have been studied and we 
will look at the results from these studies. Ten weeks of donepezil treatment improved 
accuracy on a verbal working memory task (n-back, letter stimuli) and this was 
associated with increased left PFC and occipital activation, and decreased left 
temporal activation (Saykin et al., 2004). Increased left PFC activation correlated 
positively with accuracy improvements. Five days of galantamine treatment improved 
speed and accuracy on a visual working memory task (n-back, letter stimuli) and this 
was associated with increased activation in right precuneus and right PFC (BA 9, 47) 
(Goekoop et al., 2004). 
The effects of ACEI on attention have been studied in AD and treatment 
appears to improve attention. Treatment with the ACEI tacrine, which has been 
withdrawn due to adverse effects, improved accuracy and reaction time during 
attention test in AD (Riekkinen et al., 1997; Sahakian et al., 1993). Not all AD 
patients responded to treatment and responders were less impaired on world list recall, 
category fluency, letter fluency and MMSE; furthermore, non-responders 
demonstrated severe frontal dysfunction evident as decreased resting glucose 
metabolism (Riekkinen et al., 1997). The authors interpreted their results as indicating 
that frontal dysfunction due to decreased cholinergic neurotransmission resulting from 
the BFCS pathology blocks the therapeutic effects of ACEI. This makes sense 
because local cholinergic innervation is required for ACEI treatment to take effect on 
cholinergic neurotransmission. A study examining the effects of one year of treatment 
with the newer ACEIs rivastigmine (n=29) or donepezil (n=47) found improved 
sustained attention as measure by the trail making test part A which requires 
participants to connect a sequence of numbers presented on an A4 sized paper 
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(Borkowska et al., 2005). Part A of the trail making test therefore measures sustained 
attention and attentional engagement, disengagement, orientation and re-engagement, 
and time and accuracy are recorded as performance measures. The participants in the 
study did not show any benefits of ACEI treatment on the MMSE or trail making test 
part B. Part B has the same format as part of A but subjects are required to alternate 
between two cognitive sets: sequential numbers and sequential letters of the alphabet. 
The authors concluded that although the treatment improved performance during a 
sustained attention task it did not prevent deterioration in working memory and 
executive functions. A controlled study of donepezil treatment in AD found improved 
accuracy during a selective attention task (Foldi et al., 2005). The task required 
participants to identify and mark target stimuli from amongst distractors on a sheet of 
paper. Accuracy during the task was measured using signal-detection theory similar to 
what we employed for behavioural data analysis and this is discuss in more detail in 
the methods section (§3.9.1.3). The use of signal-detection theory to analyse 
behavioural performance makes it possible to calculate a measure of response bias. 
The study by Foldi et al. found that patients who were treated had a more conservative 
bias in association with improved accuracy. This study had a small sample size (n=17) 
and the authors concluded that using higher order behavioural measures such as signal 
detection theory makes it possible to study the effects of interventions on small 
samples. The results also suggest that increased cholinergic availability directly 
affects attention and that measures of selective attention appear sensitive to detect 
treatment effects. A study which combined behavioural and PET measures to examine 
the effects of 12 weeks of donepezil treatment found that the degree of cortical AChE 
inhibition correlated positively with performance on a working memory task, 
requiring sustained attention and conflict resolution, but not with any measures of 
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episodic memory (Bohnen et al., 2005b). The effects of donepezil on cortical AChE 
inhibition at standard clinical dosing regimes were modest overall (22%) and most 
robust in the anterior cingulated cortex followed by the DLPFC, posterior cingulated, 
parietal and lateral temporal cortices.  It was also demonstrated in this AD group  
(n=15) by comparison to controls (n=12) that mean cortical AChE activity, combined 
for all the regions of interest mentioned above and for the temporal areas separately, 
was significantly associated with measures of attention and working memory but not 
with tests of episodic memory (Bohnen et al., 2005a).  These findings are a further 
indication of the relationship between cholinergic function, working memory and 
attention. 
Taken together these findings indicate improvements in working memory and 
attention following ACEI treatment in health, AMCI and AD that correlate with 
regional cortical metabolism. Improved working memory and sustained attention 
following ACEI treatment may therefore also benefit performance during divided 
attention tasks that make heavy demands on these. 
 
1.7.6 The Current Status of ACEI Treatment in AD and MCI  
Cochrane reviews of treatment efficacy have been completed for rivastigmine, 
donepezil and galantamine and for all three combined in AD (Birks, 2006; Birks and 
Melzer, 2000; Loy and Schneider, 2004). All three ACEI show efficacy on cognition, 
behaviour and everyday activities but these effects are small and do not appear to 
persist beyond 12 months of treatment. It appears that the effects on separate 
cognitive domains such as memory and attention have not reached significance as 
only improvement in global measures such as the MMSE and Alzheimer’s Disease 
Assessment Scale have been reported.  
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A recent review of published and unpublished data concluded that ACEI treatment 
does not have any significant effects on cognition or behaviour in AMCI-multiple 
domain (Raschetti et al., 2007). It did however highlight the variable application of 
available diagnostic criteria for AMCI and the lack of more advanced cognitive 
measures that can examine both cognitive speed and accuracy. It is therefore difficult 
to generalise these results to patients with AMCI and further studies will be required 
to determine if these treatments are of benefit in AMCI. Current national clinical 
guidelines based on available findings do not recommend ACEI treatment in AMCI 
(NICE, 2006 (Amended 2007, 2009)). 
 
Summary 
Acetylcholine plays a pivotal neuromodulatory role in cortical processing of memory 
and attention and cholinergic deficits in AD have detrimental effects on these 
cognitive processes. Cholinergic enhancement in health and AD with ACEIs benefits 
attention and working memory but not episodic memory. It appears from available 
findings that ACEI treatment effects are modest at best and only reliably evident in 
AD and not in AMCI. However, the cognitive impairment in AMCI is mild and only 
modest improvements may be expected from treatment that only partially addresses 
cortical processing deficits. The effects of ACEI treatment on attention had not been 
studied in AMCI and it therefore appeared appropriate to do so with sensitive 
behavioural measures and functional neuroimaging. 
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2. Rationale and Aims of the Thesis  
Prevention is considered the gold standard in health promotion, followed by curative 
and then symptomatic treatment. Developing effective prevention and treatment 
methods requires a detailed understanding of a disease or disorder. The work reported 
in this thesis was undertaken with this purpose in mind.  
 
2.1 Overall Aims 
The overall aims of this study were to: 
1. Investigate if attentional processing is impaired and/or altered in prodromal 
AD.  
2. Determine the neural correlates of the established episodic amnesia in 
prodromal AD.  
3. Determine the functional and behavioural effects of current drug treatments in 
prodromal AD. 
 AMCI is considered a prodromal stage for AD and detailed characterisation of the 
neuropsychological and functional brain changes evident in AMCI could aid in early 
diagnosis, treatment development and treatment response monitoring. 
Early diagnosis is required if early intervention is to be achieved. AD is associated 
with several modifiable risk factors and reliable early identification of AD can allow 
targeted prescription of risk-modifying treatments that may be costly and associated 
with side effects. Understanding AD disease mechanisms and their effects on brain 
function is essential for the development of targeted treatments. Functional 
neuroimaging increasingly appears to be a valuable research method that allows 
investigation of brain function in vivo. Measuring treatment effects using 
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neuroimaging allows greater understanding of disease processes and can aid in 
treatment development by indicating cortical areas displaying treatment response.  
This work sets out to answer the following questions:  
1. Is divided attention impaired in AMCI as predicted, and if so, what are the 
neural correlates? 
2. Is there evidence of altered visual and auditory attentional processing in 
AMCI that could contribute to divided attention deficits and amnesia? 
3. Is the amnesia in AMCI related to failing executive control of encoding 
processes and if so, what are the neural correlates? 
4. What are the effects of ACEI treatment on attention in AMCI? 
I set out the rationale and specific hypothesis for each of the experiments below in 
turn. 
 
2.2 Divided Attention 
Divided attention deficits had been predicted in the prodromal stages of AD because 
attentional deficits were found in very mild AD and typically followed the onset of 
episodic amnesia (Chun and Turk-Browne, 2007; Perry and Hodges, 1999). Divided 
attention appears to be the first non-memory cognitive domain affected in AD. It 
makes heavy demands on the distributed cortical network that support attention; 
furthermore, key areas in this network are affected by AD neuropathology in AMCI 
and divided attention is therefore likely to be affected in prodromal AD. Attentional 
deficits had been demonstrated in the more heterogeneous MCI group and these were 
associated with increased dementia conversion risk (Levinoff et al., 2005; Nestor et 
al., 2004). The few studies of attention in AMCI have found behavioural deficits on a 
task requiring selective attention and a task requiring working memory that controls 
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the allocation of attentional resources (Bozoki et al., 2001; Perry and Hodges, 2003). 
These results appear to indicate a failure of attentional selection or top-down (task 
driven) control of attention. Top-down attentional control is associated with activation 
in the PFC and parietal areas, key constituents of the attentional network, and appears 
mediated by cholinergic neurotransmission. AD neuropathology affect processing in 
PFC and parietal areas directly (via local neuropathology) and indirectly (via 
decreased cholinergic neurotransmission due to basal forebrain neuropathology) early 
in the course of AD. These findings in addition to the cholinergic hypothesis of AD 
form the rationale for expecting divided attention deficits associated with altered 
cortical activation, and ACEI treatment response in AMCI. 
Attentional deficits have been associated with reduced activation in right PFC, 
anterior pole and occipital areas in AD and this could be explained by the finding that 
increasing cognitive demand, in the face of limited resources, commonly leads to 
attenuated activation within that region (Goldberg et al., 1998; Nestor et al., 1991). 
The PFC is a key component of the attentional network and AD neuropathology has 
been demonstrated in the PFC in AD and AMCI (Guillozet et al., 2003; Kordower et 
al., 2001; Markesbery et al., 2006; Riley et al., 2002). Divided attention is strongly 
associated with activation in the PFC, which already demonstrates AD 
neuropathology in AMCI, and is therefore likely to be affected in AMCI. Functional 
neuroimaging could reveal evidence of functional abnormalities even in the absence 
of behavioural deficits, as demonstrated by the studies on memory processing in other 
high-risk AD groups (Bookheimer et al., 2000; Johnson et al., 2006b; Smith et al., 
1999). We therefore examined divided attention in AMCI for evidence of the 
predicted functional and behavioural deficits. 
Hypotheses: 
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1. Behavioural deficits will be evident during divided attention in AMCI. 
2. Altered cortical activation will be evident in attention processing areas during 
divided attention in AMCI. 
 
2.3 Visual and Auditory Selective Attention 
Basic sensory attention processing had not been investigated in prodromal AD in spite 
of the fact that deficits in basic attention processing may affect higher order 
processing during divided attention and encoding. Altered cortical activation had been 
reported in advanced AD; PET imaging studies of visual attention of AD have found 
reduced activation in occipital visual areas (Johannsen et al., 1999). However, 
primary sensory areas are spared from AD neuropathology until the more advanced 
stages. The status of basic sensory attention processing therefore remained to be 
determined in prodromal AD and we therefore decided to examine basic visual and 
auditory attention processing.  
Hypotheses: 
1. Based on the relatively late appearance of AD neuropathology in sensory 
cortices, we hypothesised that functional brain activation would be unchanged 
compared to controls in AMCI. 
 
2.4 Verbal Episodic Memory 
The functional correlates of the characteristic episodic memory impairment in AMCI 
remains to be established and most of the studies that had been conducted examined 
visual memory. However, verbal memory tests are used routinely in clinical practice 
and modern life is heavily dependent on language. Furthermore, functional 
neuroimaging studies of memory in AMCI have almost exclusively focussed on the 
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MTL areas in spite of the fact that memory is processed by a network of areas. It is 
therefore appropriate to investigate verbal memory processing in prodromal AD using 
whole brain fMRI. The MTLs are essential for episodic encoding and the PFC also 
makes important contributions to memory processing (§1.4.2.1-2). MTL lesions cause 
dense amnesia for events and their context and PFC lesions cause amnesia for 
context; furthermore, the MTLs and left PFC consistently activation during verbal 
episodic encoding (§1.4.2.3). Left PFC activity relates to deep meaning-based 
(semantic) processing which optimises memory and disruption of semantic 
elaboration results in decreased left PFC activation and reduced memory 
performance. Additionally, the extent of activation of the left PFC and hippocampus 
during verbal encoding correlates positively with subsequent successful recognition. 
Moreover, AD neuropathological has been found in the PFC and MTL in AMCI 
(§1.2.2). Taken together, the role of the PFC in episodic memory and the early 
appearance of AD neuropathology that can affect PFC function suggest that episodic 
amnesia in prodromal AD may in part be due to PFC dysfunction. 
We therefore set out to study verbal episodic encoding and retrieval in AMCI 
by comparison to controls. In order to study functional activation related to verbal 
encoding and the possible contributions of executive failure to impaired encoding in 
AMCI, we employed whole brain fMRI and a verbal encoding task sensitive to 
semantic elaboration (§3.9.3.1). The episodic memory paradigm requires semantic 
elaboration and can therefore examine PFC function as described above. The 
combination of sensitive measures of encoding with fMRI allows correlation analyses 
between brain activation and behaviour that could provide additional support for any 
observed associations. 
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Hypotheses: 
1. Based on the established roles of the MTL and PFC in episodic memory 
encoding and the consistent activation in these areas during functional 
neuroimaging we hypothesised that PFC activation would correlate with 
semantic processing as revealed by recognition performance. 
2. Recognition would be impaired in AMCI and associated with altered 
activation in PFC and/or medial temporal areas. 
 
2.5 ACEI treatment Effects on Attention and Episodic Memory in 
AMCI.  
Impaired cholinergic neurotransmission due to BFCS pathology and the strong 
associations between attention, memory and cholinergic function, provided the 
rationale for treating AD with interventions that prolong the effects of Ach in 
synapses. The gradual accumulation and NFTs in the BFCS, which correlates with 
memory function, provided the rationale for similar treatment in AMCI (§1.1.2). 
Attention and memory are powerfully regulated by Ach; nevertheless, the effects of 
ACEI treatment on attention and verbal episodic memory had not been studied 
conclusively in AMCI although ACEIs had been available for the treatment of AD for 
some time.  
Studies of ACEI treatment in health and AMCI indicate beneficial effects on 
cortical activation and on working memory, which controls attention (§1.7.5). 
Improved visual and visuospatial working memory (faster reaction times) associated 
with decreased PFC and primary visual cortex activation and increased extrastriate 
visual cortex activation have been found in healthy adults following ACEI treatment 
(Bentley et al., 2004; Furey et al., 2000; Furey et al., 1997). Studies of ACEI 
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treatment on working memory in AMCI have found improved accuracy and speed, 
associated with increased PFC and occipital activation and decreased temporal and 
precuneus activation (Goekoop et al., 2004; Saykin et al., 2004). Furthermore, ACEI 
treatment has been found to improve sustained and selective attention in AD 
(Borkowska et al., 2005; Foldi et al., 2005). Taken together these findings suggest that 
ACEI treatment may improve divided attention in AMCI as it depends on working 
memory and on the attentional processes that underpin sustained and selective 
attention. These behavioural and associated functional neuroimaging findings 
provided the rationale for studying the effects of rivastigmine on basic sensory 
attention and divided attention in AMCI with fMRI. 
Verbal episodic memory, as measured by delayed verbal recall, is not significantly 
improved by ACEI treatment in healthy adults (Gron et al., 2005). Furthermore, ACEI 
treatment does not appear to benefit verbal episodic memory in AMCI. Five 
randomised controlled ACEI treatment trials were conducted in AMCI-multiple 
domain between 1999 and 2004, of which two were published (Petersen et al., 2005; 
Salloway et al., 2004), and meta-analysis of these five trials demonstrated no 
significant effects on verbal episodic memory (Raschetti et al., 2007).  
The premise of the follow-up study was that the impaired cholinergic 
neurotransmission in AMCI, which leads to attentional deficits and altered cortical 
activation, would respond to ACEI treatment and result in normalisation of attentional 
processing. 
Hypotheses: 
1. Rivastigmine treatment would improve speed or accuracy during divided 
attention in AMCI. 
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2. Rivastigmine treatment would decrease PFC activation and/or increased 
secondary sensory cortex activation during divided attention. 
3. Rivastigmine treatment would decrease primary sensory cortex activation 
during selective visual and auditory attention. 
4. Verbal episodic memory would not improve following rivastigmine treatment. 
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3. Methods 
In this chapter, we take a detailed look at the methodology used for this study. 
- Section 3.1 considers ethical issues related to early diagnosis and how this 
applies to AMCI, and particular issues related to the study I report on here.  
- Section 3.2 describes the study design. 
- Section 3.3 describes recruitment methods, Section 3.4 the AMCI sample, and 
Section 3.5 the control sample. 
- Sections 3.6 and 3.7 describes the clinical neuropsychological tests and 
behavioural measures. 
- Section 3.8 deals with fMRI methods and analysis. 
- Section 3.9 provides detailed descriptions of the cognitive paradigms. 
- Section 3.10 describes the additional methods and post hoc analyses. 
 
3.1 Ethical Considerations 
Early diagnosis is associated with ethical dilemmas for patients and healthcare in 
terms of emotional response and interventions. The response to early diagnosis 
depends mainly on the perceived seriousness of the disorder and on the effectiveness 
and availability of treatment. Early diagnosis of a curable tumour is therefore less 
likely to have adverse psychological effects compared to the diagnosis of a late 
emerging outosomal dominant disorder, like Huntington’s disease in a patient who 
already had offspring. Patients are faced with the prospect of knowing the likely cause 
of their death if the disease is terminal, like AD. Patients given this advanced warning 
may react by changing their lives to reflect neglected values such as relationships and 
desired experiences and this can often lead to a renewed appreciation of the world. 
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For other people it may be socially stigmatising and detrimental to their self-image. It 
can also have serious consequences for employment and financial matters such as 
investments and insurance. The impact on patients will also depend on the life stage 
in which they find themselves. Old age and retirement are associated with lower 
health expectations and poorer outcomes but younger patients usually have more 
dependents, and higher health and personal expectations.  
Advances in healthcare are at present moving steadily in the direction of early 
diagnosis and intervention on the back of advances in genetics. This may in time lead 
to changing public perceptions of what normal means. As I indicated in Section 1.3, 
for humans being ill appears to be the norm, whilst what is considered a disease or 
disorder depends on cultural as well as scientific values. 
The main concerns from critics of AMCI and AD centre on the ethics of 
making a diagnosis of AD or prodromal AD when it is occasionally incorrect and at 
present invariably incurable and poorly responsive to treatment. The ethics 
concerning a diagnosis of MCI, the more heterogeneous condition, has been 
considered in some detail and I will summarise the main issues that also apply to 
AMCI (Werner and Korczyn, 2008). Revealing a diagnosis relieves anxiety about 
symptoms by putting a label on them and allows patients to be involved in decision-
making regarding their future. Concerns about disclosing a diagnosis include 
precipitating fear, distress and depression, and reducing hope and positive thinking. 
However, available findings do not support this in AD and it has not been studied 
conclusively in MCI. The situation in MCI is more complex due to uncertainty 
concerning the prognosis, as not all cases will progress. The authors stress that this 
point is particularly valid in sites where there are fewer experts knowledgeable about 
the complexities of the diagnosis of MCI. This point is not unique to MCI and pooling 
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expertise and using combinations of measures that improve sensitivity and specificity, 
as implemented in our memory clinic, are reliable methods for increasing diagnostic 
accuracy that reduce the ethical dilemmas associated with inaccurate diagnosis. The 
emergence of AMCI as a more specific prodromal stage for AD and the available 
evidence supporting its validity should resolve some of the dilemmas associated with 
MCI. The level of stigma associated with MCI or AMCI is not certain yet and it will 
likely be influenced by the effectiveness and availability of treatment, and by the 
possibility of restrictions imposed on certain high-risk activities such as driving.  
In our memory clinic we deal with some of these ethical dilemmas by asking 
patients and their families if they want to know the outcome of the assessment. 
Patients unaware of their diagnosis can be managed as such in clinical settings. 
However, it is difficult to recruit such patients into research studies with potential 
adverse effects that must be explained so that informed consent can be obtained. It is 
rare in our clinic sample that patients prefer not to know their diagnosis and all the 
potential participants we approached knew their diagnosis.  
Research on patients with cognitive impairment requires additional 
consideration and care in terms of obtaining informed consent. The AMCI group in 
particular could have trouble in retaining information on which to base a decision. 
Approval for the study was obtained from the West Essex Local Research Ethics 
Committee and all participants provided written informed consent.  In obtaining 
consent, we allowed sufficient time for participants to digest and discuss the proposed 
studies with relatives and took care to simplify and repeat information. 
We thought that the extended travel involved in attending the scanning facility 
as well as noise from the scanner would be the most taxing aspects. Reports from 
participants confirmed that the procedures were noise but travel was not mentioned as 
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a problem. During the scanning sessions participants were familiarised with the 
environment before functional scanning commenced, they also had constant access to 
an emergency call button. 
The move towards earlier diagnosis assisted by advances in biotechnology is 
gathering pace. This will present us with new ethical dilemmas related to diagnostic 
disclosure, treatment and research participation, with advances in ethics more likely to 
follow technical advances. We are therefore left with the general principals of ethics 
to guide us. 
 
3.2 Study Design 
A controlled observational trial design was used to examine divided attention, verbal 
episodic memory encoding and recognition, and selective visual and auditory 
attention in AMCI. For this purpose we recruited a AMCI sample (AllAMCI) and 
follow them to also identify the subgroup that converted to AD after 2 years 
(CoAMCI)(also see §4.1). A controlled, repeated measures design was used to 
examine the treatment effects of rivastigmine on cognition in AMCI and involved 
comparing treated (RivAMCI) and untreated (NxAMCI) at baseline and after 12 
weeks on repeated measures. The total sample of participants was therefore stratified 
into four AMCI patient groups and one Control group. For the repeated measures 
design, we used different stimuli to control for learning effects whilst the rest of the 
methodology remained unchanged. The first participant was recruited and scanned in 
March 2003 and data collection was completed in October 2008.  
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3.3 Participant Recruitment 
We recruited participants diagnosed with AMCI from known patients and new 
referrals attending the Derwent Memory Clinic at St Margaret’s Hospital, Essex, and 
controls from patient’s relatives, friends and staff. All participants were studied at 
baseline and at 12 weeks follow-up. The first AMCI group recruited (RivAMCI) 
received rivastigmine after baseline for 12 weeks until follow-up. Because inclusion 
of an untreated AMCI group would likely improve the analysis of treatment effects, 
we later recruited the untreated comparison AMCI group (NxAMCI) when additional 
funding became available. The NxAMCI group (n=10) was scanned using the same 
parameters but they did not receive treatment. 
 
3.4 AMCI Patients 
We recruited right-handed patients diagnosed with AMCI from the Derwent Memory 
Clinic at Princess Alexandra and St Margaret’s Hospitals in North Essex. The clinic 
was established in 1993 and takes referrals from general practitioners and specialists 
in the area, for patients with cognitive impairment. Consultant psychiatrists and 
trainees, under close supervision of senior clinicians, carry out assessments after 
training and instruction on the specific procedures that include taking a detailed 
history, conducting a thorough physical examination, and use of special 
investigations. Particular emphasis is placed on examination of the neurological and 
cardiovascular systems that are vulnerable to many disorders that can present with 
cognitive impairment. 
Around 260 assessments are carried out annually and are comprised of both 
follow-up and initial assessments. The clinical population is aetiologically varied and 
in 2008, out of the 111 new patients, we diagnosed: 5 with vascular dementia, 2 with 
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Lewy body dementia, 24 with AD, 7 with frontotemporal dementia, 10 with mixed 
AD-vascular dementia, 3 with Parkinson’s disease dementia, 27 with AMCI (single 
and multiple domain), 7 with subjective cognitive impairment, 7 were unclear, 2 with 
unspecified dementia, 5 with depressive disorder, 2 with anxiety disorder and 10 with 
other disorders. As part of the assessment, the psychiatrist completes a standard 
battery of behavioural scales. The scales have been selected to elucidate and measure 
dementia symptoms. An assistant neuropsychologist, supervised by a clinical 
neuropsychologist, carries out a comprehensive neuropsychological test battery on all 
referrals and follow-up patients. Additional neuropsychological testing is undertaken 
when results from the standard batteries are equivocal. Assessments are discussed in a 
weekly multidisciplinary meeting that includes psychiatrists and neuropsychologists, 
and consensus diagnoses are recorded. Clinicians have access to routine structural 
imaging results (magnetic resonance imaging, computed tomography) during 
diagnostic meetings and metabolic imaging (dopamine transporter PET, glucose PET) 
is requested when indicated. Patients receive annual follow-up until a stable diagnosis 
of dementia is returned for more than a year. Assessment data are entered on a central 
database from where potential research participants can be identified.  
Participants in this study were diagnosed with AMCI using specific 
operational criteria (Petersen et al., 2001) which included: (1) memory complaint 
corroborated by an informant, (2) abnormal memory function documented by 
impaired recall on the New Learning subscale of the CAMCOG (Roth et al., 1986), 
(3) preserved general cognitive function based on  a Clinical Dementia Rating Score ≤ 
0.5 (Morris, 1993) and CAMCOG total score within 1 SD of population mean for age 
(≥78 for age <79 years; ≥75 for age>80 years), (4) intact activities of daily living, (5) 
and not meeting National Institute of Neurological and Communicative Disorders and 
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Stroke/Alzheimer’s Disease and Related Disorders Association criteria for AD 
(McKhann et al., 1984). The New Learning subscale score, which contributes to the 
memory subscale of the CAMCOG, was used as a measure of delayed recall. It is 
comprised of free recall (6 marks) followed by recognition (6 marks) of 6 pictured 
items (shoe, typewriter, scales, suitcase, barometer and lamp) encoded during a 
picture naming task, and delayed free recall of a 5 item address verbally encoded and 
written by subjects, to make a total score of 17. Episodic memory was considered 
impaired if there was a clear discrepancy between memory performance on the New 
Learning subscale and premorbid IQ as measured by the National Adult Reading Test 
(Nelson, 1982). We used a cut-off score ≤12 (1.5 SD below population mean) for 
subjects with average IQ and a cut-off score ≤ 14 for above average IQ based on 
published population data (Huppert et al., 1995). In addition to applying the criteria, 
patients were screened for any other identifiable medical or psychiatric cause of 
cognitive impairment. All participants received face-to-face feedback on their 
assessment from one of the memory clinic specialists. 
Potential participants were identified from existing AMCI patients on the 
database and from new referrals. Their case notes were systematically reviewed for 
diagnostic accuracy and for the presence of exclusion criteria relevant to fMRI. 
Patients presenting with significant vascular risk factors attracting modified Hachinski 
score ≥ 4 were excluded as they were at increased risk of having significant comorbid 
cerebrovascular disease (Hachinski et al., 1975). FMRI exclusion criteria included 
general exclusion criteria for MRI and additionally being predominantly left handed 
and having facial tattoos or extensive metal dental implants. Being left handed is 
avoided in fMRI especially when motor responses are required due to differences in 
hemispheric dominances which can influence inter-subject comparisons.  Handedness 
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was assessed using the Edinburgh Handedness Inventory (Oldfield, 1971).  Patients 
were also excluded if they suffered claustrophobia, were unable to lie supine for an 
hour, or had visual or hearing impairment that could not be corrected with aids.  
Visual impairment was corrected prior to scanning by using lens prescription 
information and fMRI compatible glasses. Hearing impairment was corrected prior to 
commencing scanning by adjusting the respective channel volume of the stereo fMRI 
compatible headphones. 
 
3.5 Controls 
Right-handed healthy control subjects, with no evidence of cognitive impairment 
were also recruited from relatives, friends of patients, and staff. Control subjects 
completed a neuropsychological test battery consisting of the CAMCOG and MMSE, 
in order to exclude cognitive impairment. Controls had to be on a stable dose of any 
medication they were prescribed for 6 months and were excluded if they were on any 
psychotropic drugs. 
 
3.6 Neuropsychological Measures 
The standard neuropsychological test battery used for assessments in our memory 
clinic includes the following measures: CAMCOG, MMSE, Wechsler Memory Scale 
- III Logical Memory Test (Wechsler, 1997), Halstead Trail Making test parts A and 
B (Davies, 1968), NART, Verbal Fluency and Category Fluency (Lezak, 1995). The 
CAMCOG, and specifically the New Learning subscale, are relevant to this thesis and 
will be discuss in more detail. 
The CAMCOG is a self-contained part of the Cambridge Examination for Mental 
Disorders of the Elderly (CAMDEX) (Roth et al., 1986). It is a standardised 
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instrument used to assess the level of cognitive impairment and therefore the extent of 
dementia. It assesses orientation, language, memory, praxis, attention, abstract 
thinking, perception and calculation. The CAMCOG consists of 67 items and includes 
all the items from the MMSE. It is divided into 8 subscales: orientation, language 
(comprehension and expression), memory (remote, recent and new learning), 
attention, praxis, calculation, abstraction and perception. The orientation subscale is 
comprised of 10 items taken from the MMSE. The language subscale assesses 
comprehension through verbal and nonverbal responses to spoken and written 
questions. Language expression is assessed through tests of naming, repetition, 
fluency and definitions. The memory subscale assesses remote memory (famous 
events and people), recent memory (news items, prime minister, etc.), and new 
learning (the recall and recognition of non-verbal and pictorial information learned 
intentionally as well as incidentally). New learning is comprised of free recall 
followed by recognition recall of 6 pictured items encoded incidentally during a 
picture naming task, and delayed free recall of a 5 item address verbally encoded and 
written by subjects. Attention is assessed by subtracting sevens serially from 100, and 
by counting backwards from 20. Carrying out instructions, copying, drawing, and 
writing assesses praxis. Performing addition and subtraction involving money is used 
for assessment on the calculation subscale. Questions on the similarities between 
items an apple and a banana, a shirt and a dress, a chair and a table, and a plant and an 
animal are used for the abstraction subscale. For the perception subscale, famous 
people and familiar objects viewed from unusual angles have to be identified from 
photos shown. The total score is 107 and the score for each subscale is as follows: 
• Orientation - 10 
• Language comprehension - 9 
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• Language expression - 21 
• Remote memory - 6 
• Recent memory - 4 
• New learning - 17 
• Attention/calculation - 9 
• Praxis - 12 
• Abstract thinking - 8 
• Perception - 9 
Population norms are available for total and subcategory scores. We used these norms 
to calculate cut-off scores for the New Learning subscale to verify episodic memory 
impairment. Episodic memory was considered impaired if there was a clear 
discrepancy between memory performance on the New Learning subscale and 
premorbid IQ as estimated by the National Adult Reading Test (Nelson, 1982). We 
used a cut-off score ≤12 (1.5 SD below population mean) for subjects with average IQ 
and a cut-off score ≤ 14 for above average IQ based on published population data 
(Huppert et al., 1995). The New Learning task controls for the effects of attention and 
includes both free recall and recognition recall, with the latter appearing more 
sensitive at distinguishing AMCI from normal ageing (Anderson et al., 2008; Bennett 
et al., 2006; Westerberg et al., 2006). Episodic memory measures can be confounded 
by rehearsal of studied items in working memory. Rehearsals is curbed on the New 
Learning task by requiring completion of unrelated tasks during a time delay between 
encoding and recall phases. 
 It is apparent from the description of the CAMCOG and New Learning 
subscale that these measures are similar to those discussed in Section 1.2.3 that have 
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high sensitivity and specificity in identifying individuals with progressive AMCI. 
This increases the validity of considering our AMCI sample as prodromal for AD. 
  
3.7 Behavioural Measures 
Our standard memory clinic assessment involves completion of behavioural measures 
included to aid in the identification of comorbid disorders and to quantify impairment. 
These include measures of everyday functioning: Instrumental Activities of Daily 
Living (Lawton, 1969), Clinical Dementia Rating (CDR)(Morris, 1993). We also use 
the Geriatric Depression Scale to screen for depression, which due to associated 
cognitive impairment requires exclusion for a more valid diagnosis of AMCI.  
The Instrumental Activities of Daily Living scale is used to ascertain if there 
are any impairments in everyday activities, which if present would indicate dementia 
rather than AMCI. The activity areas covered included telephone use, shopping, food 
preparation, housekeeping, washing laundry, transportation, responsibility for own 
medications and ability to handle finances. Impairment in any of these areas can be 
due to cognitive and/or physical impairment and this distinction is considered when 
functional impairment is evaluated. 
The CDR measures functioning in six domains:  memory, orientation, 
judgment and problem solving, community affairs, home and hobbies, and personal 
care. It yields a global score and a summated score (sum of box score) and is used to 
measure dementia severity and change in everyday activities in response to treatment 
in MCI (Petersen et al., 2005). A diagnosis of AMCI is compatible with a global score 
of 0.5 if this results from a 0.5 score in the memory domain. A 0.5 score in the 
memory domain indicates “consistent slight forgetfulness; partial recollection of 
events; benign forgetfulness”. A score of more than 0.5 is more indicative of dementia 
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as it implies impaired everyday activities whilst a score of 0 indicates the absence of 
persistent memory complaints that is therefore incompatible with AMCI. We 
diagnosed AMCI when the score was equal to 0.5. Another way to use the CDR is to 
add up the scores from the domain boxes and this sum of box score is predictive of 
progression to dementia. The likelihood of dementia increases by a factor of 2.3 for 
every point increase on the CDR sum of box score (Lynch et al., 2006). The sum of 
boxes score appears to be a more sensitive indicator of severity than the global score 
as the range of possible scores is wider. We used the CDR global score to aid in 
diagnosis and the sum of boxes score to investigate the difference between the treated 
and untreated AMCI groups, which I discuss later. 
3.7.1 Statistical Methods for Behavioural Data Analyses 
Analysis of variance (ANOVA) was used to compare behavioural data between 
groups on normally distributed data with homogeneous variances. Data violating 
normality assumptions were compared using the Mann-Whitney analysis with 
Kruskal-Wallis Exact tests. Repeated measures factorial analyses were conducted to 
examine for interaction effects on repeated measures. All data were analysed in SPSS 
12 for Microsoft Windows. The coefficient of determination, R2 is reported as a 
measure of effect size: ±0.01 = a small effect, ±0.10 a medium effect, ±0.25 a large 
effect. R2 indicates how much of the variability in one measure is accounted for by the 
measure it correlates with; R2 multiplied by 100 gives the percentage of variability 
e.g. R2=0.30 indicates 30% variability explained by the correlate. 
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3.8 Functional Magnetic Resonance Imaging 
Functional neuroimaging increasingly appears to be a valuable research method that 
allows investigation of brain function in vivo. It can identify brain areas 
demonstrating increased or decreased activity at rest or during specific task 
conditions. To this end, groups can be compared on activation maps and altered 
activation patterns in clinical populations may indicate disease related activation 
failure and/or compensatory activation in other areas (for a review in AD and ageing 
see (Han et al., 2009). For example, studies of subjects at high-risk of AD by virtue of 
a positive family history have found alterations in cortical activation whilst matching 
the performance of controls (Bookheimer et al., 2000; Johnson et al., 2006b; Smith et 
al., 1999). These findings may indicate the consequence of local neuropathology or 
distant neuropathology resulting in reduced neural input to the areas, and/or 
compensatory recruitment of extra neurones, or increased firing rates of neurones 
required to match the performance of controls. Correlation between the magnitude of 
activation and behavioural measures can be examined and compared to results in 
controls. Loss of normal correlation associated with behavioural impairment indicates 
deficits in the area or network that supports the behaviour. The effects of drug 
treatment and other interventions on brain function can also be studied using fMRI 
(for a review see (Dickerson, 2007). Treatment effects may be indicated by the 
restoration of normal activation patterns and correlations. It may also be evident from 
factorial analysis of data from repeated measures in treated and control groups by the 
presence of Group x Time interactions. Interaction effects indicate that activation 
varied significantly over time between the groups as a consequence of the intervention 
under investigation. Measuring treatment effects using neuroimaging allows greater 
understanding of disease processes and can aid in treatment development by 
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indicating cortical areas displaying treatment response.  We next look at the 
theoretical background, technical aspects and statistical analysis of fMRI in more 
detail. 
 
3.8.1 Biophysics  
FMRI is a whole brain functional imaging modality that employs the difference in 
magnetic properties between oxygenated and deoxygenated haemoglobin to estimate 
changes in blood oxygenation and by further inference neuronal activity. Neuronal 
activity results in an initial decrease in oxyhaemoglobin due to increase oxygen use, 
followed by a relative over supply of oxyhaemoglobin, peaking between 4 and 8 
seconds after the onset of activity, due to local vasodilatation via neurovascular 
coupling (Villringer and Dirnagl, 1995). The signal detected is known as the blood 
oxygenation level dependent (BOLD) signal and appears to be generated by the 
combined post synaptic activity of large populations of neurones thus, fMRI allows 
examination of cognition at a system level (Logothetis, 2002; Logothetis et al., 2001; 
Rugg et al., 2002). FMRI, at the commonly used 1.5 Tesla field strength, has a finer 
temporal (typically a few seconds) and spatial resolution (typically 3mm x 3mm x 
6mm) than positron emission tomography (PET) and single photon emission 
tomography. This makes it particularly useful in investigating higher cognitive 
processes such as memory and attention on tasks with durations ranging from a few 
seconds to minutes. Cognition is examined by comparing the cognitive function of 
interest, such as verbal episodic encoding, to a reference or control condition; 
activation during the control condition is subtracted from activation during the 
experimental condition. By matching the experimental condition and the control 
condition as closely as possible, apart from on the cognitive function of interest, 
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activation only evident during the experimental condition can be inferred as specific 
to that function. This type of design is typically implemented in a block-designed 
paradigm where blocks of the experimental condition are alternated with blocks of the 
control condition. 
 
3.8.2 Imaging Sessions 
Participants were transported, accompanied by the researcher, to the Institute of 
Psychiatry by private taxi on the day of scanning. All task procedures were revised in 
a dedicated room prior to scanning. Patients were positioned in the scanner after site-
specific consent was obtained and fMRI safety checks performed by the 
radiographers. 
Participants held a three-button response box in their left hand during scanning 
sessions; they responded with the index, middle and ring fingers of the right hand.  
The button box was designed specifically for the study and the buttons were laid out 
so that they were easily accessible and provided tactile feedback when a response was 
made. 
Before fMRI could commence, a localiser and a high-resolution structural 
scan were obtained on which any imaging artefacts would be apparent. Participants 
with poor alignment evident from these scans were repositioned. For follow-up scans, 
participants were carefully positioned so that head alignment fell within 1° of 
previous alignment parameters in order to optimise transformation of functional data 
to structural templates. 
Auditory and visual stimulus perception was tested before functional scanning 
was commenced. The instructions for each task were repeated immediately prior to 
scanning. Participants were able to indicated distress or discomfort by pressing an 
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emergency button or by speaking to the research team via a microphone mounted on 
the head coil. 
 Functional and structural scans were acquired in a sequence dictated by task 
design. The sequence was as follows: High resolution structural scan, visual-auditory 
attention task, encoding task, spoiled gradient structural scan, divided attention task, 
recognition task, and a T2 fast spin-echo structural scan. The first high-resolution 
structural scan is used during the functional data analysis as the subject-specific 
template and the latter two structural scans to examine for evidence of structural brain 
pathology. 
 
3.8.3 Image Acquisition 
Gradient echo echo-planar imaging (EPI) data were acquired on a neuro-optimised 
GE Signa 1.5 Tesla system (General Electric, Milwaukee WI, USA) at the Institute of 
Psychiatry, King’s College London.  Image quality was ensured by a semi-automated 
quality control procedure.  A quadrature birdcage head coil was used for radio 
frequency transmission and reception.  Foam padding was placed around the subject’s 
head in the coil to minimize head movement. T2*-weighted whole-brain volumes 
were acquired during the paradigms at each of 16 near-axial non-contiguous planes 
parallel to the intercommissural (anterior commisure-to-posterior commisure) line 
(matrix = 64 x 64). Imaging parameters for each of the paradigms appear in Table 3. 
The encoding paradigm had a shorter echo time (TE) and included a pass delay of 2.5 
s after presentation of each stimulus in order to sample BOLD signal after overt 
speech production in order to minimise movement artefact. These EPI data sets 
provided almost complete brain coverage.  A high-resolution gradient echo image of 
the whole brain was also acquired for co-registration of functional images (43 slices; 
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slice thickness=3 mm; gap =0.3 mm; TR = 3 seconds; flip angle = 90o; matrix = 128 
x128). 
 
 Encode Recognition Visual-
Auditory 
Attention 
Divided 
Attention 
Number of 
slices 
16 16 16 16 
Slice thickness 7 mm 7 mm 7 mm 7 mm 
Gap 0.7 mm 0.7 mm 0.7 mm 0.7 mm 
TR 1500 ms 2000 ms 2000 ms 2000 ms 
TE 40 40 40 40 
Flip angle 90 o 70 o 70 o 70 o 
Nr of images 
per location 
112 280 144 140 
Total scan 
time 
07:28 09:28 04:56 04:48 
Total number 
of images 
1808 4496 2320 2256 
Pass delay 2500 ms    
Table 3. Imaging parameters for fMRI paradigms. 
TR= repetition time, TE= echo time. 
 
3.8.4 Data Analysis 
Data analysis was undertaken using the XBAM software package written and 
maintained by the Institute of Psychiatry at King’s College London, UK 
(http://brainmap.it). It was conceived by Ed Bullmore and Michael Brammer in 1995 
with the aim of writing “an fMRI analysis package with the minimum possible 
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number of assumptions” because testing for activation at thousands of different points 
in the brain required rigorous methods. The standard methods at the time involved 
either correlational analysis between the experimental design and the time series at 
each voxel (volumetric pixels), or t-statistics using means and variance. Both these 
approaches assume normal theory approximations, which have not being established 
in large samples of fMRI data. These types of analyses are typical of the more 
commonly used fMRI analysis software packages such as SPM 
(http://www.fil.ion.ucl.ac.uk/spm/), which are more sensitive than non-parametric 
approaches such as XBAM but also more prone to false positives. SPM is probably 
the most widely used functional neuroimaging analysis package and the default 
analysis settings are usually appropriate for analysing functional data from healthy 
control groups. XBAM analysis differs significantly from SPM analysis by not 
assuming normality of activation data and consequently implements permutation 
testing to construct the null distribution to make inference about the probability of 
activation under the null hypothesis. A recent large fMRI study (81 subjects) 
investigated the assumption of normality in fMRI analysis and found substantial 
departure in 22% of voxels; this was improved to 9% using the standardized statistics 
adopted by XBAM (Thirion et al., 2007). Based on their findings the authors 
recommended the use of cluster level statistics, robust and permutation-based testing 
rather than normal theory based inference, strategies already adopted by XBAM. 
Median statistics are used in XBAM rather than means in order to control for outlier 
effects. XBAM analysis adopts a two-level approach to data analysis in which the 
response sizes computed from the model fit for each individual are standardised with 
respect to their variances before embarking on the second, multi-subject, phase of 
analysis. This permits mixed-effects analyses of group level fMRI data by taking into 
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account both intra and inter subject variances. Mixed-effects analysis allows 
generalisation of findings from the participant population to the sampled population 
(Brammer et al., 1997).  Wavelet-based time series permutation is used to control for 
the noise in fMRI data (Bullmore et al., 2001; Bullmore et al., 1999). XBAM uses 3-
dimentional cluster-level statistics based on cluster mass (the sum of all statistical 
values from all the voxels in the cluster) for activation thresholding and the typical 
statistical threshold is therefore usually described as the probability value where less 
than one false cluster will be evident per volume. We next look in more detail at the 
implementation of the analysis at individual and group levels. 
 
3.8.4.1 Individual analysis 
To minimise motion related artefact, the data were first realigned by calculating a 3-
dimensional volume template consisting of the average intensity at each voxel over 
the whole experiment and then realigning 3-dimensional image volume at each time 
point to this template by computing the combination of rotations (around the x, y, and 
z axes) and translations (in x, y and z) that maximised the correlation between the 
image intensities of the volume in question and the template (Bullmore et al., 1999). 
The data were then smoothed using a Gaussian filter (full width at half maximum of 5 
mm) to improve signal to noise characteristics of the images. This resulting value for 
each voxel is the weighted average of all the neighbouring voxels with the average 
more weighted towards the central voxel. Responses to the experimental paradigms 
were then detected by time-series analysis using Gamma variate functions (peak 
responses at 4 and 8 sec) to model the BOLD response. The analysis was 
implemented as follows. First, each experimental condition was convolved separately 
with the 4 and 8 second Poisson functions to yield two models of the expected 
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haemodynamic response to that condition. The weighted sum of these two 
convolutions that gave the best fit to the time series at each voxel was then computed. 
This weighted sum effectively allows voxel-wise variability in time to peak 
haemodynamic response. In order to constrain the possible range of fits 
physiologically plausible BOLD responses, a constrained fitting procedure was used 
(Friman et al., 2003). Following this fitting operation, a goodness of fit statistic was 
computed at each voxel. This was the ratio of the sum of squares of deviations from 
the mean intensity value due to the model (fitted time series) divided by the sum of 
squares due to the residuals (original time series minus model time series). This 
statistic is called the SSQratio. The percentage BOLD signal change at each voxel 
was also calculated. This was: ((fitmax – fitmin)/mean signal intensity) * 100, where 
fitmax and fitmin were the maximum and minimum values of the fitted response for 
the time series in question. 
In order to sample the distribution of SSQratio under the null hypothesis that 
observed values of SSQratio were not determined by experimental design (with 
minimal assumptions), the time series at each voxel was permuted using a wavelet-
based resampling method (Breakspear et al., 2003; Bullmore et al., 2001). This 
process was repeated 20 times at each voxel and the data combined over all voxels, 
resulting in 20 permuted parametric maps of SSQratio at each plane for each subject.  
The same permutation strategy was applied at each voxel to preserve spatial 
correlational structure in the data during randomisation.  Combining the randomised 
data over all voxels yields the distribution of SSQratio under the null hypothesis.  A 
test that any given voxel is activated at any required type I error can then be carried 
out by obtaining the appropriate critical value of SSQratio from the null distribution. 
For example, SSQratio values in the observed data lying above the 99th percentile of 
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the null distribution have a probability under the null hypothesis of <=0.01. This 
permutation method gives very good type I error control with minimal distributional 
assumptions (Breakspear et al., 2003; Bullmore et al., 2001). 
 
3.8.4.2 Group mapping  
In order to extend inference to the group level, the observed and randomised SSQratio 
maps were transformed into the standard space. This involved a two stage process 
requiring first a rigid body transformation of the fMRI data into a high-resolution 
gradient echo image of the same subject followed by an affine transformation on to a 
structural template (Brammer et al., 1997). By applying the two spatial 
transformations computed above for each subject to the statistic maps obtained by 
analysing the observed and wavelet-randomised data, a generic brain activation map 
could be produced for each experimental condition. The median observed SSQratio 
over all subjects at each voxel (median values were used to minimise outlier effects) 
can then be tested at each intracerebral voxel in standard space against a critical value 
of the permutation distribution for median SSQratio ascertained from the spatially 
transformed wavelet-permuted data (Brammer et al., 1997). The standard space used 
for analyses in this study was that of Talairach (Talairach, 1988). In order to increase 
sensitivity and reduce the multiple comparison problem encountered in fMRI, 
hypothesis testing was carried out at the cluster level using a method shown to give 
excellent cluster-wise type I error control in functional fMRI analysis (Bullmore et al., 
1999). When applied to fMRI data, this method estimates the probability of 
occurrence of clusters under the null hypothesis using the distribution of median 
SSQratio computed from spatially transformed data obtained from wavelet 
permutation of the time series at each voxel.  Image-wise expectation of the number 
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of false positive clusters under the null hypothesis is set for each analysis at <1. 
Consequently, correction for multiple comparisons was not required, as thresholds 
were set on an image-wide basis, not a voxel-wise basis. 
 
3.8.4.3 Group differences 
For group comparisons, analysis of variance was carried out on the SSQratio maps in 
standard space by first computing the difference in median SSQratio between groups 
at each voxel. Subsequent inference of the probability of this difference under the null 
hypothesis was made by reference to the null distribution obtained by repeated 
random permutation of group membership and recomputation of the difference in 
median SSQratios between the two groups obtained from the resampling process. As 
with the generic brain activation maps, cluster-level maps were then obtained with the 
cluster-wise probability equivalent to less than one false positive cluster per image. 
 
3.8.4.4 Correlation analysis 
Correlational analysis can be performed between the BOLD effect data for each 
individual and behavioural data. To implement this, the Pearson product-moment 
correlation coefficient (r) between the observed behavioural and BOLD effect data is 
first calculated, followed by calculation of the null distribution of correlation 
coefficients by permuting the BOLD data at each voxel many times (a minimum of 
50) and combining the data over all voxels. Thresholded voxel and cluster level maps 
where r is significant can then be computed at any desired level of expected voxel or 
cluster-level type I error.  
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Correlations between activation data and behavioural data can also be 
examined by extracting the peak SSQ value for each participant from the coordinates 
of the most activated voxel in a cluster of difference. Spearman’s correlation 
coefficients are then calculated due to the relatively small sample sizes and non-
normally distributed data. Values deviating more then 2 standard deviations from the 
mean are excluded. 
 
3.8.4.5 Interaction analysis 
Interaction effects are tested for in factorial design studies where two (or more) 
groups (i.e. controls and patients) perform a single task at two time points (baseline 
and follow-up). The analysis is implemented by constructing a design matrix coding 
for the non-repeated group factor, the repeated condition factor and the interaction, 
which is the product of the first two factors. The interaction column tests for regions 
where the effect of one factor is modulated by the status of the other. If there is no 
interaction between group and condition, supporting the null-hypothesis, then plotting 
mean data for the groups and conditions will reveal parallel lines between the two 
time points. Conversely, if an interaction is present then the lines will deviate. 
Interpreting interactions therefore requires plots of activation data to be examined 
along with interaction maps.  
 
3.4.8.6 Local permutation  
For group comparisons of functional data we used an advanced method compared to 
our earliest reports. This method became available during the course of this study. It 
was designed to be more sensitive in brain areas where there is relatively smaller 
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signal change. It entailed a different method of random permutation, which is the 
process of generating a null distribution by repeated random sampling of the observed 
data at all, time points. This local permutation involved calculating a voxel-specific 
critical threshold as opposed to a critical threshold calculated from all voxels in the 
volume studied (global permutation). With global permutation, statistics from each 
voxel from the observed data is compared against a single threshold of significance 
used across the brain, which is taken from the null distribution of F-statistics 
calculated from all voxels over all randomisations. Therefore, voxel statistics from 
areas with large signal change enter into the global distribution and increase the 
significance threshold across the brain, decreasing detection in areas with smaller 
signal change. The magnitude of differences at thousands of spatially removed voxels 
therefore determines the significance at any one voxel. At a voxel threshold of e.g. 
0.05 the value of the test statistic at that percentile (95th) of the null distribution is 
calculated and any voxel with a test statistic larger than the critical value is identified 
as significant. Global permutation therefore assumes uniform voxel statistic 
magnitudes across the brain, an assumption that has not been established and is 
unlikely to hold in disease states such as AD. With local permutation a voxel-specific 
threshold is calculated and significance at each voxel is assessed against its own null 
distribution. This voxel-specific threshold is therefore not contaminated by statistics 
from other brain areas. Cluster level significance testing was still done against a null 
distribution of cluster mass generated from supra threshold voxel statistics across the 
brain as a local test of cluster mass is not available yet. However, the cluster level null 
distribution now included statistics from voxels that would otherwise not have 
contributed due to their comparatively smaller task related signal change. 
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3.4.8.7 UNIX analysis 
Anonymised data were transferred to the UNIX computer system at the Institute of 
Psychiatry at King’s College London. Each experiment was assigned a unique 
identifier. Corrupted data files were removed and raw experimental data were 
archived. A specific data file containing information about the experimental 
conditions was created for each experiment; these are known as infiles for block-
designed experiments and as newstarts for event related designs. Table 4 shows the 
infile data for the encoding task, and how it corresponds to the experimental condition 
and stimuli for the task. Experiments were processed in batches using server clusters. 
Most of the analyses were carried out remotely via the Internet, using Secure Shell 
Host and Hummingbird Exceed software.  Each analysis step produces a log file and 
each of these were examined to ensure that the analysis ran as planned. 
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Infile data Condition Stimulus 
1 Experimental flag 
1 Experimental cross 
1 Experimental pole 
1 Experimental symbol 
1 Experimental stars 
1 Experimental stripes 
1 Experimental march 
1 Experimental England 
0 Control wait 
0 Control wait 
0 Control wait 
0 Control wait 
1 Experimental cabin 
1 Experimental scout 
1 Experimental summer 
1 Experimental pack 
1 Experimental lake 
1 Experimental trail 
1 Experimental canvas 
1 Experimental holiday 
Table 4. Infile data for experimental analysis. 
The data in the Infile data column informs the analysis procedure by indicating if the 
volume acquired represents the experimental or control condition. In this example 
from the encoding paradigm, it can be seen that the experimental condition is coded 
with the digit 1, and this corresponds to the presentation of different English nouns. 
The repeated presentation of the word “wait” comprises the control condition that is 
coded with the digit 0. 
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3.4.8.8 Identifying areas of activation  
Brain areas where task related activation or group differences occurred were 
identified by their coordinates and cluster size using the Talairach atlas (Talairach, 
1988). Clusters containing less than 10 voxels were ignored. Brain areas containing a 
cluster and surrounding areas up to 10 mm away were included in identified areas.  
Clusters were followed in all three spatial dimensions in order to identify all relevant 
brain areas. Figure 8 shows the Talairach z-coordinates for axial images from the 
Talairach template used in XBAM; it has 25 slices with a 5.5mm gap between slices. 
 
 
Figure 8. Talairach template. 
The map shows axial brain slices with corresponding Talairach atlas z-coordinates. 
Slices with a negative z-value are located below the line that extends from the anterior 
commisure to the posterior commisure (AC_PC) that serves as an anatomical 
landmark. Axial slices proceed from left to right, from the most caudal in the top left 
corner to the most rostral in the right bottom corner of the map. The left hemisphere 
appears on the right and vice-versa. 
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3.8.5 Stimuli Presentation 
Auditory stimuli were presented via MRI compatible air-conducting headphones and 
visual stimuli were back-projected with a LCD projector (Proxima Desktop Projector 
5500) onto a screen 2.5m from the subject’s head and were visible to the subject via a 
prism mounted on the head coil. The tasks were programmed in Microsoft Visual 
Basic Professional 6.0, presented on a PC running MS Windows NT and triggered by 
the scanner during image acquisition where applicable. 
 
 
3.9 Overview of cognitive paradigms 
All of the cognitive paradigms that were used in this study were designed specifically 
for use with fMRI. The encoding, recognition and visual-auditory paradigms had been 
designed at the Institute of Psychiatry and used in prior studies. We designed the 
divided attention paradigm and piloted it on controls and patients. I discuss the 
cognitive paradigms in detail below. 
 
3.9.1 Divided Attention Paradigm 
We designed a divided attention paradigm to examine the associated behaviour and 
brain activation. The rationale for examining divided attention has already been 
discussed (§2.2) and what follows below are details of the theoretical background, 
experimental design, behavioural data analysis and pilot data. 
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3.9.1.1 Theoretical background 
Processing two streams of information simultaneously or completing two cognitive 
tasks simultaneously has a cost in terms of accuracy and\or speed known as the dual-
task decrement. This appears related to limitations in executive control of attentional 
resources, attentional resources per se, and interference effects (Sarter and Turchi, 
2002). The dual-task decrement results in decreased speed and/or accuracy during 
divided attention but this can vary between subjects so that differential impairment on 
either speed or accuracy can occur depending on automatic or conscious cognitive 
strategies favouring one or the other. Interpreting such data presents a difficulty and 
usually requires calculation of a behavioural index that combines speed and accuracy. 
Adequate performance, well above chance level, is also necessary in order to make 
inferences about task related functional activation. FMRI paradigms are therefore 
often designed to ensure behavioural equivalence that then allows interpretation of 
functional activation data with fewer assumptions. Extensive practice on a divided 
attention task may reduce dual-task cost in terms of response accuracy which then 
allows reaction time (RT) to be used as a valid measure of residual divided attention 
cost (Sarter and Turchi, 2002)). A carefully designed divided attention task together 
with sufficient practice on the task therefore allows comparisons between groups on 
RT.  Moreover, as divided attention appears to be the first non-memory cognitive 
domain to be affected in mild AD, abnormal brain function may be evident on fMRI 
in the absence of behavioural differences. 
We designed a divided attention task using relatively naturalistic stimuli 
(spoken numbers and visually presented letters and numbers).  Using familiar letter 
and number stimuli reduces cognitive processing related to novelty detection and this 
was desirable because the aim was to minimise non-attentional processing during the 
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task so that results specifically related to attentional functioning. Processing the 
stimuli on the task already involved some automatic semantic processing related to 
targets identification and the aim was to limit any other non-relevant processing. 
A blocked designed paradigm was used because this type of design has 
excellent BOLD signal detection properties. Optimal detection power was required 
due to the similarity between the experimental and control conditions and because 
AMCI patients may have reduced functional activation similar to that demonstrated 
in AD. Block duration is a further consideration and blocks should be long enough 
for the BOLD signal to return to baseline (>10 s) in areas not activated by a 
condition, as this ensures maximal variability in the data which in turn increases 
detection power. Block length during this task was 26 s.  
In order to generate an fMRI contrast specific for the divided attention 
condition (DA), it was contrasted it with a control attention condition (CA). An ideal 
fMRI paradigm has a contrasting condition that matches the experimental condition 
on all sensory and processing aspects apart from those of interest.  If this can be 
achieved then activation only evident during the experimental condition will likely be 
specific to the cognitive processing of the experimental condition. This subtraction 
logic hypothesis underpins most fMRI paradigms. By this logic, subtracting control 
condition activation from experimental condition activation leaves only activation 
particular to the experimental condition. 
 
3.9.1.2 Experimental design 
The final task consisted of 10 blocks: 5 DA blocks alternating with 5 CA blocks. Each 
block comprised 16 pairs of stimuli with an inter-stimulus interval of 1.75 s and ran 
for 26 s giving an overall duration of 280s for the task. Subjects practised the task 
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outside the scanner until they were comfortable with the instructions and able to 
complete it with high accuracy. The stimuli used for practice were different from 
those used during the experiment. Subjects were reminded of instructions 
immediately prior to commencing scanning. Instructions were identical for both 
conditions. Subjects were instructed to press the button with their right index finger 
whenever they saw the target letter “q” or heard the target number “8”.  The auditory-
digit component consisted of the numbers 0 to 9 read aloud in a pseudo-random order 
by an unfamiliar male voice. The visual-letter component comprised of discrete lower 
case letters (a, b, I, l, m, q, r, s, u, w, z) presented in a pseudo-random order. Letters 
were coloured yellow and appeared in a large familiar font (Times New Roman) on a 
blue background. During the DA-blocks, subjects were simultaneously presented with 
visual (letters) and auditory (spoken digits) stimuli (Figure 9). Each block contained 
three auditory and three visual targets. The CA blocks were designed to match the 
auditory, visual and motor aspects of the DA blocks. Subjects were presented with 
matching identical auditory and visual stimuli (e.g. an auditory “eight” and visual 
“8”), in a repeating sequence, with a target cue every third stimulus (008008008…). 
Table 5 contains a sample of the first 48 stimulus pairs, reaction time, accuracy and 
time stamp from a response file. The designs characteristics as explained above are 
evident from the table. 
Subjects were not warned of a switch from the DA to the CA blocks and 
block length differed from that used during training sessions in order to minimize 
habituation that could reduce cortical activation. RT and accuracy of each response 
were recorded for all stimuli. 
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Figure 9. Divided attention task. 
During the DA condition (top panel) pairs of stimuli were presented every 1.75 s and 
comprised of numbers between zero and nine, and discreet lower case letters. Targets 
were the number “eight” and the letter “q”. The CA condition (centre panel) 
comprised of a repeating sequence of semantically identical verbal and visual stimuli. 
Blocks of 16 stimuli pairs (bottom panel) alternated so that five blocks of each 
condition were presented. 
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Table 5. Divided attention response file. 
The table contains a sample result of the first 48 stimuli pairs, reaction time, accuracy 
and time stamp. Blocks are colour coded with DA light grey and DA dark grey in the 
Letter and Number columns. In the Stimuli column, the shaded boxes indicate 
instances where the subject did not respond to targets. In the RT column the shaded 
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boxes indicate examples of instances where the RT-rule (stimulus nr. 34) and button 
rule (stimulus nr. 41) would be applied (see below). 
 
3.9.1.3 Behavioural analysis 
Behavioural measures collected for group comparisons of divided attention 
processing included: visual stimuli RT (Vis-RT), auditory stimuli RT (Aud-RT), and 
discrimination index (PrDA). Behavioural measures were calculated and collated in 
Microsoft® Office Excel 2003. Each response file was imported into a worksheet and 
the formulas were then copied from a master sheet. Response data were then 
inspected and cleaned according to standard rules. We devised rules to deal with RT 
longer than 1.75 s (long RT rule) and for instances where subjects accidentally kept 
the response button depressed after making a response therefore resulting in a 
erroneous response recorded for the next stimuli pair (button rule). For the long RT 
rule we inspected data for instances where a false alarm response to a non-target was 
made following an apparently missed target, and the RT was < 0.3 s. We considered 
such a response as a late response to a target because valid responses to stimuli in 
under 0.3 s are not ordinarily possible. The adjusted RT was calculated as the sum of 
the RT on the non-target and the inter-stimulus duration (1.75 s). Making this 
adjustment improves the accuracy measure, whilst a time penalty for a slow response 
enters analysis, which would otherwise have been lost if not adjusted. For the button 
rule, we inspected data for occurrences of very fast RTs (<1.0 s) following responses 
to targets. In these cases the incorrect responses were removed because they would 
otherwise be calculated as incorrect responses. Examples of instances where both 
rules would be applied are shown in Table 5. 
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For DA-RT and CA-RT, we calculated means from RTs on correct responses, 
excluding RTs on false alarms. The mean for each block was first calculated and then 
the mean for the five blocks. To measure recognition accuracy we used the corrected 
recognition rate (Pr) calculated from the Hit Rate (HR) and False Alarm Rate (FAR) 
as follows: 
Pr = Hit Rate (targets correctly identified / total targets) minus False Alarm 
Rate (false alarms / non-targets). 
It is evident from the calculation that Pr can vary between 1 and 0, with 1 
indicating an ideal performance (Snodgrass and Corwin, 1988). By including the 
FAR in the calculation an adjustment is made for subjects who have a liberal 
response bias and make more errors on non-targets. Using Pr is an advance over the 
traditional use of percentage correct responses (= targets correctly identified/total 
targets) where false recognition is not taken into account. 
 
3.9.1.4 Piloting the divided attention task 
We piloted an initial version on 12 healthy volunteers who were able to complete the 
task satisfactorily. Five patients with mild AD and two with AMCI then completed 
the task. Some of the patients performed poorly on accuracy and reported that this 
was due to the fast rate of stimulus presentation. In response, we increased the inter-
stimulus interval from 1.25 s to 1.75 s in order to ensure high accuracy on the task. 
Due to the longer inter-stimulus interval, the number of stimuli per block had to be 
reduced from 24 to 16 in order to maintain overall block and task length. The task 
was tested in the scanner environment on two runs to ensure compatibility. Pilot 
behavioural data are reported in the Results section (§4.4). 
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3.9.2 Visual and Auditory Selective Attention Paradigm 
We compared the CoAMCI and Controls at baseline on auditory and visual attention 
processing in order to establish if there were any generalised non-specific effects of 
AMCI on fMRI signal. We compared RivAMCI and NxAMCI over time to ascertain 
if there were any generalised effects of ACEI treatment on visual and auditory 
attention processing which could affect the interpretation of results on the divided 
attention and memory tasks. We used an existing paradigm to study basic auditory 
and visual attention. The attentional conditions are considered selective rather than 
sustained because the scanner environment introduces highly salient sensory 
distraction in the form of scanner noise (see §1.5.1 for definitions of attention).  
 
3.9.2.1 Experimental design 
This paradigm had a blocked design that comprised of three alternating conditions. 
The control condition consisted of crosshair fixation (FIX), the visual condition of a 
circular black and white checkerboard pattern that filled up the entire screen a (VIS), 
and the auditory condition of lists of English nouns (AUD). Conditions were 
presented in alternating epochs. During the VIS component, the checkerboard squares 
were reversed at three distinct frequencies (2, 4 and 8 Hz) for fixed epochs of 16 
seconds. The order of reversal frequencies was randomised within each set of three 
consecutive stimulation/fixation cycles. The auditory component consisted of a male 
voice reading a list of nouns presented at three randomised word rates (30, 60 and 90 
words per minute) for fixed epochs of 24 seconds. The visual and auditory stimuli 
were presented asynchronously from each other over the 288 seconds duration of the 
entire task and overlapped (VISAUD) for 136 seconds. For functional analysis, we 
modelled four conditions: VIS, AUD, FIX and VISAUD. 
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3.9.3 Verbal Episodic Encoding Paradigm 
We used an existing verbal encoding paradigm that we adapted by reducing the 
number of stimuli. The paradigm was designed to measure the effects of semantic 
elaboration related to PFC function, which we hypothesised may be impaired in 
AMCI. I describe the task in detail below by reference to its theoretical 
underpinnings, experimental design and behavioural data analysis. 
 
3.9.3.1 Theoretical background 
We set out to study functional activation related to verbal encoding and the possible 
contributions executive failure makes to impaired encoding in AMCI. We therefore 
employed fMRI and a verbal episodic memory encoding task similar to the Dees-
Roediger-McDermott memory paradigm (Deese, 1959; Roediger and McDermott, 
1995). In this paradigm, false recognition (incorrect recognition of a novel item as a 
studied item) can be manipulated by including recognition probes that are either 
unrelated (novel) or semantically related (lures) to studied items. It is therefore 
sensitive to the effects of spontaneously adopted, unsupported encoding strategies that 
reflect everyday memory function and reflect semantic processing. In healthy 
subjects, semantic elaboration at encoding predictably increases the misidentification 
of semantically related items (called lures) as studied items (targets). False 
recognition of lures can be quantified and AD patients show reduced false recognition 
of lures due to failure to generate and encode semantically related information (Balota 
et al., 1999; Budson et al., 2000; Budson et al., 2002; Budson et al., 2003). This 
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paradigm can therefore be used to study the possible contribution of executive failure 
during attempted encoding in individuals with AMCI.  
 
3.9.3.2 Experimental design 
We adapted an existing blocked-designed encoding task by reducing the number of 
stimuli, which reduced the overall duration of the task and made it practical for our 
purposes. The adapted task consisted of alternating epochs of experimental encoding 
(ENCODE) and control (CONTROL) conditions. The ENCODE blocks required 
subjects to read aloud and memorise commonly occurring English nouns, visually 
presented in 9 lists (Table 6). Audible speech was used in order to monitor 
compliance during the task. Each list contained 8 words semantically highly related 
to a critical non-presented word taken from a known list (Stadler et al., 1999). For 
example, the items hiking, pack, trail, scout, cabin, summer, lake, canvas and holiday 
made up the list related to the critical non-presented word camp.  Each word in the 
task was presented for 2.5 sec followed by a fixation cross presented for 1.5 sec and 
thus a new word was presented every 4 sec. ENCODE blocks were alternated with 
CONTROL blocks which consisted of 4 consecutive presentations of the word ‘wait’, 
which also had to be read aloud (Figure 10). CONTROL blocks matched ENCODE 
blocks for attention to a visual stimulus, reading and vocalisation, but not on the 
requirement to encode words or on the variety of vocalisation associated with the 
ENCODE stimuli. Participants were trained on the tasks prior to entering the scanner 
using a set of training stimuli, and reminded of the instructions immediately prior to 
commencing. They were instructed to read all the words out loud, including the word 
“wait”, and to memorise as many words as possible because recognition would be 
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tested during a subsequent task. They were aware of task duration and of the number 
of words and lists.  
 
 
Figure 10. Verbal encoding task. 
Commonly occurring English nouns were presented sequentially in lists of eight 
during ENCODE blocks which alternated with CONTROL blocks during which the 
word “wait” was presented four times. Each word was presented for 2.5 seconds 
followed by a pass delay of 1.5 seconds during which time a white cross was 
presented. Nine blocks of each condition were presented.  
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List 1 List 2 List 3 List 4 List 5 
flag cabin sour pin bed 
cross scout bitter sewing yawn 
pole summer candy haystack night 
symbol pack good  thimble snore 
stars lake cake cotton snooze 
stripes trail nice thorn blanket 
march canvas tooth point awake 
England holiday honey injection dream 
wait wait wait wait wait 
wait wait wait wait wait 
wait wait wait wait wait 
wait wait wait wait wait 
 
List 6 List 7 List 8 List 9  
daft hive mad rubber  
fool bumble fear bounce  
dense hornet temper nylon  
genius hum tension tyre  
slow sting punch ball  
loser insect jealous band  
clever keeper hate foam  
dim wax drunk glue  
wait wait wait wait  
wait wait wait wait  
wait wait wait wait  
wait wait wait wait  
Table 6. Word lists presented at baseline for the encoding paradigm. 
Nine lists comprised of eight discreet words and four repetitions of the word “wait” 
were presented during encoding. Words from lists 1 and 9 were not included as 
recognition probes in order to control for recency and primacy. 
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3.9.3.3 Behavioural analysis 
Overt speech was used during this task in order to monitor compliance with task 
instructions. Speech was monitored continuously during the task for correct 
identification of words and overt vocalisation. Encoding success was measured on the 
recognition paradigm, which I describe next. 
  
3.9.4 Verbal Episodic Memory Recognition Paradigm 
We employed a recognition task to accompany the encoding task in order to measure 
behavioural performance during recognition and associated functional brain 
activation. The task was adapted from an existing task by reducing the number of 
stimuli in accordance with the shortened encoding task.  
 
3.9.4.1 Theoretical background 
We have seen in the introductory section that episodic memory can be tested by tasks 
measuring free recall or cued recall. Recognition is a type of cued recall that is 
supported by presentation of probe stimuli that are either targets or distractors. During 
a yes/not recognition task, a single probe is presented and the subject has to decide if 
it is a target or not. Recognition tests appear more sensitive at distinguishing AMCI 
from normal ageing (Anderson et al., 2008; Bennett et al., 2006; Westerberg et al., 
2006) and may also be more sensitive than free recall in distinguishing normal ageing 
from AD because it is less affected by age-related changes (Craik and McDowd, 
1987; Parker et al., 2004). These findings suggest that a recognition task would be 
preferred to a free recall task for our purpose of examining recognition in AMCI, 
which falls between ageing and AD. Furthermore, both item and associative memory 
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appears affected in AMCI (Dudas et al., 2005). Taken together these findings suggest 
that an associative learning task with a yes/no recognition phase may be a particularly 
sensitive measure to discriminate AMCI from normal ageing. 
Recognition can be further divided into familiarity which refers to a feeling of 
prior exposure to an item without recall of associated contextual information, and 
recollection referring to the retrieval of the item bound to contextual features such as 
the time, place or source of experience (Yonelinas, 2002). 
 The recognition task we used was yes/no implicit associative item recognition 
task, which followed an intentional encoding phase. The associations are implicit as 
all the words in a list are semantically related but subjects are not explicitly made 
aware of this, which enables examination of distinct memory processes such as 
automatic semantic elaboration.  
In summary, these findings suggest the potential of specific recognition tasks 
to examine distinct memory processes that appear differentially affected in ageing and 
AMCI. Combining such tasks with functional neuroimaging has the potential to reveal 
the functional neuroanatomy of recognition processing in controls and AMCI. 
 
3.9.4.2 Experimental design 
Recognition was tested after a delay of 12 minutes during which an unrelated 
attention task and a structural scan were performed. This delay was included to curb 
rehearsal of studied items because recognition following rehearsal would reflect 
working memory capacity rather than episodic encoding success. Probe words were 
presented individually on a screen and subjects used a button to indicate their choice 
from three possible responses: “Remember” (familiarity with both recognition of the 
probe and recollection of study episode), “Know” (familiarity in the absence of 
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recollection of the study episode) or “New” (unfamiliar). The position of choices 
presented on the screen was similar to the position of the buttons on the button box so 
that “Know appeared to the bottom right, “Remember” to the top middle, and “New” 
to the bottom right. The probe list consisted of 17 target words, 16 novel words and 
14 lures. The first and last lists, as well as the first and last words in each of the 
remaining lists, were excluded from the recognition task to control for the effects of 
recency and primacy. Targets were typically words in position 2, 5 and 7 in the 
remaining lists. The lures consisted of the non-presented critical word highly 
semantically associated with words in each list plus one more non-presented word 
from the list associated with the lure (Figure 11). Novel words were taken from non-
presented word lists.  “Remember and “Know” responses were added together as 
familiarity responses during behavioural analysis. “Remember" refers to recollection 
of a studied item which is accompanied by conscious retrieval of aspects of the 
individual’s experience at the time of study, which may include what they thought 
about or what preceded it, so in a sense being able to relive the moment of study. 
Knowing implies only recollection of the studied item (Tulving, 1985). This 
distinction was included as there is mounting evidence for distinct neural networks 
involved in remembering and knowing with PFC activity predominantly involved 
during remembering (for a review see (Knowlton, 1998). The difference between 
“Remember” and “Know” was explained to participants, they practiced the task 
outside the scanner, and were reminded of instructions immediately prior to scanning. 
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Figure 11. Recognition task. 
The figure illustrates the relationship between the critically non-presented highly 
semantically associated word “hiking” and words that were studied during encoding 
(blue), and words used as lures (black).  
3.9.4.3 Behavioural analysis 
For behavioural analysis we calculated corrected recognition rates (Pr) exactly as 
described in the section above on divided attention. We also calculated a response 
bias measure (Br) after Feeman and Snodgrass who found normal response bias for 
patients with isolated amnestic disorders (Korsakoff’s, MTL pathology) but more 
liberal response bias for patients with AD (Snodgrass and Corwin, 1988). 
 Br = false alarm rate / (1- Pr)  
Subjects might have high levels of familiarity for both old and new probe items if 
stimuli were not encoded distinctively or when semantic memory representations have 
been inappropriately activated by prior presentation of target and distractor items. 
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Stimuli that were not encoded distinctively at presentation could adequately match 
stored representations of similarly poorly encoded target items or very familiar items 
in semantic memory, leading to a general increase in recognition responses to both old 
and new items. A difference in response bias between AMCI and controls could 
therefore indicate impaired semantic processing. 
We also examined whether the groups were comparable on false recognition of lures 
by calculating the false recognition rate for lures: 
Lure Pr = lure HR - FAR 
Recognition responses can be classified into four categories (Figure 12).  Targets can 
be correctly identified as previously studied or old (hits) or fail to be recognised 
(misses).  Whereas novel or distractor items can be incorrectly recognised as old (false 
alarm) or correctly rejected as not studied previously (correct rejection).  The two-
high-threshold model of recognition memory can be used for interpreting the 
cognitive processes underlying these four behavioural responses (Snodgrass and 
Corwin, 1988). This model assumes that recognition involves selection between 
discrete memory states rather than a continuum of memory strengths as signal 
detection models of memory assumes (Snodgrass and Corwin, 1988).  Recognition of 
an item is therefore based on the memory signal trace meeting a specific threshold 
level. This proposes the existence of distinct memory thresholds for the recognition of 
old items as old and for the recognition of new items as novel.  These two thresholds 
separate three possible memory states that can be experienced by individuals: 
recognition of items as old/familiar, recognition of item as novel/unfamiliar and an 
intermediate state of uncertainty. Items are correctly recognised as old or familiar 
when the strength of the memory trace crosses the “high” threshold level. Conversely, 
if an item fails to activate a memory trace over the “low” threshold it is not recognised 
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and therefore deemed as new. If the level of memory trace associated with an item is 
too strong to be novel or too weak to be familiar and therefore ambiguous, then it falls 
into the uncertain state. Items in the uncertain state are classified as old or new based 
on the individual’s particular response biases in that situation (e.g. “I must have seen 
that before” or  “If I had not seen that I would remember”).  The HR represents the 
number of times that an individual correctly recognised a target item plus the correct 
guesses from the uncertain recognition state. The FAR originates from the uncertain 
recognition state and occurs when a novel item is not recognised as new and a target 
not recognised as such. Both the Pr and Br are obtained from the HR and FAR which 
indicates that these measures take into account all the behavioural responses. 
 
  Source of Stimuli 
  Target Distractor 
  
“Old” 
  
Hit 
  
False Alarm 
  
  
  
Subject 
Responses   
“New” 
  
Miss 
  
Correct Rejection 
Figure 12. Recognition response classifications. 
Targets can be correctly identified as previously studied or old (hits) or fail to be 
recognised (misses).  Novel or distractor items can be incorrectly recognised as old 
(false alarm) or correctly rejected as not studied previously (correct rejection).  
  
On a recognition task with equal numbers of targets and novel distractor items, a Br 
value of 0.5 represents the neutral or chance value indicating that the individual is 
equally likely to say that an unrecognised item is old or new.  A value < 0.5 represents 
a conservative bias or a tendency to say that an item is new and a value > 0.5 
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represents a liberal bias or a tendency to say that unrecognised items are old when 
uncertain.  
 
The functional analysis of this task was event related and required that events of 
interest be defined and that the timing of each event of interest was required for each 
experimental run. 
 Based on the two-high-threshold model of recognition we set up the functional 
analyses of the recognition data to examine activation during five events: 
1. Remember and Know (Old) responses to targets (Hits) 
2. New responses to targets (Misses) 
3. Remember and Know (Old) responses to lures (False alarm on a lure) 
4. New responses to lures (Correct rejection of a lure) 
5. New responses to novel and lure distractors (Correct rejection of any 
distractor) 
Examining these conditions in conjunction with the semantic processing manipulation 
could enable us to draw conclusions about the nature of recognition failure in AMCI. 
Table 7 shows the recognition task response data from a sample file for the task at 
baseline. Probes were presented in the order in which they appear in the table. The 
timing of presentations was used to create the newstarts file mentioned in the fMRI 
methods section and identifies the conditions of interest during the analysis process.  
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Stimuli Word Response Time Stimuli Word Response Time 
1 salt know=wrong 0.001 1 attack new=correct 346.002 
2 scout rem=correct 8.002 2 bumble know=correct 364.002 
1 scissors know=wrong 16.002 1 wing new=correct 372.002 
3 leaf know=wrong 26.002 3 chess rem=wrong 382.002 
3 oak rem=wrong 44.002 3 sound rem=wrong 398.002 
2 canvas know=correct 52.002 1 gentle rem=wrong 406.002 
3 write new=correct 66.002 3 scribble rem=wrong 418.002 
1 idiot know=wrong 76.002 2 keeper rem=correct 428.002 
2 awake rem=correct 94.002 3 cage rem=wrong 444.002 
1 sleep know=wrong 102.002 2 yawn new=wrong 452.002 
2 sewing know=correct 116.002 3 tiger know=wrong 464.002 
2 fool new=wrong 132.002 1 sugar know=wrong 474.002 
1 bee know=wrong 144.002 2 cotton know=correct 484.002 
3 piano know=wrong 152.002 1 needle know=wrong 500.002 
2 sting know=correct 166.002 1 silk rem=wrong 512.002 
2 nice rem=correct 182.002 2 point new=wrong 520.002 
3 branch new=correct 192.002 1 camp know=wrong 538.002 
1 furious new=correct 200.002 3 gym new=correct 546.002 
2 hate rem=correct 214.002 1 attack new=correct 346.002 
3 circus know=wrong 226.002 2 bumble know=correct 364.002 
2 slow rem=correct 236.002 1 wing new=correct 372.002 
1 buzz know=wrong 252.002 3 chess rem=wrong 382.002 
3 lion new=correct 264.002 3 sound rem=wrong 398.002 
2 cake rem=correct 276.002 1 gentle rem=wrong 406.002 
3 tree rem=wrong 286.002 3 scribble rem=wrong 418.002 
3 fit new=correct 302.002 2 keeper rem=correct 428.002 
2 clever rem=correct 310.002 3 cage rem=wrong 444.002 
3 dice rem=wrong 328.002 2 yawn new=wrong 452.002 
2 fear rem=correct 336.002 3 tiger know=wrong 464.002 
1 attack new=correct 346.002 1 sugar know=wrong 474.002 
2 bumble know=correct 364.002 2 cotton know=correct 484.002 
1 wing new=correct 372.002 1 needle know=wrong 500.002 
3 chess rem=wrong 382.002 1 silk rem=wrong 512.002 
3 sound rem=wrong 398.002 2 point new=wrong 520.002 
1 gentle rem=wrong 406.002 1 camp know=wrong 538.002 
3 scribble rem=wrong 418.002 3 gym new=correct 546.002 
2 keeper rem=correct 428.002      
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Table 7. Recognition task response data at baseline. 
The table shows the type of recognition probe (1=lure; 2=target; 3=novel), probes, 
response, accuracy, and time of presentation from the start of the task for the 
recognition task at baseline. The probe list consisted of 17 target words, 16 novel 
words and 14 lures.  
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3.9.5 Post Hoc Analyses  
3.9.5.1 Stratification of AMCI groups to examine for potential selection bias 
After it became apparent that the RivAMCI and NxAMCI groups differed 
significantly on cortical activation at baseline on the divided attention task (see results 
section), we decided to explore this further in order to see if this was related to any 
identifiable systematic error or bias introduced due to the later recruitment of the 
NxAMCI group. We first investigated if the groups were different as far as the 
severity of cognitive impairment was concerned. Based on population data available 
for the CAMCOG, we devised a procedure designed to calculate a predicted 
maximum total score against which each subjects actual score could be measured 
(Huppert et al., 1995). We could therefore judge the relative level of global cognitive 
impairment for subjects at the time of their participation in the study. Similar methods 
have been used in studies where the sum of the boxes rather than the global CDR 
score is used as a measure of impairment; an increase in CDR sum of boxes is 
associated with increased risk of being diagnosed with dementia (Lynch et al., 2006). 
AMCI patients have also been stratified according to their level of functional 
impairment using the CDR sum of boxes for fMRI studies (Celone et al., 2006). The 
CAMCOG predicted maximum schedule is shown in Table 8. In order to stratify 
participants into more and less impaired groups, we calculated the percentage 
difference between predicted and actual scores. 
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Gender Male +2 
 Female -2 
Age <65 +14 
 65-70 +9 
 71-75 +5 
 76-80 -0 
 81-85 -5 
 >85 -10 
Education <12 -4 
 12-13 -2 
 14 -0 
 15-16 +2 
 >17 +4 
Social Class Unskilled -4 
 Skilled manual -0 
 Skilled non-manual +2 
Table 8. Predicted total CAMCOG score calculation 
Variables derived from the above table are used to calculate the individual predicted 
CAMCOG total by adding or subtracting from a starting total of 85. A maximum 
predicted score of 107 is possible. 
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4. Results 
4.1 Participants Demographics  
We recruited 22 right-handed AMCI patients (14 women, 8 men, mean age 69 years, 
range 44 to 81 years) and 11 right-handed healthy control subjects (Controls) who 
were comparable on age (6 women, 4 men, mean age 68 years, range 50 to 84; 
F=0.03; p<0.9) and educational attainment (AMCI mean 11.3, SD 2.0, range 9 to 15, 
Controls mean 10.0; SD 1.3; range 9 to 12; F=3.1; p<0.9). Sixty-three potential AMCI 
participants were screened and 60 screened positive. Participants failed screening due 
to being left-handed and suffering significant neurological disorders since being 
diagnosed with AMCI; meningitis and transient ischaemic attack. 
AMCI patients were recruited to two groups: The RivAMCI group received 
rivastigmine treatment after baseline and the NxAMCI group did not receive drug 
treatment. Patients were recruited in two phases as indicated in Figure 13. The first 
participant was recruited and scanned in March of 2003 and data collection was 
completed in October 2008. Control and RivAMCI groups participated from March 
2003 onwards and the majority completed within nine months. The untreated 
NxAMCI group participated between November 2004 and October 2007. We 
replaced one participant from the RivAMCI group when it became clear they suffered 
diffuse Lewy body disease and this accounts for the recruitment of RivAMCI patient 
in July of 2007. At two-year follow-up, four patients in the RivAMCI group remained 
stable, four had progressed to mild probable AD, two to mild dementia of probable 
mixed AD and vascular aetiology. In the NxAMCI group, six patients converted to 
AD, three remained stable and one was lost to follow–up. All Controls remained 
cognitively normal at 2-year follow-up. 
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Figure 13. Recruitment and group allocation of AMCI participants. 
The Control and RivAMCI groups participated from March 2003 and the NxAMCI 
group from November 2004 onwards (upper panel). For the later analysis on the 
RivAMCI group one patient was replaced as it became obvious that he was suffering 
diffuse Lewy body disease, accounting for the recruitment of a replacement patient in 
July of 2007. AMCI participants were recruited to the RivAMCI and NxAMCI groups 
and, for functional and behavioural analysis, these two groups were combined as the 
AllAMCI group whilst those AMCI that converted to AD after 2 years of follow-up 
were pooled as the CoAMCI group that represent prodromal AD (lower panel).  
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For behavioural and functional analysis, data were pooled from the RivAMCI 
and NxAMCI samples into the AllAMCI group, and from AMCI patients in the 
RivAMCI and NxAMCI groups that subsequently converted to AD into the CoAMCI 
group. Findings from the AllAMCI group can therefore be used to make inferences 
about clinical samples of AMCI whereas findings from the CoAMCI group can be 
used to make inferences about prodromal AD at the stage of AMCI. AllAMCI and 
CoAMCI groups were compared to Controls at baseline for the behavioural and 
functional analyses of attention and memory. To study the effects of rivastigmine in 
AMCI, participants were grouped into treated (RivAMCI) and untreated groups 
(NxAMCI) and compared over time. 
 
4.2 Neurocognitive Results 
Results for Controls, AllAMCI and CoAMCI at baseline are summarised in Table 9. 
Controls and AllAMCI were comparable on age and education although the mean age 
for the AMCI converter group (CoAMCI) was older. AllAMCI and CoAMCI groups 
scored lower on the CAMCOG and MMSE compared to Controls. Controls performed 
better than AllAMCI and CoAMCI groups on the New Learning subscale but the 
groups were comparable on attention.  
A significant correlation was evident between age and CAMCOG total for Controls 
and CoAMCI (r= -0.35; p<0.05; R2=0.12) but not on new learning.
 182 
 
    
Control vs 
AllAMCI 
Control vs 
CoAMCI 
  
Control 
n=10 
AllAMCI 
n =20 
CoAMCI 
n=12 P F R2 P F R2 
Age 68.0 (13.5) 68.8 (10.3) 74.5 (6.1) ns   ns   
Years in 
education 10.0 (1.3) 11.3 (2.0) 11.1 (2.2) ns   
 
ns 
  
NART 115 (5.2) 112 (9.3) 
113 
(8.8) ns   
ns   
MMSE 28.8 (1.2) 26.4 (1.9) 26 (2.0) <0.01 10 0.3 0.001 15 0.5 
CAMCOG 
(max=107) 100.1 (2.5) 89.1 (5.1) 86.6 (4.6) 0.001 25 0.5 
 
<0.001 
 
63 
 
0.6 
Attention   
(max=9) 8.8 (0.4) 8.0 (0.9) 8.5 (0.7) ns   
 
ns 
  
New Learn   
(max=17) 14.4 (1.3) 9.1 (3.8) 8.0 (3.1) 0.001 18 0.4 
 
<0.001 
 
38 
 
0.6 
Table 9. Neurocognitive data and group comparisons for Controls and AMCI 
groups. 
Controls were comparable to AMCI patients on age, years in education, premorbid 
intelligence (NART) and attention score, and they performed better that patients on 
global cognitive measures (MMSE, CAMCOG) and new learning. Data are presented 
for Controls, all AMCI participants (AllAMCI) and AMCI dementia converters 
(CoAMCI). 
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Data are mean (standard deviation), ns=not significant, F=ANOVA test statistic. The 
coefficient of determination, R2 is reported as a measure of effect size: ±0.01 = a 
small effect, ±0.10 a medium effect, ±0.25 a large effect. 
 
 
4.3 Overview of Scanning Sessions 
We conducted 63 scanning sessions on 32 participants. One participant completed 
only one session as structural imaging revealed evidence of a cortical infarct and he 
was therefore excluded from further participation. Seventeen of the 252 experimental 
runs had to be restarted or abandoned due to technical failure or poor compliance with 
task instructions. Behavioural performance was monitored throughout experimental 
runs and experiments were repeated where necessary. Four runs of the recognition 
task had to be abandoned and consequently no useful functional data were collected. 
On one run a participant refused to complete the task due to discomfort in the scanner 
and on three other runs technical problems resulted in loss of functional data. 
Behavioural data were unusable on five runs of the recognition task: three due to 
compliance issues (holding the button box upside down, continuously pressing a 
button); data from the remaining two runs could not be used because the encoding 
task had to be repeated, with a different set of stimuli, that therefore interfered with 
the encoding – recognition sequence required for valid use of the task. During 
recognition tasks, distractor items that are presented are automatically encoded and 
subjects are inclined to make false recognition responses to such items if the task is 
repeated. It is therefore not possible to collect reliable data by repeating a recognition 
task. A disproportionate number of technical and compliance problems occurred 
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during the recognition task (9 out of 15) and this is likely due to the task being 
presented last, when participants were tired. 
 
4.4 Divided Attention Task Pilot Data 
During the development of the divided attention task, we collected data from 14 
controls, 5 mild AD patients and 2 AMCI patients. Task parameters were adjusted 
based on these data to ensure high accuracy in all participants. As mentioned in the 
Methods (§3.9.1), RT is considered a reliable and useful performance measure in 
divided attention experiments when tasks are well practiced and completed with very 
high accuracy levels. Controls had high accuracy on both DA (PrDA=0.97) and CA 
(PrCA=0.97) conditions at the initial interstimulus interval of 1.25 s. We also 
collected data on patients with mild AD who would already suffer some impairment 
in divided attention. Their performance was impaired on DA (PrDA=0.59) and CA 
(PrCA=0.86) conditions. By increasing the interstimulus interval to 1.75 s, we 
ensured high accuracy in the patient group (PrDA=0.84; PrCA=0.98). This level of 
accuracy in the mild AD group suggested that patients with AMCI with no obvious 
attentional impairment should be able to perform as well as controls. This was 
confirmed in the AMCI patients (PrDA=0.98; PrCA=1.0) and by the behavioural 
results reported on below. 
  
4.5 Divided Attention at Baseline 
We compared Controls with AllAMCI and CoAMCI at baseline to determine if 
AMCI is associated with impaired divided attention and related functional activation. 
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4.5.1 Behavioural Results 
Results at baseline for comparisons on divided attention are summarised in Table 10. 
Controls and AMCI had high accuracy on the dA and cA conditions. Responses were 
faster for visual targets than for auditory targets and Controls and AMCI were faster 
and more accurate on the cA condition. Between-group comparisons revealed 
comparable auditory RT and high accuracy (Pr); however, AllAMCI and CoAMCI 
subjects had significantly slower visual RT. VisRT did not correlate with age and all 
groups demonstrated longer RT to auditory targets. 
    
Control vs 
AllAMCI 
Control vs 
CoAMCI 
  
Control 
n=10 
AllAMCI 
n=20 
CoAMCI 
n=12 P F R2 P F R2 
dA- condition 
Corrected 
recognition 
rate (Pr) 
0.94 (0.16) 0.92 (0.07) 0.89 (0.08) ns   ns   
Visual RT 0.60 (0.03) 0.67 (0.07) 0.69 (0.09) 0.01 7 0.3 0.01 9 0.3 
Auditory RT 0.73 (0.14) 0.76 (0.09) 0.77 (0.09) ns   ns   
cA-condition  
Corrected 
recognition 
rate (Pr) 
0.99 (0.02) 0.99 (0.03) 0.98 (0.03) ns   ns   
RT 0.46 (0.07) 0.51 (0.08) 0.51 (0.08) ns   ns   
Table 10. Divided attention task behavioural results and group comparisons at 
baseline. 
All participants had high target recognition accuracy during divided attention as 
indicated by corrected recognition rates (Pr). AMCI patients were slower than 
controls on visual target response speed (Visual RT) but comparable on auditory 
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target response speed (Auditory RT). Data are presented for Controls, all AMCI 
(AllAMCI) and AMCI dementia converters (CoAMCI). Data are mean (standard 
deviation), ns=not significant; F=ANOVA test statistic. The coefficient of 
determination, R2 is reported as a measure of effect size: ±0.01 = a small effect, ±0.10 
a medium effect, ±0.25 a large effect. 
 
4.5.2 Functional Results 
4.5.2.1 Group activation  
Combining Controls and AllAMCI revealed activation in bilateral medial parietal 
areas (precuneus), fusiform gyrus (BA 37), extrastriate visual cortex (BA 19) and 
cerebellum, and in left hemispheric DLPFC (BA 9, 46), VLPFC (BA 44, 45, 47), 
premotor cortex (BA 4, 6), insula and anterior cingulate (Table 11). 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
All subjects 
Prefrontal cortex L 4, 6, 9, 44, 45, 
46, insula  
-40 4 31 173 
Medial frontal L 32 -4 11 42 51 
Medial parietal L 19, 31 -25 -70 26 100 
Medial parietal R 19, 31 25 -60 31 22 
Cerebellum L Cerebellum, 19, 
37 
-40 -56 -18 76 
Cerebellum R Cerebellum, 19, 
37 
43 -63 -18 104 
Table 11. Functional activation during divided attention for Controls and 
AllAMCI combined. 
The table and brain activation maps show the areas where activation increased during 
the divided attention condition compared to the control attention condition across all 
participants. Activation was evident in PFC, parietal and occipitotemporal areas (see 
text for details).  
Table legend: The table contains the cerebral region and Talairach coordinates of the 
voxel of maximal activation in each cluster and the cortical or Brodmann areas 
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activated in the cluster; the area of maximal activation appears in bold.  Areas of 
activation are indicated on the brain map. Results are reported at a cluster-wise 
probability of less than one false positive cluster per volume, unless otherwise 
specified. Axial slices proceed from left to right, from the most caudal to the most 
rostral. Lines on the saggital image indicate the level of axial slice with the lowest 
slice corresponding to the far left image. Z-coordinates appear in red above axial 
slices. The left hemisphere appears on the right and vice-versa. L= Left hemisphere; R 
= Right hemisphere; BA = approximate Brodmann’s or cortical area. 
 
4.5.2.2 Group differences 
Controls vs AllAMCI: AllAMCI had decreased activation in right hemispheric 
extrastriate visual cortex (BA 18, 19), hippocampus and occipitotemporal areas (BA 
37, 39) (Table 12). This was confirmed after controlling for the possible effects of 
slower reaction times on the BOLD signal in AMCI using analysis of covariance 
(ANCOVA) with visual RT as covariant. Slower RT could therefore not account for 
decreased activation in AMCI participants. There were no areas of greater activation 
in AMCI. 
 
Controls vs CoAMCI: CoAMCI had decreased activation in right cerebellum, inferior 
temporal lobe (BA 20, 36, 37), auditory cortex (BA 22, 42), visual cortex (BA 18, 
19), hippocampus, insula, medial parietal (BA 31) and lateral parietal areas (BA 40), 
and in left fusiform gyrus (BA 37), auditory association cortex (BA 21, 22) and lateral 
parietal lobe (BA 40) (Table 13).  
CoAMCI activated more in bilateral thalamic, brainstem and medial parietal areas 
(BA 29, 30). 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls >AllAMCI 
Occipital R Cerebellum, 
hippocampus, 
18, 19, 37, 39 
22 -81 -13 100 
Table 12.Functional activation differences on divided attention between Controls 
and AllAMCI. 
The table and brain activation maps show the areas where Controls had greater 
activation compared to all AMCI participants on divided attention. Differences were 
apparent in a large cluster in occipitotemporal areas (see text for details). For table 
legend, see Table 11.
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls >CoAMCI 
Occipital R Cerebellum, 
hippocampus, 
insula, 18, 19, 
20, 22, 37, 42, 40 
22 -81 -13 127 
Occipitotemporal R 18, 19, 31, 35, 
36, 37 
29 -33 -7 190 
Temporoparietal L 21, 22, 37, 40 -50 -44 26 68 
 
CoAMCI > Controls 
Midbrain-thalamic L Thalamus, 
brainstem, 29, 30 
-10 -37 4 75 
Table 13. Functional activation differences on divided attention between 
Controls and CoAMCI. 
The table and brain activation maps show the areas where Controls had greater 
activation compared to CoAMCI (top) and vice versa (bottom). Controls had greater 
activation in three clusters covering occipitotemporal and temporoparietal areas 
whereas CoAMCI had greater activation in a posterior midline cluster (see text for 
details). For table legend, see Table 11. 
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4.5.2.3 Functional-behavioural correlations 
A negative correlation of medium effect size was evident between VisRT and 
activation in right occipitotemporal cortex (fusiform gyrus; BA 36) where CoAMCI 
had attenuated activation (Table 14; Figure 14). A positive correlation of medium 
effect size was evident between VisRT and activation in the midbrain-thalamic area 
where CoAMCI had increased activation (Figure 15). 
Positive correlations with medium and small effect sizes were evident between 
activation in all three cortical areas where CoAMCI had attenuated activation, and 
CAMCOG total and New Learning subscale scores.  
 
 Controls + CoAMCI R2 
VisRT vs Right Occipital ns  
VisRT vs Right Occipitotemporal -0.45 (<0.05) 0.20 
VisRT vs Left Temporoparietal ns  
VisRT vs Midbrain-thalamic  0.54 (<0.05) 0.29 
CAMCOG vs Right Occipital 0.41 (<0.05) 0.17 
CAMCOG vs Right Occipitotemporal 0.50 (<0.01) 0.25 
CAMCOG vs Left Temporoparietal 0.53 (<0.01) 0.28 
CAMCOG vs Midbrain-thalamic ns  
New Learn vs Right Occipital 0.44 (<0.05) 0.19 
New Learn vs Right Occipitotemporal 0.49 (<0.01) 0.24 
New Learn vs Left Temporoparietal 0.42 (<0.05) 0.18 
New Learn vs Midbrain-thalamic ns  
Table 14. Correlations between activation and behavioural measures for 
Controls and CoAMCI on divided attention. 
The table shows correlations between behavioural measures and cortical areas where 
Controls and CoAMCI differed significantly.  
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Data are: Spearman’s correlation coefficient (p). The coefficient of determination, R2 
is reported as a measure of effect size: ±0.01 = a small effect, ±0.10 a medium effect, 
±0.25 a large effect. 
 
 
Figure 14. Functional-behavioural correlation of visual processing speed and 
cortical activation in the right occipitotemporal area in Controls and CoAMCI. 
A significant correlation (r= -0.5 (p<0.05) was evident between visual processing 
speed (VisRT) and the magnitude of activation (SSQ) in the right occipitotemporal 
area where CoAMCI had attenuated activation and associated slower visual target 
response times during divided attention. 
SSQ in right occipitotemporal area 
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Figure 15. Functional-behavioural correlation of visual processing speed and 
cortical activation in the midbrain area in Controls and CoAMCI. 
A significant correlation (r= 0.5; p<0.05) was evident between visual processing 
speed (VisRT) and the magnitude of activation (SSQ) in the midbrain-thalamic area 
where CoAMCI had greater activation and associated slower visual target response 
times during divided attention.  
 
4.6 Visual and Auditory Selective Attention at Baseline 
We compared AMCI subjects with Controls at baseline on selective visual and 
auditory attention in order to determine if basic sensory attention processing is altered 
in AMCI. 
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4.6.1 Functional Results Visual Selective Attention  
4.6.1.1 Group activation for visual selective attention 
Combining Controls and AllAMCI revealed activation in bilateral cerebellum, 
primary visual cortex (BA 17), extrastriate visual cortex (BA 18, 19) and fusiform 
gyrus (BA 37) (Table 15). 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
All subjects 
Cerebellum L+R Cerebellum, 
17,18, 19, 37 
18 -78 -13 870 
Table 15. Functional activation on visual selective attention for Controls and 
AllAMCI combined. 
The table and brain activation maps show areas of increased activation during 
selective visual attention to a highly salient reversing chequerboard stimulus across all 
participants. A large cluster of activation was evident in bilateral occipitotemporal 
visual areas (see text for details). For table legend, see Table 11. 
 
4.6.1.2 Group differences for visual selective attention 
Controls vs AllAMCI: AllAMCI had decreased activation in bilateral cerebellar 
cortex, extrastriate visual cortex (BA 18, 19), occipitotemporal areas (BA 39) and 
brainstem, and in left hemispheric primary visual cortex (BA 17) (Table 16). 
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Controlling for the possible effects of age on the BOLD signal in the AMCI 
participants (ANCOVA) revealed similar results with additional decreased activation 
in AllAMCI in the hippocampus. Generalised effects of ageing on cortical activation 
could therefore not account for these differences. 
 
Controls vs CoAMCI: CoAMCI demonstrated greater activation in left MTL 
(hippocampus, parahippocampus (entorhinal (BA 28) and perirhinal (BA 35) areas)) 
and brainstem, and in right insula, medial frontal, prefrontal (BA 46, 47), anterior 
temporal (BA 38), hippocampal, extrastriate visual (BA 19) and lateral parietal (BA 
39) areas, and in bilateral thalamus, caudate and anterior cingulate (BA 24, 25) 
(Table 17). There were no areas of greater activation in Controls at the set threshold; 
however, running the analysis at a less conservative threshold (expected number of 
false clusters per volume < 2, conventional analysis <1) revealed increased activation 
in a cluster in right occipitotemporal areas (BA 19, 37). 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls > AllAMCI 
Cerebellum R Cerebellum, 18, 
19, brainstem  
7 -48 -35 156 
Cerebellum R Cerebellum, 18, 
19, 37 
21 -78 -13 110 
Occipital cortex L Cerebellum, 17, 
18, 19, 37, 
brainstem 
-32 -85 -7 70 
Table 16. Functional activation differences on visual selective attention between 
Controls and AllAMCI. 
The table and brain activation maps show areas of increased activation in Controls 
compared to all AMCI participants during selective visual attention. Thee clusters of 
increased activation were evident in occipitotemporal visual areas and in the 
brainstem (see text for details). For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
CoAMCI > Controls 
Medial temporal L Hippocampus, 
brainstem, 28, 
35 
-14 -22 -13 54 
Medial frontal L+R Thalamus, 
caudate, 24, 25 
18 26 -7 238 
 R Insula, 
hippocampus, 
32, 38, 46, 47 
    
Occipitoparietal R 19, 39 36 -70 26 52 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls > CoAMCI       
Occipitotemporal R 19, 37 40 -63 -2 48 
Table 17. Functional activation differences on visual selective attention between 
Controls and CoAMCI. 
The table shows the areas where CoAMCI had greater activation than Controls during 
the visual attention condition (top), and where Controls had greater activation than 
 198 
CoAMCI (bottom). The increased activation in occipitotemporal areas seen in 
Controls was the only cluster of difference evident at a less conservative statistical 
threshold (see text for details).  
For table legend, see Table 11. 
 
4.6.2 Functional Results Auditory Selective Attention 
4.6.2.1 Group activation for auditory selective attention 
Combining Controls and AllAMCI revealed activation in bilateral symmetrical 
clusters including primary auditory cortex (BA 41, 42), auditory association cortex 
(BA 21, 22), occipitotemporal areas (BA 37), temporal pole (BA 38), inferior parietal 
lobe (BA 40), VLPFC (BA 44, 45, 47) and insula (Table 18).  
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
All subjects 
Temporal lobe R 21, 22, 37, 38, 
40, 41, 42, 44, 
47, insula 
58 -19 -2 283 
Temporal lobe L 21, 22, 37, 38, 
40, 41, 42, 44, 
45, 47, insula 
-54 -19 4 423 
Table 18.  Functional activation on auditory selective attention for Controls and 
AllAMCI combined. 
The table and brain activation maps show areas of increased activation during 
selective auditory attention to English nouns across all participants. Bilateral large 
clusters of activation were evident in lateral temporal auditory areas (see text for 
details). For table legend, see Table 11. 
 
4.6.2.2 Group differences for auditory selective attention 
Controls vs AllAMCI: AllAMCI had decreased activation in two clusters on the left 
including DLPFC (BA 9), premotor (BA 6), anterior cingulated (BA 24, 32), posterior 
cingulate (BA 7, 31), and lateral parietal areas (BA 39, 40).  A cluster on the right 
included medial parietal (BA 7, 30, 31) and lateral parietal areas (BA 40) (Table 19).
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Further analyses controlling for the possible effects of age on the BOLD signal in the 
AMCI participants (analysis of covariance (ANCOVA)) revealed similar results thus, 
it could not be accounted for by the effects of ageing on cortical activation. 
 
Controls vs CoAMCI: CoAMCI had greater activation in bilateral auditory 
association cortices (BA 21, 22) and hippocampi, and left putamen, thalamus and 
insula (Table 20). There were no areas of greater activation in Controls. 
 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls > AllAMCI 
Medial parietal R 7, 30, 31, 40  25 -44 26 131 
Medial parietal L 7, 19, 31, 39, 40 -25 -55 48 176 
Frontal L 6, 9, 24, 32 -29 0 42 148 
Table 19. Functional activation differences on auditory selective attention 
between Controls and AllAMCI. 
The table and brain activation maps show areas of increased activation in Controls 
compared to all AMCI participants during selective auditory attention. Clusters of 
increased activation were evident in bilateral parietal cortex and in frontal areas (see 
text for details). For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
CoAMCI > Controls 
Temporal  L Hippocampus, 
insula, thalamus, 
putamen, 20, 21, 
22 
-54 -15 -7 129 
Temporal R Hippocampus, 
21, 22 
54 -4 -2 79 
Table 20. Functional activation differences on auditory selective attention 
between Controls and CoAMCI. 
The table shows the areas where CoAMCI had greater activation than Controls during 
selective auditory attention. Increased activation was evident in bilateral MTL areas 
(see text for details). For table legend, see Table 11. 
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4.7 Verbal Episodic Encoding at Baseline 
We compared Controls with AllAMCI and CoAMCI at baseline to determine if the 
episodic amnesia in AMCI is associated with altered cortical activation during verbal 
episodic memory encoding. 
 
4.7.1 Behavioural Results 
Encoding performance is deduced from recognition results success and these are 
presented in the following section on recognition (§4.8.1; Table 25). 
 
4.7.2 Functional Results 
4.7.2.1 Group activation 
Combining Controls and AllAMCI revealed activation in bilateral cerebellum, 
primary and extrastriate visual cortex (BA 17, 18, 19), in right hippocampus, 
amygdala, entorhinal (BA 28, 34), anterior cingulate (BA 24, 32), frontal pole (BA 9), 
posterior cingulate (BA 30, 31), fusiform (BA 35, 36), insula, premotor ((BA 4, 6), 
primary auditory (BA 41, 42) and VLPFC areas (BA 40) (Table 21). Activation was 
also evident in left insula, frontal pole (BA 8, 10), VLPFC (45, 47), DLPFC (BA 9, 
46), anterior cingulate (BA 24, 32, 33) and posterior cingulate (BA 23). 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
All subjects 
Cerebellum R Cerebellum, 17, 
18,19  
18 -74 -13 173 
Cerebellum L Cerebellum, 17, 
18 
-14 -81 -13 67 
Brainstem R Hippocampus, 
amygdala, 
brainstem, 19, 
28, 30, 31, 34, 
35, 36 
0 -48 4 108 
Occipital cortex L 18, 19 -22 -78 31 42 
Precentral R Insula, 4, 6, 40, 
41, 42, 44 
40 -22 42 125 
L Insula, 6, 8, 9, 
10, 23, 24, 32, 
33, 45, 46, 47 
Insula 
R 9, 24, 32 
-36 26 15 850 
Table 21. Functional activation during verbal episodic encoding for Controls and 
AllAMCI combined. 
The table and brain activation maps show the areas where activation increased during 
overt reading and encoding of words lists compared to repeatedly reading a control 
word, across all participants. Several clusters of activation were evident in occipital, 
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MTL, lateral temporal, PFC and cingulate areas (see text for details). For table legend, 
see Table 11. 
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4.7.2.2 Group differences 
Controls vs AllAMCI: AllAMCI had decreased activation in left frontal pole cortex 
(BA 9, 10) (Table 22). Including age as covariant revealed similar results. 
Controls vs CoAMCI: Greater activation was evident in CoAMCI in right insula, 
primary auditory cortex (BA 41, 42), auditory association cortex (BA 21, 22), anterior 
cingulate (BA 24, 32), thalamus and putamen, and in bilateral posterior cingulate (BA 
31, 32), medial parietal (BA 7) and extrastriate visual cortex (BA 18) (Table 23). 
  
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls>AllAMCI 
Prefrontal cortex L 9, 10 -18 41 31 66 
Table 22. Functional activation differences during verbal episodic encoding 
between Controls and AllAMCI. 
The table and brain activation maps show areas of increased activation in Controls 
compared to all AMCI participants during verbal encoding. A single cluster of 
increased activation was evident in PFC in Controls (see text for details). For table 
legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
CoAMCI > Controls 
Temporal lobe R Insula, putamen, 
caudate, 
thalamus, 21, 22, 
41, 42 
51 -7 9 162 
Medial parietal L+R 7, 18, 23, 31 0 -70 15 125 
Table 23. Functional activation differences during verbal encoding between 
Controls and CoAMCI. 
The table and brain activation maps show areas of increased activation in CoAMCI 
compared to Controls during verbal encoding. Clusters of increased activation were 
evident in medial parietal and lateral temporal areas (see text for details). For table 
legend, see Table 11. 
 
4.7.2.3 Functional –behavioural correlations 
Activation in the areas of difference showed significant correlations with recognition 
measures (Table 24). Negative correlations were evident between Pr and activation in 
right temporal and posterior cingulate areas (Figures 16 and 17). Negative 
correlations were also evident between activation in the posterior cingulate and Pr for 
lures. Neuropsychological measures also correlated significantly with activation: 
CAMCOG score showed inverse correlation with activation in temporal and cingulate 
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areas so that better performers had less activation. New Learning subscale scores also 
showed a negative correlation with posterior cingulate activation. Large effect sizes 
were evident for the correlations between activation and neuropsychological 
measures. 
 
 Controls + CoAMCI R2 
Pr vs Right Temporal -0.40 (<0.05) 0.16 
Pr vs Bilateral Posterior Cingulate -0.41 (<0.05) 0.17 
FAR vs Right Temporal ns  
FAR vs Bilateral Posterior Cingulate ns  
Pr lures vs Right Temporal ns  
Pr lures vs Bilateral Posterior 
Cingulate 
-0.36 (<0.01) 0.13 
CAMCOG vs Right Temporal -0.42 (<0.05) 0.18 
CAMCOG vs Bilateral Posterior 
Cingulate 
-0.55 (<0.01) 0.30 
New Learn vs Right Temporal ns  
New Learn vs Bilateral Posterior 
Cingulate 
-0.58 (<0.01) 0.34 
Table 24. Correlations between activation and behavioural measures for 
Controls and CoAMCI on verbal episodic encoding. 
The table shows correlations between behavioural measures and cortical areas where 
Controls and CoAMCI differed significantly (see text for details). 
Data are: Spearman’s correlation coefficient (p). The coefficient of determination, R2 
is reported as a measure of effect size: ±0.01 = a small effect, ±0.10 a medium effect, 
±0.25 a large effect. 
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Figure 16. Functional-behavioural correlation of encoding performance and 
cortical activation in the right temporal area in Controls and CoAMCI. 
A significant negative correlation (r= -0.40 (p<0.05)) was evident between encoding 
success as measured by corrected recognition rates (Pr) and the magnitude of 
activation (SSQ) in the right temporal area where CoAMCI had greater activation and 
associated impaired verbal episodic memory. 
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Figure 17. Functional-behavioural correlation of encoding performance and 
cortical activation in the posterior cingulate area in Controls and CoAMCI. 
A significant negative correlation (r= 0.41 (p<0.05)) was evident between encoding 
success as measured by corrected recognition rates (Pr) and the magnitude of 
activation (SSQ) in bilateral posterior cingulate areas where CoAMCI had greater 
activation and associated impaired verbal episodic memory. 
 
 
4.8 Recognition at Baseline 
We compared AMCI patients to Controls on verbal episodic memory performance to 
determine if the amnesia in AMCI is in part due to semantic elaboration failure. 
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4.8.1 Behavioural Results 
Results are summarised in Table 25. AMCI were impaired on corrected recognition 
(Pr) and this was predominantly due to higher false alarm rates (FAR) (Figure 18). 
As a proportion of false alarms, AMCI subjects displayed significantly reduced false 
recognition for lures (Pr lures). In the AMCI groups the ranges of values for Pr and 
FAR were wide and groups were compared using non-parametric tests. The 
differences in response bias (chance bias = 0.5; liberal bias >0.5; conservative 
bias<0.5) between Controls and AMCI groups did not reach statistical significance. 
Significant correlations were evident on divided attention and recognition 
measures that Controls and CoAMCI differed on: VisRT during divided attention 
correlated with Pr (r= -0.45; p<0.02; R2= 0.20), FAR (r= 0.63; p<0.001; R2= 0.40) 
and Pr lures (r= -4.7; p<0.02; R2= 0.22). Age did not correlate significantly with any 
of the measures that differed between CoAMCI and Controls. 
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Control vs 
AllAMCI 
Controls vs 
CoAMCI 
  Control AllAMCI CoAMCI P F R2 P F R2 
Recognition 
(Pr) 
0.66 (0.2) 0.46 (0.2) 0.40 (0.1) 0.003 * 0.3 0.001  0.1 
Hit rate (Hr) 0.76 (0.2) 0.71 (0.2) 0.67 (0.2) ns   ns   
False alarm 
rate (FAR) 
0.10 (0.1) 0.25 (0.1) 0.26 (0.1) 0.001 * 0.1 0.003  0.01 
Bias rate 
(Br) 
0.35 (0.3) 0.51 (0.3) 0.47 (0.2) ns   ns   
Pr Lures 0.21 (0.2) 0.01 (0.2) -0.01 (0.2) 0.01 7 0.1 0.02 7 0.3 
Table 25. Behavioural results for the recognition task for Controls, AllAMCI 
and CoAMCI. 
The table shows behavioural recognition data for Controls, AllAMCI and CoAMCI. 
Controls performed better on corrected recognition (Pr) and false alarm rates (FAR), 
had higher false recognition for lures rates (Pr Lures) and the groups were 
comparable on hit rates (Hr). 
Data are mean (standard deviation), ns=not significant; F=ANOVA test statistic, 
*=MannWhitney test. The coefficient of determination, R2 is reported as a measure of 
effect size: ±0.01 = a small effect, ±0.10 a medium effect, ±0.25 a large effect. 
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Figure 18. Recognition task performances for Control and CoAMCI groups. 
The boxplot depicts behavioural results for the encoding task for the Control group 
(left) and CoAMCI group (right). Although the groups had comparable hit rates, the 
CoAMCI group had a lower corrected recognition rate that was mediated by a higher 
false alarm rate. The CoAMCI group had a significantly lower false recognition rate 
for lures. On the boxplot the central black lines indicate median values; upper and 
lower edges of boxes represent the interquartile range. 
 
4.8.2 Functional Results 
Behavioural data from 9 Controls, 16 AMCI and 11 CoAMCI were sufficient to allow 
functional analysis and comparisons of hits, correct rejection and false recognition of 
lures.  
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4.8.2.1 Group activation 
Results for hits (targets correctly identified) are reported for all subjects with available 
data (9 Controls + 16 AMCI) as the groups did not differ on behavioural measures. 
Functional results on correct rejection of any distractor (lure and non-lures) and false 
recognition of lures are reported for Controls because the patient and control groups 
differed significantly on these measures.  
Hits (all subjects): Activation was evident in bilateral cerebellum, visual cortex (BA 
17, 18, 19), fusiform (BA 36, 37), caudate, lentiform nucleus (putamen, globus 
pallidus), thalamus, DLPFC (BA 9, 46), VLPFC (BA 44, 45, 47), premotor (BA 4, 6) 
auditory association cortex (BA 21, 22), insula, temporoparietal areas (BA 39, 40), 
anterior cingulate (BA 24, 32), posterior cingulate (BA 7, 31), and brainstem (Table 
26). Activation in the left hemisphere was evident in primary auditory cortex (BA 41, 
42) and somatosensory areas (BA 1, 2, 3). 
Correct rejection of any distractor (in Controls): Activation was evident in bilateral 
cerebellum, visual cortex (BA 17, 18, 19), fusiform (BA 36, 37), caudate, lentiform 
nucleus (putamen, globus pallidus), DLPFC (BA 9, 46), VLPFC (BA 44, 45,), 
premotor (BA 4, 6), insula, temporoparietal areas (BA 39, 40), anterior cingulate (BA 
24, 32), and posterior cingulate (BA 31) (Table 27). Activation on the left was 
evident in primary auditory (BA 41, 42), auditory association (BA 22), and on the 
right in the thalamus. 
False recognition of lures (in Controls): Activation was evident in a cluster in left 
PFC (Talairach coordinates: x= -36; y=33; z=9; size = 56 voxels) than included 
VLPFC (BA 45, 47), DLPFC (BA 46) and anterior polar cortex (BA 10), and in a 
cluster in right PFC (Talairach coordinates: x= 43; y=7; z=20; size = 132 voxels) that 
include VLPFC (BA 44, 45, 47), anterior polar cortex (BA 10) and insula. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Correct recognition of targets in all subjects 
Striatum R Striatum 22 0 15 98 
Temporal R Insula, caudate, 
lentiform nucleus, 
thalamus, 44, 45, 46, 
47 
43 22 -2 48 
Temporal R 4, 6, 9, 44, 45, 46, 47 40 0 37 115 
L+R Cerebellum, 7, 17, 
18, 19, 21, 22, 31, 32, 
36, 37, 39, 40 
-22 -67 26 2649 Occipital 
 
 
 L 1, 2, 3, 41, 42      
Frontal L Insula, thalamus, 
brainstem, 4, 6, 24, 
31, 32, 44, 45, 46, 47 
-4 -4 48 181 
Table 26. Functional activation during correct recognition of targets (hits) for 
Controls and AllAMCI combined. 
Combining all participants revealed activation in PFC, temporal, striatal, occipital, 
parietal and brainstem areas during correct recognition of targets (see text for details). 
For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Correct rejection of any distractor in Controls 
Prefrontal  R 4, 6, 9, 44, 45, 
46, insula, 
caudate, 
thalamus, 
lentiform nucleus 
43 8 20 338 
Occipital L 22, 41, 42  33 -67 -18 2517 
R 4, 6, 9, 44, 45, 
46, insula, 
caudate, 
lentiform nucleus 
     
L+R Cerebellum, 7, 
17, 18, 19, 24, 
31, 32, 36, 37, 
39, 40,  
    
Table 27. Functional activation during correct rejection of any distractor in 
Controls. 
Controls showed activation in two large clusters during correct rejection of any 
distractor in predominantly bilateral PFC, occipitotemporal, medial and lateral 
parietal, striatum, insula, thalamus, and cerebellar areas (see text for details). For table 
legend, see Table 11. 
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4.8.2.2 Group differences 
We compared 9 Controls and 11 CoAMCI on three conditions. 
Hits: Controls vs. CoAMCI: CoAMCI had decreased activation in bilateral 
cerebellum, 
visual (BA 17, 18, 19), fusiform (BA 37), insula, VLPFC (BA 44, 45, 47), posterior 
cingulate (BA 31) areas,  in right DLPFC (BA 9, 46), and in left PFC (BA 6), 
auditory association (BA 22), primary auditory (BA 41, 42), putamen and caudate 
areas (Table 28). 
CoAMCI had increased activation in bilateral anterior frontal cortex (BA 9, 10), 
medial temporal (BA 28, 34, amygdala, hippocampus, NBM), brainstem, fusiform 
(BA 36) in right auditory association (BA 21), perirhinal (BA 35), temporal pole (BA 
38), and in left DLPFC (BA 46), putamen and caudate areas (Table 29). 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls>CoAMCI 
Occipital R Cerebellum, 17, 
18, 19, 37 
40 -82 -2 118 
Frontal L Putamen, 
caudate, insula, 
6, 22, 41, 44, 45, 
47, 
-51 11 4 138 
Frontal R Insula, 9, 44, 45, 
46, 47 
50 19 4 58 
Temporal L Cerebellum, 17, 
18, 19, 31, 37 
-36 -59 -13 216 
Table 28. Functional activation differences during hits between Controls and 
CoAMCI: Controls > CoAMCI 
CoAMCI had decreased activation in cerebellar, occipitotemporal visual, PFC, 
cingulate, temporal auditory, putamen and caudate areas compared to controls during 
cortical processing of hits (see text for details). For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
CoAMCI>Controls 
Medial temporal R Hippocampus, 
amygdala, 21, 
27, 28, 30, 34, 
35, 36, 38  
33 -26 -7 171 
Posterior medial parietal L Putamen, 
caudate, 
brainstem, 
amygdala, 
hippocampus, 
nucleus basalis, 
25, 27, 28, 30, 
34, 35, 36 
-11 -41 -2 116 
Frontal pole L+R 10, 11 0 59 20 467 
Table 29. Functional activation differences during hits between Controls and 
CoAMCI: CoAMCI > Controls 
CoAMCI had increased activation in anterior frontal, medial temporal, brainstem, 
temporal pole, and PFC areas (see text for details). For table legend, see Table 11. 
 
Correct rejection of any distractor: Controls vs CoAMCI: CoAMCI had decreased 
activation in bilateral visual (BA 17, 18, 19), fusiform (BA 37), posterior cingulate 
(BA 31), VLPFC (BA 44, 45) and insula, and left thalamus, striatum, and caudate, 
and right  DLPFC (BA 9, 46, 47) (Table 30). 
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CoAMCI had greater activation in bilateral frontal pole (BA 10), anterior cingulate 
(BA 32), and frontal cortex (BA 9, 47), and in left frontal pole (BA 11), anterior 
cingulate (BA 25), caudate, putamen and insula, and in right anterior cingulate, (BA 
25). 
 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls>CoAMCI 
Occipital R 17, 18, 19, 37, 31 38 -81 -2 118 
Frontal L Insula, thalamus, 
striatum, 
caudate, 44, 45 
-51 11 4 138 
Frontal R Insula, 9, 44, 45, 
46, 47 
50 19 4 58 
Temporal L Cerebellum, 17, 
18, 19, 31, 37 
-36 -60 -13 216 
 
CoAMCI>Controls 
Frontal pole L+R 9, 10, 32, 47 0 59 20 467 
 L 10, 25, caudate, 
putamen, insula 
    
 R 25     
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Table 30. Functional activation differences during correct rejection of any 
distractor between Controls and CoAMCI. 
CoAMCI had decreased activation in occipitotemporal visual, medial parietal, PFC, 
insula, thalamus and striatum during correct rejection of any distractor (top). 
CoAMCI had greater activation in a large anterior cluster in frontal polar, anterior 
cingulate, caudate and insular areas (bottom). For table legend, see Table 11. 
 
False recognition of lures: Controls vs CoAMCI: CoAMCI had decreased activation 
in left cerebellum, extrastriate visual (BA 18, 19), fusiform (BA 37), and inferior 
parietal (BA 39) areas (Table 31). 
CoAMCI had greater activation in left VLPFC (BA 47), hippocampus, 
parahippocampus (BA 28, 35), fusiform gyrus (BA 36), temporal pole (BA 38), insula 
and amygdala. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
Controls>CoAMCI 
Cerebellum L 18, 19, 37, 39, 
cerebellum 
-47 -59 -18 134 
 
CoAMCI>Controls 
Frontotemporal L Insula, 
amygdala, 
hippocampus, 
20, 21, 28, 34, 
35, 36, 38, 47 
-43 22 -13 204 
Table 31. Functional activation differences during false recognition of lures 
between Controls and CoAMCI. 
CoAMCI had decreased activation in a cluster in left cerebellar, occipitotemporal and 
lateral parietal areas during false recognition of lures (top). CoAMCI had greater 
activation in left PFC, MTL, temporal pole and insula (bottom). The CoAMCI > 
Controls result is at a cluster p-level where 1.02 false cluster can be expected instead 
of <1. For table legend, see Table 11. 
 
 222 
4.9 Rivastigmine Treatment Effects on Divided Attention in AMCI 
We compared RivAMCI and NxAMCI on repeated functional and behavioural 
measures on the divided attention task to determine the treatment effects of 
rivastigmine. 
 
4.9.1 Rivastigmine Dosage and Tolerability 
The average daily dose of rivastigmine during the study period was 5.09 mg (Range 3 
to 9 mg). Side effects were common; five patients reported nausea and vomiting, three 
reported nausea only and one suffered significant weight loss. One year after initiating 
treatment six patients remained on rivastigmine, three on another cholinesterase 
inhibitor and one was not taking treatment due to intolerable adverse effects. 
 
4.9.2 Neurocognitive and Behavioural Results  
Baseline (T1) and follow-up (T2) neurocognitive and divided attention behavioural 
results for RivAMCI and NxAMCI are summarised in Table 32. Groups were 
comparable on age, education and premorbid intelligence but the NxAMCI group had 
superior performance on MMSE and Attention subscale scores.  
Group comparisons revealed significantly faster VisRT and AudRT on the 
divided attention task in RivAMCI at follow-up. Entering MMSE as a covariant into 
the analysis revealed similar results on VisRT (p<0.05; F=3.7; R2=0.3) and AudRT 
(p<0.02; F=5.2; R2=0.4). The groups were comparable on other measures. A trend 
towards improvement over time in accuracy and speed was evident in RivAMCI 
whilst a trend towards deteriorating performance was evident in NxAMCI. Results are 
reported as significant at p<0.05. 
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PrDA Main effect of time: There were no time effects evident between the groups as 
all performed at ceiling at baseline (T1) and follow-up (T2). 
PrDA interaction (Group x Time): No interaction effects were evident indicating that 
rivastigmine treatment did not affect accuracy. 
VisRT Main effect of time: There were no significant effects of time on VisRT. 
VisRT Group x Time interaction: There were no significant interaction effects on 
VisRT although a trend towards improved performance in RivAMCI appeared 
(Figure 19). 
AudRT Main effect of time: There were no significant time effects on AudRT. 
AudRT interaction (Group x Time): A significant interaction effect (F(1, 18)=6.2) was 
evident indicating faster RT in RivAMCI following treatment with slower RT in 
NxAMCI (Figure 20). 
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RivAMCI 
vs 
NxAMCI 
  RivAMCI NxAMCI P F R2 
Age 70.7 (9.2) 66.9 (11.5) ns     
Years in education 10.7 (2.4) 11.9 (1.5) ns     
NART 111.1 (9.1) 111.8 (10.0) ns     
MMSE 24.9 (1.9) 27.8 (1.6) 0.001 * 0.5 
CAMCOG 87.3 (5.1) 90.9 (7.1) ns     
Attention  8.0 (0.9) 9.0 (0.00) 0.003 * -0.5 
New Learning  8.8 (3.3) 9.4 (4.4) ns     
T1  Pr 0.90 (0.1) 0.93 (0.1) ns     
T2  Pr 0.92 (0.1) 0.88 (0.1) ns     
T1 VisRT 0.65 (0.1) 0.70 (0.1) ns     
T2 VisRT 0.59 (0.1) 0.72 (0.2) 0.043 4.8 0.2 
T1 AudRT 0.74 (0.1) 0.78 (0.1) ns     
T2 AudRT 0.69 (0.1) 0.86 (0.2) 0.007 9.2 0.3 
Table 32. Demographic, neuropsychological and divided attention task 
behavioural data at baseline (T1) and follow-up (T2) for RivAMCI and NxAMCI 
groups. 
The groups were comparable on age, education and premorbid intelligence but the 
NxAMCI group had superior performance on MMSE and Attention subscale scores.  
RivAMCI were significantly faster on auditory and visual RT at follow-up. A trend 
towards improvement over time in accuracy and speed is evident in RivAMCI and a 
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trend towards deteriorating performance in NxAMCI. Results are reported as 
significant at p<0.05. 
Pr=corrected recognition; VisRT=visual target reaction time; AudRT=auditory target 
reaction time; ns=not significant; F=ANOVA test statistic; *= Mann-Whitney test. 
The coefficient of determination, R2 is reported as a measure of effect size: ±0.01 = a 
small effect, ±0.10 a medium effect, ±0.25 a large effect. 
 
 
 
Figure 19. Interaction (Group x Time) effects on visual reaction time (VisRT) in 
RivAMCI and NxAMCI groups. 
VisRT is faster in RivAMCI following rivastigmine treatment and slower in untreated 
NxAMCI over time. Means for VisRTs are displayed on the vertical axis and time on 
the horizontal axis. 
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Figure 20. Interaction (Group x Time) effects on auditory reaction time (AudRT) 
in RivAMCI and NxAMCI groups. 
AudRT is faster in RivAMCI following rivastigmine treatment and slower in 
untreated NxAMCI over time. Means for AudRT are displayed on the vertical axis 
and time on the horizontal axis. 
 
4.9.3 Functional Results 
Group comparisons at T1: RivAMCI had greater activation at T1 in bilateral 
cerebellum and visual cortex (BA 17, 18), and in left fusiform gyrus (BA 37) on the 
divided attention task (Table 33). There were no areas of greater activation in 
NxAMCI. 
Main effect of time: Significant time effects were evident in left temporal auditory 
association cortex (BA 21, 22), inferior temporal lobe (BA 20), anterior temporal pole 
(BA 38) and hippocampus where both groups reduced activation over time (Table 
34). Both groups increased activation over time in bilateral posterior cingulate (BA 
23, 29, 31) and hippocampal areas, in right somatosensory (BA 1), temporal (BA 22), 
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insula, fusiform (BA 37), extrastriate visual (BA 19), caudate and parietal (BA 40) 
areas, and in left  brainstem, thalamus, parahippocampus (BA 28) and cerebellum. 
Main effect of group: None. 
Interaction effects (Group x Time):  Significant interaction effects were evident in left 
primary and auditory association cortex (BA 21, 22, 42), fusiform (BA 37), 
extrastriate visual (BA 19), insula, premotor (BA 4, 6), DLPFC (BA 9, 46), striatum 
and lateral parietal areas (BA 39) (Table 35; Figures 21, 22). In these areas 
RivAMCI decreased activation and NxAMCI increased activation over time.  
No linear correlations were evident between activation change over time and change 
in reaction times in RivAMCI. This may indicate a binary effect or lack of power to 
demonstrate linear effect 
 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI > NxAMCI 
Cerebellum L+R Cerebellum, 17, 
18, 19, 37 
-15 -70 -29 90 
Table 33. Group differences at baseline on divided attention between RivAMCI 
and NxAMCI groups. 
The table and brain activation maps show the cerebellar and occipitotemporal areas 
where RivAMCI had greater activation during divided attention at baseline compared 
to NxAMCI (see text for details). For table legend, see Table 11. 
 228 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
T1 > T2 
Temporal  L 20, 21, 22, 38, 
hippocampus 
-47 -26 -13 86 
 
T2 > T1 
Temporal R 1, 19, 20, 
caudate, insula, 
hippocampus, 22, 
23, 29, 37, 40  
40 -41 -13 159 
Parietal L Brainstem, 
cerebellum, 
hippocampus, 
thalamus, 23, 28, 
29, 31 
25 -26 37 352 
Table 34. Main effects of time on the divided attention task for the pooled 
AllAMCI sample (RivAMCI + NxAMCI). 
The table and brain activation maps show areas of increased activation in the 
combined AMCI groups at baseline in temporal areas (top), and at follow-up (bottom) 
in temporal, parietal and midbrain areas. See text for details. For table legend, see 
Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI decrease vs NxAMCI increase 
Occipital L 18,19, 21, 22, 37, 
39, 42 
-25 -70 15 70 
Prefrontal L 4, 6, 9, 46, 
insula, striatum  
-36 -4 37 73 
Table 35. Interaction effects (Group x Time) for RivAMCI and NxAMCI groups 
on the divided attention task. 
The table and brain activation maps show occipitotemporal and frontotemporal 
clusters where RivAMCI decreased activation following rivastigmine treatment 
compared to increased activation in NxAMCI (see text for details). For table legend, 
see Table 11. 
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Figure 21. Interaction (Group x Time) effects on divided attention between 
RivAMCI and NxAMCI in left DLPFC. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decrease and NxAMCI increase activation over time in the left DLPFC. 
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Figure 22. Interaction (Group x Time) effects on divided attention between 
RivAMCI and NxAMCI in left occipital area. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decrease and NxAMCI increase activation over time in the left occipital area. 
 
4.9.4 Post-hoc Analyses  
We conducted post hoc analyses to determine if the group differences in functional 
activation evident at baseline were due to sampling bias as the groups were recruited 
at different times, albeit with identical sampling procedures. The groups did not differ 
on the severity of cognitive impairment as measured by the deviation of individual 
scores from predicted CAMCOG totals. The ten less severely impaired AMCI group 
included six NxAMCI and the more impaired group four (Table 36). Eight Controls 
were in the group of ten least impaired participants. Insufficient data was available to 
calculate a predicted CAMCOG score for one control. 
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Subject % Predicted 
CAMCOG 
Rank 
Control 127 1 
Control 123 2 
Control 122 3 
Control 118 4 
NxAMCI 118 5 
Control 114 6 
Control 112 7 
Control 110 8 
Control 110 9 
RivAMCI 108 10 
RivAMCI 108 11 
RivAMCI 106 12 
Control 106 13 
RivAMCI 106 14 
NxAMCI 106 15 
NxAMCI 106 16 
NxAMCI 105 17 
NxAMCI 105 18 
NxAMCI 103 19 
RivAMCI 101 20 
NxAMCI 101 21 
RivAMCI 100 22 
NxAMCI 99 23 
RivAMCI 98 24 
NxAMCI 96 25 
RivAMCI 94 26 
RivAMCI 93 27 
RivAMCI 91 28 
NxAMCI 83 29 
Table 36. Participant stratification based on predicted CAMCOG total. 
The table shows percentage of total predicted CAMCOG scores obtained by 
participants. Group A (RivAMCI) was recruited at the same time as control subjects 
and recruitment of group B (NxAMCI) followed that. In the rank column, the ten least 
impaired AMCI appear in the light grey cells and the 10 more impaired AMCI in 
darker grey cells. 
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4.10 Rivastigmine Treatment Effects on Visual and Auditory 
Selective Attention 
We examined the effects of rivastigmine on functional activation during basic visual 
and auditory attention processing by comparing RivAMCI and NxAMCI on repeated 
functional measures. 
 
4.10.1 Functional Results 
4.10.1.1 Visual selective attention 
Main effect of time: Both groups decreased activation over time in bilateral premotor 
(BA 4, 6) and anterior cingulate cortex (BA 24, 32), and in right caudate (Table 37). 
Both groups increased activation over time in left amygdala, hippocampus and 
parahippocampus (BA 28), fusiform, (BA 36), anterior temporal pole (BA 38), 
auditory (BA 21, 41, 42), lateral parietal (BA 39, 40), caudate, putamen and 
extrastriate visual cortex.  
Main effect of group: RivAMCI had greater activation at both time points in bilateral 
visual cortex (BA 17, 18, 19) and posterior cingulate (BA 31), and in right cerebellum 
(Table 38). NxAMCI had greater activation at both time points in bilateral caudate, 
thalamus, striatum and insula, in right superior temporal cortex (BA 22) and PFC (BA 
6, 44), and left PFC (BA 45). 
Interaction effects (Group x Time):  Significant interaction effects were evident in 
right lateral temporoparietal areas (BA 21, 22, 37, 39, 40, insula) where RivAMCI 
decreased and NxAMCI maintained activation over time (Table 39; Figure 15). 
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Further interaction effects were evident in PFC areas where RivAMCI increased 
activation and NxAMCI decreased activation (Figure 16). These differences illustrate 
the treatment effects of rivastigmine on visual attention processing. 
 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
T1>T2 
Premotor L+R 4, 6, 24 -22 -11 42 201 
 L 8     
 R Striatum, 1, 32     
 
T2>T1 
Temporal L Hippocampus, 
thalamus, 
striatum, 21, 22, 
28, 35, 37, 38, 
39, 41 
-51 -52 -2 287 
Table 37. Main effects of time on visual selective attention in RivAMCI and 
NxAMCI groups. 
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Both groups demonstrated larger activation in lateral and medial frontal areas at 
baseline (top) and larger activation in temporoparietal areas at follow-up (bottom). 
For table legend, see Table 11. 
 
 
Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI>NxAMCI 
Occipital L+R 17, 18, 19, 31 -4 -78 -15 171 
 R Cerebellum     
 
NxAMCI>RivAMCI 
Prefrontal L+R Caudate, 
striatum, 
thalamus, insula 
54 4 9 263 
 L 45     
 R 6, 22, 44     
Table 38. Main effects of group on visual selective attention in RivAMCI and 
NxAMCI groups. 
RivAMCI had larger activation in posterior medial areas compared to NxAMCI over 
time (top) and NxAMCI had larger activation in PFC and temporal areas (bottom). 
For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI decrease vs NxAMCI maintain 
Temporal R Insula, 21, 22, 
37, 39, 40 
54 -41 9 91 
 
RivAMCI maintain vs NxAMCI decrease 
Prefrontal L+R Caudate, 9, 10, 
24, 32, 45 
-7 56 31 415 
 L 46     
 R Insula, 44, 47     
Table 39. Interaction effects (Group x Time) for RivAMCI and NxAMCI groups 
on the visual selective attention condition. 
RivAMCI decreasing activation over time in right lateral temporoparietal areas (top) 
and NxAMCI decreased activation in frontal areas (bottom) compared to RivAMCI, 
revealing the neural correlates of rivastigmine treatment in RivAMCI. For table 
legend, see Table 11. 
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Figure 23. Interaction (Group x Time) effects on visual selective attention 
between RivAMCI and NxAMCI in right lateral temporal area. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decrease and NxAMCI maintained activation over time in the right lateral temporal 
area. 
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Figure 24. Interaction (Group x Time) effects on visual selective attention 
between RivAMCI and NxAMCI in left PFC. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
increased and NxAMCI decreased activation over time in the left PFC.  
 
4.10.1.2 Auditory selective attention 
Main effect of time: Both groups activated more at baseline a cluster in bilateral 
cerebellum, brainstem, in left parahippocampal (BA 27, 30) and fusiform areas, and in 
a cluster in PFC (BA 45), putamen, thalamus and insula (Table 40). Both groups 
activated more in bilateral occipitoparietal (BA 19, 39, 40) areas at follow-up.  
Main effect of group: RivAMCI had greater activation across time in left temporal 
(BA 21, 22, 42), parietal (BA 39, 40), visual (BA 19), anterior cingulate (BA 24), 
motor and premotor (BA 1, 2, 3, 4, 6) areas (Table 41). NxAMCI had greater 
activation across time in bilateral medial parietal (BA 7, 23, 29, 30, 31), left visual 
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(BA 17, 18) and cerebellar areas, and in right lateral parietal (BA 39), medial 
temporal (hippocampus) and insula. 
Interaction effects (Group x Time):  Significant interaction effects were evident in a 
cluster in right cerebellum, visual and fusiform areas ((BA 19, 36, 37) (Figure 17), a 
cluster in bilateral medial occipitoparietal (BA 17, 31) (Figure 18) and right visual 
areas (BA 18, 19) (Figure 19), and a cluster in left temporoparietal (BA 21, 22, 40, 
41, 42) and somatosensory areas (BA 1, 2, 3) (Table 42). In these areas RivAMCI 
demonstrated relatively decreased activation compared to NxAMCI. Further 
interaction effects were evident in brainstem, medial occipitotemporal (BA 19, 34, 
amygdala, hippocampus), posterior cingulate (BA 29, 30), thalamus and striatum 
where RivAMCI had increased activation over time and NxAMCI decreased (Figure 
20).  
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
T1>T2 
Cerebellum L+R Cerebellum, 
brainstem, 27, 
30,  
-4 -52 -18 189 
 L 35, 36, 37     
Frontotemporal L Insula, thalamus, 
putamen, 45 
-29 26 9 152 
 
T2>T1 
Parietal R 19, 21, 39, 40 54 -41 26 140 
 L 19, 39, 40 -33 -70 26 130 
Table 40. Main effects of time on auditory selective attention in RivAMCI and 
NxAMCI groups. 
The groups had relatively larger activation in left frontotemporal and bilateral 
occipitoparietal and brainstem areas at baseline (top), and in bilateral occipitoparietal 
areas at follow-up (bottom). For table legend, see Table 11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI > NxAMCI 
Temporal L 1, 2, 3, 4, 19, 21, 
22, 24, 37, 39, 
40, 42 
-43 -37 15 309 
 
NxAMCI > RivAMCI 
Medial parietal L+R 7, 23, 30, 31  4 -59 20 377 
 L Cerebellum, 17, 
18 
    
 R Hippocampus, 
insula, 39  
    
Table 41. Main effects of group on auditory selective attention in RivAMCI and 
NxAMCI groups. 
RivAMCI had greater activation in lateral occipitotemporal areas across time (top) 
and NxAMCI in medial occipitoparietal areas (bottom). For table legend, see Table 
11. 
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Cerebral Region  L/R Brodmann’s or 
cortical area 
Talairach 
coordinates 
x              y             z 
Cluster size 
(voxels) 
RivAMCI decrease vs NxAMCI increase 
Cerebellum R Cerebellum, 19, 36, 
37 
29 -41 -29 192 
Occipital L 17, 18, 19, 31 -7 -70 2 121 
Temporal R 1, 2, 3, 21, 22, 40, 41, 
42 
54 -15 -2 138 
 
RivAMCI increase vs NxAMCI decrease 
Occipital L+R Brainstem, 19, 34  -4 -41 4 179 
 L Thalamus, striatum, 
amygdala, 
hippocampus, 29, 30 
    
Table 42. Interaction effects (Group x Time) for RivAMCI and NxAMCI groups 
on the auditory selective attention condition. 
RivAMCI decreased activation over time in cerebellar, occipital and lateral temporal 
areas (top) and increased activation in brainstem areas (bottom) compared to 
NxAMCI and this reveals the neural correlates of rivastigmine treatment. For table 
legend, see Table 11. 
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Figure 25. Interaction (Group x Time) effects on auditory selective attention 
between RivAMCI and NxAMCI in right cerebellum. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decreased and NxAMCI increased activation over time in the right cerebellum. 
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Figure 26. Interaction (Group x Time) effects on auditory selective attention 
between RivAMCI and NxAMCI in left occipital areas. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decreased and NxAMCI increased activation over time in the left occipital areas. 
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Figure 27. Interaction (Group x Time) effects on auditory selective attention 
between RivAMCI and NxAMCI in right temporal areas. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
decreased and NxAMCI increased activation over time in right temporal areas. 
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Figure 28. Interaction (Group x Time) effects on auditory selective attention 
between RivAMCI and NxAMCI in brainstem areas. 
The boxplot shows baseline (T1) and follow-up (T2) data for the groups. RivAMCI 
increased and NxAMCI decreased activation over time in the brainstem. 
 
4.11 Rivastigmine Treatment Effects on Verbal Encoding and 
Recognition 
4.11.1 Behavioural Results 
There were no significant differences between the RivAMCI and NxAMCI groups on 
any of the recognition measures at any time point, and the differences between these 
groups and Controls evident at baseline remained (Table 43). All participants showed 
decreased Pr and increased FAR at follow-up. A main effect of time was evident for 
FAR in RivAMCI and NxAMCI, revealing overall increased FAR at follow-up 
(F(1,17)=8.4; p<0.01); however,  the consequential decrease in Pr was only near-
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significant (F(1,17)=3.5; p=0.77). No main time effects were evident on Br or Pr for 
Lures. No interactions (group x time) were evident on FAR, Pr, Br or Pr for Lures. 
 
4.11.2 Functional Results 
Longitudinal functional data from the encoding task were not analysed for the 
RivAMCI and NxAMCI rivastigmine treatment comparison because treatment had no 
apparent effect on recognition performance and evidence from treatment studies in 
control and AMCI groups failed to demonstrate beneficial effects on verbal memory 
(§1.7.4). In addition, insufficient data were available for meaningful analysis of the 
recognition task due to the technical and participant factors discussed before (§4.3). 
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RivAMCI 
vs 
NxAMCI 
RivAMCI 
vs 
Control 
Control  
vs 
 NxAMCI 
  Control RivAMCI NxAMCI P F R2 P F R2 P F R2 
Corrected recognition rates (Pr) 
T1 0.66 (0.2) 0.48 (0.1) 0.43 (0.2) ns     0.01 7 0.3 0.007 9 0.6 
T2 0.61 (0.1) 0.38 (0.2) 0.36 (0.2) ns     0.01 8 0.4 0.002 14 0.7 
Hit rates (Hr) 
T1 0.76 (0.2) 0.71 (0.2) 0.71 (0.2) ns     ns -    ns     
T2 0.75 (0.2) 0.66 (0.2) 0.72 (0.2) ns     ns -    ns     
False alarm rates (FAR) 
T1 0.10 (0.1) 0.22 (0.1) 0.28 (0.1) ns     0.01 8 0.4 0.003 12 0.6 
T2 0.14 (0.1) 0.28 (0.2) 0.36 (0.1) ns     0.04 5 0.3 0.001 21 0.7 
Bias rates (Br) 
T1 0.35 (0.3) 0.47 (0.2) 0.55 (0.3) ns     ns     ns     
T2 0.41 (0.4) 0.46 (0.2) 0.61 (0.2) ns     ns     ns     
Lure recognition rates (Pr lures) 
T1 0.21 (0.2) 0.05 (0.2) -0.03 (0.2) ns     0.05 * 0.2 0.01 * 0.5 
T2 0.13 (0.2) -0.07 (0.2) -0.21 (0.2) ns    0.05 * 0.2 0.001 * 0.6 
Table 43. Behavioural results for Controls, RivAMCI and NxAMCI at baseline 
(T1) and follow-up (T2) on the recognition task. 
There RivAMCI and NxAMCI groups were comparable on all recognition measures 
across time and differences with Controls evident at baseline remained. Pr decreased 
and FAR increased across all participants at follow-up.  
Data are mean (standard deviation), ns=not significant, F=ANOVA test statistic; *=Mann-
Whitney test. The coefficient of determination, R2 is reported as a measure of effect size: 
±0.01 = a small effect, ±0.10 a medium effect, ±0.25 a large effect. 
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5. Discussion 
We examined episodic memory and attention in prodromal AD and the effects of 
ACEI treatment on deficits in these cognitive domains. We therefore used fMRI to 
examine the neural correlates of attention and memory processing in AMCI that 
represent prodromal AD. The longitudinal demographic and neurocognitive findings 
from our patient group lend strong support to the validity of AMCI diagnosed in 
specialist memory clinics as prodromal AD (§5.1-3). Continued follow-up of AMCI 
patients enabled us to identify those who progressed to AD, the CoAMCI group, and 
to compare them with Controls in allowing us to examine attention and memory in 
prodromal AD. Comparisons between Controls and the pooled AllAMCI group 
(RivAMCI + NxAMCI), that was overall less impaired than the CoAMCI group, 
provide some insight into altered behaviour and activation earlier on in the 
progression of AD, although continued follow-up will be required to determine if all 
our AMCI subjects progress to AD. 
CoAMCI demonstrated altered cortical activation during selective visual and 
auditory attention suggesting that basic attentional processing is affected by AD 
neuropathology in the prodromal stages (§5.7). Behavioural and functional findings 
on the divided attention task indicate its sensitivity to differences in relatively small 
groups and therefore its appropriateness for fMRI studies of attention in AMCI (§5.5). 
Altered functional activation and impaired behavioural performance during divided 
attention indicate that attentional deficits occur early in the course of AD (§5.6).  
Behavioural findings from the verbal episodic memory task indicate that executive 
failure contributes significantly to the episodic amnesia in AMCI and functional 
findings suggest that this is associated with failed cognitive regulation and 
compensatory activation (§5.8-9). The recognition task revealed altered activation 
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areas including the posterior cingulate that accords with findings from other studies 
and supports the suggestion that altered posterior medial parietal (cingulate) activation 
appears early and consistently in AMCI (§5.6.2.2). 
The longitudinal study on the behavioural and functional effects of ACEI 
treatment on attention in AMCI revealed that rivastigmine treatment improved visual 
and auditory response processing during divided attention (§5.10). This was 
associated with decreased activation in primary and secondary visual and auditory 
cortices, and in the PFC and lateral parietal areas of the executive-attention network 
suggesting improved cortical processing efficiency. 
Rivastigmine treatment was associated with decreased activation in non-
relevant auditory and language processing areas during the selective visual attention 
condition and in visual processing areas during selective auditory attention, 
suggesting improved down regulation of activation in areas not relevant to a given 
condition following rivastigmine (§5.11). Rivastigmine had no apparent behavioural 
effects on recognition (§5.12). All these findings are discussed in more detail below. 
 
5.1 Participant Demographics 
Controls and AMCI groups did not differ significantly on age and education although 
the mean ages of the AllAMCI and CoAMCI groups were older (§4.1; Table 9). The 
non-significance of the age difference may be due to the relatively small sample sizes 
reducing statistical detection power. However, statistical analysis of other functional 
and behavioural variables will suffer from the same lack of statistical power, 
consequently observed significant differences will have large effect sizes, and would 
therefore remain significant in larger samples. Nonetheless, differences in age should 
be taken into account and where possible controlled for by matching samples because 
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age cannot be covaried for as it is systematically related to the defining characteristic 
(episodic memory) of the AMCI group and doing so would remove real variance and 
corrupt the grouping variable itself (Miller and Chapman, 2001). The potential effects 
of age differences between CoAMCI and Controls were examined by correlation 
analyses with behavioural and neurocognitive measures on which the groups differed 
significantly (CAMCOG and New Learning subscale §4.2; VisRT on divided 
attention §4.5.1; Pr, FAR and Pr lures on recognition §4.8.1). The only significant 
correlation was an inverse correlation between age and total CAMCOG scores in 
CoAMCI and Controls, indicating that 12% of the difference between the groups 
could be attributed to differences in age. The age difference between these two groups 
therefore accounts for less than two of the 15-point difference on mean total 
CAMCOG scores. The absence of any significant correlations between age and any of 
the experimental behavioural measures that differed between Controls and CoAMCI 
suggests that age is unlikely to account for related observed functional differences. 
Numerically different age-means are evident in several referenced studies 
comparing AD and AMCI to controls (Celone et al., 2006; Chetelat et al., 2003; Laine 
et al., 2008; Okonkwo et al., 2008; Tales et al., 2005a; Tales et al., 2008; Trivedi et 
al., 2008). This is likely due to the increasing incidence of comorbid medical 
conditions in older adults that preclude participation as controls and because of the 
increased incidence of AMCI with age increasing the likelihood of recruiting older 
AMCI patients. Age is not a reliable predictor of progression from AMCI to AD, 
despite being a predictor of incident AMCI and AD, and increasing age therefore does 
not appear to correlate with the time it takes to progress to dementia, and therefore 
decreasing cognitive functioning, in AMCI samples (Artero et al., 2003; Fleisher et 
 252 
al., 2007). The effects of age are therefore more relevant to comparisons of different 
aged controls whilst not appearing relevant to comparisons between AMCI groups. 
We were able to identify and excluded participants who progressed to 
dementia other than AD, thereby improving the homogeneity of the AMCI patient 
group. This is reflected by the high AD conversion rate that makes our results 
generalisable to prodromal AD populations but no to MCI samples that have more 
heterogeneous aetiologies.  
We report findings for the AllAMCI and CoAMCI groups as we consider the 
former group to present prodromal AD despite the fact that not all members had 
progressed to AD after 2 years. All participants were recruited using the same 
methods and this, together with the findings that (1) the AllAMCI group’s mean 
scores on behavioural measures fall between that of Controls and CoAMCI (Tables 9, 
10, 25) and (2) that AllAMCI differ from Controls on less voxels than do CoAMCI on 
divided attention (Tables 12-13), visual attention (Tables 16-17) and encoding (Tables 
23-24), leads to the conclusion that the non-converters are less impaired but will 
progress in future. 
Taken together these findings indicate that age differences are frequently 
encountered in studies of AMCI and that it is unlikely to account for the observed 
differences from Controls in our results. Furthermore, we can identify AMCI with a 
high rate of progression over a relatively short follow-up period. AMCI that did not 
progress are still likely to progress and findings from behavioural and functional 
measures suggest they are intermediate between Controls and converters. Continued 
follow-up of non-converters will enable further clarification of the sensitivity and 
specificity of our measures. 
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5.2 Neurocognitive Findings 
Lower CAMCOG, MMSE and New Learning subscale scores were anticipated in 
AMCI and indicate episodic memory impairment. The absence of impairment on the 
attention subscale of the CAMCOG illustrates the low sensitivity of this measure. The 
attention subscale score is derived from the serial-seven subtraction and counting 
backwards from 20 tasks, and therefore tests working memory and executive 
functioning. Demonstrating slower RT on divided attention in AMCI suggests that 
more sensitive measures of attention are useful in evaluating attention in clinical 
settings. 
 
5.3 Diagnostic Stability and Disease Progression 
More than half of the AMCI patients had progressed to AD after two years. This high 
conversion rate is similar to that demonstrated by studies using sensitive and specific 
cognitive, CSF or structural neuroimaging indicators of disease progression (Artero et 
al., 2003; Hansson et al., 2006; Korf et al., 2004; Sarazin et al., 2007). Furthermore, it 
confirms the construct validity of AMCI as prodromal AD and illustrates the high 
sensitivity and specificity of rigorously applied operationalised diagnostic criteria in 
expert memory clinic settings. 
 
5.4 Overview of Scanning Sessions 
Our results are characterised by high follow-up and technical success rates (§4.3). We 
conducted 63 scanning sessions on 32 participants and we were unable to use data 
from only three sessions; two sessions were excluded as the participant was 
subsequently diagnosed with Lewy body dementia and one session was excluded 
form a participant who had evidence of a cortical infarct on structural imaging. 
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Seventeen experimental runs had to be restarted or abandoned due to technical failure 
or poor compliance. Eleven of these were on the recognition task; four runs had to be 
abandoned without collection of useable functional data, behavioural data from five 
runs could not be used due to compliance issues, and data from two runs were 
corrupted by the necessity to repeat the encoding task using different stimuli as the 
initial run failed. This relatively high failure rate adversely affected the functional 
analysis of the recognition task because not enough events of the conditions of 
interest were available to allow adequate statistical power. Most of the failures 
occurred on the recognition task, which was presented last, and it may therefore be 
related to participant fatigue. It therefore appears that in its present form the task is 
suitable for behavioural studies but not ideal for functional studies in AMCI. 
 
5.5 Piloting the Divided Attention Task 
We designed a divided attention paradigm suitable for fMRI that proved useful in 
demonstrating behavioural and functional changes in AMCI. We used data from the 
pilot study (§4.4) to adjust task parameters to ensure high response accuracy across 
AMCI and Controls that renders RT a useful outcome measure (§3.9.1),  and the high 
accuracy scores in Controls and AMCI confirmed this. Furthermore, the difference 
demonstrated on RT between Controls and AMCI groups illustrates the utility of the 
task to measure aspects of attentional processing and indicates that it may be useful in 
identifying AMCI and in monitoring treatment responses in clinical practice (§4.5.1). 
The task generated functional activation in areas associated with divided attention and 
the cognitive contrast (experimental condition  - control condition) therefore appears 
suitable for evaluation of the neural correlates of divided attention (§4.5.2.1). 
Comparing Controls and AMCI on the task at baseline revealed functional brain 
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activation differences indicating the paradigm is also suitable for group comparisons 
(§4.5.2.2). Furthermore, the behavioural and functional results from the rivastigmine 
treatment study reveal the potential of the task in studying the neural and behavioural 
correlates of treatment interventions (§4.9). The short training period required and the 
short task duration make it practical for clinical and research use.  
 
5.6 Divided Attention in AMCI at Baseline 
We compared AMCI to Controls on divided attention at baseline to investigate if 
prodromal AD is associated with attentional impairment as predicted by the 
cholinergic hypothesis and the presence of attentional deficits in very mild AD. We 
found that the CoAMCI group that converted to dementia had slower visual target 
processing during divided attention and this was associated with altered activation in 
relevant sensory and attention processing areas. Activation in visual processing areas 
correlated positively with visual processing speed in other words superior 
performance required increased activation. CoAMCI had attenuated activation in 
these visual areas suggesting impaired cognitive regulation. This is supported by the 
inverse correlation between activation in midbrain areas - which activate during very 
high attentional demand - and visual target processing response speed, suggesting that 
processing speed decrements were more pronounced in AMCIs that found the task 
more demanding. These results suggest disconnection between midbrain areas that 
drive attention and cortical areas that process stimuli in prodromal AD. 
 
5.6.1 Behavioural Findings 
General task related findings 
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All subjects found the dA condition more demanding than the cA condition as 
demonstrated by increased RT and lower accuracy on the former (§4.5.1; Table 10). 
These findings indicate the expected dual task decrement in performance during 
divided attention and are in line with published findings (Klingberg, 1998; Loose et 
al., 2003; Posner, 1978). 
The groups did not differ on accuracy during the dA or cA tasks, indicating 
that the task design allowed the high accuracy levels required to utilise RT as an 
outcome measure as described in the methods section (§3.9.1.1). 
AMCI groups and Controls took longer to respond to auditory compared to 
visual stimuli during the dA condition and this is likely due to the physical 
characteristics of the stimuli. All the information necessary for identification is 
presented instantly for visually presented letter stimuli but auditory-presented number 
stimuli require longer evaluation for identification. This difference in appraisal time is 
therefore the likely cause of RT differences between visual and auditory targets. 
 
Behavioural deficits on divided attention in CoAMCI 
We demonstrated slower visual RT during the dA condition in CoAMCI indicating 
impaired target response speed during divided attention in prodromal AD. We initially 
demonstrated this in the RivAMCI group and this was the first report of impaired 
divided attention in AMCI (Dannhauser et al., 2005). One prior study had 
demonstrated impaired visual selective attention in AMCI, evident as longer RTs on a 
task designed to examine the effects of interference from distractor stimuli (Perry and 
Hodges, 2003). Their task required subjects to ignore a non-target stimulus that 
briefly appeared before a target and is therefore similar in some aspects to the divided 
attention condition where non-target distractor stimuli appear before and 
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simultaneous with targets. These findings of slower visual target processing may 
therefore be related.  A later study that controlled for the effects of ageing also 
revealed impaired visual attention (slower RT) in AMCI and AD, which distinguished 
these conditions from normal ageing (Tales et al., 2005a). Their visual search task 
required selective visual attention and attentional shifting and these processes are also 
required for the dA condition. A more recent study found impaired visual selective 
attention and attentional shifting in AMCI (Silveri et al., 2007). Impaired visual 
divided attention and visual-auditory divided attention have subsequently been 
reported in AMCI (Laine et al., 2008; Okonkwo et al., 2008). Our initial results have 
therefore being replicated and taken together these findings indicate impaired divided 
attention in AMCI whilst our findings in CoAMCI indicate impaired divided attention 
in confirmed prodromal AD.  
 Neuropsychological testing at baseline revealed that CoAMCI had isolated 
episodic amnesia and did not differ from Controls on measures of attention. Taken 
together, these findings indicate that visual attention and divided attention deficits are 
evident in AMCI when sensitive measures are used that record RT. Moreover, 
available findings suggest that deficits are restricted to the visual domain as all the 
tasks were either visual or had a visual component. These visual attention deficits may 
be related to failing executive top-down (task driven) control of attentional selection 
that depends on cholinergic neurotransmission (§1.6.3). Some support for this notion 
comes from our functional results that reveal decreased activation during selective 
visual attention in occipital visual processing areas that are regulated by PFC and 
parietal nodes of the attentional networks (§4.6.1.2; Tables 16, 17). 
Divided attention was also impaired in the AllAMCI group that included 
converters and non-converters suggesting that divided attention may, similar to 
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delayed recall, predict AD.  It remains to be seen if divided attention is as good a 
predictor of progression to AD in AMCI and longer follow-up is required to establish 
if all our AMCI patients will progress to AD. 
 
Taken together our results indicate that episodic amnesia in progressive AMCI does 
not occur in isolation, as it appears accompanied by impaired divided attention. 
 
The presence of divided attention deficits in AMCI is an important finding because it 
can partly explain the episodic amnesia. The interaction between memory and 
attention is complex and memory processing in everyday life requires intact divided 
attention for such functions as source monitoring that improves episodic recall 
(§1.6.1). Memory has a limited capacity and it can be influenced by the demands 
made on attentional selection. Disease processes affecting attentional resources can 
therefore impair memory by inhibiting attentional selection. This is further supported 
by the strong correlations between visual target response speed decrements and 
recognition deficits in the CoAMCI groups (§4.8.1).  
Encoding processes generally make large demands on cognitive resources, 
which make them particularly vulnerable to the effects of attention deficits (Craik et 
al., 1996; Nyberg et al., 1997). The bidirectional relationship between divided 
attention and memory appears to explain the rapid decline from early deficits towards 
generalised cognitive impairment and dementia (Sarter and Turchi, 2002). Studies of 
cortical cholinergic function in mild AD have found that it correlates with attention 
but not with episodic memory and this suggests a more central role for attentional 
impairment in prodromal AD (Kadir et al., 2006). The exact contribution of divided 
attention decrements to episodic memory deficits in AMCI remains to be established. 
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Sustained attention in AMCI 
We found comparable performance on sustained attention (cA condition), suggesting 
it remains intact in CoAMCI. This is supported by recent reports of impaired visual 
divided attention but comparable sustained and selective attention in AMCI 
(Okonkwo et al., 2008). However, the cA condition arguable also required an element 
of selection due to the noisy scanner environment and this should be taken into 
account when interpreting results. Nevertheless, at present there are no reports of 
impaired sustained attention in AMCI suggesting considerable resilience in the 
network underpinning it; alternatively current measures are insensitive to deficits. 
Divided attention depends on sustained and selective attention and it is useful to 
confirm that these are unimpaired prior to making inferences about findings on 
divided attention. Okonkwo et al. used a different measure of visual divided attention 
that determined the processing time required to perform at 75% accuracy on the task 
by varying the presentation time of targets. Their results indicate that AMCI require 
longer visual processing time, similar to our results.  
 
Taken together, these findings from behavioural studies indicate impairment in visual 
target processing during divided attention in AMCI; however, auditory processing has 
not been studied sufficiently to determine its status in AMCI. AMCI could be 
associated with isolated visual processing deficits or visual attention may be more 
vulnerable to the effects of AD neuropathology and therefore show impairment 
earlier. Future studies can clarify this by using auditory divided attention task or 
across modal tasks that do not include visual stimuli. 
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Disease mechanisms 
BFCS lesions 
It has been proposed that disruption of two neural systems may underlie the 
attentional deficits in AD and these therefore also apply to AMCI (Perry and Hodges, 
1999). The first is the BFCS that provides the main cholinergic input to the 
neocortical areas involved in attention, especially the prefrontal and parietal cortex 
and the thalamus (Mesulam and Geula, 1988). The BFCS includes the nucleus basalis 
of Meynert, which is one of the areas prominently affected by neuropathology in AD 
(Arnold et al., 1991). Cholinergic neurotransmission is prominently affected in AD 
where degeneration of cholinergic neurones of the basal forebrain nuclei diminish 
cortical and hippocampal input (Francis et al., 1999; Perry et al., 1999; Sarter et al., 
2003). The presence of neurofibrillary tangles and pre-tangle cytopathology have 
been reported in autopsied MCI patients, with pre-mortem measures of cognitive 
impairment correlating with the percentage of neurones affected (Mesulam et al., 
2004). This suggest that cholinergic neurotransmission is affected in AMCI and 
findings from studies of in vivo cholinergic activity support this, indicating a similar 
pattern of deficiency as seen in AD and correlation with cognitive impairment (Rinne 
et al., 2003) (Sabri et al., 2008). Decreased cortical AChE activity in AMCI also 
appears to predict conversion to AD (Herholz et al., 2005). Several lines of evidence 
indicate that attentional processing is mediated via cholinergic input to sensory 
cortices (signal-driven or bottom-up modulation), and to frontal and parietal cortex 
(task driven or top-down modulation) (Sarter et al., 2005). Considering the role of 
cholinergic innervation from the BFCS in attentional processing and the early 
presence of AD neuropathology in this area, impaired divided attention in AMCI is 
likely related to impaired attentional modulation in sensory and frontoparietal cortices 
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due to interrupted cholinergic innervation from the BFCS. The correlations between 
activation in visual processing areas and visual processing speed evident from our 
results support the suggestion of impaired modulation in sensory cortices. 
 
Cortico-cortical pathway lesions 
The second neural system relevant to attentional dysfunction in AMCI is comprised of 
the cortico-cortical pathways, such as the longitudinal fasciculi that connect frontal 
and parietal cortices. Neocortical synapse density in frontal and parietal cortices are 
highly correlated with dementia severity (Samuel et al., 1994) and AD 
neuropathology is present early in the neocortex in very mild AD (Morris et al., 
1991). Autopsy studies in MCI found early neuropathological changes of AD (Price 
and Morris, 1999). A longitudinal study which followed MCI patients (up to 9.5 
years) reported that 100% progressed to AD and 84% had neuropathological changes 
of AD at autopsy (Morris et al., 2001). Furthermore, PET studies of amyloid reveal 
widespread cortical deposition in AMCI and specific increases in prefrontal, parietal, 
lateral temporal and medial parietal areas (Jack et al., 2008; Kemppainen et al., 2007; 
Lowe et al., 2009). Although no neuropathological study of AMCI appears to have 
been conducted, the findings from mild AD and MCI, and amyloid PET studies 
strongly suggest that AD neuropathology will be present in the cortex in AMCI. This 
in turn suggests that functional connectivity between cortical areas may be impaired 
in AMCI and this has recently been demonstrated in AMCI, supporting view that AD 
neuropathology is present in the cortex in AMCI (Sorg et al., 2007; Sorg et al., 2009). 
Several lines of evidence therefore suggest that cortico-cortical pathways may be 
affected in AMCI and therefore that decreased processing speed in AMCI during 
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divided attention may be secondary to altered functional connectivity between cortical 
attention network nodes such as the PFC and parietal cortex. 
 
Sensory impairment 
Greater visual impairment has been reported in AD compared to controls, and vision 
impairment correlates positively with cognitive impairment (Uhlmann et al., 1991). 
Similar findings have been reported in relation to hearing impairment and AD 
(Uhlmann et al., 1989). It is not known if these sensory impairments are related to 
pathology in the sensory apparatus or visual processing; however, impaired 
performance on visual targets during divided attention in CoAMCI is unlikely to be 
related to sensory visual impairment as this was controlled for by optimising the 
visual acuity for all participants. Nevertheless, a comparison of visual acuity between 
AMCI and controls has not been done yet and AMCI may be associated with greater 
visual impairment. 
 
Ageing 
Divided attention is underpinned by processing speed, working memory and 
executive processing and therefore vulnerable to the effects of age-related decline in 
these processes (§1.3.3.2). Divided attention performance does decrease with age; 
however, these deficits are more pronounced on more complex dual tasks with 
complex task rules that require working memory encoding or item manipulation 
(Sarter and Turchi, 2002). A visual and auditory dual-task requiring visual letter-
stimulus matching and simple choice reaction to an infrequent auditory stimulus 
revealed no difference in performance between two elderly age groups (60-69 years; 
70-79 years) suggesting that age-related differences are unlikely to be a source of 
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significant variability in this age group during similar divided attention tasks 
(Greenwood and Parasuraman, 1991). Furthermore, no significant correlations were 
evident between age means and behavioural measures that CoAMCI and Controls 
differed on (VisRT, Pr, FAR, Pr lures; §5.1), indicating that generalised ageing effects 
are unlikely to be responsible for the observed differences. 
The effects of ageing on alerting, which achieves and maintains a heightened 
state of arousal in preparation for a task, have only been demonstrated on long 
(30min) sustained attention tasks (Mouloua and Parasuraman, 1995). Although the 
divided attention task required sustained attention, the duration was relatively short 
and it is therefore unlikely that ageing effects on alerting impacted on performance. 
Orienting, which focuses attention on one stimulus amongst many (selective 
attention) and relies on shifting attention from one stimulus to the next shows age-
related impairment and this appears more pronounced when target stimuli are 
presented with highly similar distractor stimuli, and less pronounced when target 
stimuli are preceded by a cue, diminishing the need to process irrelevant stimuli 
(Hartley, 1993; Rogers, 2000). Stimuli were presented in pairs in different sensory 
modalities after a visual cue (cross-hair) during the dA condition and there was no 
interference from simultaneous similar distractor stimuli. The effects of ageing on 
selecting stimuli for processing are therefore likely limited. 
Although the effects of ageing on executive control remains controversial, 
deficits have been demonstrated which remain after controlling for the general effects 
of slowed processing speed. We have seen above that ageing effects are more 
pronounced on more complex dual-tasks but that differences were not evident in one 
study that compared older groups spanning the age range of our groups. As mentioned 
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above, age did not correlate with any of the measures that differed between CoAMCI 
and Controls and all of these relied on executive processing.  
Ageing affects many aspects of cognition but it is unlikely that the slightly 
younger age of controls can explain the observed differences because (1) they are also 
evident and more pronounced in AD, (2) age did not correlate with visual target 
processing speed, and (3) age did not correlate with episodic memory measures on 
which CoAMCI were impaired, thereby also discounting the possible deleterious 
effects of age related memory deficits on attentional processing. Furthermore, our 
results of impaired divided attention are supported by findings from a study 
comparing AMCI (mean age 70 years; n=51) and older controls (mean age 68 years; 
n=58) where sample sizes were larger and groups were matched more closely on age 
(Okonkwo et al., 2008). The divided attention deficits seen in the AMCI group 
therefore appears to be due to underlying AD neuropathology and if ageing did 
contribute, then it was not pronounced and unlikely to explain the observed 
differences. 
 
Summary 
In summary, we demonstrated slower visual RT during the dA condition in CoAMCI 
indicating slower visual attention processing during divided attention in prodromal 
AD. It therefore appears that episodic amnesia does not occur in isolation, even in 
AMCI, but is accompanied by attentional impairment. Attention and memory are 
closely related and deficits in these domains evident in AMCI also appear related. 
This may be due to memory-attention interactions or shared upstream disease 
mechanisms affecting both. AD neuropathology can affect attention in AMCI by 
disrupting regulation in sensory cortices via lesions in the BFCS and/or locus 
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coeruleus. Support for these causative mechanisms comes from the correlations 
between visual areas activation and visual processing speed. 
Findings from larger age-matched studies together with the absence of significant 
correlations between age and behavioural measures indicate that generalised ageing 
effects are unlikely to be responsible for the observed differences. 
Our results also support the current view that sustained attention is unimpaired in 
AMCI. Below we look at the neural correlates of divided attention and functional 
brain changes in AMCI associated with impaired divided attention. 
 
5.6.2 Functional Findings 
Activation was evident in cortical areas associated with sensory, attentional and 
executive processing. The CoAMCI group demonstrated attenuated activation in 
visual (extrastriate, fusiform, inferior temporal lobe), auditory (lateral temporal, 
insula) and attentional processing (cerebellum, lateral parietal) areas and this was 
associated with slower visual target processing. CoAMCI demonstrated greater 
activation in the thalamus. Slower visual target processing correlated with attenuation 
of activation in visual processing areas (fusiform) and with greater activation in 
midbrain-thalamic areas associated with demanding attentional tasks. These findings 
are discussed in more detail below. 
 
5.6.2.1 Task related activation 
The dA condition required (1) appraisal of simultaneously presented auditory stimuli 
(numbers read by a male voice) and visual stimuli (lower case letters presented on a 
screen) followed by, (2) a motor response upon target detection or, (3) response 
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inhibition when presented with distractor stimuli. In terms of attention, it required 
sustained attention over the duration of the condition and, for divided attention, a 
repeating sequence of attentional orientation, response selection, behavioural response 
execution or inhibition, and attentional disengagement. Attentional disengagement 
and orientation, the key elements of divided attention, are not required during the cA 
condition where the visual and auditory targets provided identical semantic 
information (numbers). The subtraction analysis (dA – cA) therefore provides 
information about neural activity specifically required for attentional switching during 
dA, whilst closely matching other attentional requirements and sensory stimuli. 
Combining activation data for all Controls and AllAMCI during dA revealed 
activation in areas associated with processing visual stimuli (extrastriate, fusiform), 
attention (PFC, anterior cingulate, parietal, cerebellum) and letter stimuli (insula) and 
we look at these in turn (§4.5.2.1; Table 11). 
 
Visual processing areas 
Activation in bilateral extrastriate and fusiform areas most likely reflects processing 
of visually presented letter stimuli necessary only during the divided attention 
condition. Processing different visual stimuli, and different attributes of identical 
stimuli, activate discreet regions of extrastriate visual cortex (Corbetta et al., 1991; 
Heinze et al., 1994; Mangun et al., 1997). Furthermore, functional and behavioural 
studies in healthy controls indicate the presence of separate neural substrates for letter 
and digit processing (Polk and Farah, 1998). The additional activation in visual areas 
during divided attention is therefore likely related to letter processing. 
The absence of additional activation in auditory cortex is in line with findings of 
activity decreases in sensory cortices during divided attention compared to selective 
 267 
attention (Corbetta et al., 1991; Johnson and Zatorre, 2006; Loose et al., 2003), and 
the absence of additional parietal activation appears to indicate that it is already 
sufficiently or maximally engaged by the cA condition. 
 
PFC, anterior cingulate and medial parietal areas 
Task related activation during divided attention occurred in areas reliably associated 
with dividing attention (PFC) and sustained sensory attention (anterior cingulate, 
medial parietal) (Johnson and Zatorre, 2006; Loose et al., 2003; Vohn et al., 2007). 
The left PFC is associated with executive tasks including attentional orientation, 
divided attention, response inhibition, cognitive set-shifting, memory encoding and 
retrieval, working memory and organisation of information, and activation here 
during divided attention likely reflects executive processing (Cabeza and Nyberg, 
2000; Floel et al., 2004; Johnson et al., 2003; Nyberg et al., 1996). The combination 
of PFC, anterior cingulate and parietal activation, as seen in our groups, reliably 
activate specifically during tasks requiring response inhibition e.g. the divided 
attention task. 
Our findings are consistent with the result of a similar fMRI divided attention 
study, employing visual and auditory stimuli, in healthy young subjects (Loose et al., 
2003). The auditory targets for their divided attention task were successive 
presentation of identical frequency tones and this makes greater demands on working 
memory than our task. Other studies requiring older participants to monitor visual and 
somatosensory modalities have reported right PFC and parietal activation (Johannsen 
et al., 1997). Differences in the laterality of PFC activation between studies may be 
related to the different sensory modalities of stimuli as these determine the attentional 
network recruited for each individual task (Corbetta et al., 1991; Johannsen et al., 
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1999; Johannsen et al., 1997). For example, in the study by Johannsen et al. (1999) 
study participants were told to expect targets but none were presented and activation 
due to target responses were therefore absent whilst response inhibition processing 
was active, furthermore the absence of behavioural measures makes it difficult to 
establish if participants were complying with task instructions. Bilateral prefrontal 
and parietal activation has been reported on more complex dual tasks requiring 
working memory and semantic processing (Iidaka et al., 2000b; Koechlin et al., 
1999). A study comparing bimodal visual and auditory sustained attention, selective 
attention and divided attention also found left PFC activation only during divided 
attention (Johnson and Zatorre, 2006). A more recent study contrasting within-modal 
against across-modal conditions revealed greater activation during across-modal 
divided attention in bilateral DLPFC (BA 46), left DLPFC (BA 9), medial PFC (BA 
8), and inferior parietal lobe (BA 40) and, in right anterior cingulate (BA 32), 
suggesting that the increased demand for coordination of cross-modal attentional 
resources required more top-down control of attentional processing (Vohn et al., 
2007). From the few available studies, it appears that across-modal divided attention 
may be the more processing intensive attentional function and specifically associated 
with left DLPFC activation, similar to our task and findings.  
 Activation in the anterior cingulate has been found during divided attention 
and when visual attention is maintained at a single spatial location (Vandenberghe et 
al., 2000; Vandenberghe et al., 1997), and both these conditions occur during our dA 
condition.  
Medial parietal activation in the left hemisphere has been demonstrated in 
studies requiring silent reading similar to that required on our divided attention task 
(Cabeza and Nyberg, 2000).  
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Insula and cerebellum 
Activation in the insula may be related to processing of the visually presented letter 
stimuli or to working memory maintenance of the target letter as this area frequently 
activates during tasks requiring reading and working memory maintenance of letters 
or words (Cabeza and Nyberg, 2000).  
Cerebellar activation has been associated with attentional orientation such as is 
required during divided attention (Cabeza and Nyberg, 2000). 
 
Summary 
In summary, our findings are in line with those from studies of divided attention 
whilst activation in other areas area likely related to specific characteristics of the 
task. Taken together, our findings indicate that the divided attention task is a useful 
paradigm for examining divided attention. 
 
5.6.2.2 Group differences 
Reduced activation in CoAMCI 
The CoAMCI group demonstrated less activation in areas associated with visual 
object processing (extrastriate, fusiform, inferior temporal lobe), auditory speech 
processing (primary auditory and auditory association, insula) and attentional 
processing (cerebellum, lateral parietal), and these activation changes were associated 
with slower visual target processing (Table 13). In AD, impaired performance of a 
divided attention task that required monitoring of visual (chequerboard) and 
somatosensory (vibro-tactile) stimuli was associated with both increased activation 
(primary visual cortex, putamen, thalamus) and decreased (pons and cerebellar 
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peduncle) (Johannsen et al., 1997). The methodology and patient group of this study 
makes it unsuitable for detailed comparison with our findings; however, it illustrates 
that divided attention deficits associate with functional changes in AD. Consequently, 
decreased activation in visual areas could be caused by local or distant pathology that 
explains the decrements in processing speed in AD. Indeed, better performance during 
divided attention correlates with greater activation in sensory cortices in healthy 
controls, supporting this view (Johnson and Zatorre, 2006). 
 
Functional-behavioural correlations  
Slower responses to visual targets in AMCI correlated with decreased activation in 
visual processing areas (fusiform), indicating that cortical processing deficits in these 
areas contribute significantly to the behavioural deficits seen (Table 14). Indeed, 
better performance during divided attention correlated with greater activation in 
sensory cortices in healthy controls (Johnson and Zatorre, 2006) further supporting 
this conclusion. 
 
Inter-sensory cortex inhibition or failed cognitive regulation  
AD neuropathology could decrease activation in visual areas via altered inter-sensory 
cortex inhibition or failed cognitive regulation. Activation during divided attention 
appears not to be a simple summation of activation during selective attention and it 
consistently decreases in relevant sensory cortices during divided attention compared 
to selective attention. This has been ascribed to inter-sensory cortex inhibition or to 
limitations on processing control (§1.5.3). If decreased visual area activation was due 
to inter-sensory cortex inhibition then one might expect greater activation in the other 
sensory cortex i.e. auditory cortex during dA. However, activation was also decreased 
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in auditory cortex suggesting rather failed cognitive regulation. These findings imply 
that activation in both sensory areas decreased more in the CoAMCI group during the 
dA condition, or that it was already decreased during selective attention and only 
revealed by the dA condition.  
We did not study selective visual and auditory attention using the stimuli from 
the divided attention task but we can consider the findings from the visual-auditory 
task to look for evidence of impaired selective attention in the CoAMCI group 
(§4.6.1.2; Table 17). Findings on visual attention indicate greater activation in a small 
area of visual cortex (BA 19) and in several other apparently task non-relevant areas 
in CoAMCI; however, this task involved letter stimuli and processing in the ventral 
visual stream is therefore not comparable with the reversing chequerboard thereby 
limiting the conclusions that can be drawn from a comparison. However, greater 
activation in many task non-relevant areas in CoAMCI strongly suggests impaired 
cortical regulation. The auditory conditions of the two tasks are very similar as both 
consisted of common English nouns. The CoAMCI group had greater activation than 
Controls in bilateral auditory association cortices during auditory attention; 
consequently, decreased activation during the dA condition indicates more 
pronounced decreases in these areas (Table 20). Greater auditory cortex activation in 
CoAMCI during auditory attention indicates failed attentional control per se, and 
decreased activation in both visual and auditory areas during divided attention is 
further evidence of failed attentional control; furthermore, the functional findings on 
the dA condition are supported by behavioural findings. Taken together, these 
findings indicate deficits in attentional resource allocation that result in behavioural 
deficits in AMCI. 
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Auditory processing during divided attention  
Decreased activation in auditory association cortex during the dA condition may, 
similarly to that in visual cortex, indicate deficits and auditory processing; however, 
although CoAMCI responded slower to auditory targets the groups did not differ 
significantly.  This suggests that auditory processing is more robust against the effects 
of AD neuropathology or that our methods were not sensitive enough. 
 
Decreased lateral parietal activation in AMCI 
CoAMCI also had decreased activation in cerebellar and lateral parietal areas that 
underpin attentional orientation. The dA condition makes high demands on attentional 
orientation because attention needs to be shifted between two stimuli every 1.75s. 
Lateral parietal areas, along with the PFC, exercises top-down control of attention by 
modulation of sensory cortex responsiveness. Consequently, decreased parietal 
activation may be expected to correlate with decreased sensory cortex activation and 
behavioural impairment in AMCI, but this was not evident. Nonetheless, lateral 
parietal activation did correlate with CAMCOG and New Learning subscale scores 
and this may indicate that parietal activation correlates more with global cognition 
and episodic memory than divided attention in AMCI. 
 
Disease mechanisms 
It is striking that CoAMCI had decreased activation in many of the key areas required 
for processing this task and not only in visual, auditory or general attention areas. This 
suggests that AD neuropathology has widespread cortical effects in AMCI. Of the two 
leading hypotheses of behavioural impairment in AD discussed above, damage to 
BFCS neurones could cause such widespread functional alteration as the BFCS 
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provides the main source of Ach that is released throughout the cortex during high 
attention demand. Functional connective deficits due to synaptic loss in cortico-
cortical pathways can also contribute and impaired functional connectivity between 
parietal and medial temporal areas have been demonstrated in AMCI and AD (Sorg et 
al., 2007; Sorg et al., 2009). 
 
Comparison with published findings  
Our first report of divided attention in AMCI detailed the results of the comparison 
between Controls and RivAMCI at baseline that revealed decreased left PFC 
activation associated with slower RT in AMCI (Dannhauser et al., 2005). These 
functional and behavioural result have been replicated in AMCI using a similar 
divided attention task comprising visual and auditory stimuli (Laine et al., 2008). 
Unfortunately, the authors limited their analysis to PFC regions only and further 
comparisons with our findings are not possible. 
The results reported here are different to our initial report and this is likely due to 
sample characteristics and fMRI analyses differences. The CoAMCI group reported 
on here comprised patients who progressed to AD whereas not all the members of the 
RivAMCI group of the initial report had progressed and they are therefore arguably 
less impaired or heterogeneous. Deterioration everyday activities, which precipitate 
the clinical dementia syndrome, are strongly correlated with executive impairment but 
not amnesia and executive functioning is strongly associated with PFC activity 
(Bisiacchi et al., 2008; Royall et al., 2004; Royall et al., 2005). Disparate PFC 
activation between these two patient groups and Controls may therefore be related to 
dissimilar disease severity and explain the absence of activation differences between 
CoAMCI and Controls in PFC areas. Resting state PFC activation appears altered in 
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AMCI and this maybe more or less pronounced in CoAMCI and during task 
performance (Qi et al., 2010). Some support for the influence of disease severity 
appears evident from our finding that Controls differed from AllAMCI in 100 voxels 
but from CoAMCI in 469 voxels (Tables 12, 13). The other possible explanation for 
the disparate results is related to the advanced fMRI analysis technique implemented 
for the results reported in this thesis but not for our first report on divided attention in 
AMCI mentioned above. This method is more sensitive in areas with smaller signal 
change and this could explain the increased number and extent of observed 
differences (§3.4.8.6). Analyses with this technique revealed functional-behavioural 
correlations that accord with theoretical and experimental data whereas such 
correlations were not found on the initial analysis. The newer technique therefore 
appears superior but it is not widely used yet and our results await replication. 
 
Greater activation in CoAMCI 
CoAMCI had greater activation in a medial posterior area that included the thalamus, 
brainstem and medial parietal cortex (posterior cingulate). 
Thalamus 
CoAMCI demonstrated greater activation in the thalamus; furthermore, this correlated 
negatively with visual target processing speed.  Thalamic activity has an established 
relationship with attention and animal studies reveal that thalamic stimulation 
increases alertness whilst lesions impair aspects of attention (Newman and Burk, 
2005). In humans, thalamic and brainstem activation associates with the onset of 
attention demanding choice reaction tasks, similar to the transition between the cA 
and dA conditions (Kinomura et al., 1996; Raizada and Poldrack, 2008). Thalamic 
activation appears related to attentional orientation and it plays a pivotal role in 
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sensory processing as information from the senses enter the cortex via the thalamus 
(for a review see (Newman, 1995)). It also has extensive reciprocal cortical 
connections with unimodal and polimodal association cortices and appears to mediate 
decisional processing by linking sensory stimuli with actions (Newman and Mair, 
2007). Thalamic activation is therefore associated with non-specific attentional 
arousal that increases during periods of increased attentional demand. Consequently, 
greater activation in CoAMCI may indicate compensatory efforts to overcome deficits 
in functional connectivity with relevant sensory areas. The inability to overcome these 
deficits could therefore result in increased thalamic and decreased visual area 
activation, similar to our results. Alternatively, increased thalamic activation could be 
related to decision-making processes particular to the dA condition. Irrespective of the 
exact attentional process that is supported by the thalamus during the divided attention 
task, it appears altered in AMCI and correlates with behavioural impairment 
suggesting it is affected by AD neuropathology. 
 
Medial parietal 
CoAMCI demonstrated greater activation in the ventral posterior cingulate that forms 
part of the medial parietal area, which includes the precuneus and retrosplenial cortex. 
The medial parietal areas (BA 23, 29, 30, 31) form part of the default network that is 
further comprised of medial prefrontal (BA 9, 10, 24, 32), MTL (hippocampus, BA 
28, 34, 35), lateral parietal (BA 39, 40) and lateral temporal areas (BA 21). This 
network is active at rest and its activity appears related to inwardly directed cognitive 
processes including memory and planning. The magnitude of deactivation in the 
default network correlates with task difficulty in healthy controls suggesting that more 
difficult tasks require more outwardly directed cognitive processes that in turn 
 276 
reduces default activity due to cognitive resource limitations (for a review see 
(Buckner et al., 2008; Raichle et al., 2001). The degree of deactivation in medial 
parietal areas has been correlated with the severity of impairment in AMCI : less 
impaired AMCI deactivate more and show slower cognitive decline (Celone et al., 
2006; Miller et al., 2008). These findings have been considered as evidence of 
compensatory efforts or loss of cognitive regulation. In AD, failure to deactivate 
regions of the default network correlates with poorer cognitive performance and has 
similarly been interpreted as loss of functional regulation (Lustig et al., 2003). 
Evidence of failed compensatory activation or, viewed differently, failed deactivation 
has been found in medial DLPFC areas (BA 9) in poorer performing healthy controls 
during divided attention (Johnson and Zatorre, 2006). The authors suggested that poor 
performers were unable to sufficiently recruit sensory cortices during divided 
attention and that greater activation in DLPFC represents compensatory efforts and 
illustrates functional interactions between PFC and sensory cortices. However, their 
findings also fit a failed deactivation interpretation. According to this view, greater 
activation evident in the medial parietal area in CoAMCI may be related to a failure 
of deactivation similar to that seen in the studies mentioned above. This is further 
supported by the fact that this failure of deactivation is evident in the CoAMCI group 
that progressed to AD but not in the AllAMCI group that included non-converters and 
was therefore arguably less impaired. Furthermore, this apparent failure of medial 
parietal deactivation is associated with impaired performance on the divided attention 
task in the CoAMCI group. Viewed this way, our findings support the suggestion that 
failure to deactivate medial parietal and other default network areas, during 
demanding task conditions, predicts conversion to dementia in AMCI. 
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Recent work relates the default network to so-called cortical hubs that 
represent cortical areas with a high degree of activation correlation across the entire 
brain (Buckner et al., 2009). Cortical hubs and default network areas overlap most 
strikingly in the medial and lateral parietal, and medial prefrontal areas and this in 
turn shows considerable overlap with areas of amyloid deposition (Buckner et al., 
2005; Jack et al., 2008; Kemppainen et al., 2007; Lowe et al., 2009). These hubs are 
thought to be areas that integrate diverse information sources. They thereby reduce 
the need for segregated, specialised pathways, and minimise wiring and metabolism 
costs by providing a limited number of long-distance connections which integrate 
local networks (Bassett and Bullmore, 2006). 
 The medial parietal area appears particularly vulnerable to AD related 
structural and functional changes. Volumetric differences in this area have been 
demonstrated on comparisons of normal and AMCI subjects, decreased volume here 
predicts dementia conversion and the area suffers accelerated atrophy in progressive 
AMCI. Functional studies reveal medial parietal hypoperfusion and hypometabolism 
which predicts conversion and correlates with episodic memory performance (for a 
review see(Ries et al., 2008))(Xu et al., 2007). The medial parietal areas receive 
cholinergic input from the BFCS via the medial cholinergic pathways and are the 
most distant areas supplied via these pathways (Selden et al., 1998). Functional and 
structural changes could therefore be related to AD neuropathology in the BFCS 
affecting cholinergic innervation and therefore cholinergic regulation, first affecting 
the most distant medial parietal areas innervated by the medial cholinergic pathway 
(§1.6.4; Fig 1.6). This notion is supported by recent findings from diffusion tensor 
imaging studies that demonstrated microstructural pathology in the posterior cingulate 
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that distinguished AMCI from non-AMCI subjects with sensitivity of 80% and 
specificity of 60% (Chua et al., 2009).  
Although functional and structural neuroimaging studies consistently reveal 
abnormalities in the medial parietal area, the direction is inconsistent as resting 
studies show decreased activity and studies using activation tasks show a correlation 
between failed deactivation and performance. This could however be explained by 
available findings: functional isolation of default network areas due to lesions 
affecting neurovascular coupling and connectivity and with other areas could leave 
them firing at a relatively stable rates that would appear reduced in resting studies and 
increased during tasks where it is deactivated in controls. Further support for this 
notion comes from a recent resting state functional study in AMCI that found 
decreased activation in the default network (bilateral medial parietal, right inferior 
parietal lobule, and left fusiform areas) increased activation in left PFC, inferior 
parietal and middle temporal areas (Qi et al., 2010). 
The explanatory models discussed above for increased activation in AMCI 
differ and it is not implied that one mechanism will be responsible for the functional 
changes reported, indeed it is more likely that a variety of mechanisms contribute to 
the observed findings. 
 
Functional-behavioural correlations 
Better performance during divided attention has shown positive correlations with 
greater activation in sensory cortices in healthy controls (Johnson and Zatorre, 2006). 
Our results revealed similar correlations between activation in sensory areas and 
visual processing speed. Furthermore, visual processing speed during divided 
attention showed an inverse correlation with activation in the posterior medial area of 
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the thalamus. The thalamus is associated with alerting and attentional orienting and 
this correlation may indicate increased thalamic effort in more impaired CoAMCI.  
These correlations link behavioural and functional findings and provide strong 
support for the notion that the behavioural deficits are caused by abnormal brain 
metabolism in these areas. 
 
Summary 
Our results revealed altered activation during divided attention in task related sensory 
and attention processing areas and this correlated with impaired performance. 
Furthermore, abnormal default network activation was evident only in AMCI that 
progressed to AD and it therefore appears to predict disease progression in our 
sample, commensurate with findings from similar studies. It therefore appears that 
divide attention is impaired in AMCI and associated with activation changes related to 
local and/or distant AD neuropathology. Furthermore, altered activation correlated 
with neuropsychological measures of overall cognition and episodic memory and this 
indicates that memory and attention deficits share a common mechanism in AMCI. 
The most likely mechanism would involve the BFCS based on the crucial role it plays 
across a variety of cognitive processes including memory and attention, and the 
presence of AD neuropathology in the area very early on (§1.1.2; §1.6.4). Crucially, 
mounting evidence now indicates that progressive AMCI is associated with 
attentional deficits that should be considered part of the clinical syndrome and 
assessed more accurately as it predicts progression. 
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5.7 Visual and Auditory Selective Attention in AMCI at Baseline 
We examined selective visual and auditory attention in AMCI at baseline by 
comparison to controls in order to determine if basic sensory attention processing is 
altered in prodromal AD. 
 
5.7.1 Functional Findings - Visual Selective Attention 
5.7.1.1 Task related activation 
Visual stimulation was produced by a reversing circular chequerboard image and this 
generated the expected activation in bilateral visual processing areas (§4.6.1.1; Table 
15). Cerebellar activation was also evident and is likely related to attentional 
processing and in particular attentional orientation (Cabeza and Nyberg, 2000). 
Activation in the cerebellum suggests that processing the visual stimuli required 
additional attentional resources compared to the control condition (attending to a 
small white cross presented on a uniform light grey background) and this is expected 
as the reversing chequerboard stimuli were highly salient and would therefore engage 
attention more. 
 
5.7.1.2 Group differences 
Control vs AllAMCI 
Controls had greater activation in primary and visual association areas compared to 
AllAMCI (Table 16). Decreased visual cortex activation was also evident in this 
group during selective auditory attention that was accompanied by low level visual 
stimulation and therefore implies decreased visual cortex activation also during lower 
salience visual stimuli (§4.6.2.2.). These findings indicate altered basic visual sensory 
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processing in AMCI; however, primary sensory cortices are relatively spared by NFTs 
and show only modest accumulations even in advanced AD; NFT numbers increase 
gradually from primary sensory cortex, to primary (sensory) association cortex and 
non-primary (higher) association cortex (Arnold et al., 1991). NFT density in the 
higher order association cortices (ventromedial temporal lobe, inferior parietal lobe) 
distinguishes between normal, AMCI and AD subjects and episodic memory (delayed 
word recall) shows significant negative correlation with NFT counts in higher order 
association areas (entorhinal cortex, hippocampus) (Markesbery et al., 2006; Mitchell 
et al., 2002). These findings suggest that basic visual and auditory attention 
processing should be intact in prodromal AD if it only depends on local neuronal 
function. On the other hand, attentional modulation depends on long cortico-cortical 
interneurones between sensory and association cortices that appear particularly 
sensitive to NFT formation in AD. Therefore, the altered activation is more likely the 
effect of distant pathology. 
 
Selective attention to a sensory modality leads to greater activation in the relevant 
sensory cortex and decreased activation in the cortex of the ignored sensory 
modalities. Decreased activation in AMCI may therefore be related to impaired 
cholinergic innervation due to AD neuropathology affecting the BFCS or due to 
lesions along the paths of the cholinergic bundles in deep white matter, or due to 
lesions in PFC which relays signals from visual cortex to the basal forebrain 
(Rasmusson et al., 2007; Selden et al., 1998).  
Cholinergic modulation of sensory cortex (auditory) via stimulation of the 
basal forebrain has been demonstrated in animals (Metherate and Ashe, 1991) and 
somatosensory cortex responsiveness can be increased by repeated pairing of basal 
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forebrain stimulation and sensory stimulation. Furthermore, these modulatory effects 
of basal forebrain stimulation are inhibited by atropine, which blocks cholinergic 
stimulation of muscarinic receptors, and by chemical (muscimol) inactivation of PFC. 
(Rasmusson and Dykes, 1988; Rasmusson et al., 2007; Tremblay et al., 1990).  
Regardless of the specific mechanism, this apparent impairment in basic sensory 
attentional processing may underlie the increasing number of studies reporting 
attentional impairment in AMCI; however, this will need to be clarified by employing 
basic sensory attention processing paradigms that incorporate behavioural measures. 
Taken together these findings suggest that decreased primary and secondary 
visual cortex activation may be due to distant lesions affecting functional connectivity 
thereby impairing attentional regulation. 
 
Controls vs CoAMCI 
Comparing Controls to CoAMCI did not reveal similar decreased visual cortex 
activation in the latter group as seen in AllAMCI and this may be related to 
comparatively less detection power on the smaller CoAMCI group comparison. A 
slightly less conservative statistical threshold did reveal the expected decreased 
activation in primary and secondary visual areas and adding some support to notion 
that distant pathology impairs modulation of cortical processing in early sensory areas 
(Table 17).  
CoAMCI had greater activation in visual object processing areas (medial 
temporal, fusiform, occipital, caudate), attentional control processing areas 
(brainstem, PFC, lateral parietal, anterior cingulate, lateral geniculate nucleus of the 
thalamus), and in the anterior temporal pole that is associated with language 
processing. Greater activation in CoAMCI in such widespread visual and attentional 
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processing areas strongly suggests failed top-down regulation of attentional and 
sensory resources, resulting in compensatory hyperactivation and failed down-
regulation of non-relevant areas. There are two alternative explanations for these 
findings: compensatory hyperactivation and poor task compliance. Although greater 
activation could be accounted for by compensatory activation, none was required as 
the task only required selective attention to the highly salient reversing circular 
chequerboard. Nonetheless, increased activation in the lateral parietal, fusiform, 
occipital and thalamic areas have been observed in young controls as a consequence 
of increased task load across visual attention and visual working memory tasks and 
this indicates the neural substrate of increased attentional processing demands 
(Tomasi et al., 2007). Increased activation in these areas in CoAMCI may indicate 
that they found the task more demanding due to failing resources. Greater activation 
in executive attentional control processing areas (lateral PFC, anterior cingulate, 
brainstem) could reflect failed compensatory efforts of top-down attentional 
modulation mechanisms to down-regulate activation in sensory and attentional 
processing networks that was triggered by the highly salient stimuli. We have already 
seen that the PFC and lateral parietal areas are affected by AD neuropathology 
resulting in altered functional connectivity (§1.1.3) and this could cause the failure of 
top-down attentional modulation. Impaired top-down regulation of attention can in 
turn alter activation in the visual attention areas mentioned above. 
Activation in the anterior temporal pole is associated with word processing 
that occurs during the verbal condition and continued activation during the visual 
condition suggest failed down-regulation of this area due to deficits in top-down 
attentional modulation. Compensatory and top-down regulatory efforts could 
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therefore explain the increases in activation seen in the CoAMCI group but these 
interpretations are limited by the absence of behavioural measures.  
Another possible but less likely explanation for the altered activation seen in 
CoAMCI is that they did not comply with task instructions and were engaged in other 
cognitive processes. These processes could have been related to the task, 
automatically precipitated by the stimuli, or unrelated and internally generated. The 
verbal and visual stimuli were highly salient and it would be very difficult to attend to 
any other stimuli and the likelihood of unrelated processing is therefore  minimised. 
Furthermore, poor task compliance is not supported by our findings from the divided 
attention task that demonstrated good compliance but impaired performance. A 
potential contribution from poor compliance to the current findings cannot be 
excluded due to the absence of behavioural measures; however, given the 
characteristics of the task and participant compliance on the other tasks it is unlikely 
to account for the observed differences. 
 
Thalamus 
The role of the thalamus in attention has been discussed in detail above (§5.6.2.2). 
Greater thalamic activation during selective visual attention in CoAMCI may be 
related to perceived increased attentional demand and therefore compensatory efforts 
to overcome deficits in functional connectivity with relevant sensory areas. 
 
Brainstem locus coeruleus and PFC 
Greater activation in CoAMCI occurred in the brainstem area of the locus coeruleus. 
The role of the locus coeruleus in attention and memory has been discussed in detail 
in the introduction (§1.6.5). As the sole source of noradrenaline to the neocortex, 
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cerebellum, hippocampus and thalamus, it plays an important role in attentional 
selection and arousal related to environmental challenges (Aston-Jones, 2005; Foote 
et al., 1983). The modulatory effects of the locus coeruleus on attention and memory 
depend on its noradrenergic neurotransmission to key areas including the 
hippocampus, PFC and thalamus. Locus coeruleus lesions can exacerbate memory 
impairment caused by cholinergic deficits due to BCFS lesions, and promote amyloid 
deposition and neuronal loss in affected projection areas (Heneka et al., 2002; Heneka 
et al., 2006). Furthermore, an important role for locus coeruleus pathology early in the 
course of AD is suggested by the invariable and substantial neuronal loss affecting the 
small number of neurones of which it is comprised, and the associated significant 
reduction of cortical and limbic noradrenaline levels in AD that is highly correlated 
with disease progression, memory deficits and cognitive impairment. (Lyness et 
al.2003)(Grudzien et al., 2007; Heneka, 2009). Moreover, the extensive neuronal loss 
in the locus coeruleus correlates closer with disease progression than cholinergic cell 
loss in the BFCS (Forstl et al.,1994; Zarowet al., 2003). Several lines of evidence 
therefore indicates a central role for locus coeruleus lesions in the pathogenesis of AD 
and suggest that similar but less severe lesions are present in AMCI and responsible 
for altered activation during attention demanding tasks. 
Findings from functional neuroimaging studies suggest that on challenging 
tasks attentional resources are controlled by a frontal-brainstem network wherein the 
brainstem signals the onset of a challenging attentional condition and the right PFC 
allocates cognitive resources (Raizada and Poldrack, 2008). Close correlation between 
activation in the PFC, locus coeruleus, visual, auditory and parietal areas was evident 
on a task that used sudden highly salient visual (flashed white disc) and auditory 
(bursts of noise) stimuli. The visual stimuli match those of our visual condition in as 
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far as they were highly salient, attended to and appeared at unpredictable intervals. 
Our results of increased locus coeruleus activation and decreased visual cortex 
activation in CoAMCI may therefore indicate compensatory increased drive from the 
locus coeruleus to visual cortex, that is maintained because the effects are not 
sufficient to down regulate locus coeruleus activity. In other words, decreased cortical 
noradrenaline due to reduced locus coeruleus release can hyperactivate the locus 
coeruleus and diminish connectivity with the PFC that controls sensory cortex 
responsiveness (§1.6.5) (Berridge and Waterhouse, 2003; Minzenberg et al., 2008). 
This interpretation is supported by finding that activation is also increased in the right 
PFC that we have seen above appears responsible for top down regulation of sensory 
cortices. 
Alternatively, increased activation in the locus coeruleus may be related to 
anxiety in CoAMCI. The locus coeruleus also shows increased activation under other 
stressful situations including loud noise, punishment, pain, emotionally aversive 
images of snakes and angry faces (Raizada and Poldrack, 2008). Arguably, 
challenging attention tasks and anxiety producing stimuli overlap significantly: the 
latter will be processed as challenging especially if they appear relevant to survival, 
and the former may induce anxiety if particularly difficult. Both anxiety and task 
difficulty could therefore play a role in increased brainstem activation in CoAMCI. 
Increased “stress susceptibility” has been demonstrated in MCI. A 3-year prospective 
study of the association between anxiety symptoms and progression to AD in MCI 
found that anxiety symptoms were twice as prevalent (47%) as in the healthy elderly 
population; furthermore, MCI patients with anxiety symptoms were twice as likely to 
develop AD (83%)(Ausen et al., 2009; Palmer et al., 2007). Clinical observations 
therefore indicate that anxiety is more prevalent in MCI that progress to AD, therefore 
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most likely AMCI, and increased locus coeruleus activation is therefore very likely 
partly related to this. 
In summary, based on the role of the locus coeruleus in attention and the 
presence of AD neuropathology in this area and the known effects thereof on 
attention, our result in CoAMCI suggest that locus coeruleus lesions may contribute 
to altered activation and attentional performance in AMCI. Furthermore, the increased 
prevalence of anxiety in prodromal AD and the established association between locus 
coeruleus activity and anxiety suggest that increased anxiety in the CoAMCI group – 
related to perceived increased task difficulty on the background of AD 
neuropathology- may also contribute to increased activation. 
The resolution of fMRI is not sufficient to be certain that the activation in the 
brainstem is located in the locus coeruleus. However, Raizada and Poldrack argue 
persuasively that other nearby nuclei are unlikely to activate under the given task 
conditions and activation on the locus coeruleus under demanding and stressful 
attention conditions is supported by animal studies (Raizada and Poldrack, 2008). 
Localising activation during challenging attention tasks to the locus coeruleus is 
therefore supported by (1) the pattern of neural activity, (2) established functional 
connectivity and (3) the task conditions under which it occurs. 
  
Behavioural data 
Without behavioural data, it is not possible to determine the exact contributions from 
compensatory efforts and poor compliance to the altered activation in AMCI; 
however, the results do indicated impaired basic sensory processing in AMCI that 
could be associated with impaired behavioural performance similar to that seen on the 
divided attention task. To date, three studies have reported impaired selective visual 
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attention performance in AMCI and it is therefore likely that the functional 
differences we demonstrated in AMCI are associated with behavioural deficits (Perry 
and Hodges, 2003; Silveri et al., 2007; Tales et al., 2005a).  
 
Summary 
Taken together, our findings indicated altered selective visual attention processing in 
AMCI that may indicate compensatory mechanisms and/or failed cortical regulation. 
Differences were evident across the cortex and this could be caused by pathology in 
the BFCS and/or locus coeruleus that both have widespread afferents to the brain and 
influence on activation.  
Selective visual attention processing appears altered in AMCI and this has 
potentially far reaching clinical and research implications. Altered visual processing 
can potentially confound tests of any cognitive domain if they require visual 
processing. Clinically, evidence of altered visual processing together with impaired 
divided attention suggest that patients with AMCI may be at risk when completing 
complex everyday activities that depend heavily on these functions, such as driving. 
 
5.7.2 Functional Findings - Auditory Selective Attention 
5.7.2.1 Task related activation 
Robust activation in bilateral auditory (lateral temporal) and verbal processing 
(VLPFC, temporal pole, insula) areas, as well as lateral parietal attention areas 
occurred in response to auditory verbal stimulation. Activation in auditory and 
language processing areas were expected and increased parietal activation likely 
indicates that this condition had additional attentional processing demands compared 
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to the control condition (for a review of language processing see (Demonet et al., 
2005). 
 
5.7.2.2 Group differences  
CoAMCI demonstrated greater activation in auditory association, language processing 
(insula, putamen), attentional orienting and alerting (thalamus), and MTL areas. 
Similar greater MTL (hippocampal) and thalamic activation was seen in CoAMCI on 
the visual condition discussed above, indicating that it persists across sensory 
modalities suggesting it may be generalised. 
 
Greater activation in CoAMCI 
MTL 
The MTL is not strongly associated with attentional processing and greater activation 
in CoAMCI suggests impaired functional regulation that normally deactivates non-
relevant cortices. The MTL and particularly the hippocampal formation is part of the 
default network that is active at rest and thought to be concerned with inwardly 
directed cognitive processes that included episodic memory and therefore MTL 
activity (§5.6.2.2). Altered activation in this area appears an increasingly consistent 
finding in AMCI. The magnitude of deactivation in the default network correlates 
with task difficulty in healthy controls indicating that inwardly directed cognitive 
processes are abandoned when task demands are high (for a review see (Buckner et 
al., 2008) (Raichle et al., 2001). Greater hippocampal activation in MCI compared to 
controls (hyperactivation) during episodic memory encoding (novel face name pairs, 
novel scenes) predicted faster rates of subsequent cognitive decline (Celone et al., 
2006; Miller et al., 2008). In AD, failure to deactivate regions of the default network 
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also correlates with poorer cognitive performance and this has been interpreted as loss 
of functional regulation (Lustig et al., 2003). Taken together, these findings suggest 
that AD and AMCI are associated with impaired cognitive regulation resulting in 
maintained activation in default network that hinders processing in task relevant areas 
and impairs performance. Our findings suggest that this inverse correlation between 
hippocampal activation and cognitive performance is not specific to memory 
processing but also evident during attentional processing that therefore points to a 
more generalised deficit. 
 
Thalamus 
CoAMCI demonstrated greater activation in the thalamus and this was also evident 
during selective visual attention (§5.7.1.2) and divided attention (§5.6.2.2). It is 
therefore evident across selective and divided attention conditions, and in visual and 
auditory sensory modalities in CoAMCI. Activation in the thalamus is associated with 
the onset of attention demanding tasks and it mediates decisional processing. Greater 
thalamic activation can therefore be related to increased or compensated non-specific 
attentional arousal or to specific sensory attentional processing and decision making 
particular to the dA condition. Furthermore, increased thalamic activation was also 
evident in CoAMCI during verbal episodic encoding and the fact that this was evident 
across attentional conditions suggests that it may be related to attentional processing 
during encoding. The findings of greater thalamic activation across tasks suggest that 
it is a robust generalised alteration in brain activation in AMCI that predicts disease 
progression. 
 
Overlap of areas of increased activation in CoAMCI across experiments.  
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Areas of increased activation in CoAMCI overlapped in several areas on verbal 
episodic encoding and selective auditory attention. These included attention 
(thalamus), auditory (primary, association) and language processing (insula, putamen) 
areas. Both experimental conditions required word processing and increased 
activation across conditions suggest generalised altered language processing.  
 
Summary 
CoAMCI had greater activation in visual object processing areas, attentional control 
areas and in language processing areas during the visual attention condition. These 
findings suggest failed top-down regulation of attentional and sensory resources. 
Impaired top-down regulation of attention can in turn alter activation in attentional 
orienting and alerting areas (brainstem, thalamus) and other visual processing areas.  
Greater activation in the locus coeruleus, the main source of noradrenaline to the 
brain, may reflect changes in arousal during challenging attention tasks and/or 
increased anxiety in AMCI. AD neuropathology is present in the locus coeruleus in 
AMCI and can potentially have widespread effects leading to impairment in attention 
and memory. 
CoAMCI demonstrated greater activation in auditory, language, attention and MTL 
areas on selective auditory attention. Similar greater MTL and thalamic activation 
was seen in CoAMCI on the visual condition discussed above and this persistence 
across sensory modalities indicates that it is generalised. MTL activity likely reflects 
failed deactivation of default network areas suggesting failed cognitive regulation, as 
found in AD.  
Greater thalamic activation may be related to increased or compensated non-
specific attentional arousal or to specific sensory attentional processing and decision 
making. Increased thalamic activation was evident across visual, auditory and divided 
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attention, and also evident in CoAMCI during verbal episodic encoding. This 
indicates that increased thalamic activation is a robust generalised brain activation 
alteration in AMCI that predicts disease progression. Furthermore, several areas of 
increased activation overlapped between verbal episodic encoding and selective 
auditory attention, indicating generalised altered language processing. Taken together, 
these findings indicate altered cortical processing of basic visual and language stimuli 
in CoAMCI that may contribute significantly to altered processing and correlated 
behavioural deficits that we report on higher attention and episodic memory. These 
findings suggest generalised altered processing that is most likely caused by AD 
neuropathology in the BFCS and/or locus coeruleus noradrenergic systems that 
provide Ach and NA that regulate almost every aspect of cognition. 
 
 
5.8 Verbal Episodic Encoding at Baseline 
We studied verbal episodic memory in AMCI to determine the behavioural and 
functional correlates of the characteristic amnesia in prodomal AD. Available findings 
suggest that the episodic amnesia may in part be due to PFC dysfunction and related 
executive failure and we therefore employed a verbal memory paradigm sensitive to 
executive semantic processing. In relation to the neural correlates of amnesia, we 
conducted whole brain fMRI to investigate for potential contributions from 
abnormalities in MTL and other areas to episodic amnesia in prodromal AD.  
The behavioural results revealed that verbal episodic amnesia in AMCI partly 
relate to executive failure (semantic elaboration deficits) at encoding and also to more 
liberal response bias as seen in AD. Furthermore, memory deficits correlated 
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positively with attention deficits, suggesting that executive failure contributes to 
deficits across cognitive domains in prodromal AD. 
Functional comparisons revealed greater activation in CoAMCI in visual, 
auditory, language and attention processing areas, and in default network areas. 
Correlations were evident between activation in these areas, memory performance and 
neuropsychological measures. These findings suggest compensatory activation in task 
related areas and failed cognitive regulation (attenuation) in non-relevant areas in 
prodromal AD. These findings are discussed in detail below.  
 
5.8.1 Behavioural Findings 
Encoding success is measured indirectly by recognition tests and behavioural findings 
from the recognition task are therefore discussed in this section.  
 
Corrected recognition 
CoAMCI and AllAMCI were impaired on recognition as indicated by decreased 
corrected recognition rates and this is in keeping with the clinical diagnosis of AMCI 
(§4.8.1; Table 25).  Corrected recognition was even further decreased in CoAMCI 
compared to AllAMCI, suggesting that the advanced pathology that lead to 
progression to AD in the former group resulted in lower corrected recognition rates. 
Corrected recognition rate (Pr) is a compound score and the difference 
between Control and CoAMCI were predominantly due to elevated false alarm rates 
in CoAMCI, whereas the groups were comparable on hit rates. Equivalent hit rates 
but higher false alarm rates in the CoAMCI group could be explained by a response 
bias towards familiarity i.e. more liberal, resulting in a greater tendency to select 
KNOW and REMEMBER responses. This notion is supported by trends towards 
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liberal bias in CoAMCI and towards conservative bias in Controls. In very mild AD, 
unequivocal liberal bias, unrelated to impaired recognition, has been found during 
verbal encoding (mean MMSE= 26) and appeared related to PFC or hippocampal 
dysfunction (Budson et al., 2006). Available evidence supports the notion that liberal 
response biases may be due to PFC dysfunction in AD; normal response biases have 
been demonstrated in patients with isolated amnestic disorders (Korsakoff’s, MTL 
pathology) but more liberal response biases for patients with AD that is associated 
with PFC dysfunction (Snodgrass and Corwin, 1988). The liberal bias observed in our 
AMCI groups may therefore represent an early manifestation of that found in AD. 
The respective contributions from encoding and recognition processing 
deficits to altered response bias in prodromal AD cannot be determined from our data. 
It could be argued that reliable encoding processes, such as that evident in Controls, 
would lead to conservative recognition bias because responses would be made with 
greater certainty. On the other hand, unreliable encoding may lead to consciously 
adopted compensatory strategies that involve more guesswork as suggested by the 
higher false alarm rates in AMCI. Although the exact mechanism remains to be 
determined, prodromal AD appears to be associated with more liberal response biases 
similar to AD. 
 
 
False recognition for lures 
As a proportion of false alarms, AMCI subjects had significantly reduced false 
recognition for lures. The parameter false recognition rate for lures [lure hit rate 
(lures identified/total lures) – false alarm rate (false alarms/non-targets) has a value 
anywhere between 1 and -1. A rate of zero, as seen in the AMCI group, indicates 
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similar lure hit rates and false alarm rates; a value above zero, as seen in the control 
group, indicates a lure hit rate that exceeds the false alarm rate. Healthy memory 
functioning is associated with higher lure hit rates because it depends on semantic 
elaboration that in turn makes it more vulnerable to false recognition of semantically 
associated lures. Reduced false recognition rates for lures evident in AMCI have also 
been reported in AD and taken as evidence for semantic elaboration failure (Koutstaal 
et al., 2001; Schacter et al., 1997). Whether this failure occurs at encoding or 
recognition is not clear; nevertheless, verbal memory impairment in amnestic 
syndromes (due to MTL and PFC damage) appears to be mediated by semantic 
elaboration failure at encoding rather than failure of retrieval (Verfaellie et al., 2005). 
Similarities between behavioural measures and lesion locations in AMCI and 
amnestic syndromes suggest that semantic elaboration failure occurs at encoding in 
AMCI. 
Semantic elaboration failure at encoding may be related to impaired 
generation (recall of related information), maintenance or encoding of semantic 
information and semantic generation deficits (impaired person naming and category 
fluency) have recently been demonstrated in AMCI (Artero et al., 2003; De Jager et 
al., 2003; Dudas et al., 2005). In AMCI, reduced false recognition rates for lures in 
the face of comparable hit rates indicate that correct familiarity decisions (hits) were 
made largely independently from semantic processing. We suggest this is due to 
failed generation and encoding of semantic information because both these processes 
are impaired in AMCI.  
Taken together these findings indicate that verbal episodic amnesia in 
prodromal AD is partly related to semantic elaboration failure at encoding. More 
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liberal response biases at recognition, that increase the number of commission errors, 
may also contribute to amnesia. 
  
Correlations between encoding and divided attention behavioural measures 
Visual processing speed was impaired during divided attention in AMCI and this 
correlated with verbal recognition performance: faster visual processing speed 
correlated positively with better recognition performance and higher false recognition 
rates for lures, and negatively with false alarm rates. Superior recognition 
performance and high false recognition rates for lures depend on semantic 
elaboration and therefore executive processing. Divided attention also depends on 
executive processing and the positive correlation between recognition and divided 
attention performance indicates the presence of generalised executive deficits that 
contribute to attentional and memory deficits in prodromal AD. Furthermore, finding 
that age did not correlate with measures that differed between CoAMCI and Controls 
indicates that executive impairment in prodromal AD is related to neuropathology and 
not age. 
 
In summary, executive failure appears to contribute significantly to verbal episodic 
amnesia in prodromal AD. Moreover, the correlations between memory and attention 
deficits in AMCI indicate a central role for executive failure in the cognitive deficits 
of prodromal AD. These findings suggest that pathology outside the MTL affects 
cognition early in the course of AD and, considering the pivotal role cholinergic 
neurotransmission plays in executive processing, that BFCS lesions may be 
responsible. 
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5.8.2 Functional Findings 
5.8.2.1 Task related activation 
For the encoding task, overt vocalisation and intentional encoding of different words 
were contrasted with only overt vocalisation of a repeated control that therefore did 
not require encoding. Encoding and control conditions were therefore matched in 
terms of the sensory processing and overt reading, whilst crucially differing on the 
requirement to encode. Although it is desirable to minimize movement during fMRI, 
we considered overt vocalisation desirable in order to ensure compliance throughout 
the relatively long duration of the task, given the cognitive deficits of the patient 
group. The potential difficulty of movement artefact was addressed by inserting a 
delay after vocalisation and prior to image acquisition, as used in similar studies (Birn 
et al., 2004; Shuster and Lemieux, 2005). 
Activation was evident in areas related to encoding and semantic elaboration, reading 
and speech production, and visual attention (§4.7.2.1; Table 21). We will look at these 
in turn. 
 
Encoding and semantic processing areas 
Activation in PFC, MTL and cerebellar areas was expected due to encoding and 
semantic processing. The activation of left PFC during verbal encoding is similar to 
that reported in 21 out of 24 studies involving intentional or incidental verbal 
encoding in controls (Fletcher and Henson, 2001) and in early AD (Lustig et al., 
2003). A positron emission tomography imaging study in healthy controls examined 
overt single word processing with an experimental design similar to the one we used. 
Bilateral activation was found in DLPFC when words were read aloud without further 
processing, and additional left VLPFC and anterior cingulate cortex activation when 
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semantic elaboration took place (Petersen et al., 1988). PFC activation therefore 
appears related to semantic and speech processing. 
We have seen in the introduction (§1.4.5) that left PFC activity relates to deep 
meaning-based semantic processing that optimises memory and which involves the 
executive processes of generating, maintaining, selecting and organising semantically 
related information. Furthermore, disruption of left PFC function impairs verbal 
encoding and disrupting semantic elaboration results in decreased left PFC activation 
and reduced memory performance. These findings indicate the pivotal role that the 
PFC plays in semantic elaboration. Activation in the left VLPFC relates to semantic 
processing during verbal encoding whereas activation in DLPFC reflects the working 
memory processes of reorganising information and subvocal rehearsal of working 
memory content (for reviews see(Desgranges et al., 1998; Fletcher and Henson, 
2001). Activation in both PFC regions indicates that both semantic and working 
memory processing took place during encoding. Semantic elaboration improves 
encoding and the left PFC activation seen in our groups probably reflects such a 
spontaneously adopted encoding strategy (Craik and Lockhart, 1972; Craik and 
Tulving, 1975; Logan et al., 2002).  
 Our findings of bilateral PFC activation are in line with the hemispheric 
asymmetry reduction in old adults (HAROLD) model that proposes a reduced 
lateralisation in older adults (Cabeza, 2002; Dolcos et al., 2002). It is not clear what 
causes the loss of lateralisation in older adults and possible mechanisms include 
compensatory activation and/or a reduction in the number of task specific networks 
with the result that non-specific networks are activated (Cabeza et al., 2000; Logan et 
al., 2002; Reuter-Lorenz et al., 2001). A study specifically designed to examine the 
causes of additional activation in contralateral areas concluded that increased 
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activation in additional areas was related to extra attentional and monitoring demands 
required for superior performance (Anderson et al., 2002). 
Encoding and semantic elaboration interact closely as revealed by findings 
demonstrating that the extent of activation of the left frontal cortex and hippocampus 
during verbal encoding correlates positively with subsequent successful recognition 
(Morcom et al., 2003; Wagner et al., 1998). Furthermore, activation in MTL and PFC 
predicts subsequent recall performance across a variety of encoding tasks and 
demonstrate the interaction between these two key areas in episodic encoding 
(Kirchhoff et al., 2000; Sperling et al., 2003a; Staresina and Davachi, 2008; Wagner 
et al., 1998). 
Right-sided posterior MTL activation was evident in the combined groups. 
Encoding verbal material is most often associated with left sided activation but 
several studies have revealed activation similar to what we found (Cabeza and 
Nyberg, 2000; Henson, 2005). Recent studies have also revealed correlations between 
memory performance and parietal and cerebellar activation (Brassen et al., 2006; 
Fliessbach et al., 2007; Staresina and Davachi, 2006). 
In summary, the PFC and MTL are key nodes in the network that underpins 
verbal episodic memory and this network also receives contributions from other 
cortical areas depending on the task. 
 
Reading and speech related areas 
Activation in auditory and language processing areas were expected as the task 
required overt reading (for a review of language processing see (Demonet et al., 
2005). Bilateral cerebellar activation, present in both our groups, has frequently been 
found during verbal episodic encoding and also during overt speech generation 
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(Cabeza and Nyberg, 2000). Additional cerebellar activation during the ENCODE 
condition is likely related to word form complexity and articulation differences 
between the various words read during the ENCODE condition and the single 
repeated CONTROL word. Alterations in word form have been shown to induce 
cerebellar activation (Shergill et al., 2003). Other areas activated in both groups are 
also associated with overt speech and include left primary motor cortex (BA 4), 
premotor cortex (BA 6), insula and superior temporal cortex (Wernicke’s area) 
(Shuster and Lemieux, 2005). 
 
Visual processing and attention areas 
Activation in visual processing areas following letter stimuli has been discussed in 
detail above (§5.6.2.1). Activation in extrastriate and fusiform areas indicates letter 
processing that differs from the control condition (Corbetta et al., 1991; Heinze et al., 
1994; Mangun et al., 1997).  
 
5.8.2.2 Group differences 
Decreased activation in AllAMCI 
AllAMCI had decreased activation in the left PFC (frontal pole) and this was 
associated with impaired semantic processing.  
In AMCI, impaired memory in association with decreased PFC activation has been 
demonstrated on a face-name paired associates encoding (Petrella et al., 2006), 
intentional picture naming encoding (Trivedi et al., 2008) and incidental picture 
encoding (Mandzia et al., 2007) (§1.4.6.2). These results are similar to what we report 
in the PFC; however, the use of visual stimuli and semantic elaboration support in 
these other studies disallows direct detailed comparisons. However, decreased PFC 
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activation occurred in AMCI across these memory tasks. Altered PFC activation 
therefore appears to contribute to the memory across picture and verbal encoding 
tasks and is likely associated with decreased semantic elaboration (§1.4.2.3).  
An fMRI study of activation exclusively for words that were subsequently 
retrieved demonstrated greater activation in AMCI subjects in left MTL, medial PFC, 
anterior cingulate and post central areas (Kircher et al., 2007). Increased activation 
therefore appeared compensatory. Due to the differences in methodology direct 
comparisons are not possible; we examined all encoding attempts so our results are of  
activation during successful and failed encoding. However, altered PFC activation 
appears across several of the available studies of episodic memory in AMCI and 
therefore appears to contribute significantly to the observed amnesia. This is in line 
with current models of memory processing networks and the distribution of AD 
neuropathology; furthermore, it suggests that even at the early stages of AD, 
pathology outside the MTLs contribute to amnesia. 
Given the multiple correlations between PFC activity and semantic elaboration 
(§1.4.5), the results in the AllAMCI group suggest that the semantic processing 
failure is closely related to decreased PFC activation which in turn may be due to 
local pathology or decreased cholinergic innervation from the BFCS (§1.6.2) or 
decreased NA from the locus coeruleus (§1.6.5; 5.7.1.2). Interestingly, in very mild 
AD, in-vivo PET imaging of amyloid deposition have revealed greater amyloid load 
in frontal cortex compared to parietal and medial temporal cortices (Klunk et al. 
2004). We have already seen that AD neuropathology can alter activation in cortical 
areas because of local pathology, or deficits in cognitive regulation (§5.6.2.2). 
Including age as a covariant produced similar results and indicates that 
functional differences are predominantly due to AD neuropathology. 
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Taken together, these findings indicate a central role for altered PFC activation and 
associated semantic processing failure in AMCI with unknown outcome. We next 
look at the results from the CoAMCI group that progressed to dementia. 
 
Increased activation in CoAMCI 
CoAMCI had greater activation in areas processing sound, language, attention, and 
visual stimuli. Significant correlations were evident between activation in the areas of 
difference, behavioural measures, and neuropsychological measures. We will look at 
these in turn. There are to our knowledge no published findings on verbal episodic 
encoding in progressive AMCI and direct comparisons of findings is therefore not 
possible. We therefore make comparisons with available findings.  
 
Language and visual processing areas 
CoAMCI had greater activation in right lateral temporal and insular areas that activate 
during overt reading, language processing, environmental noise processing and 
reordering of verbal items in working memory (Cabeza and Nyberg, 2000; de 
Zubicaray et al., 1998). All of these cognitive processes likely occur during the 
encoding task. It is apparent that the majority of Controls did not activate the right 
temporal auditory cortex whereas the majority of CoAMCI did (Figure 16). This 
suggests compensatory activation or impaired cognitive regulation.  
Compensatory efforts could include working memory-based strategies such as 
subvocal word rehearsal that activate auditory cortex. Although such a strategy is 
possible, it would not be very practical because as the list grows there would not be 
enough time to rehearse it between stimuli. 
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Alternatively, increased activation may indicate impaired cognitive regulation 
similar to that seen in several cortical areas during the divided attention task in 
CoAMCI (§5.6.2.2). For example, AMCI may have deficient down-regulation of 
activation in auditory areas induced by environmental (scanner) noise, resulting in 
greater activation compared to Controls that have intact down-regulation. Failed 
cognitive regulation can interfere with the processing of relevant stimuli and this is 
supported by the finding that better performance correlates with greater deactivation 
in right temporal areas. We have seen evidence for impaired cognitive regulation on 
other tasks in AMCI and this is certainly the leading explanation for increased 
activation in task-irrelevant areas. The same holds for increased activation seen in 
extrastriate visual areas. It is difficult to determine if increased activation in areas that 
process both relevant and irrelevant stimuli, such as words and environmental noise, 
is due to compensatory activation or failed regulation; however, the distinction may 
be that compensatory activation should normalise behaviour whilst failed regulation 
would not.  
 
Posterior cingulate and medial parietal areas 
CoAMCI demonstrated greater activation in the posterior cingulate and precuneus 
during encoding and this correlated negatively with corrected recognition rates, lure 
recognition rates, CAMCOG scores and New Learning subscale scores (Table 24; 
Figure 17). Greater activation in this area in CoAMCI is therefore negatively 
correlated with 4/5 behavioural measures on which they are impaired. The posterior 
cingulate forms part of the default network (§5.6.2.2) and similar findings were 
evident on the divided attention task. Moreover, we have seen how the magnitude of 
deactivation in the default network correlates with task difficulty in healthy subjects 
 304 
and that failure to deactivate medial parietal areas correlates with greater severity and 
decline in AMCI (Buckner et al., 2008; Celone et al., 2006; Miller et al., 2008; 
Raichle et al., 2001). This has also been found in AD, where failed deactivation of 
default network areas correlates with poorer cognitive performance, and it has been 
attributed to impaired functional regulation (Lustig et al., 2003). Our results 
correspond with those in AMCI and AD and this indicates that episodic memory 
deficits are due in part to failed cognitive regulation of the default network in AMCI.  
Moreover, we have reported greater activation in the medial parietal area on 
two separate tasks (encoding, divided attention) in CoAMCI but not in AllAMCI. 
AllAMCI included non-converters that are arguably less impaired and this finding 
corresponds with those mentioned above indicating that medial parietal deactivation 
failure correlates with greater severity and decline in AMCI. Our findings therefore 
correspond with those from studies in AMCI and AD and indicate that failed default 
network deactivation, and in particular in the medial parietal areas, is a pervasive 
abnormality in AMCI that predicts progression to dementia. 
 
Anterior cingulate, caudate, putamen and thalamus 
Anterior cingulate activation occurs during sustained attention, verbal working 
memory tasks, problem solving, semantic elaboration, episodic encoding and retrieval 
(Cabeza and Nyberg, 2000). Activation in the caudate and putamen is also associated 
with verbal working memory encoding and maintenance. Activation in the right 
caudate appears specifically involved in verbal working memory maintenance and 
taken together these findings support the notion that increased activation in these 
areas in CoAMCI may be related to compensatory efforts that involve verbal rehearsal 
strategies (Chang et al., 2007).  
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Increased activation was also evident in the right thalamus and we have seen 
that the thalamus activates during attention demanding tasks and it mediates 
decisional processing (§5.6.2.2). Greater activation is therefore likely related to 
increased or compensated attentional arousal efforts due to perceived greater task 
difficulty in CoAMCI. Increased thalamic activation was also evident during selective 
visual (Table 17; §4.6.1.2), selective auditory (Table 20; §4.6.2.2) and visual-auditory 
divided attention (Table 13; §4.5.2.2), and this indicates altered attentional arousal 
processing across attention conditions. The relationship between thalamic activation 
and attention is supported by the positive correlation between thalamic activation and 
visual processing speed during divided attention (Table 14; Figure 15). It therefore 
appears that thalamic activation is increased across attentional conditions in AMCI 
due to compensatory attentional arousal efforts. 
 
Functional-behavioural correlations  
We have seen that superior recognition performance correlated with decreased 
activation in lateral temporal (Figure 16) and medial parietal areas (Figure 17) where 
CoAMCI had increased activation. We also studied correlations between activation in 
these areas and neurocognitive measures (Table 24). Similar negative correlations 
between activation in these two areas were evident with CAMCOG total scores, 
indicating that it generalises to out-of-scanner cognitive performance. Furthermore, 
activation in the medial parietal area also correlated inversely with New Learning 
subscale scores, illustrating that it generalises across verbal episodic memory tasks. 
This lends further support to the growing body of evidence that abnormality in the 
medial parietal areas is an early feature of AMCI that predicts conversion to AD. 
Finding that medial parietal activation also correlates inversely with false recognition 
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for lures indicates that normal default network deactivation correlates with increased 
semantic elaboration. 
 
 
Decreased activation in CoAMCI 
There were no areas of decreased activation in CoAMCI whereas decreased activation 
was evident in the PFC in AllAMCI. It also does not appear as if this is due to a lack 
of detection power as a more liberal statistical threshold did not reveal PFC 
differences. The only conclusion that can be drawn is that PFC activation was 
comparable between CoAMCI and Controls, indicating maximal activation, and that 
the non-converters in the AllAMCI group somehow had decreased PFC activation 
that contributed to the observed difference. A bi-phasic pattern of cortical activation 
changes have been demonstrated in AMCI in MTL areas during encoding and a 
similar pattern could be responsible for these findings in our groups (§1.4.6.2)(Celone 
et al., 2006). 
 
Summary 
Behavioural findings on the verbal episodic encoding task indicate that failed 
semantic elaboration contributes substantially to verbal episodic amnesia in AMCI. 
Furthermore, the correlations between encoding and divided attention performance 
indicates a central role for executive impairment in the symptomatology of AMCI and 
AD. This accords with findings indicating that deterioration everyday activities, 
which precipitate the clinical dementia syndrome, are strongly correlated with 
executive impairment but not amnesia (Bisiacchi et al., 2008; Royall et al., 2004; 
Royall et al., 2005).  
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Our findings suggest the presence of both compensatory and failed cognitive 
regulatory mechanisms during verbal episodic memory encoding in CoAMCI. 
Functional findings indicate that altered activation outside the MTL contributes 
significantly to the amnesia in AMCI. In particular, failed medial parietal deactivation 
was evident in AMCI that converted to AD and this correlated with episodic amnesia. 
Failed medial parietal deactivation was also evident and associated with impaired 
performance on divided attention in CoAMCI. Taken together with the findings from 
the divided attention and visual-auditory attention tasks, AMCI appears to be 
associated with failed cognitive regulation across encoding and attention conditions. 
Furthermore, we have now presented functional and behavioural evidence of 
executive impairment on two task and this suggests a much more central role for 
executive failure in disease progression in AD. This in turn supports disease models 
such as BFCS and locus coeruleus pathology that have generalised effects on 
cognition such as we have discussed. 
 
5.9 Recognition at Baseline 
We examined the functional correlates of verbal recognition in AMCI to (1) 
determine if successful recognition is associated with altered functional activation that 
suggests compensatory activation or strategies, and (2) to examine the functional 
correlates associated with failed recognition. The behavioural results from the 
recognition task have been discussed in detail in the above section on encoding 
(§5.8.1), and behavioural findings related to the discussion of functional data are 
provided in relevant sections and briefly summarised below. 
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5.9.1 Behavioural Findings 
AMCI patients were impaired on recognition as indicated by lower corrected 
recognition rates (§4.8.1; Table 25). They had elevated false alarm rates that appear 
related to more liberal response bias rates, similar to that demonstrated in AD. As a 
proportion of false alarms, AMCI subjects displayed significantly reduced false 
recognition for lures suggesting failure of semantic elaboration at encoding. Visual 
processing speed was impaired during divided attention in AMCI and this correlated 
with verbal recognition performance: faster visual processing speed correlated (1) 
positively with better recognition performance and higher false recognition rates for 
lures, and (2) negatively with false alarm rates. These correlations of measures across 
tasks suggest impairment in a shared mechanism and a prime candidate is executive 
functioning because it controls attention and optimises memory. These correlations 
therefore support the notion that executive failure contributes to cognitive deficits in 
prodromal AD. 
 
5.9.2 Functional Findings 
5.9.2.1 Task related activation 
Verbal recognition typically activates right hemispheric DLPFC, VLPFC, anterior 
cingulate, parietal areas (Cabeza and Nyberg, 2000). A study involving a large control 
group of 77 healthy young and middle-aged adults found activation in posterior 
cingulate, precuneus, lateral parietal lobe, right lateral temporal lobe and right 
prefrontal cortex (Johnson et al., 2006a); activation was lateralised to the right. These 
same areas showed activation during the processing of hits and activation was less 
lateralised in line with the HAROLD model as discussed above (§5.8.2.1) and in the 
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introduction (§1.1.3)(Tables 26, 27). Activation during the processing of correct 
rejections was similar to that reported in as healthy older adults during a similar 
verbal recognition task (Heun et al., 2007). Findings during recognition processing are 
therefore in line with published findings, which therefore indicate the task can be 
utilised for group comparisons in older adults. 
 
5.9.2.2 Group differences 
Hits – behavioural results 
Behavioural findings suggest altered cortical processing during correct target word 
recognition (hits) in prodromal AD, as evident from two findings. Firstly, although 
Controls and CoAMCI were comparable on hit rates, a trend towards lower hit rates 
in CoAMCI suggests that impairment may be evident given larger samples.  
Secondly, there is some indication that CoAMCI achieved statistical behavioural 
equivalence via disparate cognitive processing: comparable hit rates were associated 
with increased false alarm rates. More liberal response bias rates appear to have 
elevated hit rates in CoAMCI as participants were more inclined to make familiarity 
responses; however, this came at the expense of increased false alarm rates resulting 
in overall poorer corrected recognition rates. In other words, CoAMCI appear to have 
comparable hit rates because they were more likely to choose REMEMBER or 
KNOW responses when they were unsure. This notion of disparate cognitive 
processing is supported by the imaging data that revealed altered activation in 1284 
voxels. We next look at these activation differences.  
 
Hits - decreased activation in CoAMCI 
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CoAMCI had decreased activation in areas processing visual stimuli (visual cortex, 
fusiform) executive attention (PFC, thalamus, brainstem, cerebellum, posterior 
cingulate), working memory (caudate) and language (auditory cortex, insula, 
putamen) (Table 28). This could either indicate processing deficits that were 
insufficient to cause behavioural impairment or the use of compensatory strategies 
that were less reliant on the processes that activate these areas in Controls.   
A recent fMRI study of recognition in AMCI found predominantly decreased left 
parietal and right posterior temporal activation compared to controls; however, a 
picture encoding task was used and activation examined during all recognition 
attempts and direct comparisons with our results are therefore not appropriate 
(Machulda et al., 2009). In spite of these methodological differences, it appears that 
recognition deficits are associated with altered cortical activation in prodromal AD for 
both verbal and visual episodic memory. 
 
Hits – increased activation in CoAMCI 
Increased activation occurred in several areas including frontal polar, medial parietal, 
MTL, brainstem, secondary visual and auditory, caudate and putamen (Table 29). 
Frontal polar cortex (BA 9,10) is strongly associated with episodic memory retrieval, 
problem solving and sustained attention, and increased activation here may indicate 
that greater cognitive effort was required in task related areas to match hit rates of 
Controls (Cabeza and Nyberg, 2000).  
Increased activation also occurred in bilateral MTL and medial parietal areas, that 
form part of the default mode network that also includes anterior polar cortex 
discussed above. We have seen previously (§5.6.2.2) that activation in this network 
appears related to inwardly directed cognitive processes and that the magnitude of 
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deactivation in the default network correlates with task difficulty in healthy controls 
and with the severity of impairment in AMCI (less impaired AMCI deactivate more 
and show slower cognition decline). Furthermore, greater hippocampal activation in 
MCI compared to controls (hyperactivation) during episodic memory appears to 
predict faster rates of cognitive decline (Celone et al., 2006; Miller et al., 2008). 
Accordingly, greater medial parietal and MTL activation in CoAMCI may be related 
to deactivation failure caused by impaired cognitive regulation resulting in maintained 
activation in default network that hinders processing in task relevant areas and impairs 
performance. Our findings therefore suggest that cognitive performance correlates 
negatively with activation in MTL and medial parietal areas across encoding, 
recognition and divided attention processing. 
Opposite findings in the medial parietal area have been reported during picture 
recognition in AMCI (n=14; 8 receiving cholinesterase inhibitor treatment) compared 
to age-matched elderly controls (Johnson et al., 2006a). Comparisons with our results 
are limited because the outcome measure used by Johnson et al. (percentage correct) 
does not take account of false recognition and their AMCI group was not impaired on 
recognition, which is difficult to reconcile with a diagnosis of AMCI. Furthermore, 
the majority of their AMCI group received ACEI treatment that can alter cortical 
activation (§1.7.5). 
 Positive correlations between retrieval performance and activation in the MTL and 
medial parietal areas have been demonstrated across a large group comprised of MCI, 
AD and age-matched control subjects (Heun et al., 2006a). Their memory paradigm 
was similar to ours, requiring encoding of visually presented nouns followed by and 
yes/no recognition task, and it revealed similar behavioural impairments. A significant 
positive correlation was evident between the magnitude of activation for hits and 
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corrected recognition rates in the left hippocampus and posterior cingulate gyrus 
across the groups but not for the subgroups. They did not report on group differences 
so it is unclear if activation differed between controls and AMCI. Although not 
reported, their results indicate that AMCI would have demonstrated decreased 
activation in the MTL and medial parietal areas given the positive correlations with 
recognition performance, therefore the opposite of our results. 
A recent study of picture recognition in AMCI found decreased MTL and 
increased PFC activation, the MTL findings therefore also being the opposite of what 
we found (Trivedi et al., 2008). Their AMCI group differed from our CoAMCI as 
they were older and better educated and arguably less impaired, as they were not 
selected because of progression to AD. Our imaging results on attention and encoding 
that indicate (1) greater volume (voxels) of differences between CoAMCI and 
Controls than AllAMCI and Controls (§4.5.2; 4.6.1.2; 4.7.2.2), and (2) the 
correlations between activation and performance (Figures 14-6) suggest that disease 
severity significantly influences activation. Moreover, other studies have also found 
that the degree of functional alteration correlates with the severity of cognitive 
impairment and speed of cognitive decline in AMCI (Celone et al., 2006; Miller et al., 
2008). Therefore, the most likely explanation for the discrepancy between our results 
and those of Trevedi et al.is that their AMCI group was less impaired than our 
CoAMCI group. Task characteristics may also contribute to the different findings as 
picture and verbal memory engages both overlapping and different areas. Also, they 
compared activation during hits with that during misses, whereas we compared hits to 
all non-task activation, the contrasts generated are therefore different. Furthermore, 
significant results were only obtained when their analysis was limited to specific 
regions of interest whereas our results were evident on whole brain analysis. Direct 
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comparisons between our findings and those of Trevedi et al. are therefore limited by 
the group, task and analysis differences, and our work therefore awaits replication 
before firmer conclusions about can be drawn about processing of hits in prodromal 
AD. 
 
Correct rejection 
Functional differences between CoAMCI and Controls on correct rejections overlaps 
largely with that seen on hits suggesting that these closely related cognitive processes 
are affected by very similar processing changes (Table 30). CoAMCI showed 
increased activation in PFC (BA 6) and VLPFC (BA 44, 45) and similar findings in 
AMCI has lead to the suggestion that it could be used as an early marker of AD (Heun 
et al., 2007). 
 
False recognition of lures 
CoAMCI had decreased activation in occipitoparietal areas and increased activation in 
frontotemporal areas on the false recognition for lures contrast (Table 31). This was 
associated with decreased false lure recognition rates indicating impaired semantic 
elaboration at encoding. To date no other findings on false recognition for lures have 
been reported in AMCI. The findings suggest that decreased false recognition for 
lures associates with altered processing during recognition processing and not only 
during encoding as discussed above.  Further studies, controlling for semantic 
elaboration during encoding, are required to determine the contribution of altered 
recognition processing on false recognition for lures.  
 
Summary 
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In summary, only a few functional studies have examined recognition in prodromal 
AD and no firm conclusions can be drawn from their findings. Taken together, our 
results and published findings all indicate altered activation during recognition in 
AMCI and altered activation in the posterior cingulate appears the most consistent 
finding.  We have seen in preceding sections (§5.6.2.2) that altered posterior medial 
parietal (cingulate) activation and atrophy appears a consistent finding in AMCI and 
the results discussed above supports it. 
 
5.10 Rivastigmine Treatment Effects on Divided Attention in AMCI 
We conducted a controlled treatment trial of rivastigmine treatment to determine the 
effects of ACEI treatment on attention in AMCI. Our results indicate that rivastigmine 
treatment increased visual and auditory attention processing speed during divided 
attention. These behavioural improvements were associated with treatment related 
activation decreases in relevant sensory and executive attention processing areas. 
These findings suggest that rivastigmine improves signal-to-noise ratios in relevant 
sensory cortices that consequently reduce regulatory processing requirements 
dependent on executive areas. These findings are discussed in detail below. 
 
5.10.1 Rivastigmine Dosage and Tolerability 
Rivastigmine treatment did not cause any serious adverse effects and the gastro-
intestinal side effects (nausea, vomiting) that occurred in half of the patients at the 
start of treatment are in line with findings from ACEI treatment studies ((Raschetti et 
al., 2007) and references therein). All RivAMCI patients were able to tolerate the drug 
throughout the study period. Nine RivAMCI participants continued on an ACEI for 
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up to one year: six on rivastigmine, three on donepezil. ACEI treatment is therefore 
well tolerated in this patient group.  
 
5.10.2 Demographics and Neurocognitive Results 
The RivAMCI and NxAMCI groups differed significantly on MMSE and Attention 
subscale scores suggesting that the NxAMCI group was less impaired (Table 32). The 
RivAMCI was older than NxAMCI, although this did not reach statistical 
significance, and NxAMCI spent more years in formal education, and these findings 
could explain their higher MMSE and Attention subscale scores. The difference in 
Attention subscale scores may indicate larger cognitive reserve related to more years 
in formal education. Although younger age in NxAMCI may contribute to the 
attention difference, it is more likely related to education because available evidence 
indicates that education improves working memory and attention whilst age affects 
episodic memory (Gomez-Perez and Ostrosky-Solis, 2006). Superior Attention 
subscale performance did not predict better performance on the divided attention task. 
This is most likely due to the nature of the tasks as only accuracy is measured on the 
Attention subscale whereas speed is additionally measured on the divided attention 
task. The Attention subscale of the CAMCOG is therefore limited as it measures only 
one domain of importance to overall attentional processing.  
Randomised treatment allocation is often not practical or ethical and pre-
treatment differences occur commonly in neuropsychological research. Statistically 
significant differences apparent prior to treatment in non-randomised patient groups 
complicate the interpretation of results on the effects of treatment on group 
(allocation), time and interactions (group x time). However, if baseline differences 
favour the untreated group and the treated group then shows an improvement over 
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time, then any treatment effect should be considered significant because it stands to 
reason that the treated group improved from a more disadvantaged pre-treatment 
level. This is the case for the treatment comparisons between RivAMCI and NxAMCI 
as the later group was younger and performed better on neuropsychological measures 
at baseline. 
 
5.10.3 Behavioural Findings 
RivAMCI and NxAMCI were comparable on visual and auditory target processing 
speed, and on accuracy at baseline (§4.9.2; Table 32). This indicates that all 
participants had sufficient practice on the task and validates the use of reaction time as 
a treatment outcome measure for this experiment (§3.9.1.1). This is further supported 
by the absence of main time effects on behavioural measures. Following rivastigmine 
treatment, RivAMCI improved their visual and auditory processing speed resulting in 
faster speeds with large effect sizes for both (Figures 19, 20). This is indicated by 
faster RTs on visual and auditory targets at follow-up and interaction effects (group x 
time) for auditory RTs. This is in line with findings of faster visual processing speed 
on attentional tasks following physostigmine in healthy subjects (Bentley et al., 2004; 
Furey et al., 2000; Furey et al., 1997; Goekoop et al., 2004)(§1.7.5). Improvement in 
processing speed and accuracy have been found on the few studies of working 
memory in AMCI. Ten weeks of donepezil treatment improved accuracy on a verbal 
working memory task (n-back, letter stimuli) (Saykin et al., 2004) and five days of 
galantamine treatment improved speed and accuracy on a visual working memory 
task (n-back, letter stimuli)(Goekoop et al., 2004). 
Increasing the availability of Ach following ACEI treatment was anticipated to alter 
speed and/or accuracy in AMCI but only a trend was evident on accuracy. The 
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absence of changes in accuracy is most likely related to task design as both groups 
performed near or at ceiling for accuracy. 
Taken together, out behavioural findings indicate that rivastigmine improves 
attentional processing speed in AMCI during divided attention. 
 
5.10.4 Functional Findings 
5.10.4.1 Baseline between group comparisons 
RivAMCI had greater activation than NxAMCI in task related primary and secondary 
visual processing areas (Table 33). This was associated with better Attention subscale 
and MMSE scores, and trends towards superior performance on on all the other 
neuropsychological measures in NxAMCI (Table 32). NxAMCI therefore appear less 
impaired than RivAMCI. Taken together these findings suggest that the activation 
differences between RivAMCI and NxAMCI are due to greater disease severity in the 
former group as indicated by poorer performance on MMSE and Attention subscale 
scores, and similar trends on all other neuropsychological measures at baseline. 
The differences between RivAMCI and NxAMCI could be related to sampling 
error or pathological heterogeneity in AMCI patients. Sampling error could have 
occurred as the groups were recruited sequentially and we conducted post hoc 
analyses to exclude that activation differences were due to sampling bias (§3.9.5; 
4.9.4). It could be argued that increased awareness of MCI lead to patients presenting 
earlier and the last group recruited (NxAMCI) may therefore include less impaired 
patients. However, identical recruitment procedures were followed for both groups 
and results indicate that the groups did not differ on the severity of cognitive 
impairment as measured by the deviation of individual scores from predicted 
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CAMCOG totals (Table 36). Patients therefore appear to have been recruited at 
similar severity levels given their age, education, gender and social class. The groups 
were therefore comparable on norm adjusted severity measures. Equivalence on 
severity measures does not discount the possibility that activation changes occured 
independent of relative severity i.e. activation could correlate with neurocognitive 
measures irrespective of age, education, gender and social class. 
As far as the interpretation of our results is concerned, it is fortuitous that the 
treated group appears more impaired at baseline. If baseline differences favour the 
untreated group and the treated group then improves over time then they do so from a 
more disadvantaged pre-treatment level, adding support to any beneficial treatment 
related effects. Taken together, these findings indicate that the RivAMCI group may 
have been more impaired at baseline but that this was not due to systematic sampling 
error and that any behavioural improvements evident in this group occurred from a 
more disadvantaged starting point compared to NxAMCI. 
 
5.10.4.2 Main effects of Time 
Activation reduced over time in the combined groups in left temporal auditory areas 
and MTL (Table 34). Decreased activation at follow-up is likely related to repetition 
suppression or priming, that has been reported in temporal auditory cortical areas for 
spoken words similar to the verbal stimuli in the divided attention task (Badgaiyan et 
al., 2001; Gagnepain et al., 2008). Repetition priming refers to reduced activation in 
task related areas upon repeated perceptual or conceptual exposure; it appears related 
to increased cortical processing efficiency and is associated with maintained 
performance. Priming in MTL and auditory areas have been reported on several tasks 
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that involve verbal processing, supporting the suggestion that the observed differences 
over time is priming related (Cabeza and Nyberg, 2000). 
 Activation decreased in both groups over time in medial parietal,  
MTL, temporal, somatosensory, visual processing, attention processing, and 
cerebellar areas.  These changes were not associated with significant main effects of 
time on any of the behavioural measures thereby limiting further interpretation. 
 
5.10.4.3 Interaction effects  
Interaction effects were evident in left hemispheric visual and verbal language 
processing areas, and in prefrontal executive attention processing areas (Table 35; 
Figures 21, 22). In these areas, RivAMCI decreased activation and NxAMCI 
increased activation over time indicating the treatment effects of rivastigmine. The 
effects of ACEI on attentional processing are mediated via top-down (task-driven) 
effects in prefrontal and parietal cortices and via bottom-up (signal-driven) effects in 
sensory cortices (§1.7.5). Decreased activation in language processing areas may 
indicate greater repetition suppression following rivastigmine. Similar enhanced 
repetition suppression has been observed in visual areas for visual stimuli following 
physostigmine in young controls and AD patients (Bentley et al., 2003; Riekkinen and 
Riekkinen, 1999). This suggest that rivastigmine enhances cortical efficiency related 
to attentional processing in primary sensory and association areas that in turn reduce 
the demands made on top-down regulating executive attention areas, resulting in 
decreased PFC and parietal activation. Similar findings have been reported on tasks of 
working memory that make heavy demands on divided attention.  Improved visual 
working memory (faster reaction times) accompanied decreased PFC and increased 
extrastriate visual cortex following single dose physostigmine administration in 
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healthy adults (Furey et al., 2000; Furey et al., 1997). These findings indicate that 
improved perceptual processing in sensory cortices simplifies working memory 
demands that in turn required less PFC participation. This is supported by findings 
from animal studies demonstrating that visual cortex stimulation increases local 
acetylcholine release via a pathway that proceeds from visual cortex to PFC, the 
BFCS and back to visual cortex. Consequently, increased sensory cortex 
responsiveness following physostigmine could require less PFC signalling required to 
enhance sensory cortex excitability (Rasmusson et al., 2007). Physostigmine also 
improved processing speed whilst decreasing primary visual cortex activation and 
increasing extrastriate cortex activation during visuospatial working memory and 
selective visual attention tasks (Bentley et al., 2004). These results suggest that ACEI 
related enhanced sensory processing during working memory tasks result from (1) 
improved signal-noise ratios in primary sensory cortices that reduces local activation 
and (2) increases activation in higher visual areas leading to (3) reduced requirements 
of top-down regulation from the PFC resulting in decreased activation. Our finding of 
decreased activation in left PFC following rivastigmine is commensurate with these 
findings and suggested mechanism. 
Only one functional study has examined ACEI treatment in AMCI by 
comparing treated and untreated groups. Five days of galantamine treatment improved 
speed and accuracy on a visual working memory task (n-back, letter stimuli) and this 
was associated with increased activation in right precuneus and right PFC (BA 9, 47) 
(Goekoop et al., 2004). The only conclusions to be drawn from this study in relation 
to our results are that ACEI appears to improve processing speed and that this 
associates with altered cortical activation.  
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 We did not find linear correlations between activation and processing speed 
changes over time in RivAMCI. This suggests that treatment has a binary rather than 
a scalable effect on cortical activation and/or behaviour. Alternatively, our study 
might lack sufficient power to demonstrate linear effects.  
 
Summary 
Taken together our findings indicate improved attentional processing whilst the 
associated decreased cortical activation suggests enhanced processing in line with 
findings in controls and supported by functional circuitry identified in animals. 
Further studies are required if a coherent model of ACEI treatment response in AMCI 
is to emerge; however, the apparent lack of efficacy of ACEI treatment in AMCI 
argues against further studies.  
 
5.11 Rivastigmine Treatment Effects on Visual and Auditory 
Selective Attention 
We studied the effects of rivastigmine treatment in AMCI on selective visual and 
auditory attention processing in order to control for the possibility that treatment 
effects may generalise across attentional conditions rather than being condition and 
area specific. Generalised effects would suggest that treatment effects could occur via 
non-cortical mechanisms such as increased cardiac output or systemic effects such as 
vasodilatation. Our findings argue against such effects because the areas where 
interaction effects occurred following treatment overlapped minimally across the 
visual (§4.10.1.1) and auditory conditions (§4.10.1.2); moreover, there was minimal 
overlap with interaction areas demonstrate during the divided attention task (§4.9.3). 
Rivastigmine therefore appears to have task- and region- specific effects during 
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attentional processing and this accords with findings from ACEI studies discussed in 
the introduction (§1.7.5).  
Interaction effects (group x time) evident on selective visual and auditory 
attention conditions occurred in task related areas. Following rivastigmine treatment, 
activation decreased in RivAMCI in auditory and language processing areas during 
the visual attention condition, and in visual processing areas during auditory attention. 
These findings suggest improved down regulation of activation in areas not relevant 
to a given a given attention condition following rivastigmine.  
 
5.11.1 Behavioural Findings 
Behavioural measures were not collected during the visual and auditory selective 
attention task and this precluded correlation analysis, thereby limiting the conclusions 
that can be drawn. However, including behavioural responses on the task would alter 
the attentional and executive processing required during the task practically rendering 
it a simple choice reaction time task. The findings reported therefore reflect 
attentional processing when participants are required to attend but not respond, similar 
to the processing that takes place in everyday life, that is associated with intact 
episodic recall in controls. 
 
5.11.2 Visual selective attention 
Rivastigmine treatment effects were evident as interactions in lateral temporoparietal 
areas where RivAMCI decreased activation over time whilst it remained stable in 
NxAMCI (Table 39; Figure 22). The right temporal cortex processes complex non-
verbal sounds, such as scanner noise, and decreasing activation in RivAMCI may 
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indicate enhanced cognitive down regulation of non-relevant areas ((Engelien et al., 
2001) and references therein). Decreased parietal activation lends further support to 
this suggestion as parietal activation increases during selective auditory attention and 
the converse could therefore indicate decreased auditory attention processing (Pugh et 
al., 1996). As mentioned above, the lack of behavioural measures precludes further 
interpretation as it is unclear if activation changes following rivastigmine causes 
behavioural changes; however, the results from the divided attention study indicate 
improved processing of visual and auditory stimuli that was associated with decreased 
activation in relevant auditory and visual cortices following rivastigmine. The results 
from the visual condition in RivAMCI may therefore indicate improved cognitive 
regulation following rivastigmine but future studies will need to confirm this. 
A further interaction was evident in PFC where RivAMCI maintained and NxAMCI 
decreased activation (Table 39; Figure 24), and this may reflect enhanced activation 
related to top-down regulatory efforts that decrease activation in non-relevant lateral 
temporoparietal areas, as discussed above. 
Taken together, these results indicate that rivastigmine treatment alters cortical 
activation during selective visual attention processing. Initial data suggests enhanced 
cortical down-regulation of non-relevant sensory areas that is achieved via greater 
PFC activation.  
 
5.11.3 Auditory selective attention 
Rivastigmine treatment effects were evident in occipitotemporal-visual areas and 
temporoparietal-auditory areas, where RivAMCI decreased activation relative to 
NxAMCI (Table 42; Figures 25 -27). Decreased activation in both these areas support 
the hypothesis that enhanced cognitive regulation results in down-regulation of non-
 324 
relevant cortices. Processing in posterior visual areas and in the right sided auditory 
areas, that process complex non-verbal sounds such as scanner noise, are not required 
during the verbal condition and activation in these areas are therefore down-regulated 
((Engelien et al., 2001) and references therein). It is not clear why activation 
decreased in somatosensory areas as the task did not include specific somatosensory 
stimuli; however, environmental somatosensory stimulation occurred continuously 
during the experiments and it may be that enhanced top-down cognitive regulation 
also affects somatosensory signals via PFC and parietal areas. 
Rivastigmine treatment effects were also evident as increased activation in RivAMCI 
in the brainstem, medial occipitotemporal areas (extrastriate visual, entorhinal, 
hippocampus, amygdala), thalamus and striatum (Table 42; Figure 28). 
Environmental stress activates the brainstem locus coeruleus via the amygdala and 
increased activation suggests greater attentional arousal and vigilance. This is 
supported by increased thalamic activity that is associated with the onset of 
demanding attentional tasks (Kinomura et al., 1996; Raizada and Poldrack, 2008). 
Thalamic activity contributes to attentional orientation, sensory processing and 
decision making and activation is therefore associated with non-specific attentional 
arousal that increases during periods of increased attentional demand (for a review see 
(Newman, 1995)) (Newman and Mair, 2007). Consequently, increased activation in 
these areas may indicate enhanced attentional response following rivastigmine. The 
absence of behavioural measures precludes direct correlations; however, improved 
auditory processing during divided attention (§5.10.3) suggests that processing may 
also be improved during selective auditory processing.   
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Increased posterior cingulate activation may be related to enhanced processing 
of the verbal stimuli as activation in this area frequently occurs during verbal memory 
retrieval tasks (Cabeza and Nyberg, 2000).  
Hippocampal activation is evident on tasks where participants are not 
instructed to encode stimuli an appears related to automatic episodic encoding, and 
recent work demonstrated that the level of activation remains unchanged when 
participants were instructed to encode the stimuli; however, it was accompanied by 
PFC activation (Dove et al., 2006). PFC activation therefore appears related to the 
processes that accompany conscious intentional encoding. In contrast to activation in 
non-relevant sensory cortices that may be overactive in AMCI due to impaired 
cognitive regulation, automatic hippocampal activation may be expected and 
increased activation may be related to improved cognitive down regulation elsewhere. 
These suggested mechanisms could not be examined further with our available data; 
however, the encoding paradigm employed by Dove et al. provides a potential method 
of study. Their task involved either passive viewing or intentional encoding of 
abstract images and recognition was tested after viewing. Collecting recognition data 
for the verbal material could clarify if enhanced hippocampal and posterior cingulate 
activation is associated with increased retrieval performance of incidentally encoded 
verbal material. 
 
Summary 
Taken together these results suggest enhanced activation in task-relevant areas and 
decreased activation in non-relevant areas during selective auditory attention 
following rivastigmine in AMCI. This in turn suggests improved cognitive regulation. 
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Available data do not allow behavioural correlations and further studies will be 
required to confirm these tentative conclusions. 
 
5.12 Rivastigmine Treatment Effects on Verbal Episodic Memory 
Rivastigmine treatment had no apparent effects on verbal episodic memory in AMCI 
(§ 4.11.1). Behavioural results indicate that the groups remained comparable at 
follow-up and interaction effects, indicative of treatment effects, were not evident on 
any of the behavioural measures. Furthermore, the differences between the AMCI 
groups and Controls evident at baseline remained at follow-up, thereby indicating that 
the AMCI groups did not improve compared to Controls. These findings are in line 
with those from the meta-analysis of rivastigmine and other ACEI treatments in 
AMCI-multiple domain and MCI that failed to show treatment benefits on cognition 
(Birks, 2006; Birks et al., 2000; Birks et al., 2009; Raschetti et al., 2007). 
 All participants showed increased FAR at follow-up and this may indicate that 
the two versions of the task used at baseline and follow-up are not matched on 
difficulty, alternatively it may indicate reduced motivation and compliance at follow-
up that is related to the task being presented at the end of the scanning session when 
participants may be fatigued. Reversal of the versions in future studies can help to 
clarify this. 
Functional data were not analysed because results were unlikely to have 
significant interpretive value given our behavioural findings and similar findings 
published during the course of our work, which failed to show any benefit of ACEI 
treatment on episodic memory in AD. These findings argue against further 
investigations of ACEI treatment effects on memory in AD. The disproportionate 
number of technical and compliance failures that occurred on the recognition task 
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indicate that it may not be suitable in its present form, or should be presented earlier 
to eliminate the effects of participant fatigue (§4.3). This needs to be clarified before 
future studies are undertaken with this task. 
 
Summary 
Taken together these findings indicate that ACEI treatment does not benefit verbal 
episodic memory in AMCI. The lack of treatment efficacy may be due to the faulty 
assumption that cortical cholinergic inputs have predominantly tonic activity as 
discussed in the introduction (§1.7.5). It is unlikely that the complex neuronal systems 
mediating episodic memory operate via tonic activity and increased synaptic Ach is 
therefore unlikely to compensate for the loss of presynaptic neuronal function and 
may in fact impair memory processing. Given the currently available findings, it 
appears that further study of ACEI treatment on verbal memory in AMCI is not 
warranted. 
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6. Conclusions and Future Directions 
The work reported, summarised and discussed in this thesis has lead to a number 
of conclusions and suggestions for related future studies.  
- AMCI rigorously diagnosed in specialist settings can be considered 
prodromal for AD and the high AD progression rate in our sample 
indicates it is similarly prodromal (§6.1).  
- Our findings in AMCI that progressed to AD indicate altered and impaired 
attentional processing, leading to the conclusion that attentional deficits 
should be considered integral to AD at the stage of AMCI (§6.2).  
- In relation to episodic memory processing in AMCI, we conclude that 
executive failure and altered activation in areas outside the MTL contribute 
significantly to the characteristic amnesia (§6.3).  
- We found that rivastigmine treatment in AMCI improved attention but not 
memory, leading to the conclusion that treatment effects were task- and 
region-specific, and not sufficient to support routine treatment in AMCI 
(§6.4).  
- Our findings also lend support to suggestions that (1) pathology affecting 
areas with widespread cortical influence, such as the BFCS and locus 
coeruleus, may be central to the development of AD, and (2) that AD 
neuropathology consistently affects medial parietal areas across functional 
and structural studies (§6.5). 
- Furthermore, fMRI appears to be a valuable tool in the study of prodromal 
AD and further methodological advances will increase our understanding of 
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disease progression in AD (§6.6).  
Each of these conclusions is discussed in more detail below. 
 
6.1 AMCI as Prodromal AD 
6.1.1 AMCI 
AD continues to be the leading cause of dementia and the predicted increase in 
prevalence makes it essential to develop preventative, curative and symptomatic 
treatments. This will only be possible through better understanding of the disease 
process, from genetic- to population-level. Whilst much work has been done in 
established AD, relatively little is known about its prodromal stages. 
At present there is no single reliable biomarker for AD, which is 
unsurprising as the exact pathological mechanism remains unclear and comorbidity 
is common (§1.1.3). Even the diagnostic gold standard of autopsy has relatively 
low sensitivity and specificity. Given these limitations to the construct validity of 
AD itself, the question arises if we can identify prodromal AD reliably enough for 
rigorous scientific study. Available findings indicate that it can be identified with 
high sensitivity and specificity using specialist clinical procedures (§1.2.3). 
Moreover, the high AD progression rate in our AMCI sample over a relatively 
short follow-up period compares favourably with the most sensitive and specific 
methods published and leads to the conclusion that our methods obtained 
sufficient sensitivity and specificity to consider our AMCI sample prodromal for 
AD (§ 4.1; §5.3). Furthermore, considering the relatively short follow-up period 
and published conversion rates, it is likely that the majority of non-converters will 
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eventually progress to AD (§5.1).  We therefore conclude that our AMCI sample 
can be considered prodromal for AD and that AMCI diagnosed in specialist 
memory clinic settings, using rigorous procedures and norm-based 
neuropsychological measures, is sensitive and specific for prodromal AD whilst 
also being more practical than biochemical biomarkers. 
We were able to investigate attention and memory in AMCI that had 
progressed to clinically confirmed AD (CoAMCI), thereby eliminating the 
diagnostic uncertainty associated with participants that remained AMCI. 
Although this is not practical in all studies of prodromal AD, the different results 
compared to the larger AllAMCI group, that contained converters and non-
converters, suggest that potentially useful findings about disease progression may 
be evident in groups that are followed to confirm disease progression. 
CoAMCI were older than Controls although this did not reach statistical 
significance. The potential effects of age differences were examined by correlation 
analyses with behavioural and neurocognitive measures on which the groups 
differed significantly (§4.2; §4.5.1; §4.8.1). The only significant correlation was 
between age and global cognition (CAMCOG total) in CoAMCI and Controls, 
indicating that 12% of the difference can be attributed to age and it therefore 
accounts for less than two of the 15-point difference on CAMCOG total means. In 
the absence of any significant correlations between age and any of the 
experimental behavioural measures that differed between Controls and CoAMCI, 
we conclude that age difference is unlikely to solely account for the observed 
functional differences. 
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6.1.2 Ageing 
Controversy remains regarding the relationship between ageing, AMCI and AD. 
Distinguishing between AD and normal ageing is complicated by the lack of clarity 
on the exact aetiology of AD and ageing related cognitive decline (§1.3.2). Moreover, 
AD develops gradually and the exact time of the transition between ageing, AMCI 
and AD depends on the diagnosing clinician, not on accurate biomarkers (§1.2.2). The 
distinction between normal/healthy and disease as it pertains to AD, AMCI and 
ageing can therefore appear arbitrary at present. However, recent neuropathological 
findings indicate that AMCI and AD is qualitatively distinct from ageing (§1.3.3).  
Distinguishing between AD and normal ageing is further complicated by the 
ambiguity of prevailing definitions and concepts of disease and normality (§1.3.1). 
Both these definitions depend on prevailing cultural opinions that in turn rely on the 
influence of environmental exposure (experience, medical intervention) on a 
population’s genetic expression. In other words, these definitions and concepts appear 
to change over time as science conquers more of nature. If we take into account how 
an individual’s opinions are influenced by their environment, society and culture - all 
of which in turn evolve over time- then it becomes clear that neither normal or disease 
are fixed definitions and that both will evolve over time. I therefore conclude that, 
irrespective of the relationships between ageing, AMCI and AD, efforts to prevent 
and treat these health states will continue as long as individuals and societies 
considers them unwanted. 
It can therefore be conclude that AD is sufficiently distinct from normal 
ageing to allow separate investigation and that we can reliably identify AMCI 
prodromal for AD to do so. Furthermore, in spite of the continued debate about the 
relationship between AD and ageing and the ethical dilemmas associated with the 
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diagnosis (§3.1), diagnosing and studying reliably discernable prodromal stages of 
AD appear ethically justifiable as long as it these stages are potentially treatable. 
Furthermore, it appears necessary to study prodromal stages because it is here that AD 
progression should be arrested if it cannot be prevented. 
 
 
Future directions 
Since AMCI prodromal for AD can be diagnosed with increasing sensitivity and 
specificity, clinicians and patients will have to decide if diagnostic disclosure of AD 
should take place. Ethical considerations dictate that this should only be done if the 
stress of diagnosis can be offset by clinical gain (§3.1). At present, AD is incurable; 
however, available evidence strongly suggests that certain lifestyle choices and regular 
participation in certain activities and can reduce the risk of AD by 34% (Larson et al., 
2006). It remains to be determined if these activities provide preventative benefits 
when prescribed as treatment in AMCI. A major obstacle in studying the effects of 
activities in AMCI is the poor uptake of these activities by older adults. Therefore, a 
delivery methods that engages people in these activities long-term is required before 
their clinical potential can be assessed. Working towards this, we have a study 
underway (ThinkingFit) that examines the effects of an evidence based motivational 
approach on participant compliance with an activity program. Once satisfactory 
participant engagement has been achieved, we plan to conduct a controlled treatment 
trial of the interventions. 
 Our AMCI group and those from several other studies were numerically older 
than Controls (§4.1; §5.1). Although the effects of ageing on cognition do not appear 
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to account for the observed differences between Controls and CoAMCI in our studies, 
future work should match participants closely on age in order to control for potential 
ageing effects. 
 
6.2 Attention in prodromal AD 
Attention is impaired early in the course of AD and the first deficits are evident in 
divided attention, followed by deficits in selective and then sustained attention. 
Attention is crucial for everyday functioning and underpins almost all other cognitive 
processing and attentional deficits could therefore have widespread effects on 
behaviour. Clinical and theoretical data predicted attention deficits early in the course 
of AD and our findings lead to the conclusions that attentional processing is altered 
during selective visual and auditory attention, and impaired on visual-auditory divided 
attention in prodromal AD.  
 
6.2.1 Visual selective attention 
The status of sensory attention processing in prodromal AD had not been established 
conclusively. We studied attention processing using fMRI to determine if there are 
brain activation changes evident in AMCI. One study of attention in AMCI preceded 
our work and reported subtle behavioural deficits in selective visual attention 
(§1.5.4)(Perry and Hodges, 2003).  
Our result in CoAMCI revealed decreased activation in visual processing 
areas, and increased activation in attentional control areas (thalamic) and in non-
relevant auditory and default (MTL) areas. From this it can be concluded that basic 
visual attention processing is altered in prodromal AD. These results suggest (1) 
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failure of top-down attentional control mechanisms to sufficiently activate task 
relevant areas leading to decreased sensory cortex activation, (2) failed down-
regulation of activation in non-relevant default network and sensory areas, and (3) 
compensatory hyperactivation in attentional control areas, indicating increased 
perceived task difficulty in prodromal AD  (§5.7.1.2). Due to the prominence of AD 
neuropathology in attentional control areas and the relative sparing of sensory 
cortices, we conclude that AD neuropathology affecting attentional control areas is 
the likely cause of altered processing in AMCI. Relevant attentional control areas that 
show early AD neuropathology include the PFC, anterior cingulate, lateral parietal 
areas, BFCS and brainstem locus coeruleus (§1.2.2; 1.6.3-5). Our findings are not 
supported by behavioural data as none were collected during the task; however, 
subsequent studies of attention in AMCI support our conclusions because they 
revealed attentional impairments on attentional tasks that require selective visual 
attention (Perry and Hodges, 2003; Silveri et al., 2007; Tales et al., 2005a). 
 Deficits in selective visual attention processing can have far reaching effects 
on cognition because of the prominence and importance of vision in everyday 
activities. Furthermore, it is likely to affect many other observable cognitive processes 
and studies of higher order cognition should take this into account. Indeed, altered 
visual attention processing is evident during visual-auditory divided attention 
processing in AMCI (§5.6) and it remains to be determined if divided attention is 
impaired across non-visual modalities or only when visual attention is involved. 
  
6.2.2 Auditory selective attention 
CoAMCI demonstrated greater activation in auditory, language, attention control and 
MTL areas during selective auditory attention. Similar greater MTL and thalamic 
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activation was also seen on the visual condition discussed above and supports the 
conclusions drawn there.  
The persistence of MTL and thalamic activation changes across sensory 
modalities suggests that it may generalise to all selective sensory attention conditions, 
lending further support to the conclusions of regulatory failure and compensatory 
activation in prodromal AD discussed above. 
Furthermore, increased thalamic activation was also evident during divided 
attention (§5.6.2.2) and verbal episodic encoding in CoAMCI, leading to the 
conclusion that it is altered across several attentional conditions and likely caused by 
compensatory attentional arousal efforts during times of high attentional demand. The 
thalamus is severely affected by neuronal and synaptic loss in AD and the presence of 
taupathy in the thalamus distinguishes it from age matched controls (Paskavitz et al., 
1995). The thalamus also shows close functional connectivity with the locus coeruleus 
and nucleus basalis of Meynert that are key areas in attentional processing and that 
show early AD neuropathology (§1.6.4-5). Increased thalamic activation could be 
caused by compensatory increased cholinergic release from the BFCS, resulting in 
greater activation. Compensatory cholinergic release may in turn be driven by failed 
thalamic drive of sensory and association cortices due to local neuropathology. 
Altered thalamic activation in AMCI can therefore be due to local or distant AD 
neuropathology. Whatever the cause may be, we conclude that altered thalamic 
processing during attention appears to contribute significantly to the attention and 
memory deficits in AMCI. 
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6.2.3 Visual-auditory divided attention 
Attention is impaired early in the course of AD and divided attention appears 
particularly vulnerable. Only one study of attention in AMCI preceded our initial 
publication and this reported impaired visual selective attention. We found impaired 
divided attention in AMCI that correlated with functional activation changes in a 
manner that suggests impaired up-regulation of activation in relevant sensory and 
attention areas, and deficient down-regulation in non-relevant areas. Furthermore, 
increased activation in the thalamus correlated inversely with processing speed 
suggesting disconnection between midbrain-thalamic  areas that drive attention and 
cortical areas that process stimuli, in other words failed compensatory attentional 
control efforts. Increased thalamic activation was also evident on selective visual and 
auditory attention and episodic encoding, indicating that it contributes to functional 
and behavioural impairments across several tasks in prodromal AD, and the 
conclusions related to these findings have been discussed above (§6.2.2). 
 Our initial publication reported impaired divided attention and the behavioural 
and functional findings from this study have since been replicated in AMCI using 
PET imaging and a task using visually presented line drawings and auditory presented 
Finnish town names (Dannhauser et al., 2005; Laine et al., 2008). Divided attention 
deficits have also been found in AMCI with impairment in other cognitive domains 
(AMCI-multiple domain) and results indicate a gradual decline in divided attention as 
AD progresses (Belleville et al., 2007). Taken together, these findings lead to the 
conclusion that divided attention is impaired in prodromal AD and that the supposedly 
isolated amnesia in AMCI is in fact accompanied by attentional deficits. These 
behavioural and functional changes could be used as early markers of AD 
neuropathology. Clinical studies will be required to determine the diagnostic and 
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predictive value of divided attention in elderly patients complaining of amnesia, and 
we are in the process of setting up such a study (§6.6.7). Based on our results, divided 
attention may be used as an additional marker of AD neuropathology that can be 
measured to study the effects of new treatments for AD. 
Finding impaired divided attention in AMCI is of further importance for 
patient safety as even minor deficits in divided attention can affect performance on 
tasks such as driving that make high demands on divided attention. Deficits on tasks 
requiring working memory and executive control have also been reported in AMCI 
(Bozoki et al., 2001; Traykov et al., 2007). Findings of executive deficits may also 
have bearing on cognitive rehabilitation efforts in AMCI because executive deficits, 
including impaired divided attention, correlate closely with deterioration in activities 
of daily living, whereas isolated progressive amnesia does not (§1.6.2)(Bisiacchi et 
al., 2008; Royall et al., 2004; Royall et al., 2005). The association between memory 
deficits and impaired activities of daily living is mediated via executive failure, 
illustrating the pivotal role of executive control in everyday activities. Therefore, 
cognitive rehabilitation that targets executive control may be more effective than 
memory training at maintaining functional independence in AD. Deficits in executive 
control and attention in AMCI may also partly explain impairments reported in other 
cognitive domains such as semantic memory, naming, digit span and verbal fluency 
(Bennett et al., 2006; Dudas et al., 2005).  
 
Summary 
Attentional performance and processing is impaired in AMCI prodromal for AD. The 
clinical conceptualisation of AMCI as comprising isolated amnesia is therefore 
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inaccurate. Selective sensory attention processing appears altered in AMCI and it may 
play a more prominent role in the symptomatology of prodromal AD. 
Divided attention performance and cortical processing is impaired in 
prodromal AD, suggesting failed cognitive regulation and compensatory efforts. 
These changes appear in areas know to be affected early by AD neuropathology and 
support disease models proposing that widespread altered cortical processing is 
caused by pathology in a few key areas that are particularly vulnerable to AD 
neuropathology. 
 
Future directions 
Considering the relationship between memory and divided attention, the assessment 
of patients with AMCI will need to include sensitive behavioural measures of divided 
attention for a coherent picture of cognitive impairment to emerge at this stage. 
Impaired visual processing during divided attention can affect a broad range of 
everyday activities due to the predominance of visual processing in humans and it 
may be this dependence on visual information that renders it more vulnerable to 
neurodegeneration. We want to explore the relationships between memory and 
attention and visual attention and everyday activities further and we therefore plan to 
include the divided attention task in our standard clinical battery. 
We have also been approached by a commercial group interested in including the 
divided attention task in their computerised cognitive assessment for dementia 
research. This will require acquiring data on the task in a large cohort to establish 
clinical norms. This can be conducted using our established memory clinic patient 
cohort and controls from relatives that attend the clinic with patients.  
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We also plan to include a behavioural measure in the basic visual-auditory 
processing paradigm for future research. This would require the use of different 
stimuli such as abstract images and sounds that minimises automatic semantic 
elaboration, followed by a post-test recognition task that provides the behavioural 
measure. This should allow compliance monitoring and correlations with cortical 
activation. This project is suitable for a master’s degree and will be offered at the 
Institute of Psychiatry, King’s College, London. 
Available evidence suggests that altered cognitive processing of attention may 
precede behavioural impairment, similar to that demonstrated in healthy younger 
adults at increased genetic risk of AD (Bookheimer et al., 2000; Johnson et al., 2006b; 
Smith et al., 1999). Indeed, we have recently demonstrated altered cortical processing 
of divided attention in patients diagnosed with subjective cognitive impairment who 
are at increased risk of dementia and characterised by complaints of memory 
impairment in the absence of any abnormality on neuropsychological testing, medical 
or psychiatric assessment (Rodda et al., In press). These patients are being followed 
long term to determine if they progress to dementia so that we can correlate activation 
with clinical outcomes. 
 
 
6.3 Verbal episodic memory in prodromal AD 
Amnesia is characteristic of AD and AMCI and has largely been ascribed to 
neuropathology in the MTL. In clinical settings, memory is tested with verbal 
memory tasks; however, few functional neuroimaging studies have examined 
verbal memory in a manner that resembles clinical practice and most research 
studies have focused on the MTL areas and visual memory. The whole-brain 
neural correlates of verbal episodic amnesia in AMCI therefore remained to be 
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determined. Available findings indicate paradoxical correlations between MTL 
activity and memory performance in AMCI: increased activation associates with a 
higher risk of rapid decline. Away from the MTL, recent findings from functional 
neuroimaging studies have highlighted the role of the PFC in normal memory 
processing and our methods were optimised to study the whole brain and 
particularly the PFC and executive processing in AMCI.  
AMCI had impaired verbal episodic memory performance and results 
revealed evidence of semantic processing deficits during encoding leading to the 
conclusion that executive failure contributes substantially to verbal episodic 
amnesia in prodromal AD (§5.8). Poor episodic memory performance correlated 
with increased activation in several areas including the medial parietal default 
mode network area (discussed below in §6.5), thereby suggesting failed cognitive 
down-regulation of non-task relevant areas. Decreased activation was evident in 
the PFC that is key to semantic processing in AllAMCI but not CoAMCI and this 
suggests that PFC dysfunction precedes the more widespread abnormalities found 
in the more severely affected CoAMCI group that progressed to AD. It also 
supports the notion that activation changes are non-linear in AD progression 
(§5.8.2.2)(Celone et al., 2006). Demonstrating executive failure in AMCI accords 
with findings indicating that deteriorating everyday activities, which precipitates 
the clinical dementia syndrome, correlate strongly with progressive executive 
deficits but not amnesia (Rapp and Reischies, 2005; Royall et al., 2004; Royall et 
al., 2005). Executive failure in AMCI therefore foreshadows that seen in the mild 
dementia that follows as the disease progresses. Based on our findings of altered 
activation in several areas outside the MTL, it can be also be concluded that 
studies of episodic memory should examine the whole brain if a coherent picture 
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of memory processing is to emerge. 
We also demonstrated impaired divided attention that can contribute to 
memory processing deficits due to the reciprocal relationship between divided 
attention and memory processing (§1.6.1). Our findings support this notion as we 
found close correlations between episodic memory and divided attention 
performance in CoAMCI. Impaired divided attention during memory processing 
therefore likely contributes to the clinical presentation of prodromal AD. 
 
Summary 
At the time when these experiments were designed, little was known about the 
functional correlates of the characteristic verbal episodic memory impairment in 
AMCI and we were first to demonstrate the contribution of failed semantic processing 
and associated prefrontal cortex (PFC) dysfunction (Dannhauser et al., 2008). These 
findings are commensurate with those from a study of visual episodic memory in 
AMCI (Mandzia et al., 2007). Based on our results and the available findings it can be 
concluded that executive processing deficits contribute significantly to amnesia in 
prodromal AD at the stage of AMCI. This is associated with altered activation in 
areas outside the MTL indicating that neuropathology outside the MTL is partly 
responsible. Furthermore, the correlations between attention and memory 
performance indicate a central role for executive failure in the clinical presentation of 
AMCI. The disease mechanisms that may underpin executive failure are discussed in 
more detail below (§6.5).    
 
Future directions 
 342 
The associations between executive failure on attention and memory tasks and altered 
activation in several brain areas support the notion that neuropathology affecting brain 
areas that have widespread cortical influence may be pivotal in the development of 
AD. We have seen that neuropathology in the BFCS and locus coeruleus can affect a 
wide range of cognitive processes and that these areas are particularly vulnerable to 
AD neuropathology, and this is discussed in more detail below (§6.5).  The precise 
contributions from neuropathology in these areas to altered brain metabolism remains 
to be determined; however, it is beyond the reach of current functional neuroimaging 
techniques due to their locations and relatively small sizes. However, considering the 
success of deep brain stimulation to restore function in brain disorders such as 
Parkinson’s disease, obsessive compulsive disorder and depression, and the potential 
it may hold for the treatment of AD, it appears relevant to clarify the functional 
connectivity between key areas affected in prodromal AD (Barnikol et al., 2010; Kuhn 
et al., 2010). 
Episodic memory can be improved by supporting semantic elaboration during 
encoding and this can be used to develop behavioural programs and environmental 
support to treat the amnesia. We have included semantic elaboration support 
techniques in our ThinkingFit study that examines the effects of evidence based 
motivational interventions on compliance with health promoting activities in MCI. 
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6.4 ACEI treatment in Prodromal AD 
Our evaluation of rivastigmine treatment on attention and memory processing in 
AMCI revealed significant behavioural effects only on attention and these were 
accompanied by functional changes that suggest enhanced cortical processing.  
 
6.4.1 Visual and auditory selective attention 
FMRI can be used to examine the effects of medication on brain activation; however, 
it should be kept in mind that drugs may not only effect the signal of interest (BOLD) 
via neurovascular coupling but also non-specific local and global blood flow. 
Potential confounding effects from non-specific regional blood flow changes can be 
controlled by employing tasks during fMRI (paradigms) that contrast active 
conditions which would be equally effected by non-specific blood flow changes, 
rather than one active condition subtracted from a baseline resting condition (Thiel, 
2003). We studied the effects of rivastigmine treatment in AMCI on selective visual 
and auditory attention processing to determine if treatment effects are generalised or 
specific to attentional conditions and task related areas. Results revealed treatment 
effects in task related areas and suggest enhanced cognitive regulation during 
selective visual and auditory attention task (§5.11.2-3). Treatment effects occurred 
during each attentional condition in areas that overlapped minimally across the visual 
and auditory conditions; moreover, there was minimal overlap with areas 
demonstrating treatment effects on the divided attention task (Tables 35, 39, 42). The 
absence of behavioural data precludes any firm conclusions on the effects of ACEI 
treatment on selective attention processing in AMCI; however, our results suggest 
enhanced cognitive regulation similar to that evident on divided attention discussed 
below.  Taken together, these findings lead to the conclusion that the effects of ACEI 
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on attention is task and region specific as it occurred in task related areas and on tasks 
contrasting active conditions.  
 
6.4.2 Divided attention 
We studied the effects of ACEI treatment on divided attention in AMCI. Attention 
depends on intact cholinergic neurotransmission and it is impaired in AMCI where 
AD neuropathology affects the BFCS that provides cholinergic input to the brain. 
Attentional deficits in AMCI are therefore potentially responsive to increased synaptic 
Ach following ACEI treatment.  
Rivastigmine treatment increased visual and auditory attention processing 
speed during divided attention and this was associated with decreased activation in 
participating sensory and executive processing areas (§5.10.3; 5.10.4.3). These 
findings lead to the conclusion that improved signal-to-noise ratios in sensory areas 
following ACEI treatment reduced the need for top-down regulatory processing in 
executive areas, resulting in reduced activation. This conclusion is in line with those 
from ACEI treatment trials in healthy adults and AMCI and supported by the 
identification of the proposed functional circuits in animal models (Bentley et al., 
2004; Furey et al., 2000; Furey et al., 1997; Goekoop et al., 2004)(§1.7.5). ACEI 
treatment therefore appears to benefit divided attention in prodromal AD. 
 The clinical relevance of these results remains to be determined. Meta-
analyses of treatment efficacy for the available ACEIs (rivastigmine, donepezil, 
galantamine) have revealed (1) modest effects on global cognitive measures in AD, 
but none specific to attention, and (2) no effects on cognition in AMCI (Birks, 2006; 
Birks and Melzer, 2000; Loy and Schneider, 2004; Raschetti et al., 2007). 
Furthermore, current national clinical guidelines based on available findings do not 
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recommend ACEI treatment in AMCI and recent studies suggest that side effects may 
be more serious and common than initially believed (Gill et al., 2009; NICE, 2006 
(Amended 2007, 2009)). Trials of ACEI treatment in prodromal AD may therefore be 
appropriate to study disease mechanisms whilst the available evidence does not 
support routine treatment.  
 
6.4.3 Verbal episodic memory 
ACEIs are colloquially known as drugs that enhance memory in AD but this is not 
supported by available evidence that reveal no benefit to episodic memory, and that 
emerged after the experiments reported on in this thesis were initiated, (Birks, 2006; 
Birks et al., 2000; Birks et al., 2009; Loy and Schneider, 2006). Meta-analysis of 
ACEI treatment in AMCI also failed to demonstrate beneficial effects on episodic 
memory (Birks, 2006; Birks et al., 2000; Birks et al., 2009; Raschetti et al., 2007). 
Our results are in line with these findings and we conclude that rivastigmine treatment 
has no apparent effects on verbal episodic memory in prodromal AD (§ 4.11.1). These 
findings suggest that improved divided attention does not result in better episodic 
memory following ACEI treatment in AMCI.  
 The lack of treatment efficacy is likely due to the faulty assumption, that 
cortical cholinergic inputs have predominantly tonic activity, whereupon the treatment 
rational is based (§1.7.5). The complex neuronal systems that underpin episodic 
memory are unlikely to operate via tonic activity and increased synaptic Ach is 
therefore unlikely to compensate for the loss of presynaptic neuronal function. It 
therefore appears that further study of ACEI treatment on verbal memory in AMCI is 
not warranted. 
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Functional results were unavailable due to technical and compliance failures 
but the lack of treatment efficacy on behavioural measures and published studies 
argues against further studies.  
It can be concluded from the disproportionate number of technical and 
compliance failures on the recognition task that it requires revision (§4.3). 
 
Summary 
From our results and published findings, it can be concluded that ACEI treatment 
improves attentional processing in prodromal AD and that this appears task- and 
region- specific. Our findings further illustrate the potential of fMRI to investigate 
subtle treatment related changes not evident on conventional behavioural assessments.  
Our findings on episodic memory support the general consensus that ACEI treatment 
does not benefit memory in prodromal AD. Taken together these results suggest a 
very limited scope for further study of ACEI in prodromal AD and do not support 
routine treatment. 
 
6.5 Disease Mechanisms in AD 
The aetiology of the sporadic form of AD remains unclear and the characteristic 
lesions (amyloid/senile plaques, neurofibrillary tangles, vascular lesions) of the three 
leading hypotheses most often appear together (§1.1.2). The presence of these lesions 
in key areas early in the course of AD has lead to proposals that impaired functional 
connectivity to and from key areas promote AD neuropathology elsewhere, causing 
cognitive deficits. At present, the BFCS and locus coeruleus appear to be prime 
candidates for promoting neuropathology due to the early appearance and gradual 
accumulation of AD neuropathology in these areas that are pivotal in regulating 
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cognition, as demonstrated by the (1) consequences of local lesions to memory and 
attention performance and (2) close correlations between pathological load and 
cognitive performance (§1.1.2; §1.1.3.2). Functional neuroimaging of brain disorders 
can reveal altered cortical activation and functional connectivity that indicate 
compensatory or failed cognitive processing caused by neuropathology. Findings 
from functional neuroimaging studies can therefore support neuropathological 
hypotheses of disease causation (§1.1.3.3). Our results support hypotheses related to 
disease processes in the BFCS, locus coeruleus and medial parietal default network 
area, and these are discussed in more detail below. The potential contributions to 
widespread cognitive impairment from neuropathology in the BFCS and locus 
coeruleus are illustrated in Figure 29.  
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Figure 29 Disease mechanisms in AD. 
The figure illustrates the pivotal role that the BFCS (BFCS; blue arrows) and locus 
coeruleus (LC; Green arrows) play in cognitive regulation and demonstrates how 
lesions of these structures can cause the range of cognitive deficits evident in AD.  
The BFCS provides acetylcholine to the cortex and hippocampus (HC) whilst the 
locus coeruleus provides noradrenaline to the BFCS, cortex, thalamus (Thal) and 
hippocampus. Afferents connections from both these areas contribute to executive 
functioning via their connectivity with the executive network that comprises the PFC, 
anterior cingulate (AntC) and parietal cortex (Par). The executive network optimises 
memory and controls attention, and both appear impaired in prodromal AD suggesting 
that an underlying mechanism that can impair executive functioning, such as BFCS or 
locus coeruleus lesions, may contribute or cause the memory and attention deficits. 
(PostC = posterior cingulate) 
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6.5.1 BFCS lesions and the cholinergic hypothesis of AD 
The BFCS is the major source of acetylcholine in the brain and provides its primary 
cholinergic input to the hippocampus and entorhinal cortex, and it also projects to all 
neocortical areas and the amygdala (§1.6.4). It is therefore pivotal in cognitive 
regulation throughout the brain and experimentally induced lesions cause memory and 
attention deficits in the absence of other lesions (§1.7.1). BFCS lesions may therefore 
explain memory, attention and other cognitive deficits in AD and AMCI because they 
interrupted functional connectivity with relevant brain areas. Cholinergic 
neurotransmission is prominently affected in AD and findings indicate that AMCI and 
AD are associated with reduced cholinergic innervation and receptors on the 
background of very early pathology in the BFCS.  
Impaired divided attention and altered cortical processing of divided and selective 
attention evident in AMCI indicates impaired attentional regulation, occurring across 
attentional conditions, suggesting interrupted cholinergic innervation from the BFCS 
to key areas (§5.6.1). Correlations between activation and attention performance, 
evident from our results, support this notion of attentional regulation via activity in 
key areas (§4.5.2.3). Further support for a disease mechanism involving a generalised 
process comes from the positive correlations between memory and attention deficits 
that indicate the presence of an overlapping disease mechanism, such as BFCS 
pathology (§4.8.1; §5.8.1). We therefore conclude that our behavioural and functional 
results support the cholinergic hypothesis in prodromal AD; however, confirmatory 
studies will need to examine the functional connectivity between the BFCS and 
cortical areas directly and this will require advances in fMRI methodology due to the 
location and small size of the BFCS nuclei. 
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6.5.2 Locus coeruleus lesions and noradrenergic neurotransmission deficits 
The findings discussed above that support a central role for BFCS lesions in the 
progression of AD similarly apply to the locus coeruleus; furthermore, whilst our 
methods were not optimised to study BFCS activity, altered activation was evident in 
the locus coeruleus. AD neuropathology in the locus coeruleus has long been 
implicated in the pathogenesis of AD and the inevitable prominent neuronal loss and 
reduction in brain noradrenaline levels caused by NFTs, which correlate inversely 
with cognitive performance, strongly suggest that it affects cognition in AMCI 
(§1.6.5). The extensive neuronal loss in the locus coeruleus correlates closer with 
disease progression than BFCS cholinergic cell loss and it has been suggested the 
locus coeruleus lesions may precede and contribute to BFCS lesions in AD (Heneka, 
2009). Furthermore, cholinergic release from the BFCS appears to be modulated 
directly from the locus coeruleus. The locus coeruleus is the sole source of 
noradrenaline to the neocortex, cerebellum, hippocampus and most of the thalamus 
and it regulates attention, arousal, and stress reactions related to environmental 
challenges. Locus coeruleus lesions impair learning in animal models, exacerbate the 
amnestic effects of cholinergic lesions and result in cognitive and metabolic changes 
characteristic of AD. Lesions in the locus coeruleus can therefore potentially have 
widespread cortical and behavioural effects. Finding increased activation in the locus 
coeruleus during selective visual attention provides evidence of altered locus 
coeruleus function in prodromal AD, and increased activation may be due to reduced 
noradrenaline release that otherwise attenuates locus coeruleus neurone depolarisation 
(§5.7.1.2). Moreover, its pivotal role in attention and memory regulation indicates that 
local AD neuropathology could contribute substantially to cognitive impairment and 
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neuropathological findings suggest it will be affected in AMCI. It can therefore be 
concluded that our findings provide support for the proposed role of locus coeruleus 
lesions in prodromal AD. The locus coeruleus has reciprocal connections from other 
brain areas that may affect activity in AMCI and connectivity studies will be required 
for further clarification.  
 
6.5.3 Default network dysfunction 
CoAMCI demonstrating greater activation in default network areas during divided 
attention (medial parietal; §4.5.2.2), selective auditory attention (MTL. §4.6.2.2), 
verbal encoding (posterior cingulate; §4.7.2.2) and recognition (medial parietal, 
§4.8.2.2). Furthermore, failed deactivation in these default areas correlated with 
performance decrements on attention and memory tasks and neurocognitive measures 
(Table 14, Figures 16, 17). Moreover, these changes were evident in the CoAMCI 
group that progressed to AD but no in the AllAMCI group that was less impaired and 
included non-converters. From these results, it can be concluded that increased default 
mode network activity, i.e. failed deactivation, correlates with cognitive deficits 
across tasks and predicts dementia conversion in AMCI.  
The default mode network is comprised of medial PFC, MTL, medial parietal, 
lateral parietal and lateral temporal areas; it is active at rest and appears to process 
inwardly directed cognitive processes (§4.5.2.2; §5.6.2.2). Outwardly directed 
cognitive processes reduce default activity and the magnitude of deactivation in the 
network correlates with task difficulty in controls (Buckner et al., 2008; Raichle et al., 
2001). Medial parietal deactivation correlates with disease severity in AMCI; less 
impaired AMCI deactivate more and decline slower, and similar findings have been 
reported in AD (Celone et al., 2006; Lustig et al., 2003; Miller et al., 2008). Default 
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mode network activation therefore appears to correlate with disease severity and risk 
of decline. Our findings support this because deactivation failure was evident in the 
CoAMCI group that progressed to AD but not in the less impaired AllAMCI group 
that included the CoAMCI and non-converters. Furthermore, the magnitude of 
activation, in other words, the severity of deactivation failure in the medial parietal 
area correlated powerfully with attention processing speed deficits in CoAMCI. It can 
therefore be concluded that our results support the notion that impaired regulation of 
default mode activity is present in prodromal AD and that its magnitude correlates 
with disease severity and predicts progression in AMCI. 
The medial parietal area appears particularly vulnerable to AD neuropathology 
as it is reduced in size and suffers accelerated atrophy that predicts progression in 
AMCI. Functional studies reveal hypoperfusion and hypometabolism which predicts 
conversion and correlates with memory deficits  (for a review see (Ries et al., 
2008))(Xu et al., 2007). Furthermore, amyloid deposits are concentrated in default 
mode network areas in AD and it remains to be determined if this is cause or effect of 
altered default network processing (Buckner et al., 2005; Jack et al., 2008; 
Kemppainen et al., 2007; Lowe et al., 2009). 
Functional and structural neuroimaging studies of AMCI and AD consistently 
reveal abnormalities in the medial parietal area; however the direction of altered 
functional activation appears inconsistent as resting state studies show decreased 
activity and studies using activation tasks show failed deactivation that correlates with 
performance decrements. These disparate findings could be caused by functional 
isolation of default network areas due to lesions affecting neurovascular coupling and 
connectivity with other areas. Neurones in a disconnected default network could 
depolarise at relatively stable rates therefore appearing altered in a specific direction 
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in comparison with controls depending on the experimental condition i.e. resting-state 
or active tasks. Taken together, these findings suggest that in prodromal AD cognitive 
regulation is impaired and causes maintained activation in the default mode network 
that could hinder processing, across cognitive tasks, in task relevant areas due to 
resource limitations. 
 
Summary 
Our results indicate widespread alterations to cortical processing in prodromal AD 
that correlate with behavioural measures on attention and memory tasks. These 
findings, that are present across tasks and conditions, support aetiological hypotheses 
proposing that AD neuropathology may arise in, and be perpetuated from key areas 
that regulate cognitive processing in a wide range of areas, and affecting a wide range 
of cognitive functions. Pathological findings indicate that lesions are already evident 
in the BFCS in AMCI and strongly suggest their presence in the locus coeruleus in 
AMCI. Lesions in these two areas could therefore cause the deficits seen in prodromal 
AD and these deficits in cognitive regulation may explain the persistent findings of 
structural and functional changes observed in default mode network areas, in 
particular the medial parietal areas. The explanatory models for altered cognitive 
processing in AMCI differ and it is not implied that one mechanism will be 
responsible for the functional changes reported, indeed it is more likely that several 
mechanisms contribute and that they interact although there may be a primary 
initiating disease mechanism as AD. 
 
Future directions 
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The BFCS and locus coeruleus are pivotal in cognitive regulation but they are 
difficult to study with fMRI due to technical constraints. However, improved 
resolution in these areas can be achieved with optimised scanning sequences and we 
plan to implement these in future studies in order to determine if the proposed 
changes to functional connectivity with areas of abnormal activation is present. 
Altered functional connectivity between the BFCS, locus coeruleus and default mode 
network areas is of particular interest as it may explain disease progression in AD. For 
example, the medial parietal areas receive their cholinergic inputs via the medial 
cholinergic pathway from the BFCS and are the most distant supplied via this 
pathway (Selden et al., 1998). Functional and structural changes could therefore be 
related to interrupted cholinergic innervation first affecting the most distant areas 
(§1.6.4). This notion is supported by recent findings demonstrating microstructural 
pathology in the posterior cingulate, that distinguished AMCI from non-AMCI 
subjects with sensitivity of 80% and specificity of 60%, and connectivity studies are 
therefore necessary to correlate structural and functional data (Chua et al., 2009).  
 
6.6 fMRI in AMCI 
 
6.6.1 AMCI sample 
It appears that fMRI is a valuable tool for studying the neural correlates of AD 
neuropathology and for evaluating interventions. Further advances in the clinical 
identification of prodromal AD, such as the refinement of MCI with low specificity 
for AD to AMCI with high specificity, has aided the interpretation and 
generalisability of results to clinical samples. However, further challenges to data 
interpretation remain and include the uncertain effects of comorbidity and varying 
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methodology that limits comparisons between studies. Furthermore, AMCI is a health 
state that is associated with relatively rapid changes in cognitive processing, that 
appears to proceed from a compensated to a decompensated state with different 
functional neuroimaging characteristics. Matching samples on their stage of 
progression may therefore require even further sub-classification based on their 
progression, similar to our CoAMCI stratification that was based on progression to 
AD (§4.1; §5.1).  
 
6.6.2 Sample size 
We studied a relatively small but highly selected AMCI sample rather than a larger 
more heterogeneous MCI sample, as the former is more likely to represent prodromal 
AD. Although our sample was relatively small, our results indicate a high rate of 
progression to AD over a short follow-up period and therefore, the loss of detection 
power associated with smaller samples is balanced by the higher homogeneity of the 
sample, achieved by our diagnostic methods. Ten to 15 participants per group was 
acceptable for fMRI experiments when we started the study and the number generally 
recommended has now increased to 15 to 20 participants, with improved 
reproducibility of findings demonstrated for groups up to 25 (Thirion et al., 2007). 
Smaller groups suffer more from the effects of outliers that can cause atypical 
findings; however, whilst detection power (sensitivity) for activated areas is reduced 
in small samples because some activated areas may not reach the set level of 
significance, the specificity of activation is rigorously controlled for by our statistical 
methods. On the other hand, reduced sensitivity due to smaller sample size is balance 
by the implementation of local permutation that increases detection power of group 
differences (3.4.8.6). The task related activation results revealed by our paradigms are 
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in line with published findings, leading to the conclusion that our analyses methods 
and sample sizes were adequate to test our hypotheses. However, our sample sizes 
were too small to accommodate the data loss that occurred and which rendered it 
impractical to analyse the recognition task data from the rivastigmine treatment study. 
This is not a serious limitation because our behavioural data and meta-analysis of 
ACEI treatment failed to show beneficial effects on memory; however, it does 
highlight the need for larger sample sizes to allow for data loss in future studies 
(§1.7.4). 
 
6.6.3 Divided attention paradigm 
Ideally, behavioural performance on a divided attention task - which conceptually is a 
dual-task that does not require additional processing of stimuli apart from target 
recognition - would be measured by calculating the composite dual-task decrement 
(Baddeley and Della, 1996; Nebes et al., 2001). To calculate this, subjects first 
perform each of the two sub-tasks separately to measure performance. The dual-task 
is then performed. The difference in reaction time during dual-task performance and 
sub-task performance is then calculated for each of the two sub-tasks, and difference 
scores are then added together to give a composite total. This allows for individual 
differences where subjects prioritise one of the sub-tasks. Our divided attention task 
did not measure performance on the sub-tasks separately due to time and design 
constraints during fMRI. It is likely that this reduced detection power for differences 
in performance. Our current methods could be altered to include the two sub-tasks of 
the divided attention task.  
A parametric design for the divided attention task could have revealed more 
about areas where AMCI patients show attenuated activation and areas where 
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treatment is most effective. To implement this, we have already modified the task to 
include distractor items for the visual stimuli and degraded sound for the auditory 
stimuli, and pilot data collection on this task is planned for the near future. 
 
6.6.4 Visual and auditory selective attention paradigm 
This paradigm was included to study selective visual and auditory processing and the 
effects of ACEI treatment in AMCI. Although it appears suitable for these purposes, it 
may not be ideal. Auditory word stimuli automatically trigger a degree of semantic 
processing (recall of related items) during identification and this likely leads to 
activation in non-sensory areas that can complicate data interpretation. A more ideal 
task would use abstract sounds to minimize automatic semantic processing. We have 
already adapted the task along these lines and are planning to use it in future fMRI 
studies of attention. 
We did not collect behavioural data during the passive visual-auditory 
processing paradigm. Behavioural data could be used to confirm compliance with task 
instructions and aid in interpreting the decreased visual cortex activation evident in 
the AllAMCI group across auditory and visual selective attention conditions. Future 
studies are needed to clarify this because altered basic attentional processing will 
likely affect processing on any experimental task dependent on sensory attention, 
thereby affecting data interpretation. Connectivity analysis could reveal the extent to 
which altered functional activation in higher cortical areas relate to altered activation 
in visual cortex. 
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6.6.5 Encoding paradigm 
The encoding task was well tolerated and functional and behavioural data revealed the 
contribution of semantic deficits and altered activation outside the MTL in prodromal 
AD. It is therefore a useful and practical measure of verbal episodic memory encoding 
and we plan to continue using it in future. 
 
6.6.6 Recognition paradigm 
Most data were lost on the recognition task that was presented last and it may be due 
to participant fatigue. Presenting the task and analysing behavioural and functional 
data according to our methods may therefore not be suitable in AMCI. Presenting the 
task earlier in sessions could reduce participant fatigue. Collapsing specific response 
types into more general types and including more stimuli could overcome analysis 
problems. 
All participants showed increased FAR at follow-up suggesting that the two versions 
of the task are not matched on difficulty although session effects may also be 
responsible. Reversal of the two versions can help to clarify this and can be done 
outside the scanner. 
 
6.6.7 Data Analysis 
Although fMRI has revolutionised neuropsychiatric research, it should be kept in 
mind that the BOLD signal is a proxy of cognitive processing and balanced 
scepticism should be maintained when interpreting results (Ekstrom, 2010). It is 
therefore desirable to seek conformation of conclusions from several independent 
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lines of enquiry, and fMRI findings are strongly supported by concomitant 
behavioural correlations. 
FMRI has proven useful to study normal and abnormal cognitive processing in 
groups but has found very limited clinical application for individual patients. This is 
set to change with the development of machine learning that allows classification of 
data from individuals.  With this method, fMRI data from an individual can be 
compared against standardised sets and a probability calculated for each possible 
diagnosis e.g. the probability of a patient having a specific disorder could be 
determined. Machine learning can be applied to any aspect that affects brain 
activation such as diagnosis, prognosis and treatment response, as long as 
standardised data sets are available. We are in the process of setting up collaborations 
to determine if machine learning applied to our existing data will have sufficient 
predictive power to determine the risk and rate of progression of AD in individual 
patients. 
We used an advanced fMRI analysis method that is more sensitive in brain 
areas where there is relatively smaller signal. This method and the exclusion of one 
subject who was subsequently diagnosed with dementia with Lewy bodies revealed 
different functional results to what we initially reported on divided attention in AMCI 
(§6.2.3). We take the latter results as more accurate and this is supported by 
significant activation-behaviour correlations that were not evident on the initial 
analysis. However, our initial result has been replicated using PET imaging, although 
it did not involve a similar more sensitive analysis method, and the results reported in 
this thesis await replication.   
One of the important advantages of functional neuroimaging is its potential to 
reveal altered brain function or treatment related changes in relatively small samples 
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compared to traditional behavioural studies. Furthermore, the cognitive paradigms 
used during functional neuroimaging are typically computer presented which reduces 
operator bias and allows the use of more sophisticated and sensitive behavioural 
measures, that in turn reduces samples sizes and therefore cost and participant 
exposure. On the other hand, studying smaller samples requires exceptional diagnostic 
rigor to reduce aetiological heterogeneity in samples, and this is aided by sensitive 
and specific measures. Even with these methods, larger samples may be desirable to 
allow for some pathological heterogeneity and for attrition of participants that are 
followed longitudinally to determine AD conversion rates and confirm prodromal AD 
retrospectively. Ideally, follow-up should continue to autopsy to allow 
neuropathological confirmation of AD and we could implement this as an extension 
of an existing brain donation program. 
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7. Personal Contributions 
Functional neuroimaging studies involve close collaboration amongst a 
multidisciplinary group of researchers due to the variety of clinical and technical 
skills required. The work reported in this thesis involved such collaboration and the 
key contributors have been named in the Acknowledgments. My personal 
contribution to this work is detailed below. 
 
7.1 Protocol Development, Preparation and Ethical Approval. 
I developed and finalised the study protocol from a draft drawn up by my supervisors. 
I submitted and presented it to the local ethics committee and dealt with all necessary 
amendments. I prepared and submitted annual progress reports and gave notification 
of the end of study to the ethics committee. I secured Research and Development 
committee approval from the local NHS trust for the study.  
  
7.2 Participants and Memory Clinic Procedures 
I recruited all research participants and obtained their consent. I regularly assessed 
and reviewed patients in the memory clinic from where participants were recruited. I 
have continued to monitor the progress of patients in the memory clinic. During the 
study, I initiated and monitored rivastigmine for treated patients as per protocol. I 
trained all participant on the cognitive tasks in preparation for the experiments and I 
arranged transport and accompanied them to and from the Institute of Psychiatry 
where scanning took place. At the scanner, I assessed and provided participants with 
fMRI compatible prescription glasses and assisted in participant placement in the 
scanner. 
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7.3 FMRI Scanning Procedures and Data Analysis 
I ran all the cognitive paradigms during scanning whilst a radiographer operated the 
scanner. I recorded and archived all behavioural data during scanning. After receiving 
training in the XBAM fMRI analysis package, I archived and analysed all of 
experimental data and prepared it for presentation and publication.  
 
7. 4 Cognitive Paradigms 
I designed the divided attention task under supervision of S, Shergill and M. Seal and 
conducted all of the pilot studies. C. Andrews programmed the task and assisted in 
designing the response box. Neuroimaging parameters were calculated and provided 
by the Neuroimaging Research Group, under supervision of F. Zelaya. I adapted the 
encoding and recognition paradigms for our study. 
 
7.5 Statistical Analyses of Behavioural Data and Correlations with 
Functional Data. 
I prepared data and conducted all statistical analysis reported in this thesis. For this 
purpose, I created Excel spreadsheets that performed the initial calculations to prepare 
data for statistical analysis for the divided attention task, and I modified an existing 
spreadsheet to do the same for the recognition task.  
 
7.6 Procurement and Technical Maintenance of Equipment 
I procured all the computer equipment required for the study, installed software and 
performed maintenance procedures as required.  
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7.7 Manuscript Preparation and Data Presentation 
I authored this thesis, all oral and poster presentations, and all of the published 
manuscripts related to this study. I received editorial input from my supervisors and 
Dr R. Walker. 
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